Q1: When considering foundational concepts from the context, which statements best reflect the mechanistic relationship between gut microbiota, their metabolites, and immunological changes in Alzheimer's disease under altered microbiota composition?
Options:
A: The gut microbiota only influence neuroinflammation in AD by directly interacting with brain-resident immune cells, rather than through peripheral immune modulation.
B: Modulating gut microbiota composition may alter ongoing inflammation in AD, except when microbial metabolites are unable to affect brain-resident immune cells.
C: Central immunological changes in AD directly cause alterations in gut microbiota composition, while peripheral immune cells are unaffected by microbial metabolites.
D: Altered gut microbiota composition in AD can induce both peripheral and central immunological changes through the release of microbial metabolites, although the precise regulatory mechanisms remain unknown.

Q2: When considering foundational concepts of gut microbiota-mediated inflammatory pathways in Alzheimer's disease, which of the following statements accurately reflect mechanisms or regulatory effects described in the context, except when the temporal sequence of metabolite action is reversed?
Options:
A: The gut microbiota can regulate Alzheimer's disease progression both directly and indirectly through inflammatory pathways involving lipopolysaccharides and amyloid peptides.
B: Short-chain fatty acids and branched amino acids produced by gut bacteria act as metabolites that mediate the inflammatory effects of gut microbiota on Alzheimer's disease.
C: Neurotransmitters and bile acids, as functional by-products of gut microbiota, are exclusively responsible for the direct regulation of systemic inflammation in Alzheimer's disease, while LPS acts only after neuronal damage has occurred.
D: Fecal microbiota transplantation, antibiotics, and dietary interventions are discussed as potential treatments for Alzheimer's disease by targeting gut microbiota-influenced inflammatory mechanisms.

Q3: In a scenario where an aged individual with established gut microbiota dysbiosis is subjected to a high-fat diet (HFD) intervention, followed by delayed administration of phytochemical-rich foods, which of the following predictions about the hierarchical sequence of gut-brain axis modulation and Alzheimer’s disease (AD) pathogenesis is most consistent with the described mechanisms and regulatory order in the context?
Options:
A: Delayed phytochemical intake after HFD may enhance the production of anti-inflammatory and neuroprotective metabolites by the gut microbiota, potentially reducing neuroinflammation and cognitive impairment in a temporally dependent manner.
B: HFD exposure in the context of gut dysbiosis will invariably worsen Aβ levels and contextual memory, regardless of subsequent phytochemical intervention or changes in gut microbiota metabolites.
C: Immediate phytochemical administration prior to HFD would directly suppress peripheral cholesterol levels, thereby preventing any subsequent changes in gut microbiota composition or neuroinflammation.
D: The initial HFD-induced alteration of gut microbiota may create a microenvironment favoring bile acid and arachidonic acid metabolism, which could moderate neuroinflammation in the AD model before phytochemical intake exerts further anti-inflammatory effects.

Q4: When considering the foundational mechanisms by which curcumin influences neuroinflammation and metabolic disorders, which of the following statements accurately reflect context-dependent regulatory effects or pathway logic described in the text?
Options:
A: Curcumin’s activation of the NRF2 pathway enhances cellular antioxidant defenses, although this effect is diminished when curcumin is not metabolized by intestinal microbiota.
B: While curcumin’s inhibition of the NF-κB pathway reduces inflammatory markers in adipocytes and macrophages, this does not directly contribute to improvements in body composition parameters.
C: The modulation of gut microbiota by curcumin, particularly at the colon level, results in derivatives with anti-inflammatory properties that may impact both metabolic and neurodegenerative disease processes.
D: Although curcumin is stable in acidic environments, its poor solubility in water and rapid metabolism in the liver and gut limit its direct systemic effects, except when combined with lifestyle changes.

Q5: If a patient with Alzheimer's disease receives a synbiotic intervention that only partially restores gut microbiota composition, while simultaneously experiencing a selective reduction in butyrate-producing bacteria, which of the following outcomes may be most consistent with the described mechanisms, assuming no compensatory increase in propionate production?
Options:
A: The intervention may initially lead to incomplete modulation of neuroinflammation, as butyrate's role in microglial activity is diminished, unless other SCFAs compensate.
B: There may be a paradoxical increase in blood-brain barrier maintenance, since propionate's effects are always beneficial in this context regardless of butyrate levels.
C: Amyloid protein formation may remain largely unaltered, unless the partial restoration of gut microbiota directly enhances butyrate-mediated interference pathways.
D: The resilience of a healthy microbiota may appear insufficient to protect against dysbiosis-related pathologies if butyrate-producing bacteria are selectively reduced.

Q6: If a scenario arises in which mannan oligosaccharide (MOS) administration is delayed until after significant gut barrier integrity damage and LPS leak have already occurred, but short-chain fatty acids (SCFAs) supplementation is initiated simultaneously, which of the following outcomes may be expected regarding neuroinflammation and behavioral deficits in the 5xFAD Alzheimer's disease mouse model, assuming no direct modulation of microglia by MOS?
Options:
A: SCFAs supplementation may still attenuate behavioral disorders and Aβ accumulation, accompanied by balanced HPA-axis and redox status, even if MOS does not directly modulate microglia.
B: The absence of early MOS-mediated prevention of gut barrier damage may limit the ability of SCFAs to fully suppress neuroinflammatory responses, unless additional microbiota-targeted interventions are applied.
C: Delayed MOS administration, without concurrent SCFAs supplementation, would be sufficient to reconstruct gut microbiota composition and prevent LPS leak, thereby fully normalizing microglia-mediated neuroinflammation.
D: Initiating SCFAs supplementation after gut barrier damage, in the absence of MOS-induced Lactobacillus increase, may appear to improve cognitive function, but is unlikely to affect HPA-axis disorders unless overridden by direct modulation of norepinephrine expression.

Q7: When considering the foundational mechanisms by which treadmill exercise influences neuroinflammation in APP/PS1 mice, which of the following outcomes would most likely occur after 12 weeks of intervention, assuming the observed changes in gut microbiota and barrier function persist?
Options:
A: Increased abundance of intestinal Allobaculum would coincide with reduced LPS displacement and attenuated neuroinflammation.
B: Enhanced intestinal barrier protein expression would be expected to limit LPS displacement, thereby contributing to reduced neuroinflammation.
C: A rise in probiotic Akkermansia populations would be associated with enrichment of gut microbial diversity and alleviation of neuroinflammation.
D: Deterioration of gut microbiota function would directly result in increased intestine-brain barrier proteins and decreased neuroinflammation.

Q8: If an aged individual with Alzheimer's disease experiences both a partial restoration of gut microbiome homeostasis via probiotics and a persistent increase in pro-inflammatory bacteria, which of the following outcomes may be most consistent with the described gut-brain axis mechanisms?
Options:
A: Microglia morphology and function may remain altered due to ongoing age-related microbiota changes, despite some mitigation of neuroinflammatory responses by probiotics.
B: The production of microbial metabolites from residual dysbiosis may continue to influence blood-brain barrier permeability, unless overridden by complete microbiome normalization.
C: Beneficial modulation of immune responses by probiotics may appear to reduce neuroinflammation, but age-related cognitive decline will be reversed only if microglia function is fully restored.
D: Reinforcement of intestinal barrier integrity by probiotics will fully compensate for the effects of persistent pro-inflammatory bacteria on neurodegeneration.

Q9: When considering the foundational mechanisms by which indole-3-propionic acid (IPA) ameliorates cognitive deficits in LPS-induced models, which of the following statements accurately reflect the regulatory direction or context-specific relevance of the RAGE-JAK2-STAT3 pathway and IPA’s actions?
Options:
A: Colivelin TFA reverses IPA’s effects by directly inhibiting RAGE, thereby restoring neuroinflammation and cognitive deficits.
B: IPA’s inhibition of the RAGE-JAK2-STAT3 pathway leads to reduced neuroinflammation, while activation of this pathway by Colivelin TFA partially negates IPA’s neurorestorative effects.
C: IPA’s neuroprotective effects are mediated by remodeling the gut microbiota and inhibiting glial cell activation, except when the JAK2-STAT3 pathway is pharmacologically activated.
D: Activation of the RAGE-JAK2-STAT3 pathway by IPA is responsible for promoting neurogenesis and maintaining BBB integrity in LPS-induced cognitive impairment.

Q10: In a scenario where APP/PS1 mice with established gut microbiota dysbiosis are first subjected to delayed administration of Agaricus sinodeliciosus var. Chaidam exopolysaccharide (EPS) and only later receive environmental enrichment (EE) without any probiotic intervention, which of the following predictions about neuroinflammatory and cognitive outcomes can be made by integrating the regulatory hierarchy from gut microbiota composition to metabolite production and microglial activity?
Options:
A: EPS-induced increases in Ruminococcaceae abundance and serotonin formation would precede microglial activation via the mTOR-HIF-1α pathway, resulting in reduced Aβ accumulation and improved cognitive function.
B: The absence of Bifidobacterium breve intervention would prevent restoration of tryptophan metabolism, thereby limiting acetate-driven reversal of microbial metabolite changes despite subsequent EE.
C: Delayed EE following EPS administration would directly upregulate aryl hydrocarbon receptor (AhR) expression, inhibiting NF-κB signaling and reducing NLRP3 inflammasome formation independently of gut microbiota changes.
D: EPS-mediated modulation of the gut microbiome would suppress neuroinflammation and cognitive deficits even without concurrent probiotic or EE interventions, due to enhanced microglial Aβ phagocytosis and serotonin-associated behavioral improvements.

Q11: When considering the foundational concept of SDG’s mechanism in female Alzheimer’s disease mice, which of the following statements best distinguishes the regulatory direction or pathway logic underlying its neuroprotective effects, particularly in relation to gut microbiota metabolism and the GPER/CREB/BDNF pathway?
Options:
A: SDG directly increases BDNF expression in the hippocampus by upregulating gut microbiota-derived metabolites, which subsequently activate the GPER/CREB pathway.
B: While SDG modulates gut microbiota metabolism, its neuroprotective effect in female AD mice is primarily mediated through the GPER/CREB/BDNF pathway rather than by direct estrogen replacement.
C: The decline of estrogen in female AD mice is reversed by SDG through direct activation of CREB, which then alters gut microbiota composition to reduce neuroinflammation.
D: Although SDG demonstrates anti-inflammatory effects, these are independent of any modulation of the GPER/CREB/BDNF pathway or gut microbiota metabolism in female AD models.

Q12: If a scenario arises in which gut microbial dysbiosis is only partially corrected by exogenous lipase administration, but the normalization of peripheral unsaturated fatty acids is delayed, which of the following outcomes may be most consistent with the described mechanisms in the context?
Options:
A: Memory deficits in APP/PS1 mice may persist despite increased abundance of Acetatifactor and Clostridiales vadin BB60 genera, due to incomplete restoration of beneficial metabolite profiles.
B: Neuroinflammation may initially decrease following partial correction of dysbiosis, unless the delayed normalization of unsaturated fatty acids overrides the anti-inflammatory effects.
C: Fecal matter transplant from treated mice may fail to ameliorate memory deficits in AIMD wildtype mice, unless protein misfolding and clearance pathways are simultaneously enhanced.
D: Increased endotoxin production may be prevented solely by the presence of exogenous lipase, regardless of the extent of gut microbiota rebalancing or metabolite normalization.

Q13: If a female Alzheimer's disease (AD) mouse model is treated with secoisolariciresinol diglucoside (SDG) to modulate gut microbiota metabolism, but the intervention only partially restores short-chain fatty acid (SCFA) production while simultaneously suppressing butyrate but not propionate, which of the following outcomes may be most consistent with the described mechanisms?
Options:
A: The intervention may attenuate neuroinflammation and cognitive impairment, unless the reduction in butyrate overrides the beneficial effects of SDG on the GPER/CREB/BDNF pathway.
B: Central and peripheral immunological changes may persist, as propionate’s ambiguous effects on AD pathways could counteract the anti-inflammatory actions of SDG.
C: Maintenance of the blood-brain barrier (BBB) integrity may be compromised, since butyrate is specifically implicated in BBB regulation, and its suppression is not compensated by propionate.
D: Amyloid protein formation will be consistently inhibited, as partial restoration of SCFAs is sufficient to interfere with amyloidogenesis regardless of SCFA subtype.

Q14: If a scenario arises in which gut microbiota-derived short-chain fatty acids (SCFAs) are only partially suppressed, while the administration of bacterial extracellular vesicles (bEVs) from specific pathogen-free AD mice is delayed, which of the following outcomes regarding Alzheimer's disease (AD) pathology and neuroinflammation may be most consistent with the described mechanisms?
Options:
A: Amyloid-β (Aβ) plaque accumulation is likely to remain reduced, as partial SCFA suppression alone is sufficient to prevent reversal of germ-free protective effects.
B: The absence of immediate bEVs exposure may transiently protect against synaptic deficits, but partial SCFA suppression could limit the extent of this protection.
C: Microglial cells may initially display a less inflammatory state and increased phagocytotic efficiency, unless the delayed bEVs administration overrides the partial SCFA suppression.
D: Neuroinflammatory processes may appear attenuated at first, yet the eventual introduction of bEVs can reverse both microglial activation and Aβ pathology, unless SCFA levels are fully restored.

Q15: In a scenario where gut microbiota dysbiosis is first induced in a genetically susceptible mouse model of Alzheimer's disease, and only after a delay is a combined treatment of tryptophan and indole-3-lactic acid (ILA) administered, which of the following predictions about the regulatory cascade from microbial composition to neuroinflammatory outcome is most consistent with the described mechanisms and temporal sequence in the context?
Options:
A: The delayed administration of tryptophan and ILA can still prevent both amyloid-beta accumulation and cognitive impairment by activating microglia and astrocytes through the aryl hydrocarbon receptor (AhR) pathway, even after initial dysbiosis.
B: Early dysbiosis-driven increases in intestinal permeability and endotoxin translocation may exacerbate neuroinflammation via TLR4 activation before the protective effects of ILA and tryptophan can be established.
C: The combined treatment of tryptophan and ILA will immediately restore the abundance of Lactobacillus reuteri in the gut, thereby directly reversing all dysbiosis-induced neuroinflammatory changes.
D: Microbiota-derived metabolites such as ILA can modulate neuroinflammation and amyloidopathy only if administered prior to any dysbiosis, as their effects are nullified by prior gut barrier disruption.

Q16: If a mouse model of Alzheimer's disease is engineered to have delayed 5-lipoxygenase (5-LO) activity and is simultaneously maintained under germ-free conditions, but then receives a partial reconstitution of gut microbiota using only bacterial extracellular vesicles (bEVs) from specific pathogen-free AD mice, which of the following outcomes may most plausibly occur, given the described mechanisms and their interrelationships?
Options:
A: Microglial cells may initially display reduced inflammatory activation, but bEV administration could override this, leading to increased amyloid-β plaque accumulation despite delayed 5-LO activity.
B: The absence of gut-derived pro-inflammatory mediators such as LPS and bacterial amyloids will fully compensate for any residual 5-LO activity, preventing neuroinflammation regardless of bEV exposure.
C: Delayed 5-LO activity alone is sufficient to prevent both neurofibrillary tangle formation and amyloid deposition, even if bEVs restore microglial activation.
D: Partial restoration of gut microbiota via bEVs may appear to protect against synaptic deficits, unless the delayed 5-LO activity accelerates tau phosphorylation independently.

Q17: If a dietary intervention in APP/PS1 mice both delays the upregulation of norepinephrine and only partially restores the abundance of the S24-7 bacterial family, which of the following outcomes may be expected regarding neuroinflammation and cognitive function, assuming no compensatory increase in TGF-β1?
Options:
A: The intervention may appear to reduce IL-1β and IL-6 levels, but the incomplete restoration of S24-7 could limit improvements in learning and memory.
B: Suppression of neuroinflammation would be maintained due to persistent upregulation of fractalkine (CX3CL1), unless overridden by the absence of TGF-β1 compensation.
C: Cognitive function is likely to deteriorate further, as partial S24-7 restoration directly increases β-amyloid accumulation in the absence of norepinephrine modulation.
D: The intervention initially leads to increased microglial activation, as delayed norepinephrine upregulation prevents the downregulation of astrocyte activity.

Q18: In a scenario where an aged mouse model of Alzheimer's disease is first subjected to gut dysbiosis through antibiotic treatment, followed by delayed administration of Armillariella tabescens-derived polysaccharides (ATEP), which of the following predictions about the hierarchical sequence from gut microbiota alteration to neuroinflammatory outcomes and hippocampal protein expression is most consistent with the described regulatory order and feedback effects in the context?
Options:
A: The initial dysbiosis would disrupt short-chain fatty acid-producing bacteria, and subsequent ATEP supplementation would restore these bacteria, leading to enhanced antioxidant enzyme activities and suppression of the Keap-1/Nrf2 pathway, ultimately improving neuronal morphology in the CA3 region.
B: Delayed ATEP administration would directly upregulate hippocampal HO-1 and NQO-1 expression, which would then induce changes in gut microbiota composition, resulting in increased production of branched-chain amino acids.
C: Early gut dysbiosis would increase blood-brain barrier permeability, and ATEP supplementation would further exacerbate neuroinflammation by promoting iNOS and COX-2 expression in the hippocampus.
D: The restoration of gut microbiota by ATEP would first normalize fecal microbial metabolites, which would then feedback to reduce oxidative stress in the hippocampus via modulation of downstream oxidation-related enzymes.

Q19: In a scenario where IPA administration is withheld in LPS-induced cognitively impaired mice, but Colivelin TFA is introduced after a delay, and simultaneously, the gut microbiota is shifted toward increased Firmicutes and decreased Bacteroidetes, which of the following outcomes are most consistent with the regulatory hierarchy and temporal sequence described in the context?
Options:
A: The absence of IPA’s inhibition of the RAGE-JAK2-STAT3 pathway, combined with a gut microbiota profile favoring Firmicutes, would synergistically worsen both neuroinflammation and cognitive impairment due to loss of both molecular and microbial protective mechanisms.
B: The delayed activation of JAK2-STAT3 signaling by Colivelin TFA would likely exacerbate neuroinflammation, as IPA’s inhibitory effect on this pathway is absent, and the Firmicutes-dominant microbiota composition further impairs the intestinal barrier, promoting neuroinflammatory processes.
C: The introduction of Colivelin TFA after IPA withdrawal would immediately restore BBB and intestinal barrier integrity, as JAK2-STAT3 activation is upstream of glial cell activation and neurogenesis.
D: The increase in Firmicutes and decrease in Bacteroidetes would directly enhance the production of beneficial short-chain fatty acids, thereby compensating for the lack of IPA and preventing cognitive deficits.

Q20: If a scenario arises in which Crohn's disease-induced intestinal inflammation is only partially suppressed, while exogenous Candida rugosa lipase (CRL) administration is delayed until after significant neuroinflammation has developed in APP/PS1 mice, which of the following outcomes may be most consistent with the foundational concepts described in the context?
Options:
A: The delayed CRL treatment may fail to fully normalize peripheral unsaturated fatty acids, thereby limiting its capacity to reduce neuroinflammation and memory deficits, since the gut-brain axis mechanisms are already engaged.
B: Partial suppression of intestinal inflammation in Crohn's disease would directly prevent the aggregation of amyloid-beta peptides in the brain, regardless of gut microbiota composition.
C: Even with delayed CRL administration, fecal matter transplant (FMT) from treated mice could still transfer memory benefits to microbiome-depleted wildtype mice, unless the gut microbiota composition remains unaltered.
D: The absence of early gut microbiota modulation may initially lead to persistent dysregulation of the microbiota-gut-brain axis, unless overridden by compensatory increases in Clostridiales vadin BB60 genera abundance.

Q21: In a scenario where APP/PS1 transgenic AD mice are first rendered germ-free to eliminate microbiota-derived SCFA, and only after a delay are subjected to a 12-week treadmill exercise regimen, which of the following predictions about neuroinflammation and Aβ pathology most accurately reflect the temporally sequenced regulatory effects described in the context?
Options:
A: The absence of microbiota-derived SCFA initially reduces Aβ plaque load, but subsequent exercise-induced enrichment of gut microbial diversity may restore SCFA production, potentially increasing Aβ deposition despite reduced neuroinflammation.
B: Delayed treadmill exercise in germ-free mice will directly increase LPS displacement, thereby worsening neuroinflammation regardless of changes in gut microbiota composition.
C: Exercise-induced increases in intestine-brain barrier proteins will have no effect on neuroinflammation if SCFA are absent throughout the experiment.
D: The initial reduction in Aβ plaques due to lack of SCFA will be maintained even after exercise, since exercise cannot alter gut microbiota in germ-free mice.

Q22: If a therapeutic intervention in APP/PS1 mice simultaneously delays the restoration of synaptic plasticity but only partially suppresses the upregulation of aryl hydrocarbon receptor (AhR) by microbiota-derived Indoles, which of the following outcomes may be most consistent with the described mechanisms, assuming no compensatory increase in tryptophan availability?
Options:
A: The inflammatory response may remain elevated due to incomplete inhibition of the NF-κB pathway and persistent NLRP3 inflammasome formation.
B: Indoles-producing bacteria may compensate for tryptophan deficiency by increasing the permeability of the blood-brain barrier, thereby directly reducing Aβ accumulation.
C: The release of TNF-α, IL-6, IL-1β, and IL-18 may appear to decrease transiently, but neuroinflammation could persist if synaptic plasticity is not fully restored.
D: Cognitive and behavioral abilities may initially improve, unless overridden by continued Tau hyperphosphorylation resulting from insufficient Indoles-mediated AhR activation.

Q23: If a female Alzheimer's disease (AD) mouse model is treated with secoisolariciresinol diglucoside (SDG) while simultaneously experiencing partial suppression of gut microbiota-derived metabolite production, which of the following outcomes may be most consistent with the described mechanisms, assuming no compensatory upregulation of epigenetic enzyme activity occurs?
Options:
A: Altered BDNF and NMDA signaling may be fully restored by SDG alone, even in the context of suppressed gut microbiota metabolite production, provided that histone modification enzymes remain active.
B: The efficacy of SDG in reducing neuroinflammation may appear limited, since the absence of sufficient gut microbiota metabolites restricts both direct anti-inflammatory signaling and the epigenetic regulation of inflammatory genes.
C: The neuroprotective effects of SDG may be attenuated due to reduced modulation of the GPER/CREB/BDNF pathway, as gut microbiota metabolites are required for optimal pathway activation.
D: Amyloid-β plaque accumulation may initially decrease, unless overridden by persistent neuroinflammation resulting from impaired gut microbiota-epigenetic synchrony.

Q24: When considering foundational concepts for developing treatment strategies targeting neurodegenerative disease, which of the following statements accurately reflect the mechanistic rationale for profiling the gut microbiome and its metabolites in relation to neuroinflammation?
Options:
A: Profiling the metabolic microbiome is necessary to pre-screen Alzheimer's disease subjects before designing chronic titrations of gut microbiota with low-dose antibiotics.
B: Microglial activation in the aging brain is primarily a consequence of direct antibiotic modulation of the gut microbiome, rather than age-related changes.
C: Neuroinflammation is universally pathogenic in neurodegenerative diseases, regardless of the timing or context of innate immune function.
D: Identifying neuroactive metabolites from the gut microbiome is considered a peripheral approach to address neurodegenerative mechanisms.

Q25: If a patient with Alzheimer's disease experiences a delay in the restoration of gut microbial diversity while simultaneously receiving only partial suppression of neuroinflammation, which of the following outcomes may be most consistent with the mechanisms described for the gut-brain axis in AD?
Options:
A: Persistent activation of glial cells may continue to promote cognitive decline, as incomplete neuroinflammation suppression fails to fully interrupt the gut dysbiosis-driven release of proinflammatory cytokines.
B: Amyloid deposition and tauopathy may be rapidly reversed, provided that partial neuroinflammation suppression is maintained, regardless of ongoing gut dysbiosis.
C: Blood-brain barrier integrity may remain compromised, since the absence of full microbial diversity restoration limits the neuroprotective effects of bacterial metabolites.
D: Short-chain fatty acid production may initially appear normalized, unless overridden by the absence of dietary intervention to restore beneficial microbial populations.

Q26: When considering foundational mechanisms by which chiral Au nanoparticles influence neurodegeneration in Alzheimer’s disease (AD) mouse models, which of the following statements most accurately reflect outcomes dependent on gut microbiota modulation and metabolite signaling, rather than direct central nervous system intervention?
Options:
A: Chiral Au nanoparticles directly reduce amyloid-β accumulation in the brain without altering gut microbiome composition or metabolite levels.
B: Restoration of cognitive abilities in AD mice following chiral Au nanoparticle administration is associated with increased indole-3-acetic acid, a metabolite found to be lower in both serum and cerebrospinal fluid of AD patients.
C: Indole-3-acetic acid, when administered orally, can cross the blood-brain barrier and mitigate neuroinflammation and cognitive decline in AD mice.
D: Hyperphosphorylated tau aggregation is ameliorated by chiral Au nanoparticles only when indole-3-acetic acid is administered directly into the brain parenchyma.

Q27: If quinic acid administration is delayed until after high-fat diet-induced neuroinflammation is established, and sodium oligomannate (GV-971) is simultaneously introduced but only in female mice, which of the following outcomes may be most consistent with the described mechanisms and observed sex-specific effects?
Options:
A: There may be a reduction in Aβ amyloidosis and reactive microglia in female mice, but the transcriptomic changes in microglia and inflammatory responses are likely to be less pronounced than in males.
B: Both quinic acid and GV-971 will restore beneficial gut microbial tryptophan metabolites, leading to equivalent suppression of DR3/IKK/NF-κB signaling in both sexes.
C: Unless overridden by early intervention, the elevation of amino acid production and tryptophan pathway metabolites by GV-971 will fully compensate for the lack of quinic acid-induced IAA and KYNA in female mice.
D: The combination may initially lead to improved gut microbiota composition, but only partial reduction of brain oxidative stress and neuroinflammation is expected in females due to the absence of male-specific microglial transcriptome changes.

Q28: In a scenario where middle-aged APP/PS1 mice are subjected to voluntary wheel running after a period of established gut microbiota dysbiosis and concurrent reduction in circulating short-chain fatty acids (SCFAs), which of the following predictions about the regulatory cascade from gut microbiota to neuroinflammation and cognitive function is most consistent with the described findings across the context?
Options:
A: Exercise in middle-aged APP/PS1 mice will primarily reduce ADAM10 and GFAP expression in the hippocampus, but will not restore circulating SCFA levels or significantly improve cognitive function.
B: Initiating exercise at this stage will elevate key proteins involved in synaptic plasticity and reduce tau phosphorylation, thereby reversing cognitive deficits regardless of age.
C: The reduction in the Firmicutes/Bacteroidetes ratio at 12 months will directly increase the abundance of Alistipes, leading to improved memory performance.
D: Despite exercise-induced changes in gut microbiota composition, the absence of notable alterations in circulating metabolites in middle-aged mice suggests that neuroinflammation and cognitive impairment will persist.

Q29: If a middle-aged APP/PS1 mouse experiences only a partial reduction in hippocampal GFAP expression due to voluntary exercise, while simultaneously failing to exhibit notable changes in circulating metabolites, which of the following outcomes may be expected regarding neuroinflammation and cognitive function, based on the described mechanisms and regulatory order?
Options:
A: Neuroinflammation may remain insufficiently suppressed, and cognitive improvement is unlikely, as the absence of metabolite alterations precludes the compensatory benefits observed in young exercised mice.
B: The reduction in hippocampal GFAP expression may initially lead to decreased neuroinflammation, unless overridden by the persistent absence of improved gut microbiota profiles and circulating metabolites.
C: Cognitive function may appear to improve transiently due to exercise-induced changes in Allobaculum abundance, even though key anti-inflammatory metabolites and synaptic plasticity proteins remain unaltered.
D: Despite the lack of changes in circulating metabolites, partial GFAP reduction alone is sufficient to restore synaptic plasticity and fully reverse cognitive deficits in middle-aged APP/PS1 mice.

Q30: Considering the foundational concept of how gut microbiota-induced systemic chronic inflammation (GM-SCI) mechanistically contributes to neuroinflammation, neurodegeneration, and brain aging, which of the following statements most accurately reflect the sequence and regulatory direction of these interactions as described in the context?
Options:
A: Disruption of the intestinal barrier by gut microbiota and their metabolites primarily impairs BBB integrity through direct neural invasion, while systemic chronic inflammation is a secondary effect.
B: Excessive gut inflammation, often influenced by dietary components and age, initiates chronic diseases along dispersal routes and ultimately impairs BBB integrity, thereby promoting neuroinflammation and neurodegeneration.
C: The BBB acts as a passive conduit for gut-derived factors, allowing their unregulated entry into the CNS, which then triggers gut mucosal immunity dysregulation and subsequent systemic chronic inflammation.
D: Inflammatory cytokines, modulated by gut microbiota and their metabolites, disrupt BBB maintenance cues, which is indispensable for the corruption of BBB integrity and the development of brain aging.

Q31: If synbiotic therapy with Clostridium sporogenes and xylan is initiated in an AD mouse model with pre-existing gut barrier disruption, but the increase in IPA-synthesizing bacteria is only partial and bile acid signaling remains unaltered, which of the following outcomes may most plausibly result, based on the described mechanisms?
Options:
A: Gut barrier integrity may initially improve, but persistent dysregulation of bile acid signaling could prevent full recovery of immune and neuroendocrine function during AD episodes.
B: The prevalence of Aquabacterium, Corynebacterium, and Romboutsia will remain unchanged, unless overridden by a complete restoration of IPA-synthesizing bacteria and concurrent modulation of bile acid pathways.
C: Cognitive improvement may appear limited, as partial restoration of IPA-synthesizing bacteria without enhanced bile acid signaling could fail to fully suppress neuroinflammation and restore synaptic ultrastructure.
D: Amyloid-β accumulation is likely to be completely reversed, since even partial increases in IPA-synthesizing bacteria are sufficient to normalize all neurodegenerative markers in AD mice.

Q32: If a therapeutic intervention simultaneously elevates gut-derived indole-3-lactic acid (ILA) and partially suppresses the tryptophan pathway in male 5XFAD mice, while also delaying the onset of gut microbiota dysbiosis, which of the following outcomes may most plausibly result, given the described mechanisms and sex-specific effects?
Options:
A: Prevention of cognitive impairment and Aβ accumulation, unless the partial suppression of the tryptophan pathway limits ILA-mediated AhR activation.
B: Increased plaque-associated reactive microglia in female mice, unless compensated by elevated amino acid production from the microbiome.
C: Attenuation of peripheral pro-inflammatory cytokine profiles in both sexes, unless the intervention overrides the sex-specific microbiota response.
D: Reduced cerebral amyloidosis and increased homeostatic microglia, provided that aryl hydrocarbon receptor (AhR) signaling remains active in the brain.

Q33: If an aged individual with established gut dysbiosis receives a probiotic intervention that only partially restores microbial metabolite production, but microglial morphology remains altered, which of the following outcomes may be most consistent with the described gut-brain mechanisms?
Options:
A: The risk of neurodegeneration may remain elevated unless both gut microbiota composition and microglia morphology are simultaneously normalized.
B: Neuroinflammation may persist despite some reduction in systemic inflammation, as incomplete metabolite restoration fails to fully normalize microglia function.
C: Cognitive decline is likely to be reversed immediately, since any increase in microbial metabolites directly restores microglial morphology regardless of age-related changes.
D: Beneficial cognitive effects are expected only if short chain fatty acids reach pre-dysbiosis levels, as partial metabolite recovery is insufficient to impact the gut-brain axis.

Q34: When considering the foundational mechanisms by which fecal microbiota transplantation (FMT) exerts protective effects in neurological disorders, which of the following statements accurately reflect context-specific regulatory outcomes, except when the gut-brain axis is disrupted by persistent dysbiosis?
Options:
A: Although FMT is recommended for recurrent Clostridioides difficile infection, its neuroprotective effects are attributed to increased Bax and decreased Bcl-2 expression in ischemic injury.
B: FMT-mediated restoration of microbial composition leads to decreased IL-17 and IFN-γ expression, thereby suppressing neuroinflammation after ischemic stroke.
C: FMT inhibits TLR4 and NF-κB expression in Parkinson's disease, while also ameliorating inflammatory responses through modulation of the neuroimmune axis.
D: In the context of Alzheimer's disease, FMT improves cognitive function primarily by downregulating synaptic markers such as PSD-95 and synapsin-1, although amyloid-β levels remain unchanged.

Q35: Considering the foundational concept of gut microbiota’s influence on Alzheimer’s disease, which of the following statements best reflects mechanistic relationships described in the context when dietary interventions are applied to modulate disease progression?
Options:
A: Manipulation of the gut microbiota through dietary intervention is directly established as a clinical therapy for delaying AD progression, although the underlying mechanisms remain poorly understood.
B: While the effects of dietary components on brain function and microbial metabolites are examined, translating microbiome-based findings into clinical therapies for AD remains challenging.
C: The diversity and composition of the gut microbiome in AD patients are reviewed, but dietary components are not considered relevant to brain function in this context.
D: The literature supports that microbial metabolites from the host or diet regulate AD, except when dietary interventions are used to manipulate the gut microbiota.

Q36: When considering the foundational mechanisms by which high-fat diet (HFD) and Huanglian Jiedu decoction (HLJDD) influence neuroinflammation and metabolic status in APP/PS1 mice, which of the following statements most accurately reflect context-dependent outcomes or regulatory directions described in the context?
Options:
A: HFD consistently increases neuroinflammation in APP/PS1 mice, although it reduces peripheral cholesterol levels and improves contextual memory.
B: HLJDD may globally suppress both inflammation and lipid accumulation, thereby relieving cognitive impairment following HFD intervention.
C: HFD creates a favorable microenvironment for bile acid alteration and arachidonic acid metabolism, which may be associated with improved LXR/PPAR expression in APP/PS1 mice.
D: The effect of HFD on AD progression is clearly defined as detrimental, except when combined with HLJDD, which reverses all neurodegenerative changes.

Q37: If a scenario arises in which mannan oligosaccharide (MOS) administration is delayed until after significant gut barrier integrity damage has already occurred, and only partial restoration of butyrate-producing microbes is achieved, which of the following outcomes may be most consistent with the mechanisms described in the context, assuming no additional interventions are introduced?
Options:
A: The attenuation of Aβ accumulation in the cortex and hippocampus may be incomplete, as the partial enhancement of butyrate formation fails to fully suppress neuroinflammatory responses.
B: Anxiety- and obsessive-like behaviors may initially improve due to upregulation of norepinephrine, unless the persistent LPS leak overrides the behavioral benefits of MOS.
C: The HPA-axis disorders, including elevated corticosterone and CRH, are likely to resolve fully, since MOS directly upregulates norepinephrine regardless of gut barrier status.
D: The reshaped gut microbiome may appear to balance brain redox status, but persistent gut barrier damage could prevent full cognitive recovery in the 5xFAD mice.

Q38: When considering foundational mechanisms underlying Alzheimer's and Parkinson's diseases, which of the following statements accurately reflect the context-dependent influence of gut microbiota on disease pathogenesis or therapeutic targeting?
Options:
A: While gut microbiota metabolites can compromise blood-brain barrier integrity, their role in protein misfolding is only secondary to genetic mutations.
B: Inflammation-induced epigenetic alterations, promoted by a leaky gut, are implicated in the development of both AD and PD.
C: Microbiota transplantation is discussed as a potential preventive and therapeutic strategy for AD and PD through epigenetic modification.
D: Neurotoxin exposure is described as a downstream effect of gut microbiota dysregulation rather than an independent contributor to AD and PD.

Q39: When considering foundational concepts of gut microbiota influence on Alzheimer's disease pathology, which of the following outcomes would most likely occur if germ-free App(NL-G-F) AD mice are administered bacterial extracellular vesicles (bEVs) derived from specific pathogen-free AD mice, compared to maintaining germ-free conditions alone?
Options:
A: Microglial cells would shift toward a less inflammatory state, further reducing amyloid-β pathology beyond germ-free conditions.
B: The protective effect against synaptic deficits observed in germ-free AD mice would be reversed following bEV administration.
C: Amyloid-β plaque accumulation would increase, coinciding with enhanced microglial activation after bEV treatment.
D: Gut microbiota depletion would exacerbate neuroinflammatory processes, unless bEVs are administered to maintain microglial phagocytotic efficiency.

Q40: When considering foundational concepts underlying dietary interventions for neurodegenerative diseases, which of the following statements accurately reflect mechanistic distinctions in how specific dietary components or gut microbiota modifications may influence Alzheimer's or Parkinson's disease outcomes?
Options:
A: The protective properties of dietary polyphenols in neurodegenerative diseases are conclusively established in human clinical studies, unlike the effects of fermented foods.
B: Consuming complex carbohydrates such as those found in seaweed may shift the gut microbiota to a healthy enterotype, thereby reducing oxidative stress and neuronal death in both Alzheimer's and Parkinson's diseases.
C: Although altering the gut microbiota through diet can modulate beneficial metabolite production, this effect is not necessarily linked to attenuation of neurotransmitter dysfunction in neurodegenerative diseases.
D: While fermented foods and polyphenol-rich fruits can both reduce neuroinflammation, only seaweed-derived interventions have demonstrated clinical success by targeting the gut microbiota-brain axis in Alzheimer's disease.

Q41: In a scenario where 5-lipoxygenase (5-LO) activity is genetically ablated in an Alzheimer's disease (AD) mouse model, and these mice are subsequently exposed to commensal gut microbiota-derived extracellular vesicles (bEVs) after a period of germ-free housing, which of the following predictions about neuroinflammatory and amyloid pathology outcomes most accurately reflects the regulatory hierarchy and temporal sequence described in the context?
Options:
A: The protective effect of germ-free conditions on synaptic deficits will be lost after bEV administration, regardless of 5-LO status, since bEVs act upstream of 5-LO in the regulatory cascade.
B: bEV administration will directly increase tau phosphorylation in the absence of 5-LO, since bEVs act independently of 5-LO on tau pathology.
C: The absence of 5-LO will prevent bEV-induced reversal of reduced amyloid-β pathology, as 5-LO is required downstream of bEV-mediated microglial activation for plaque accumulation.
D: Microglial cells will remain in a less inflammatory state despite bEV exposure, because 5-LO is necessary for bEV-driven microglial activation and subsequent neuroinflammation.

Q42: When considering the foundational mechanisms by which chiral Au nanoparticles influence neurodegeneration in AD mice, which of the following statements accurately reflect the regulatory direction or context-specific relevance described in the context?
Options:
A: Oral administration of indole-3-acetic acid directly remodels the gut microbiota, thereby increasing chiral Au nanoparticle bioavailability in the brain.
B: Chiral Au nanoparticles restore cognitive abilities in AD mice by altering gut microbiome composition, which leads to increased indole-3-acetic acid levels.
C: Indole-3-acetic acid, when administered orally, penetrates the blood-brain barrier and alleviates both cognitive decline and neuroinflammation in AD mice.
D: Amyloid-β and hyperphosphorylated tau pathologies are reduced in AD mice only when indole-3-acetic acid is administered in combination with chiral Au nanoparticles.

Q43: When considering foundational concepts underlying the therapeutic implications of gut microbiota modulation in Alzheimer's disease, which of the following statements accurately reflect mechanistic distinctions or regulatory directions described in the context?
Options:
A: Manipulating gut microbiota can reduce tau pathology and neurodegeneration, but only in an apolipoprotein E isoform-independent manner.
B: Synbiotics and postbiotics may be used to treat Alzheimer's disease by modulating gut microbiota, although their effects are not mediated by microglial activity.
C: The resilience of a healthy microbiota confers protection against dysbiosis-related pathologies, whereas altered microbial metabolites may influence neuronal function.
D: Physical activity and exercise are considered nonpharmacological therapies that may reduce neuroinflammation-related signaling pathways, except when combined with probiotics.

Q44: When considering foundational mechanisms by which mannan oligosaccharide (MOS) administration influences the 5xFAD Alzheimer's disease mouse model, which of the following outcomes would most likely occur if MOS treatment is maintained for 8 weeks, except when the gut microbiota composition remains unchanged?
Options:
A: The reduction in Aβ accumulation in the cortex, hippocampus, and amygdala would be diminished, although HPA-axis hormone levels might still decrease.
B: The enhancement of butyrate formation and related microbial levels would be absent, while neuroinflammatory responses could remain suppressed.
C: The attenuation of anxiety- and obsessive-like behaviors would persist, even if the gut barrier integrity damage is not prevented.
D: The improvement in cognitive function and spatial memory would be less pronounced, particularly if the reshaped gut microbiome and increased SCFAs are not achieved.

Q45: If a mouse model of Alzheimer's disease is engineered to have delayed upregulation of microglial ApoE in response to SCFA, while simultaneously being exposed to partial 5-lipoxygenase (5-LO) inhibition and maintained under germ-free conditions, which of the following outcomes may most plausibly result, based on the described mechanisms and their interrelationships?
Options:
A: Reduced Aβ plaque load is likely, as both germ-free status and partial 5-LO inhibition would limit SCFA-driven microglial modulation and amyloid deposition, even if ApoE upregulation is delayed.
B: Exacerbated neuro-inflammation may occur, since delayed ApoE upregulation would be compensated by increased SCFA-induced microglial recruitment, unless overridden by the absence of gut-derived metabolites in germ-free mice.
C: The expected increase in microglial intracellular Aβ following SCFA supplementation would be absent, as germ-free conditions and partial 5-LO inhibition both disrupt the necessary pathways for this effect.
D: Amyloid plaque deposition may appear unchanged, unless the partial suppression of 5-LO is sufficient to counteract the pro-amyloidogenic influence of any residual SCFA, which is unlikely in germ-free mice.

Q46: If a therapeutic intervention in Alzheimer's disease simultaneously delays the restoration of gut microbiota homeostasis but only partially suppresses MAPK signaling, which of the following outcomes may be most consistent with the described mechanisms in the context?
Options:
A: The abundance of morganella and serratia in the gut may initially decrease, provided that MAPK signaling is only partially suppressed.
B: Cognitive deficits may persist due to incomplete inhibition of neuroinflammation, as MAPK/NF-κB signaling remains partially active and pro-inflammatory microbiota are not fully reduced.
C: Serum metabolites associated with glucose metabolism will normalize rapidly, unless the PI3K/AKT/Glut1 pathway is also delayed.
D: Full amelioration of neuronal cell damage is expected, since partial MAPK suppression is sufficient when gut microbiota restoration is delayed.

Q47: When considering foundational concepts underlying the therapeutic implications of gut microbiota modulation in Alzheimer's disease, which of the following statements accurately reflect mechanistic distinctions or context-specific relevance described in the context?
Options:
A: The resilience of a healthy gut microbiota confers protection against dysbiosis-related pathologies, although this effect is not mediated by microglial activity in the brain.
B: Probiotics, synbiotics, and postbiotics are all described as potential interventions for Alzheimer's disease through their capacity to modulate gut microbiota.
C: Physical activity and exercise are considered nonpharmacological therapies that may reduce neuroinflammation signaling pathways, except when combined with microbial metabolite interventions.
D: Manipulation of gut microbiota can reduce tau pathology and neurodegeneration in an apolipoprotein E isoform-dependent manner, while also directly preventing all forms of protein accumulation in the brain.

Q48: If a patient with early-stage neurodegenerative disease receives partial suppression of the Keap-1/Nrf2 pathway while simultaneously experiencing a reduction in short-chain fatty acid (SCFA)-producing gut bacteria, which of the following outcomes may most plausibly occur, given the interplay of oxidative stress, neuroinflammation, and gut-brain axis mechanisms described in the context?
Options:
A: Increased neuroinflammation and oxidative damage may result, as both antioxidant enzyme activity and SCFA-mediated modulation of neuroinflammatory pathways are compromised.
B: Cognitive decline may be prevented, since partial Keap-1/Nrf2 suppression is offset by the remaining SCFA-producing bacteria maintaining antioxidant responses.
C: Remodeling of the gut microbiota will fully compensate for reduced SCFA production, unless the Keap-1/Nrf2 pathway is completely inhibited.
D: Neuronal morphology in the hippocampal CA3 region may appear preserved, provided that antioxidant delivery by probiotics is initiated after the onset of oxidative stress disorder.

Q49: If aged APP/PS1 mice are exposed to malathion, resulting in partial but not complete inhibition of the serotonin (5-HT) pathway, while simultaneously receiving exogenous lipase that normalizes peripheral unsaturated fatty acids but does not fully restore gut barrier integrity, which of the following outcomes are most consistent with the described mechanisms?
Options:
A: Memory deficits may persist due to continued neuroinflammation from upregulated hippocampal IL-6 and IL-1β, despite partial normalization of lipid metabolism.
B: The abundance of Acetatifactor and Clostridiales vadin BB60 genera in the gut may increase, but this alone is insufficient to counteract the neurotoxic effects of elevated kynurenine pathway metabolites.
C: Reduced hippocampal 5-HT levels may initially lead to neurotransmitter imbalances, unless overridden by complete restoration of the gut microbiota via fecal matter transplant.
D: Full amelioration of AD-like pathology is likely, as normalization of peripheral unsaturated fatty acids directly suppresses microglial activation and synaptic dysregulation in the hippocampus.

Q50: If App(NL-G-F) AD mice are maintained under germ-free conditions but simultaneously receive oral supplementation with B. pseudolongum, and FFAR3 expression is only partially suppressed, which of the following outcomes may be most consistent with the described mechanisms, considering the absence of compensatory inflammatory pathway modulation?
Options:
A: Microglial cells may initially shift toward a less inflammatory state, but this effect could be reversed if B. pseudolongum-derived metabolites restore gut-brain axis signaling through the remaining FFAR3.
B: Amyloid-β plaque accumulation is likely to remain reduced, since germ-free conditions alone are sufficient to prevent reversal by B. pseudolongum supplementation, even if FFAR3 is partially active.
C: The protective effect of germ-free conditions on synaptic deficits may appear to persist, unless the partial FFAR3 activity allows B. pseudolongum or its metabolites to fully reestablish neuroinflammatory signaling.
D: The mice may exhibit partial restoration of cognitive function, as B. pseudolongum-derived propionic acid can still signal through residual FFAR3, unless overridden by persistent microglial activation from unmodulated inflammatory pathways.

Q51: If a scenario arises in which the gut microbiota composition in an aging individual is only partially restored to increase Lactobacillus abundance, but the formation of short-chain fatty acids (SCFAs) remains suboptimal and the aryl hydrocarbon receptor (AhR) pathway is pharmacologically inhibited, which of the following outcomes regarding Alzheimer's disease (AD) pathogenesis and neuroinflammation are most consistent with the described mechanisms?
Options:
A: The inhibition of AhR signaling, even with increased Lactobacillus and partial SCFA production, results in a paradoxical increase in neuroinflammation due to unopposed Helicobacter expansion.
B: Despite the lack of SCFA formation and AhR signaling, the upregulation of norepinephrine by increased Lactobacillus is sufficient to fully prevent cognitive impairment in AD models.
C: Incomplete restoration of the gut microbiota, without SCFA-mediated modulation, initially leads to persistent HPA-axis disorders and continued Aβ accumulation, unless overridden by direct activation of microglial autophagy.
D: The partial increase in Lactobacillus may appear to support gut barrier integrity and anti-inflammatory signaling, but the absence of SCFA enhancement and AhR activation would limit the suppression of neuroinflammation and amyloidopathy.

Q52: In a scenario where a high-fat diet (HFD) is maintained, but quinic acid (QA) administration is delayed until after the onset of increased Aβ and p-Tau levels, and simultaneously, the gut microbiota is depleted of tryptophan-metabolizing bacteria, which of the following outcomes would most likely be observed at both the metabolite and neuroinflammatory signaling pathway levels in the brain, according to the described regulatory hierarchies and temporal dependencies?
Options:
A: The delayed QA administration would fail to elevate indole-3-acetic acid (IAA) and kynurenic acid (KYNA) levels, resulting in persistent activation of the DR3/IKK/NF-κB pathway and sustained neuroinflammation.
B: Early QA administration prior to HFD-induced microbiota changes would restore IAA and KYNA levels and inhibit DR3/IKK/NF-κB signaling, thereby reducing neuroinflammation.
C: Despite the absence of tryptophan-metabolizing bacteria, QA would still suppress Aβ and p-Tau levels by directly inhibiting the DR3/IKK/NF-κB pathway, independent of gut microbial metabolites.
D: Depletion of tryptophan-metabolizing bacteria would increase IAA and KYNA production, leading to enhanced suppression of neuroinflammatory signaling even with delayed QA administration.

Q53: When considering foundational concepts of the microbiota-gut-brain axis in the pathogenesis of common brain diseases, which of the following statements accurately reflect mechanistic distinctions in bacterial and metabolite involvement, except when the regulatory direction is reversed or context is misapplied?
Options:
A: While increased Gram-negative bacteria with LPS in their cell walls promote neuroinflammation, a higher abundance of anti-inflammatory bacteria such as Faecalibacterium is typically observed in patients compared to healthy controls.
B: Although aberrant levels of short-chain fatty acids are implicated in disease pathogenesis, these metabolites are generally found in lower quantities in affected individuals.
C: Over-activated microglial cells and neuroinflammation are common mechanistic features across all seven brain diseases discussed, with gut-residing bacteria and their metabolites acting as important contributors.
D: A pro-inflammatory shift in colon microbiota, characterized by increased Alistipes and Eggerthella, is associated with the development and progression of the brain diseases mentioned.

Q54: When considering the mechanistic effects of BEP2 administration in APP/PS1 mice, which of the following statements accurately reflect foundational concepts regarding its impact on neuroinflammation and gut-brain interactions, except when regulatory direction is reversed or context is misapplied?
Options:
A: BEP2 treatment leads to a reduction in norepinephrine levels, while simultaneously increasing the abundance of the S24-7 bacterial family in the gut.
B: The upregulation of interleukin (IL)-1β and IL-6 by BEP2 is associated with improved cognitive function in APP/PS1 mice.
C: BEP2 increases the levels of fractalkine (CX3CL1) and its receptor CX3CR1 on microglia, although this is not accompanied by changes in TGF-β1.
D: While BEP2 downregulates three metabolites including norepinephrine, it also upregulates five other metabolites and suppresses neuroinflammation.

Q55: When considering foundational concepts from the multi-omics analysis of the aged mouse hippocampus, which of the following statements most accurately reflect mechanistic relationships between metabolic, gene expression, and behavioral changes, except when regulatory direction is misassigned or context is misapplied?
Options:
A: Although microglial activation and inflammation pathways are dysregulated in the aged hippocampus, these changes are only observed in the absence of altered amino acid and lipid abundance.
B: The co-expression network integrating differentially abundant metabolites and differentially expressed genes supports that metabolic and gene expression alterations are possibly linked to reduced exploration, locomotion, learning, and memory in aged mice.
C: While altered microbiota-derived metabolites (MDMs) are detected in the aged hippocampus, they are unlikely to mediate gut-brain interactions during aging according to the multi-omics data.
D: Dysregulation of synaptic signaling and metabolism in the hippocampus is identified as a feature of aging, although the underlying mechanisms remain largely unknown.

Q56: Considering the foundational concept of the microbiota-gut-brain (MGB) axis as described, which of the following statements best reflect mechanistic implications for Alzheimer's disease pathogenesis or intervention, except when the regulatory direction is misapplied?
Options:
A: The gut microbiota and its metabolites may affect Alzheimer's disease by mechanisms that are currently under review for their therapeutic potential.
B: Amyloid-beta peptide aggregation in the brain directly alters the composition of the gut microbiota, thereby initiating the MGB axis.
C: The MGB axis comprises microbial molecules from the gastrointestinal tract that can modulate brain physiology, while the aggregation of hyper-phosphorylated tau tangles is unrelated to gut microbiota.
D: Dysregulation of the gut microbiota can influence memory and learning functions through the MGB axis, although this does not necessarily involve amyloid-beta aggregation.

Q57: When considering the mechanistic basis for the neuroprotective effects of Hericium coralloides polysaccharide (HCP) in the APP/PS1 mouse model of Alzheimer's disease, which of the following statements accurately reflect foundational concepts regarding its action, except when temporal sequence or regulatory direction is misapplied?
Options:
A: The neuroprotective function of HCP is primarily attributed to its direct inhibition of amyloid-β aggregation, independent of autophagy or neuroinflammation modulation.
B: HCP reduces amyloid-β plaques and phosphorylated tau protein deposition by facilitating M2 microglial polarization through enhanced autophagy flux.
C: While HCP-induced reduction of neuroinflammation is associated with enhanced autophagy, this effect is not observed in the absence of M2 microglial polarization.
D: HCP augments autophagic flux, which in turn mitigates neuroinflammation and contributes to the reduction of amyloid-β plaques.

Q58: Considering the mechanistic interplay between diet, gut-microbiota, and brain function as described, which of the following statements accurately reflect foundational concepts regarding the impact of high-fat diet (HFD) and type-2 diabetes (T2D) on microbiota-gut-brain communication and Alzheimer's disease (AD) pathology, except when the regulatory direction or context is misapplied?
Options:
A: Cognitive impairment in AD is a direct cause of HFD-induced gut dysbiosis, while neuroinflammation is only a consequence of improved intestinal barrier function.
B: HFD-induced gut dysbiosis leads to loss of intestinal barrier integrity, which is mechanistically linked to chronic low-grade inflammation and increased risk of T2D and AD.
C: The expression of tyrosine kinases is implicated both in maintaining intestinal integrity and in microglial phagocytic clearance in the brain, suggesting a shared mechanistic pathway in T2D-linked AD.
D: While gut-microbial products are implicated in T2D and AD pathology, their impact on transcription factors is limited to non-obese individuals without cognitive impairment.

Q59: If a scenario arises in which indole-3-lactic acid (ILA) administration is delayed until after significant reduction of short-chain fatty acids (SCFAs) and a diminished Firmicutes/Bacteroidetes (F/B) ratio have already occurred in 12-month-old AD mice, but aryl hydrocarbon receptor (AhR) signaling remains only partially responsive, which of the following outcomes may be most consistent with the mechanisms described in the context?
Options:
A: Despite the reduction in SCFAs and F/B ratio, delayed ILA administration would be expected to restore both synaptic plasticity and blood-brain barrier integrity, provided that circulating TMAO levels remain stable.
B: The partial responsiveness of AhR signaling may initially lead to increased expression of pro-inflammatory cytokines such as IL-1β and TNFα, unless overridden by compensatory enrichment of tryptophan in the plasma.
C: Early administration of TMAO precursors in this context would directly activate microglia and astrocytes via the AhR pathway, thereby compensating for the loss of SCFAs and normalizing cognitive function.
D: The delayed ILA treatment may fail to fully prevent amyloid-beta (Aβ) accumulation and cognitive impairment, as the combined disruption of SCFA metabolism and reduced F/B ratio could exacerbate neuroinflammation, and only partial AhR activation may not sufficiently engage microglia and astrocytes for protection.

Q60: In a scenario where malathion exposure first induces gut microbiota dysbiosis characterized by reduced Lactobacillus and Akkermansia, and this is followed by dietary supplementation with Armillariella tabescens-derived polysaccharides (ATEP), what is the most likely sequence of regulatory and functional changes across the gut-brain axis and hippocampal neuroinflammation, considering the described molecular pathways and feedbacks?
Options:
A: The initial reduction in Lactobacillus and Akkermansia would irreversibly impair the gut barrier, making subsequent ATEP supplementation ineffective in modulating hippocampal oxidative stress or neuroinflammation.
B: ATEP supplementation would primarily act by increasing butyric acid production, which then inhibits the Akt/NF-κB pathway in microglia, independent of any changes in antioxidant enzyme activities or the Keap-1/Nrf2 pathway.
C: Malathion-induced tryptophan metabolism disruption would directly upregulate the DR3/IKK/NF-κB pathway in the hippocampus, but ATEP supplementation would counteract this by remodeling gut microbiota and regulating short-chain fatty acid-producing bacteria, ultimately reducing neuroinflammation.
D: ATEP supplementation would enhance antioxidant enzyme activities and suppress the Keap-1/Nrf2 pathway, leading to downstream changes in HO-1, NQO-1, iNOS, and COX-2 expression, thereby ameliorating hippocampal neuroinflammation despite prior malathion-induced dysbiosis.

Q61: When considering the foundational mechanisms by which indole-3-propionic acid (IPA) ameliorates cognitive deficits in LPS-induced models, which of the following statements most accurately reflect the regulatory direction or context-specific relevance of IPA’s actions as described in the context?
Options:
A: IPA promotes neurogenesis and maintains BBB integrity primarily through activation of the RAGE-JAK2-STAT3 signaling pathway, except when Colivelin TFA is present.
B: The neurorestorative effects of IPA are partially reversed when JAK2-STAT3 signaling is activated by Colivelin TFA, indicating that IPA’s benefits depend on inhibition of this pathway.
C: IPA reduces LPS-induced apoptosis and oxidative damage in HT22 cells, while also decreasing inflammation in BV2 cells, by directly stimulating glial cell activation.
D: Although IPA exhibits antioxidant and neuroprotective properties, its ability to remodel the gut microbiota and alleviate memory impairment is mechanistically linked to inhibition of the RAGE-JAK2-STAT3 pathway.

Q62: Considering the mechanistic interplay between gut microbiota and Alzheimer’s disease (AD) progression, which of the following statements accurately reflect foundational concepts regarding signaling pathways or therapeutic interventions, except when the temporal sequence of neuroinflammation is reversed?
Options:
A: While short-chain fatty acids maintain blood-brain barrier integrity, their neuroprotective effects are diminished if glial cell activation precedes gut dysbiosis.
B: The NLRP3 inflammasome and TLR4 Myd88 pathways are implicated in gut dysbiosis-mediated neuroinflammation that promotes AD progression.
C: Probiotic therapy alleviates AD pathology primarily by directly inhibiting the cGAS-STING pathway, although this effect is not observed when mitochondrial dysfunction is absent.
D: Natural extracts such as Ganmaidazao extract and xanthocerasides have been shown in preclinical studies to improve gut health and delay AD worsening.

Q63: If a scenario arises in which gut microbiota composition is altered to reduce SCFA production, but exogenous SCFA supplementation is introduced intermittently and microglial ApoE upregulation is only partially achieved, which of the following outcomes may be most consistent with the described mechanisms in Alzheimer's disease models?
Options:
A: Aβ plaque load may initially remain lower than in conventionally colonized animals, unless intermittent SCFA supplementation is sufficient to restore microglial phenotype modulation.
B: Intracellular Aβ content in microglia would increase beyond levels seen in germ-free AD mice, provided that SCFA supplementation is not continuous.
C: Despite reduced endogenous SCFA, intermittent supplementation may still promote Aβ deposition if microglial transcriptomic changes are partially induced.
D: Microglial recruitment to Aβ plaques would be completely abolished, as partial ApoE upregulation cannot support any microglial response.

Q64: When considering foundational concepts underlying the pathogenesis of Alzheimer's and Parkinson's diseases, which of the following statements accurately reflect mechanistic roles of the gut microbiota or its interventions, except when the temporal sequence of epigenetic changes is misattributed?
Options:
A: Protein misfolding and aggregation are direct consequences of dietary interventions targeting the microbiota, although these interventions are primarily discussed as preventive or therapeutic strategies.
B: While gut microbiota dysregulation can promote AD and PD by inducing inflammation-driven epigenetic alterations, this effect is contingent on the integrity of the intestinal and blood-brain barriers.
C: Neurotoxin exposure is described as a downstream effect of epigenetic changes induced by gut microbiota metabolites, although the context emphasizes neurotoxins as an origin of disease.
D: Microbiota transplantation and probiotics are highlighted as potential means to prevent or treat AD and PD by modulating epigenetic modifications, rather than by reversing established genetic mutations.

Q65: When considering the foundational mechanisms by which Kai Xin San-Jia Wei (KXSJW) ameliorates cognitive dysfunction in APP/PS1 mice, which of the following statements accurately reflect the context-dependent regulatory effects observed after two months of treatment, particularly regarding gut microbiota, metabolite modulation, and intestinal barrier integrity?
Options:
A: KXSJW administration restored the balance of intestinal flora, with a particular emphasis on Firmicutes and its major metabolite butyric acid, while also improving intestinal barrier function in AD model mice.
B: The improvement in cognitive function following KXSJW treatment was primarily attributed to direct reduction of β-amyloid deposition, independent of changes in gut microbial metabolites or intestinal peptide hormone levels.
C: KXSJW increased the release levels of intestinal peptide hormones such as Glucagon and GHRP-Ghrelin, although this effect was only observed in wild-type control mice and not in AD model mice.
D: While KXSJW regulated the concentration of gut flora metabolites, it did not restore the intestinal barrier function or alter the release of intestinal peptide hormones in the treated AD model mice.

Q66: If a neurodegenerative disease model exhibits both partial restoration of gut eubiosis via <i>Lactiplantibacillus plantarum</i> (LBP) administration and incomplete normalization of peripheral unsaturated fatty acids due to suboptimal exogenous lipase dosing, which of the following outcomes may be most consistent with the described mechanisms, assuming no compensatory increase in short-chain fatty acid production?
Options:
A: Memory deficits may persist despite reduced neuroinflammation, as incomplete normalization of unsaturated fatty acids limits the full benefit of LBP-induced eubiosis.
B: Neuroinflammatory processes may initially decrease, but impaired cognitive functions could remain unless the abundance of Acetatifactor and Clostridiales vadin BB60 genera is also increased.
C: Boosted neurotransmitter production by LBP strains may override the effects of dysbiosis, fully restoring cognitive function even if lipid hydrolysis remains suboptimal.
D: The benefits of fecal matter transplant (FMT) from treated animals may appear attenuated, unless both eubiosis and normalization of peripheral unsaturated fatty acids are achieved in the recipient.

Q67: In a scenario where germ-free (GF) App(NL-G-F) Alzheimer's disease (AD) model mice are first maintained without any gut microbiota and then, after a delay, are administered commensal gut microbiota-derived bacterial extracellular vesicles (bEVs), which of the following predictions about the sequence of neuroimmune and cognitive outcomes is most consistent with the described regulatory hierarchy and timing in the context?
Options:
A: The initial absence of gut microbiota leads to reduced amyloid-β pathology and a less inflammatory microglial state, but subsequent bEV administration reverses these effects, increasing microglial activation and Aβ plaque accumulation.
B: Delayed introduction of bEVs in GF AD mice will directly enhance synaptic marker expression and cognitive function, independent of changes in microglial activation or amyloid-β pathology.
C: The absence of gut microbiota in GF AD mice causes an immediate increase in neuroinflammation, which is then mitigated by later bEV administration through upregulation of Bcl-2 expression.
D: Administering bEVs to GF AD mice after a period of microbiota depletion will prevent the restoration of phagocytotic efficiency in microglia, thereby reducing amyloid-β clearance and worsening cognitive decline.

Q68: In a scenario where APP/PS1 mice first undergo a 12-week depletion of SCFA-producing bacteria followed by a delayed 4-week administration of Indoles, which of the following outcomes best reflects the temporally sequenced regulatory effects on neuroinflammation and cognitive function, considering the hierarchical interactions between gut microbiota metabolites, signaling pathways, and AD pathology?
Options:
A: The delayed Indoles administration upregulates AhR and inhibits NF-κB signaling, reducing neuroinflammation even after prior SCFA depletion, thereby partially restoring cognitive function.
B: SCFA depletion irreversibly impairs cognitive function, so subsequent Indoles administration cannot activate the AhR pathway or affect neuroinflammation.
C: The initial loss of SCFA-producing bacteria directly increases Aβ deposition, which then prevents Indoles from modulating the NLRP3 inflammasome at a later stage.
D: Indoles administration first restores the abundance of SCFA-producing bacteria, which then activates PPARs signaling to reduce neuroinflammation and improve cognition.

Q69: In a scenario where an aged 5xFAD Alzheimer's disease mouse model is first subjected to antibiotic-mediated gut microbiota depletion, followed by delayed administration of the prebiotic mannan oligosaccharide (MOS), which of the following outcomes would most likely be observed at both the gut metabolite and neuroinflammatory levels, considering the regulatory hierarchy from microbiota composition to brain pathology and the timing of interventions?
Options:
A: The initial microbiota depletion would attenuate Aβ deposition and phosphorylated tau accumulation, but delayed MOS administration would not further enhance short-chain fatty acid (SCFA) production or behavioral improvement due to the absence of a reshaped microbiome.
B: Delayed MOS administration after microbiota depletion would immediately restore gut barrier integrity and reduce LPS leak, leading to rapid suppression of neuroinflammatory responses independent of microbiota composition.
C: Antibiotic-mediated depletion would directly increase butyrate formation, which would synergize with MOS to further reduce Aβ accumulation and balance brain redox status, regardless of the timing of MOS administration.
D: The sequence of microbiota depletion followed by MOS would result in increased Helicobacter abundance and exacerbated HPA-axis disorders, as MOS requires intact microbiota to exert its beneficial effects.

Q70: In a scenario where germ-free (GF) APP/PS1 transgenic mice are first maintained without gut microbiota and then, after a delay, receive supplementation with both short chain fatty acids (SCFA) and a high dose of Kai Xin San-Jia Wei (KXSJW), which of the following predictions about the sequence of molecular, cellular, and systemic changes is most consistent with the described regulatory hierarchy and timing in the context?
Options:
A: SCFA supplementation will initially increase Aβ plaque deposition via microglial phenotype modulation, but subsequent KXSJW administration is expected to restore gut microbial balance, reduce butyric acid levels, and ultimately decrease Aβ deposition.
B: The delayed introduction of KXSJW after SCFA supplementation will first enhance the abundance of Firmicutes and butyric acid, then restore intestinal barrier function, and finally reduce amyloid deposition in brain tissue.
C: Immediate KXSJW administration prior to SCFA exposure would directly suppress microglial ApoE upregulation, thereby preventing any increase in Aβ plaque load regardless of SCFA presence.
D: Following SCFA-induced upregulation of microglial ApoE and increased Aβ deposition, KXSJW is likely to improve cognitive function by modulating gut microbiota composition, restoring intestinal barrier integrity, and reducing amyloid burden.

Q71: In a scenario where 5xFAD mice are first rendered germ-free to eliminate all gut microbiota, and then, after a delay, are colonized exclusively with Bifidobacterium pseudolongum while simultaneously receiving an AhR inhibitor, which of the following predictions about amyloid-beta pathology and cognitive function can be made by integrating the regulatory hierarchy from microbial colonization to metabolite signaling and receptor-mediated effects?
Options:
A: Amyloid-beta deposition will remain elevated because AhR inhibition blocks the ILA-mediated reduction pathway, even though B. pseudolongum colonization increases propionic acid production.
B: Cognitive function will improve due to increased propionic acid from B. pseudolongum, independent of AhR signaling, as confirmed by PET imaging of PA's blood-brain barrier penetration.
C: The absence of gut microbiota prior to B. pseudolongum colonization will prevent any subsequent improvement in cognitive function, since propionic acid requires a pre-existing diverse microbiome to exert effects.
D: Amyloid-beta levels will decrease because B. pseudolongum colonization alone is sufficient to activate microglia and astrocytes via AhR, regardless of receptor inhibition.

Q72: In a scenario where RAGE-JAK2-STAT3 signaling is constitutively activated in the CNS following a period of gut microbiota dysbiosis characterized by elevated TMAO and reduced serotonin production, which of the following predictions about neuroinflammation and cognitive function in Alzheimer's disease models is most consistent with the described regulatory hierarchy and temporal sequence?
Options:
A: Persistent activation of RAGE-JAK2-STAT3 will likely exacerbate neuroinflammation, and the absence of serotonin-mediated modulation from the gut will further impair cognitive function, as both pathways independently contribute to AD pathology.
B: Early restoration of gut microbiota composition to increase Ruminococcaceae abundance will immediately suppress RAGE-JAK2-STAT3 signaling, regardless of ongoing TMAO elevation.
C: Constitutive RAGE-JAK2-STAT3 activation will reduce Aβ accumulation by enhancing microglial phagocytosis, provided serotonin levels remain low.
D: Elevated TMAO and reduced serotonin will synergistically worsen neuroinflammation and cognitive deficits, but only if the mTOR-HIF-1α pathway is simultaneously inhibited.

Q73: If a patient with early Alzheimer's disease exhibits both a marked reduction in butyrate-producing genera and a simultaneous increase in Eubacterium and Desulfovibrio, which of the following may most plausibly occur, assuming no compensatory rise in other short-chain fatty acid producers and incomplete suppression of hydrogen sulfide catabolism?
Options:
A: Free water in limbic and paralimbic gray matter regions may increase, correlating with lower butyrate-producing genera, unless compensated by elevated DHPS levels.
B: Cognitive impairment may initially stabilize, as increased Eubacterium and Desulfovibrio are associated with improved brain homeostasis in the absence of butyrate producers.
C: Neuroinflammation may be exacerbated due to both decreased butyrate availability and increased hydrogen sulfide, unless overridden by alternative anti-inflammatory pathways.
D: The negative correlation between FW values and butyrate producers may be reversed, provided that hydrogen sulfide catabolism is only partially suppressed.

Q74: If a therapeutic intervention in Alzheimer's disease model mice simultaneously restores intestinal barrier function only partially and increases the concentration of butyric acid without altering the levels of branched-chain amino acids, which of the following outcomes may be most consistent with the mechanisms described in the context?
Options:
A: Amyloid-β deposition in brain tissue is likely to increase, as partial restoration of the intestinal barrier cannot compensate for unchanged negative metabolite levels.
B: Full normalization of neuroendocrine function is expected, provided that butyric acid levels are elevated, regardless of the status of other gut-derived metabolites.
C: Cognitive improvement may occur due to enhanced neuroprotective short-chain fatty acid signaling, unless the persistent barrier dysfunction overrides this effect.
D: The intervention may initially lead to improved gut microbial balance and peptide hormone release, but neuroinflammation could persist if BA signaling is not concurrently modulated.

Q75: If a scenario arises in which gut mucosal immunity is only partially restored while hepatic dysfunction persists, and Synbiotics are administered but fail to activate PPARs signaling, which of the following outcomes may be most consistent with the described mechanisms?
Options:
A: Neuroinflammation may remain elevated due to persistent systemic chronic inflammation, as Synbiotics without PPARs activation cannot fully reduce neuro-inflammatory response.
B: Aβ protein deposition is likely to be inhibited regardless of PPARs pathway status, since Synbiotics always improve cognitive function through gut microbiota modulation alone.
C: Blood-brain barrier integrity may initially appear preserved, unless overridden by continued hepatic dysfunction and incomplete gut mucosal immunity restoration.
D: Changes in gut microbiota composition may affect intestinal metabolism, but without PPARs activation, the delay in AD development is unlikely to be significant.

Q76: In a scenario where an Alzheimer's disease (AD) model is first subjected to gut microbiota depletion, followed by delayed administration of Agaricus sinodeliciosus var. Chaidam exopolysaccharide (EPS), which of the following predictions about the hierarchical sequence from microbiota composition to neuroinflammation and cognitive outcome is most consistent with the described mechanisms in the context?
Options:
A: The delayed EPS administration would fail to reconstruct gut microbiota composition, thereby limiting serotonin-associated behavioral improvements and reducing microglial Aβ-phagocytic activation via the mTOR-HIF-1α pathway.
B: Immediate EPS administration after microbiota depletion would directly suppress neuroinflammation by increasing Porphyromonas gingivalis abundance, leading to improved cognitive function.
C: Gut microbiota depletion would initially disrupt the gut-brain axis, but subsequent EPS-induced increase in Ruminococcaceae would restore eubiosis, enhance short-chain fatty acid production, and ultimately reduce neuroinflammation and cognitive impairment.
D: The absence of gut microbiota prior to EPS treatment would prevent the formation of beneficial metabolites, such as serotonin, thereby attenuating the downstream suppression of neuroinflammatory responses and cognitive improvement.

Q77: Considering the foundational concept of the diet-microbiota-gut-brain (DMGB) axis, which of the following statements best reflect mechanistic distinctions in how alterations within this axis may contribute to neurodegenerative disease onset or progression?
Options:
A: While changes in diet and microbiota composition can influence neuronal inflammation, only genetic factors are implicated in the initial insurgence of neurodegenerative diseases.
B: Although the enteric nervous system is a component of the gut-brain axis, its role in neurodegeneration is secondary to that of endocrine signals, except when mitochondrial metabolism is disrupted in the intestinal epithelium.
C: Altered metabolism in intestinal epithelial mitochondria and peroxisomes can serve as early markers and therapeutic targets for neurodegenerative diseases, whereas changes in commensal populations primarily affect disease progression rather than onset.
D: Disruption of gut-brain axis signaling, including immune and vagal pathways, is emerging as a primary overlooked cause of neuroinflammation linked to neurodegenerative disease mechanisms.

Q78: Considering the mechanistic pathways described, which of the following scenarios would most likely result in increased neuroinflammation relevant to Alzheimer’s disease, while accounting for the distinct roles of oral and gut microbiota?
Options:
A: Enhanced production of intestinal microbial metabolites that suppress microglial activity, although oral microbes remain confined to the oral cavity.
B: Oral microbes spreading to the brain via cranial nerves, thereby increasing the risk of neurofibrillary tangle formation, even if gut microbiota remain balanced.
C: Dysbiosis of gut microbiota leading to altered metabolite profiles that activate microglia and mediate neuroinflammation, despite the absence of oral microbial invasion.
D: Direct deposition of amyloid-beta protein in the brain, which subsequently induces dysbiosis of both oral and gut microbiota.

Q79: If a dietary intervention increases the abundance of <i>Agathobacter rectalis</i> but is combined with partial depletion of gut microbiota and incomplete suppression of bacterial extracellular vesicle (bEV) release, which of the following outcomes may be expected regarding microglial activation and amyloid-β (Aβ) pathology in an Alzheimer’s disease mouse model?
Options:
A: Microglial activation may be reduced due to increased butyrate production, but reversal of germ-free-associated protection against Aβ accumulation could still occur via residual bEV-mediated signaling.
B: The intervention is likely to fully prevent Aβ plaque accumulation, as increased <i>A. rectalis</i> abundance overrides any effects of bEVs on microglial state.
C: Incomplete suppression of bEVs may appear to maintain a less inflammatory microglial phenotype, provided that <i>A. rectalis</i> abundance is not accompanied by increased production of pro-inflammatory metabolites.
D: Partial microbiota depletion may initially lead to reduced synaptic deficits, unless overridden by persistent bEV release that restores microglial pro-inflammatory activation.

Q80: In a scenario where butyrate-producing bacteria are depleted due to chronic dietary fiber deficiency, and subsequently, quinic acid supplementation is introduced after the onset of neuroinflammation in a high-fat diet (HFD) mouse model, which of the following outcomes would most likely occur, considering the hierarchical regulatory effects from gut microbiota composition to neuroinflammatory signaling and AD pathology?
Options:
A: Quinic acid supplementation would increase gut microbial tryptophan metabolites such as indole-3-acetic acid and kynurenic acid, leading to suppression of DR3/IKK/NF-κB signaling and reduction of Aβ and p-Tau levels, even in the absence of butyrate-producing bacteria.
B: The absence of butyrate-producing bacteria would prevent quinic acid from improving gut microbiota composition, thereby blocking any downstream effects on brain oxidative stress and neuroinflammation.
C: Quinic acid would directly restore butyrate levels, which would then inhibit the formation of the NLRP3 inflammasome and reduce neuroinflammation independently of tryptophan metabolites.
D: Despite the initial depletion of butyrate-producing bacteria, quinic acid could still exert neuroprotective effects by modulating gut microbial metabolites that act on inflammatory signaling pathways, ultimately decreasing AD pathological markers.

Q81: In a scenario where an aged APP/PS1 mouse model with established intestinal dysbiosis and increased microglial activation is first subjected to antibiotic-induced microbiome depletion, followed by delayed supplementation with both Agathobacter rectalis and Candida rugosa lipase, which of the following outcomes would most likely occur through temporally ordered, multi-level regulatory mechanisms involving bacterial metabolites, signaling pathways, and neuroinflammation?
Options:
A: Butyric acid produced by Agathobacter rectalis would directly suppress microglial activation via the Akt/NF-κB pathway, leading to reduced neuroinflammation after the restoration of gut commensals.
B: Candida rugosa lipase administration would initially increase gut lipid hydrolysis, subsequently normalizing peripheral unsaturated fatty acids and indirectly contributing to improved memory function through microbiome-mediated effects.
C: Immediate restoration of anti-inflammatory bacteria abundance would prevent any activation of microglia, regardless of the prior state of gut dysbiosis or timing of supplementation.
D: The transfer of memory benefits via fecal matter transplant from treated mice to microbiome-depleted wildtype mice would be ineffective if postbiotic supplementation is delayed until after antibiotic treatment.

Q82: Considering the foundational concept of the "gut-brain" axis as mediated by microbial-derived metabolites, which of the following statements best reflect mechanistic implications for neuroinflammation in 5×FAD mice, according to the context?
Options:
A: The gut microbiome directly modulates neuroinflammation in the brain exclusively through immune cell migration, regardless of metabolite production.
B: Microbial-derived metabolites are hypothesized to mediate the "gut-brain" axis, potentially influencing neuroinflammation and cognitive function in Alzheimer's disease models.
C: Gut dysbiosis is associated with Alzheimer's disease progression, although the precise mutual interactions between the gut microbiome and neuroinflammation remain unclear.
D: Neuroinflammation in the brain is expected to regulate the composition of the gut microbiome by altering microbial metabolite synthesis, as established in the context.

Q83: When considering the foundational mechanisms by which indole-3-propionic acid (IPA) ameliorates cognitive deficits in LPS-induced models, which of the following statements accurately reflect the regulatory logic or context-specific outcomes described?
Options:
A: IPA’s inhibition of the RAGE-JAK2-STAT3 pathway is necessary for its reduction of neuroinflammation, although Colivelin TFA can partially counteract these effects by activating JAK2-STAT3.
B: Activation of the RAGE-JAK2-STAT3 pathway by IPA directly promotes neurogenesis and restores memory in LPS-induced cognitively impaired mice.
C: While IPA maintains the integrity of the blood-brain barrier and intestinal barrier, these effects are independent of its modulation of the RAGE-JAK2-STAT3 pathway.
D: IPA reduces LPS-induced apoptosis and oxidative damage in HT22 cells, but this effect is reversed when RAGE-JAK2-STAT3 signaling is reactivated.

Q84: When considering the foundational mechanisms by which time-restricted feeding (TRF) influences cognitive outcomes in Alzheimer's disease models, which of the following statements accurately reflect the regulatory or pathway logic described in the context?
Options:
A: TRF enhances fecal propionic acid levels, which positively correlate with cognitive function in Alzheimer's disease patients.
B: Oral administration of B. pseudolongum or propionic acid fails to reproduce the cognitive improvements observed with TRF, unless combined with FFAR3 overexpression.
C: The cognitive benefits of TRF are abolished when FFAR3 is knocked down, indicating that FFAR3 mediates the effects of increased propionic acid.
D: Amyloid-beta deposition and neuroinflammation are exacerbated by TRF in 5xFAD mice, except when B. pseudolongum is depleted.

Q85: Considering the mechanistic roles of TMAO described in the context of aging and neurocognitive disorders, which of the following statements accurately reflect foundational concepts regarding its effects on cognitive function under varying conditions?
Options:
A: Reduced synaptic plasticity and function are direct consequences of TMAO’s positive effects on blood-brain barrier integrity in the context of neurocognitive disorders.
B: TMAO supplementation consistently reduces vulnerability to cognitive decline in both normal aging and neurocognitive disorder, regardless of underlying mechanisms.
C: While TMAO may promote neuroinflammation and oxidative stress, it has also been reported to support blood-brain barrier integrity, complicating its overall impact on cognition.
D: Although higher circulating TMAO is associated with increased risk of cognitive decline, supplementation of TMAO precursors has been reported to confer cognitive benefit.

Q86: If a mouse model of Alzheimer's disease is subjected to both partial suppression of the Keap-1/Nrf2 pathway and incomplete enrichment of indole-3-lactic acid (ILA)-producing gut bacteria, which of the following outcomes may be most consistent with the described mechanisms, assuming no compensatory increase in short-chain fatty acid (SCFA) production?
Options:
A: The mouse may exhibit persistent neuroinflammation and impaired cognitive behavior, as neither antioxidant enzyme activity nor AhR-mediated microglial activation is fully supported.
B: The mouse may initially show reduced amyloid-beta accumulation due to partial Nrf2 nuclear translocation, unless overridden by insufficient ILA to activate the aryl hydrocarbon receptor.
C: The mouse may display enhanced hippocampal neuronal morphology and upregulation of HO-1 and NQO-1, provided that SCFA-producing bacteria compensate for the incomplete ILA enrichment.
D: The mouse may appear to have normalized gut-brain axis homeostasis, as partial Keap-1/Nrf2 suppression is typically offset by increased tryptophan-derived metabolite production.

Q87: If a scenario arises in which curcumin metabolism by intestinal microbiota is delayed, while at the same time, indole-3-propionic acid (IPA) administration only partially suppresses the RAGE-JAK2-STAT3 pathway, which of the following outcomes may be expected regarding neuroinflammation and cognitive function, assuming no compensatory upregulation of aryl hydrocarbon receptor (AhR) signaling?
Options:
A: The reduction in neuroinflammation may be incomplete, as IPA’s partial inhibition of RAGE-JAK2-STAT3 would not fully counteract LPS-induced glial activation, and delayed curcumin metabolism would limit the availability of its anti-inflammatory derivatives.
B: Cognitive improvement may be initially observed due to IPA’s antioxidant properties, but sustained benefit is unlikely unless the AhR pathway is activated by microbiota-derived Indoles, which is absent in this scenario.
C: Synaptic plasticity restoration may appear robust, since delayed curcumin metabolism increases the pool of parent curcumin, which directly upregulates AhR and compensates for partial IPA efficacy.
D: Inflammatory cytokine release, such as TNF-α and IL-6, may remain elevated, because both the incomplete suppression of the RAGE-JAK2-STAT3 pathway by IPA and the reduced formation of curcumin metabolites fail to sufficiently inhibit NF-κB signaling.

Q88: In a scenario where aged mice with hippocampal metabolic and gene expression alterations (including reduced microbiota-derived metabolites) are subsequently administered a synbiotic therapy containing Clostridium sporogenes and xylan for 30 days, which of the following predictions about the hierarchical sequence from gut microbiota modulation to behavioral outcome is most consistent with the described multi-omics and intervention data?
Options:
A: The synbiotic-induced increase in IPA levels would be expected to correlate with reduced amyloid-β accumulation in both the cortex and hippocampus, as part of the downstream effect.
B: Behavioral improvements in exploration and locomotion would directly result from initial changes in hippocampal gene expression, independent of gut microbiota-derived metabolite alterations.
C: Restoration of synaptic ultrastructure and suppression of neuroinflammation in the hippocampus would likely follow increased indole-3-propionic acid (IPA) production by gut microbiota, leading to improved cognitive performance.
D: Enhanced cognitive and spatial memory faculties would precede any significant changes in the abundance of IPA-synthesizing bacteria such as Lachnospira and Clostridium.

Q89: In a scenario where germ-free (GF) Alzheimer's disease (AD) mice are first maintained without gut microbiota and subsequently receive short chain fatty acid (SCFA) supplementation after microglial maturation has occurred, which of the following predictions about microglial phenotype and Aβ plaque deposition most accurately reflects the temporally sequenced regulatory effects described in the context?
Options:
A: SCFA supplementation will upregulate microglial ApoE expression and increase Aβ plaque load to levels comparable to conventionally colonized animals.
B: The absence of gut microbiota will permanently prevent microglial recruitment to Aβ plaques, even after SCFA supplementation.
C: SCFA supplementation will result in microglia containing more intracellular Aβ, thereby reducing extracellular plaque burden.
D: Delayed SCFA exposure after microglial maturation will still promote Aβ deposition via modulation of microglial transcriptomic profiles.

Q90: In a scenario where APP/PS1 mice are first subjected to a high-fat diet (HFD) that alters gut microbiota and increases peripheral inflammation, and then subsequently treated with Huanglian Jiedu decoction (HLJDD) after the onset of HFD-induced metabolic changes, which of the following predictions about neuroinflammatory and cognitive outcomes can be made by integrating the regulatory sequence from gut microbiota alteration to central nervous system effects, as described in the context?
Options:
A: The sequence of HFD-induced gut microbiota alteration followed by HLJDD treatment may result in a favorable microenvironment for bile acid and arachidonic acid metabolism, contributing to improved LXR/PPAR expression and partial remission of neuroinflammation.
B: HLJDD administration after HFD is expected to globally suppress inflammation and lipid accumulation, thereby ameliorating cognitive impairment despite persistent peripheral inflammation.
C: HLJDD treatment prior to HFD exposure would be required to observe any improvement in neuroinflammation or cognition, as post-HFD intervention is ineffective according to the described studies.
D: The initial HFD-induced increase in cholesterol and peripheral inflammation directly exacerbates Aβ levels and contextual memory deficits in APP/PS1 mice, which cannot be reversed by subsequent HLJDD intervention.

Q91: In a scenario where DHPS-producing bacteria are selectively depleted from the gut microbiome of a transgenic Alzheimer's disease mouse model, and a modified Mediterranean-ketogenic diet (MkD) is introduced only after the onset of neuroinflammation, which of the following outcomes would most likely be observed, considering the regulatory hierarchy from microbial metabolism to neurobehavioral function and the timing of intervention?
Options:
A: The late introduction of MkD would fail to upregulate neuroprotective serum metabolites, as the absence of DHPS-producing bacteria disrupts the gut-microbiome-brain axis required for metabolite-mediated hippocampal pathway modulation.
B: Despite the absence of DHPS-producing bacteria, MkD would still promote Lactobacillus growth and increase bacteria-derived lactate, leading to improved neurobehavioral outcomes via upregulation of neuroprotective receptors.
C: Early depletion of DHPS-producing bacteria would directly increase short-chain fatty acid production, thereby reducing neuroinflammation and restoring CA3 hippocampal neuronal morphology, regardless of dietary intervention.
D: The absence of DHPS-producing bacteria would result in decreased hydrogen sulfide catabolism, which, when combined with delayed MkD intervention, could exacerbate oxidative stress and impair gut-brain communication, worsening neurocognitive outcomes.

Q92: If butyrate-mediated epigenetic regulation is only partially preserved while synbiotic-induced modulation of gut microbiota is abruptly withdrawn in an individual with early Alzheimer's disease, which of the following outcomes may most plausibly result, given the described mechanisms and regulatory order?
Options:
A: The maintenance of blood-brain barrier integrity may be initially compromised, unless butyrate’s influence on neuroinflammation fully compensates for the loss of synbiotic effects.
B: Amyloid protein formation is likely to be completely suppressed due to persistent microglial maturation, even in the absence of synbiotic intervention.
C: The resilience of a healthy microbiota may appear to protect against tau pathology, provided that physical activity is simultaneously increased to modulate neuroinflammation.
D: Regulation of brain metabolism by butyrate may remain unaffected, unless the partial preservation of epigenetic regulation disrupts neuronal function.

Q93: When considering the foundational mechanisms by which Kai Xin San-Jia Wei (KXSJW) ameliorates cognitive dysfunction in APP/PS1 mice, which of the following statements accurately reflect context-dependent regulatory effects observed after two months of treatment, as opposed to mechanisms that are either temporally misapplied or incorrectly attributed?
Options:
A: KXSJW administration restored the intestinal barrier function and increased the release of intestinal peptide hormones, such as Glucagon and GHRP-Ghrelin, in AD model mice.
B: The improvement in cognitive function following KXSJW treatment was primarily due to direct inhibition of β-amyloid production in the brain, independent of gut microbiota modulation.
C: While KXSJW reduced amyloid deposition in brain tissue, this effect was observed in parallel with, rather than as a consequence of, restored gut microbial balance and increased butyric acid levels.
D: KXSJW-induced changes in gut microbiota composition, especially the increase in Firmicutes and its metabolite butyric acid, were associated with improved learning and memory in APP/PS1 mice.

Q94: In a scenario where germ-free Alzheimer's disease (AD) mice are first maintained without gut microbiota and then, after a delay, are supplemented with Hericium coralloides polysaccharide (HCP) but not with short chain fatty acids (SCFA), which of the following predictions about microglial phenotype, amyloid-β (Aβ) plaque deposition, and neuroinflammation are most consistent with the described regulatory and temporal sequence?
Options:
A: Microglia will exhibit increased M2 polarization and enhanced autophagic flux, resulting in reduced Aβ plaques and neuroinflammation, as HCP acts independently of SCFA to promote these effects.
B: Delayed HCP supplementation will upregulate ApoE in microglia and increase Aβ plaque load to levels seen in conventionally colonized mice, since HCP mimics the effect of SCFA on microglial transcriptomics.
C: The absence of SCFA will prevent HCP from reducing neuroinflammation, as SCFA are required for M2 microglial polarization and autophagy enhancement.
D: Aβ plaque deposition will remain lower than in SPF mice, and neuroinflammation will be attenuated, because HCP can reduce plaques and inflammation even in the absence of microbiota-derived SCFA.

Q95: If a therapeutic intervention in Alzheimer's disease simultaneously delays the enhancement of autophagic flux by Hericium coralloides polysaccharide (HCP) and only partially suppresses the Akt/NF-κB pathway modulation by butyric acid from Agathobacter rectalis, which of the following outcomes may most plausibly occur, given the described mechanisms and their regulatory order?
Options:
A: Neuroinflammation may persist, unless overridden by a compensatory increase in adrenal corticosteroid signaling, which is not described as a direct effect of either HCP or butyrate in the context.
B: Amyloid-β plaque reduction may be incomplete, as insufficient autophagy enhancement by HCP limits M2 microglial polarization, while only partial Akt/NF-κB suppression by butyrate fails to fully mitigate neuroinflammation.
C: Cognitive impairment is likely to be fully reversed, since partial Akt/NF-κB pathway suppression by butyrate is sufficient to compensate for delayed autophagic flux enhancement by HCP.
D: The abundance of Agathobacter rectalis in the gut will increase, directly resulting in immediate reduction of phosphorylated tau protein deposition, regardless of autophagic flux status.

Q96: If a scenario arises in which gut mucosal immunity is only partially dysregulated, leading to moderate but persistent intestinal barrier (IB) disruption, and simultaneously, dietary phytochemical intake is delayed until after the onset of neuroinflammation, which of the following outcomes may be most consistent with the mechanisms described in the context?
Options:
A: The moderate IB disruption may initially permit gut microbiota-derived metabolites to impair blood-brain barrier (BBB) integrity, promoting neuroinflammation and neurodegeneration, while delayed phytochemical intake fails to prevent early BBB corruption.
B: Delayed phytochemical intake, even after neuroinflammation is established, may appear to reverse BBB permeability changes unless overridden by ongoing gut microbiota-induced systemic chronic inflammation.
C: Persistent but moderate IB disruption, in the absence of timely phytochemical intervention, may allow chronic systemic inflammation to bridge gut and brain pathology, contributing to Alzheimer's disease progression.
D: Early dietary phytochemical incorporation would override the effects of partial gut mucosal immunity dysregulation, immediately restoring BBB integrity and halting neuroinflammation.

Q97: When considering the foundational mechanisms by which quinic acid (QA) mitigates high-fat diet (HFD)-induced neuroinflammation, which of the following statements most accurately reflect the regulatory sequence and context-specific relevance described in the context?
Options:
A: QA directly inhibits DR3/IKK/NF-κB signaling in the brain, independent of changes in gut microbial metabolites.
B: The increase in gut microbial tryptophan metabolites such as IAA and KYNA after QA administration is negatively correlated with both pro-inflammatory factors and AD indicators.
C: Administration of IAA and KYNA in HFD mice fails to reproduce the anti-inflammatory and anti-oxidative effects observed with QA treatment.
D: Transcriptomics analysis after IAA administration reveals inhibition of DR3/IKK/NF-κB signaling, supporting a mechanistic link between gut metabolites and brain inflammation.

Q98: If treadmill exercise is initiated in APP/PS1 mice after partial depletion of short-chain fatty acid-producing bacteria, and Armillariella tabescens-derived polysaccharides are administered but the Keap-1/Nrf2 pathway is only incompletely suppressed, which of the following outcomes may be most consistent with the described mechanisms?
Options:
A: Neuroinflammation in the hippocampus may be only partially alleviated, as exercise-induced enrichment of Akkermansia cannot fully compensate for reduced short-chain fatty acid production when ATEP’s antioxidant effects are limited by incomplete Keap-1/Nrf2 suppression.
B: Amyloid pathology is likely to be exacerbated, since treadmill exercise cannot modulate gut microbial diversity in the absence of full Nrf2 pathway activation.
C: LPS displacement from the intestine to the brain may remain elevated, unless the Keap-1/Nrf2 pathway is fully activated by ATEP, regardless of changes in gut barrier proteins.
D: Cognitive behavior improvements may appear to occur, unless overridden by persistent oxidative stress due to incomplete suppression of the Keap-1/Nrf2 pathway, even if probiotic bacteria increase.

Q99: If an intervention in an Alzheimer's disease (AD) animal model simultaneously delays the restoration of intestinal barrier integrity but only partially suppresses neuroinflammation, which of the following outcomes may be most consistent with the mechanisms described for SCP2 and BEP2, assuming no compensatory increase in short-chain fatty acids (SCFAs) or S24-7 family abundance occurs?
Options:
A: The abundance of norepinephrine in the brain may initially increase, unless overridden by a full restoration of the intestinal barrier.
B: The intervention may fail to significantly improve learning and memory capacity, as both gut microbiota modulation and neuroinflammation suppression are incompletely achieved.
C: The chemokine fractalkine (CX3CL1) and its receptor (CX3CR1) on microglia may be upregulated, provided that gut microbiota disorders are fully reversed.
D: The levels of interleukin (IL)-1β and IL-6 may remain elevated, since partial neuroinflammation suppression without increased SCFAs or S24-7 family abundance is insufficient for their reduction.

Q100: If a therapeutic intervention simultaneously delays the activation of Aβ-phagocytic microglia via the mTOR-HIF-1α pathway and only partially restores the abundance of Ruminococcaceae in the gut microbiota of Aβ<sub>1-42</sub>-induced AD rats, which of the following outcomes may be most consistent with the described mechanisms, considering the absence of compensatory serotonin production?
Options:
A: Cognitive improvement may be limited, as both reduced microglial Aβ clearance and incomplete gut microbiota reconstruction restrict neuroprotection.
B: The intervention may initially lead to persistent Aβ<sub>1-42</sub> accumulation in the hippocampus, unless overridden by enhanced serotonin-mediated modulation of the gut-brain axis.
C: Behavioral alterations associated with AD may appear to resolve, provided that Erysipelotrichaceae abundance is reduced independently of microglial activation.
D: Neuroinflammatory responses are likely to be fully suppressed, since partial Ruminococcaceae restoration alone is sufficient to balance brain redox status.

Q101: Based on the context, which molecular effects are directly associated with the gut microbiome or its metabolites in the modulation of neurodegenerative disease pathophysiology or ME/CFS symptoms?
Options:
A: Gut microbiota diversity can contribute to systemic inflammation.
B: Microbiome metabolites mediate both brain physiology and neurodegenerative pathology.
C: Pharmacological interventions directly upregulate gut-microbial diversity.
D: Gut epithelial barrier integrity is regulated by the gut-brain axis.

Q102: Based on the provided context, which of the following statements describe direct molecular or cellular effects related to gut microbiota or neuroinflammation in dementia or Parkinson's disease?
Options:
A: Rubusoside directly increases the abundance of Bacteroidia in the gut microbiota.
B: Activation of microglia cells is involved in the neuroinflammation observed in Parkinson's disease.
C: Bifidobacterium spp. directly increase the production of proinflammatory cytokines in the brain.
D: Bacteroides spp. are associated with inflammation and dysbiosis in elderly participants.

Q103: Based on the context, which of the following molecular effects are directly associated with Bifidobacterium pseudolongum or its metabolite propionic acid in the mitigation of Alzheimer's disease-associated cognitive impairments?
Options:
A: Bifidobacterium pseudolongum enhances propionic acid production.
B: Knockdown of FFAR3 enhances the cognitive benefits of time-restricted feeding.
C: Propionic acid inhibits the blood-brain barrier penetration of metabolites.
D: Propionic acid activates free fatty acid receptor 3 (FFAR3).

Q104: According to the context, which of the following molecular effects are directly attributed to short-chain fatty acids (SCFAs) in the regulation of osteoarthritis and gut health?
Options:
A: SCFAs maintain the integrity of cartilage and subchondral bone.
B: SCFAs preserve intestinal barrier function.
C: SCFAs inhibit the production of dietary fibers in the gut.
D: SCFAs directly increase the synthesis of neurotransmitters in the central nervous system.

Q105: Based on the provided context, which of the following statements accurately describe direct molecular effects involving exosomes or the gut-brain axis in neuroinflammation or depression?
Options:
A: Imbalances in gut microbiota can promote inflammation by increasing gut permeability.
B: Exosomes directly suppress the biogenesis of amyloid-β in Alzheimer's disease.
C: The HPA axis inhibits the production of serotonin in the gut.
D: Exosomes promote the propagation of pathological proteins in Alzheimer's disease.

Q106: Based on the context, which of the following molecular effects are directly associated with PTSD according to recent research findings?
Options:
A: ncRNA mimics directly suppress pro-inflammatory cytokines in PTSD.
B: The gut microbiome directly inhibits neuroinflammatory processes in PTSD.
C: Abnormal immune cell activation is observed in PTSD patients.
D: Elevated levels of soluble adhesion molecules are found in PTSD patients.

Q107: Based on the provided context, which of the following statements accurately describe direct molecular interactions involving NFKB1 and bile acid derivatives in the context of erectile dysfunction?
Options:
A: Butyricicoccus directly inhibits NFKB1 activity.
B: NFKB1 shows high binding affinity to Tauroursodeoxycholic acid.
C: Alistipes directly activates CYP3A4.
D: NFKB1 shows high binding affinity to Taurochenodeoxycholic acid.

Q108: Based on the context, which of the following statements describe direct molecular effects involving the gut microbiota or its metabolites on the gut-brain axis in central nervous system diseases?
Options:
A: Restoring balance to the gut microbiome can reduce inflammation associated with neurodegenerative diseases.
B: The gut microbiome directly inhibits the central nervous system through the enteric nervous system.
C: Exercise directly activates the central nervous system by increasing gut microbiota diversity.
D: Short-chain fatty acid-producing bacteria introduce key metabolites that support gut homeostasis.

Q109: Based on the provided context, which of the following molecular effects are directly associated with increased LRRK2 expression in the brain of mice with Parkinson's disease and colitis?
Options:
A: Inhibition of Nrf2 pathway
B: Activation of NF-κB pathway
C: Reduction of inflammatory cytokines IL1-β and TNF-α
D: Upregulation of ZO-1 and Occludin

Q110: Based on the context, which of the following molecular effects are directly associated with tryptophan metabolites in the gut microbiota-spinal cord signaling pathway network described in the study?
Options:
A: Suppression of gut microbiota diversity by tryptophan metabolites
B: Activation of genes involved in anti-inflammatory processes by tryptophan metabolites
C: Activation of genes involved in neuroregenerative processes by tryptophan metabolites
D: Direct inhibition of Bacillota abundance by tryptophan metabolites

Q111: Based on the provided context, which of the following molecular effects are directly associated with nicotinamide n-oxide (NAMO) in the regulation of microglial activity during herpes simplex encephalitis (HSE)?
Options:
A: NAMO restores NAD+-dependent mitophagy in microglia.
B: NAMO impairs mitochondrial function in microglia.
C: NAMO restrains microglial over-activation.
D: NAMO increases proinflammatory cytokine production by microglia.

Q112: Based on the context, which molecular effects are directly associated with indoleacetic acid (IAA) in glaucoma models, specifically regarding microglial activation and the RAGE/NF-κB pathway?
Options:
A: IAA attenuates RAGE/NF-κB pathway activation via AhR-dependent signaling.
B: IAA upregulates pro-inflammatory mediators release.
C: IAA depletes tryptophan-metabolizing bacteria.
D: IAA inhibits microglial activation.

Q113: Based on the provided context, which of the following molecular effects are directly associated with a high-fat diet (HFD) on gut and brain health in the context of type-2 diabetes and Alzheimer's disease?
Options:
A: HFD directly increases tyrosine kinase expression in the brain.
B: HFD directly activates microglial phagocytic clearance in the brain.
C: HFD causes loss of integrity of the intestinal barrier.
D: HFD induces gut dysbiosis with driven metabolites.

Q114: Based on the context, which of the following describes direct molecular effects of the gut microbiota on host physiological processes during early life or in neuropsychiatric disease?
Options:
A: Gut microbiota promote the development of the central nervous system (CNS).
B: Gut microbiota play key roles in maintaining intestinal barrier integrity.
C: Gut microbiota directly increase the risk of pediatric obesity by altering host DNA.
D: Gut microbiota eliminate all environmental factors affecting the host.

Q115: Based on the context, which molecular effects are directly exerted by Dendrobium officinale Kimura & Migo flower flavonoids (DOFF) in D-galactose-induced aging mice?
Options:
A: DOFF increases the ratio of Firmicutes/Bacteroidetes.
B: DOFF inhibits the expression of pro-inflammatory factors TNF-α, IL-6 and IL-1β.
C: DOFF down-regulates the activity of SOD, CAT and POD.
D: DOFF up-regulates the expression of ZO-1.

Q116: Based on the context, which of the following molecular effects are directly mediated by metabolites of probiotics such as Lacticaseibacillus rhamnosus GG and Bifidobacterium animalis on peroxisome proliferator-activated receptors (PPARs)?
Options:
A: Suppression of peroxisome proliferator-activated receptors (PPARs) by the immune system
B: Mediation of neuroactive effects by peroxisome proliferator-activated receptors (PPARs) in response to probiotic metabolites
C: Activation of peroxisome proliferator-activated receptors (PPARs) by probiotic metabolites
D: Direct inhibition of the gut microbiota by peroxisome proliferator-activated receptors (PPARs)

Q117: Based on the context, which of the following statements describe direct molecular effects involving metabolites or gut microbiota on immune or metabolic regulation in distant organs?
Options:
A: Gut microbial metabolites regulate gastrointestinal immune systems.
B: Gut microbial communities have significant impacts on metabolic function and immune responses.
C: Pulmonary infections directly increase the number of gut microorganisms.
D: Metabolite signatures in saliva are unrelated to Parkinson's disease.

Q118: Based on the provided context, which of the following molecular effects are directly associated with short-chain fatty acids (SCFAs) in experimental models of Japanese encephalitis or osteoarthritis?
Options:
A: SCFAs upregulate the expression of phospho-NF-kB (P-NF-kB) in brain tissue.
B: SCFAs reduce glial activation as indicated by decreased microglial counts.
C: SCFAs increase caspase-3 upregulation in JEV-infected animals.
D: SCFAs downregulate inflammatory cytokines such as TNF-α, MCP-1, IL-6, and IFN-Υ.

Q119: Based on the provided context, which of the following statements best integrate the mechanistic roles of gut microbiota-derived short-chain fatty acids (SCFAs) and intestinal barrier function in the progression or mitigation of neurological and metabolic diseases, such as Alzheimer's disease, autism spectrum disorder, and metabolic dysfunction-associated steatotic liver disease?
Options:
A: Increased production of SCFAs by gut microbiota directly leads to the onset of osteoporosis by enhancing systemic chronic inflammation and hepatic fat accumulation.
B: Therapeutic interventions that restore SCFA levels, such as manual acupuncture or probiotics, can alleviate intestinal barrier dysfunction and reduce neuroinflammation, as demonstrated in Alzheimer's disease models and supported by the beneficial associations of SCFA-producing microbes in multiple sclerosis.
C: Altered gut microbiota composition, characterized by increased Bifidobacterium and butyrate-producing genera, is a common feature in both autism spectrum disorder and insulin resistance, leading to increased intestinal permeability.
D: Reduced SCFAs contribute to impaired intestinal barrier integrity and increased inflammation, which are mechanistically linked to both neuroinflammation in Alzheimer's disease and the progression of metabolic dysfunction-associated steatotic liver disease.

Q120: Based on the provided context, which of the following statements best integrate the roles of gut microbiota composition, metabolite production, and disease progression in both neurological and systemic disorders, highlighting the mechanisms by which gut microbiota influence host health outcomes?
Options:
A: Gut microbiota only affect neurological disorders through neurotransmitter production, with no evidence for involvement in immune modulation or metabolic pathways.
B: Alistipes is beneficial in both multiple sclerosis progression and lupus suppression, as its presence is consistently linked to improved health outcomes in these disorders.
C: Alterations in gut microbiota composition can modulate disease progression in both systemic lupus erythematosus and menopause, as demonstrated by the impact of microbiota transplantation and the regulation of estrogen homeostasis.
D: Short-chain fatty-acid-producing microbes in the gut are associated with beneficial outcomes in progressive multiple sclerosis, and gut microbiota diversity after menopause influences estrogen levels, which in turn affects cognitive decline.

Q121: Based on the provided context, which of the following statements best illustrate how interventions targeting the gut microbiota can influence both immune and neurological health, requiring integration of mechanisms involving vitamin D, essential oils, and the microbiota-gut-brain axis?
Options:
A: Short-chain fatty acids produced by the gut microbiota only affect the blood-brain barrier and have no influence on immune system modulation or neuroinflammation.
B: Cannabis essential oil interacts with cannabinoid receptors to modulate gut motility and immune responses, but chronic use may alter gut microbiota composition, potentially impairing cognitive function via the gut-brain axis.
C: Essential oils, such as those from rosemary and lavender, directly increase vitamin D synthesis in the gut, thereby preventing immunosenescence and neurodegeneration.
D: Vitamin D supplementation can modulate gut microbiota diversity, which in turn promotes the synthesis of active vitamin D metabolites, enhancing immune resilience and potentially impacting neuroinflammation through the gut-brain axis.

Q122: Based on the provided context, which of the following statements accurately integrate information about the mechanisms by which dietary or microbiota-targeted interventions may modulate neuroinflammation and neurodegeneration in the context of neurodegenerative diseases or neuroangiostrongyliasis?
Options:
A: The beneficial effects of probiotics in Alzheimer's disease are solely due to their ability to increase cholinergic synaptic activity, independent of any impact on neuroinflammation or glial cell activation.
B: The ketogenic diet may reduce neuroinflammation in neurodegenerative diseases by inducing ketone body production, which is linked to immunomodulatory effects in the central nervous system.
C: Antioxidants can exert neuroprotective effects in neurodegenerative diseases by modulating the gut microbiota and influencing molecular pathways such as NF-κB and Nrf2, thereby reducing oxidative stress and neuroinflammation.
D: Short-chain fatty acids produced by Lactobacillus johnsonii are responsible for the observed improvements in neuroinflammation and survival in neuroangiostrongyliasis-infected mice.

Q123: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, immune or epigenetic mechanisms, and neurological or metabolic outcomes across different disease models, such as multiple sclerosis, ARDS-related depression, aging, and autism spectrum disorder?
Options:
A: Antibiotic-induced reduction of Bacillota and Bacteroidota in the gut directly leads to increased anti-viral IgG1/IgG2c levels and improved neurological outcomes in TMEV-infected mice.
B: Alterations in gut microbiota can influence neurological outcomes through immune pathways, as seen in both ARDS-related depression via microglial activation and ASD through neuroimmune activation.
C: Microbial metabolites produced by the gut microbiome can act as epigenetic modifiers, influencing host gene expression and potentially contributing to age-related neurodegenerative disorders.
D: Increased abundance of Bifidobacterium and butyrate-producing genera is a common feature in both ASD and insulin resistance, directly reducing neuroimmune activation and improving metabolic function.

Q124: Based on the provided context, which of the following statements best integrate findings about gut-derived factors, immune-inflammatory mechanisms, and neurological disease progression, specifically linking gut microbiota, metabolites, and molecular pathways in the brain?
Options:
A: The presence of microbial DNA in cerebrospinal fluid is sufficient to explain the mechanism by which gut inflammation leads to neurodegeneration in Parkinson's disease.
B: Short-chain fatty acids (SCFAs) produced by gut microbiota are directly responsible for the upregulation of LRRK2 in the brain, leading to dopaminergic neuron loss in Parkinson's disease models.
C: In multiple sclerosis, a decrease in short-chain fatty-acid-producing microbes and their metabolites in the gut is associated with worsening neurological disability, supporting the idea that gut-derived protective factors influence disease progression.
D: Increased LRRK2 expression in both the colon and brain, as seen in dual-hit colitis and Parkinson's disease mouse models, is associated with reduced intestinal barrier proteins and elevated inflammatory cytokines, suggesting that gut inflammation can exacerbate brain inflammation through molecular signaling.

Q125: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, gut permeability, and the kynurenine pathway in the pathogenesis and management of neurological disorders such as multiple sclerosis, and how might these mechanisms inform biomarker and therapeutic development?
Options:
A: Therapeutic strategies that restore gut microbial homeostasis, such as probiotics and dietary interventions, may suppress inflammation and modulate the kynurenine pathway, thereby reducing neuroinflammation and improving clinical outcomes in multiple sclerosis.
B: The abundance of Firmicutes in the blood microbiome is consistently elevated in all neurological and cardiovascular diseases, making it a universal biomarker for these conditions.
C: Elevated levels of Akkermansia muciniphila are protective against neuroinflammation and are associated with improved outcomes in multiple sclerosis due to their effects on gut permeability.
D: Dysbiosis-induced increases in gut permeability can facilitate the translocation of bacteria and toxins into the bloodstream, triggering systemic inflammation and neuroinflammation via the gut-brain axis, while dysregulation of the kynurenine pathway leads to neurotoxic metabolite production, both contributing to neurological disease progression.

Q126: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota and its metabolites in neurodegenerative and psychiatric disorders, specifically considering both mechanistic pathways and potential therapeutic implications?
Options:
A: Microbial metabolites such as sphingolipids and phospholipids can regulate Alzheimer’s disease pathogenic mechanisms, and interventions like probiotics or fecal microbiota transplantation aim to restore microbiota balance to improve AD symptoms.
B: Increased levels of LPS-binding protein and alpha-1 antitrypsin are consistently observed in both depressive and suicidal patients, indicating a direct link between gut permeability and suicidality.
C: The gut microbiota communicates bidirectionally with the brain, influencing neuroinflammation in Alzheimer’s disease, and targeted modulation of the microbiome is proposed as a therapeutic strategy to manage AD.
D: Platelets are the only source of BDNF in peripheral blood, and their interaction with monocytes is unrelated to microbial stimulation or the gut-brain axis.

Q127: Based on the provided context, which options correctly describe how gut microbiota modulation through dietary or antibiotic interventions can impact both immune and neurobehavioral outcomes in disease models, requiring integration of mechanisms and outcomes from multiple sections?
Options:
A: Gut microbiota interventions are only effective in modulating immune responses and have no impact on neurobehavioral outcomes or mood disorders according to the studies described.
B: Dietary component interventions that modulate gut microbiota can simultaneously inhibit abnormal tumor proliferation and improve mood behaviors in cancer patients by enhancing anticancer immune responses and regulating neurotransmitter homeostasis via the gut-brain axis.
C: Altered gut microbiota composition, whether through dietary modulation or disease states, can lead to systemic immune dysfunction and changes in neurobehavioral outcomes, as seen in both cancer-depression comorbidity and adolescent depression.
D: Antibiotic administration in the TMEV viral model of multiple sclerosis consistently improves both immune gene expression and neurological signs, regardless of timing or side effects such as dehydration.

Q128: Based on the provided context, which interventions demonstrate neuroprotective effects by both modulating gut microbiota composition and influencing neuroimmune or oxidative stress pathways, and what evidence supports their impact on cognitive function or neurodegenerative disease progression?
Options:
A: Intermittent theta burst stimulation (iTBS) improves cognitive dysfunction in DEACMP rats solely by increasing short-chain fatty acid levels in the serum.
B: Antioxidant-based interventions, including delivery by probiotics and prebiotics, exert neuroprotective effects by reducing reactive oxygen species production, modulating gut microbiota, and attenuating neuroinflammation in Alzheimer's and Parkinson's diseases.
C: Fecal microbiota transplantation (FMT) protects against ischemic injury and improves cognitive function by restoring microbial composition, reducing neuroinflammation, and lowering amyloid-β accumulation in Alzheimer's disease.
D: Bacteroides spp. abundance in elderly males is consistently associated with improved cognitive function and reduced risk of dementia-related brain pathologies.

Q129: In the context of mild chronic colitis exacerbating intracerebral inflammation in mice with Parkinson's disease, which of the following events occur sequentially after the induction of colitis and are temporally linked to the progression of brain inflammation, according to the described dual-hit (DSS+MPTP) mouse model? Select ALL that apply.
Options:
A: An increase in LRRK2 expression in both the colon and brain precedes the activation of NF-κB and inhibition of Nrf2 in the brain.
B: Activation of NF-κB and inhibition of Nrf2 in the brain are temporally associated with increased Iba-1 expression and dopaminergic neuron loss.
C: The reduction in intestinal barrier proteins ZO-1 and Occludin occurs after the upregulation of inflammatory cytokines IL1-β and TNF-α in the colon.
D: The upregulation of LRRK2 in the colon is a late event that follows the loss of dopaminergic neurons in the brain.

Q130: During the progression of herpes simplex encephalitis (HSE) caused by HSV-1 infection, which of the following events occur sequentially as a result of gut microbiota dysbiosis and can be modulated by the administration of nicotinamide n-oxide (NAMO)? Select all that apply.
Options:
A: HSV-1 infection leads to gut microbiota dysbiosis, which impairs mitophagy in microglia and results in their over-activation.
B: NAMO administration restores NAD+-dependent mitophagy, thereby restraining microglial over-activation and preventing early neuronal infection.
C: Depletion of gut microbiota by antibiotics results in hyperactivated microglia and exacerbated HSE pathology.
D: NAMO administration directly increases the production of proinflammatory cytokines by microglia during HSE.

Q131: Considering the temporal sequence of events in colorectal cancer (CRC) development, which of the following processes occur after a decrease in gut microbial short-chain fatty acid (SCFA) production, but before the initiation of tumor metastasis, according to the described regulatory hierarchy and epigenetic mechanisms?
Options:
A: Restoration of SCFA levels in the colon through microbiota modulation as a preventive strategy
B: Modification of epigenetic mechanisms such as DNA methylation and histone modifications affecting tumor initiation
C: Alterations in intestinal epithelial barrier function and immune responses linked to CRC progression
D: Exposure to environmental carcinogens leading to genetic alterations

Q132: Considering the temporal sequence of events in obesity-induced cognitive dysfunction, which of the following processes occur after the activation of enterocyte TLR signaling by a high-fat diet, but before the manifestation of neuroinflammation and brain damage? Select all that apply.
Options:
A: Alteration of the downstream MyD88-NF-κB signaling cascade and up-regulation of pro-inflammatory factors and lipopolysaccharide (LPS)
B: Loss of integrity of the intestinal mucosa and increased intestinal permeability
C: Disruption of the intestinal flora and damage to the intestinal barrier function
D: Gradual increase in childhood obesity rates

Q133: Considering the temporal sequence of microglial activation following ischemic stroke, which of the following events are likely to occur after the initial pro-inflammatory (M1) response but before the resolution of neuroinflammation, according to the described regulatory cascades and intervention strategies?
Options:
A: Immediate restoration of blood-brain barrier integrity prior to cytokine release by activated microglia.
B: Permanent suppression of all microglial activity immediately after stroke onset.
C: Activation of signaling pathways such as Toll-like receptor 4/nuclear factor kappa B and mitogen-activated protein kinases influencing microglial polarization.
D: Transition of microglia from M1 to M2 phenotype, promoting tissue repair through anti-inflammatory responses.

Q134: Considering the temporal sequence of events during menopause, which of the following processes occur after the initial decline in ovarian estrogen production, and subsequently contribute to the development of postmenopausal disorders through hierarchical regulation involving the gut microbiota and its metabolites?
Options:
A: A decrease in gut microbial diversity leads to weakened microbial decomposition, resulting in lower circulating estrogen and subsequent disorders such as osteoporosis and cognitive decline.
B: The ovaries increase estrogen production, which directly prevents changes in gut microbiota composition and maintains metabolic health.
C: Reduced microbial β-glucuronidase activity diminishes estrogen reabsorption in the enterohepatic circulation, further lowering systemic estrogen and affecting disease progression.
D: Immediate restoration of premenopausal gut microbiota diversity occurs, preventing any downstream effects on estrogen homeostasis or disease risk.

Q135: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes occur after the administration of Pectin-Zein-IPA nanoparticles, and contribute to functional recovery and reduced neuroinflammation according to the described mechanisms in the context?
Options:
A: Immediate restoration of gut microbiome balance prior to nanoparticle administration
B: Increase in L-methionine accumulation in the intestinal flora following nanoparticle administration
C: Activation of AKT/Nrf-2 signaling pathway and enhancement of axonal regeneration
D: Improvement of autophagy and inhibition of pyroptosis after nanoparticle treatment

Q136: Considering the temporal progression of neurodegenerative disorders, which of the following events would most likely occur after a sustained reduction in short-chain fatty acid (SCFA)-producing gut bacteria, and before the manifestation of cognitive impairment in HIV-associated neurocognitive disorder (HAND) patients, according to the described regulatory cascade?
Options:
A: Immediate improvement in cognitive function due to increased anti-inflammatory cytokines
B: A decrease in plasma SCFA levels leading to increased pro-inflammatory cytokines
C: A positive correlation between reduced SCFAs and elevated pro-inflammatory cytokines
D: Restoration of tissue homeostasis through in vitro host-microbiota models

Q137: Considering the temporal sequence of molecular and cellular events described in Negr1 knockout (KO) mice, which of the following occur after the early-life reduction in Akkermansia spp. but before the behavioral improvements observed with Akkermansia supplementation? Select all that apply.
Options:
A: Reduced dendritic arborization and spine density in the nucleus accumbens and dentate gyrus
B: Upregulation of mitochondrial genome-encoded genes in the nucleus accumbens and hippocampus
C: Downregulation of mitochondrial genes in the nucleus accumbens and hippocampus
D: Amelioration of anxiety- and depression-like behaviors

Q138: In the context of Alzheimer's disease mouse models, describe the temporal sequence of events following Buyang Huanwu Decoction (BYHWD) administration that leads to cognitive improvement. Which of the following events occur after the restoration of gut microbiota balance but before the amelioration of cognitive deficits, according to the described gut microbiota-C/EBPβ/AEP signaling pathway mechanism?
Options:
A: Transplantation of FMT-BYHWD from treated to germ-free 3×Tg mice
B: Initial administration of BYHWD to 3×Tg mice
C: Reduction of pathological Aβ plaque deposition and tau hyperphosphorylation
D: Suppression of the C/EBPβ/AEP signaling pathway in the hippocampus

Q139: Considering the temporal sequence of molecular and cellular events described in Negr1 knockout (KO) mice, which of the following processes occur after the early-life reduction in Akkermansia spp. but before the behavioral improvement observed with Akkermansia supplementation? Select all that apply.
Options:
A: Reduced dendritic arborization and spine density in the nucleus accumbens and dentate gyrus
B: Upregulation of mitochondrial genome-encoded genes in the nucleus accumbens and hippocampus
C: Amelioration of anxiety- and depression-like behaviors following Akkermansia administration
D: Upregulation of genes involved in T cell activation and immune homeostasis in the colon after Akkermansia supplementation

Q140: Considering the temporal sequence of molecular and cellular events described in the context of gut microbiota-derived indoleacetic acid (IAA) in glaucoma, which of the following events would be expected to occur after the restoration of AhR activation but before the preservation of visual function in the disease model?
Options:
A: Depletion of tryptophan-metabolizing bacteria such as B. fragilis in the gut microbiota
B: Reduction of retinal ganglion cell (RGC) loss
C: Lower systemic IAA levels following fecal microbiota transplantation from glaucoma patients
D: Suppression of microglial activation and inhibition of pro-inflammatory mediator release throughout the retina

Q141: Considering the temporal sequence of events following Monascus-fermented ginseng (MFG) intervention in hyperlipidemia (HLP) mice, which of the following processes are expected to occur after the gut microbiota is modulated by MFG but before improvements in lipid profiles and hepatic lipid accumulation are observed? Select all that apply.
Options:
A: Enhancement of cholesterol excretion and fatty acid β-oxidation
B: Suppression of lipogenic regulators and promotion of primary-to-secondary bile acid conversion
C: Normalization of the Firmicutes/Bacteroidetes ratio and enrichment of beneficial microbiota
D: Attenuation of hepatic lipid accumulation

Q142: Considering the temporal sequence of events in post-acute sequelae of COVID-19 (Long COVID), which of the following processes are likely to occur after the initial SARS-CoV-2 infection but before the manifestation of neuroinflammation and cognitive symptoms, according to the described gut-brain axis dysregulation and immune response cascades?
Options:
A: Resolution of neuroinflammation and normalization of serum cortisol levels.
B: Immediate restoration of beneficial short-chain fatty acid-producing bacteria such as Faecalibacterium and Bifidobacterium.
C: Increased gut leakiness allowing translocation of pathogens or lipopolysaccharide into circulation, triggering pro-inflammatory cytokine release.
D: Dysfunction of the angiotensin-converting enzyme 2 receptor leading to impaired mTOR pathway activation and reduced AMP secretion in the gut.

Q143: Considering the temporal sequence of events following HSV-1 neurotropic infection, which of the following processes occur after the initial gut microbiota dysbiosis and contribute to the regulation of microglial activation and neuroinflammation during herpes simplex encephalitis (HSE) progression?
Options:
A: Exogenous administration of nicotinamide n-oxide (NAMO) restoring NAD+-dependent mitophagy to restrain microglial over-activation.
B: Immediate restoration of microglial homeostasis by endogenous short-chain fatty acids (SCFAs) without involvement of gut microbial metabolites.
C: Direct suppression of HSV-1 replication in the gut by microglial phagocytosis prior to any changes in mitophagy.
D: Mitochondrial dysfunction and impaired mitophagy in microglia, leading to increased proinflammatory cytokine production.

Q144: Considering the temporal sequence of events following gingerol-enriched ginger (GEG) administration in female rats with neuropathic pain, which of the following changes are observed after the initial modulation of gut microbiota composition and metabolite profiles, and subsequently contribute to the mitigation of pain-associated behaviors through molecular alterations in the amygdala?
Options:
A: Downregulation of genes such as AVP, C4A, and TSPO in the amygdala following GEG-mediated shifts in gut microbiota and metabolite abundance.
B: Direct increase in anxiety-like behavior as a primary effect of GEG administration, independent of gut microbiota or gene expression changes.
C: Upregulation of genes such as APC, CCNH, and GRN in the amygdala after GEG-induced changes in gut microbiota and metabolites.
D: Immediate restoration of mechanical hypersensitivity before any detectable changes in gut microbiome diversity or metabolite levels.

Q145: Considering the temporal sequence of events following a high-fat diet (HFD), which of the following processes occur after HFD-induced gut dysbiosis but before the development of cognitive impairment in the context of type-2 diabetes and Alzheimer's disease risk? Select all that apply.
Options:
A: Cognitive impairment
B: Deposition of Amyloid β (Aβ) in the brain
C: Loss of integrity of the intestinal barrier and chronic low-grade inflammation
D: Obesity and type-2 diabetes development

Q146: Considering the temporal sequence of events in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD), which of the following processes are likely to occur after gut microbiota dysbiosis but before the development of hepatic inflammation, according to the described gut-liver axis mechanisms?
Options:
A: Enhanced intestinal permeability allowing translocation of bacterial products such as lipopolysaccharide (LPS) to the liver
B: Accumulation of hepatic lipids as a result of metabolic dysfunction
C: Activation of inflammatory responses within the liver due to microbial metabolites
D: Alteration of gut microbiome signatures serving as potential diagnostic biomarkers

Q147: Considering the temporal sequence of events in chronic kidney disease (CKD) progression, which of the following processes occur after polyphenol intake and before the slowing of CKD progression, according to the described regulatory cascades involving gut microbiota and molecular signaling pathways?
Options:
A: Polyphenols influence signaling pathways like PI3K/Akt and mTOR, which subsequently contribute to therapeutic effects on CKD.
B: Polyphenols modulate gut microbiota composition, leading to altered metabolite profiles that impact signaling pathways such as NF-κB and MAPK.
C: Slowing of CKD progression occurs prior to any modulation of gut microbiota by polyphenols.
D: CKD-induced changes in gut microbiota composition precede any intervention with polyphenols.

Q148: Considering the multi-step pathway by which gut microbiota influence estradiol metabolism and its relevance to depression in nonpremenopausal women, which of the following events would most likely occur sequentially after gut microbiota catabolize estradiol, and before the onset and course of depression, according to the described mechanisms in the context?
Options:
A: Immediate manifestation of depressive symptoms prior to any changes in estradiol metabolism by gut microbiota.
B: Gut microbiota-mediated metabolic transformation of estradiol, leading to changes in its degradation products relevant to depression pathogenesis.
C: Direct alteration of brain neurotransmitter levels by estradiol without involvement of gut microbiota.
D: Production of estradiol degradation products by gut microbiota, which then contribute to the development of depression.

Q149: Considering the temporal sequence of events in the progression of neurodegenerative diseases, which of the following processes occur after the initial production of biofilm-associated amyloid proteins by gut-colonizing bacteria, but before the exacerbation of neuronal damage? Select all that apply.
Options:
A: Cross-seeding of human amyloidogenic proteins such as amyloid-beta and α-synuclein, leading to their accelerated misfolding and aggregation.
B: Overwhelming of molecular chaperones and heat shock proteins by bacterial amyloids, resulting in compromised protein homeostasis.
C: Enhancement of biofilm resilience and antibiotic resistance by functional amyloid fibrils, complicating treatment.
D: Genetic variations in chaperone genes directly causing neurodegeneration without involvement of amyloid proteins.

Q150: Considering the temporal sequence of events in Alzheimer's disease progression as discussed in Drosophila melanogaster models, which of the following processes would most likely occur after gut dysbiosis but before the manifestation of neurocognitive impairment, according to the described gut-brain axis mechanisms?
Options:
A: Altered production of bacterial metabolites such as lactate and acetate that cross the blood-brain barrier
B: Activation of glial cells influenced by gut-derived metabolites
C: Clinical diagnosis of dementia based on cognitive impairment
D: Initial accumulation of amyloid-beta and tau proteins in the brain

Q151: Considering the temporal sequence of events in neurodegenerative diseases (NDDs), which of the following processes are likely to occur after an initial alteration in gut microbiota composition, but before the manifestation of cognitive or motor symptoms, according to the described gut-brain axis and related pathways?
Options:
A: Increased gut permeability leading to systemic inflammation and subsequent neuroinflammation via the kynurenine pathway.
B: Direct improvement of cognitive abilities in Alzheimer's disease patients without modulation of neurotrophic factors or reduction of oxidative stress.
C: Downregulation of the microbial metabolite DHPS, followed by increased hydrogen sulfide production, promoting inflammation and oxidative stress.
D: Immediate restoration of neuronal function solely through the administration of probiotics, without any intermediate molecular or immune changes.

Q152: Following bariatric surgery, a sequence of neurobiological and gut microbiota changes occurs that ultimately influences long-term metabolic health. Which of the following events are described as occurring after bariatric surgery and precede the improvement in satiety and decreased caloric intake, according to the context provided?
Options:
A: Immediate restoration of pre-surgical gut microbiota composition
B: Direct enhancement of cognitive control without any changes in gut microbiota
C: Increase in beneficial gut species such as Akkermansia muciniphila
D: Reduction in ghrelin levels and increase in GLP-1 and PYY hormones

Q153: In the context of Alzheimer's disease progression in APP/PS1 mice, which of the following events occur after a decrease in short-chain fatty acids (SCFAs) and precede the restoration of cognitive ability following manual acupuncture or probiotic intervention? Consider the temporal sequence involving gut barrier integrity, inflammatory signaling, and cognitive outcomes.
Options:
A: Initial increase in SCFAs and FFAR3 expression prior to any changes in inflammation
B: Immediate restoration of cognitive ability without changes in gut inflammation
C: Elevation of intestinal IL-1β and TNF-α levels
D: Impairment of intestinal barrier integrity and increased expression of NF-κB

Q154: Based on the described studies, which of the following events are likely to occur sequentially during the progression of Alzheimer's disease in mouse models, as supported by the context? Consider the timeline from early to late disease stages, including changes in gut microbiota, systemic inflammation, and brain pathology.
Options:
A: Significant changes in alpha diversity of gut microbiota occur before any alterations in beta diversity are detected in Alzheimer's disease mice.
B: An increased Firmicutes/Bacteroidetes (F/B) ratio is observed in Alzheimer's disease mice at 12 months, indicating improved gut microbial balance at late stages.
C: Elevated pro-inflammatory cytokines in the serum are associated with increased activity of microglia and astrocytes in memory-related brain regions as the disease progresses.
D: A reduction in short-chain fatty acids (SCFAs) is observed at both 6 and 12 months, preceding widespread disruption in gut microbial metabolism.

Q155: Considering the multi-step processes described in the context, which of the following events would most likely occur after gut microbiota-derived extracellular vesicles (MEVs) cross the intestinal barrier, but before they influence brain functionality and behavior? Select all that apply.
Options:
A: MEVs are endocytosed by host cells such as Caco-2 and hCMEC/D3, facilitating their transport across cellular barriers.
B: MEVs directly induce changes in mental and behavioral outcomes without interacting with host cellular or immune pathways.
C: MEVs immediately alter the expression of genes related to intestinal barrier integrity in Caco-2 cells.
D: MEVs stimulate immune pathways and suppress cell apoptosis processes in host cells, as revealed by RNA-seq analyses.

Q156: In the context of Alzheimer's disease mouse models, describe the temporal sequence of events following administration of Buyang Huanwu Decoction (BYHWD) that leads to cognitive improvement. Which of the following events occur after the restoration of gut microbiota balance but before the amelioration of cognitive deficits, according to the described gut microbiota-C/EBPβ/AEP signaling pathway mechanism?
Options:
A: Suppression of the C/EBPβ/AEP signaling pathway in the hippocampus
B: Reduction of pathological Aβ plaque deposition and tau hyperphosphorylation
C: Transplantation of FMT-BYHWD to germ-free 3×Tg mice
D: Initial administration of BYHWD to 3×Tg mice

Q157: Based on the described mechanisms in rheumatoid arthritis (RA) therapy using gold nanospheres (GNS), which of the following events occur after the oral administration of GNS and precede the suppression of NF-κB activation in synovial tissues? Select all that apply.
Options:
A: Upregulation of tight junction proteins Claudin-1 and ZO-1, restoring intestinal barrier function
B: Enrichment of the probiotic genus Ligilactobacillus in the gut microbiota
C: Direct inhibition of PTEN ubiquitination in synovial tissues prior to changes in gut microbiota composition
D: Immediate reduction of synovial hyperplasia before any changes in gut metabolites

Q158: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after the oral administration of medium-chain triglycerides (MCT) in 5×FAD mice, ultimately contributing to the prevention of Alzheimer's disease progression? Select all that apply.
Options:
A: Elevation of short-chain fatty acid concentrations in the brain after gut homeostasis is improved.
B: Direct inhibition of hyperactivated microglia and astroglia before any modulation of gut-derived metabolites.
C: Immediate reduction of Aβ levels in the brain prior to any changes in gut microbiota composition.
D: An increase in the relative abundance of Akkermansia in the gut microbiota, followed by reduced intestinal permeability.

Q159: During the progression of herpes simplex encephalitis (HSE) caused by HSV-1 infection, which of the following events occur after gut microbiota dysbiosis and mitochondrial dysfunction in microglia, but before the suppression of HSE progression by exogenous nicotinamide n-oxide (NAMO) administration? Select all that apply.
Options:
A: Impairment of mitophagy leading to microglial activation and increased proinflammatory cytokine production
B: Restoration of NAD+-dependent mitophagy by NAMO to restrain microglial over-activation
C: HSV-1 neurotropic infection causing gut microbiota dysbiosis and microglial antiviral immune response
D: Hyperactivation of microglia and exacerbation of HSE pathology following depletion of gut microbiota by antibiotics

Q160: Considering the temporal sequence of events following oral administration of medium-chain triglycerides (MCT) in 5×FAD mice, which of the following processes are likely to occur before the observed mitigation of memory decline, according to the described experimental findings and mechanistic insights?
Options:
A: Promotion of neurite regeneration in primary cortical neurons
B: Elevation of short-chain fatty acid concentrations in the brain
C: Increase in the relative abundance of Akkermansia in the gut microbiome
D: Direct reduction of beta-amyloid (Aβ) levels in the brain without changes in gut microbiota

Q161: Considering the temporal sequence of events following cerebral ischemia/reperfusion (I/R) injury in rats, which of the following processes are reported to occur after administration of Polygoni Multiflori Radix Praeparata polysaccharides (PMP), and contribute to the subsequent improvement in both neurological function and intestinal health? Select all that apply.
Options:
A: Reduction of inflammatory cytokines like TNF-α and IL-1β, which is associated with improved barrier integrity in both brain and intestinal tissues.
B: A negative correlation between Peptostreptococcaceae abundance and SCFA levels, which is linked to poor prognosis if not reversed by PMP intervention.
C: An increase in the abundance of beneficial gut microbiota such as Bifidobacterium and Lactobacillus, followed by enhanced production of short-chain fatty acids (SCFAs).
D: Immediate restoration of tight junction proteins in the brain and intestine prior to any changes in gut microbiota composition.

Q162: Considering the temporal progression of gut microbiota changes after spinal cord injury (SCI), which of the following statements accurately describe the sequential alterations in the abundance of short-chain fatty acid (SCFA)-producing bacteria from the subacute to the chronic phase, and their relationship to gut dysbiosis over time?
Options:
A: The chronic phase of SCI is characterized by a lower abundance of potential SCFA-producing bacteria compared to the subacute phase, indicating a temporal decline.
B: Firmicutes abundance increases in the chronic phase of SCI compared to the subacute phase.
C: Gut dysbiosis is only present in the chronic phase of SCI, with no significant changes observed in the subacute phase.
D: In the subacute phase of SCI, the relative abundance of several SCFA-producing genera such as Faecalbacterium, Ruminococcus, and Coprococcus increases compared to the chronic phase.

Q163: Considering the temporal sequence of events in menopause-related health decline, which of the following processes occur after the initial decrease in ovarian estrogen production, and contribute to the progression of postmenopausal disorders through hierarchical biological mechanisms involving the gut microbiota and estrogen regulation?
Options:
A: Secretion of β-glucuronidase by gut microbiota increases reabsorption of estrogen in the enterohepatic circulation, thereby influencing estrogen homeostasis and disease development after menopause.
B: The initial loss of ovarian function directly causes osteoporosis without involvement of gut microbiota or changes in estrogen reabsorption.
C: A reduction in gut microbiota diversity leads to weakened microbial decomposition, resulting in decreased circulating estrogen and subsequent disorders such as cognitive decline and osteoporosis.
D: Lipid metabolism disorders precede any changes in gut microbiota composition or estrogen levels during menopause.

Q164: Considering the temporal progression of gut microbiota changes after spinal cord injury (SCI), which of the following statements accurately reflect the sequential alterations in the abundance of short-chain fatty acid (SCFA)-producing bacteria and the presence of gut dysbiosis from the subacute to chronic phases of SCI?
Options:
A: The genus of potential SCFA-producing bacteria is lower in the chronic phase of SCI than in the subacute phase, indicating a temporal decline.
B: Gut dysbiosis is only present in the chronic phase of SCI and not in the subacute phase.
C: Firmicutes and Lactobacillus both increase in abundance from the subacute to the chronic phase of SCI.
D: In the subacute phase of SCI, the relative abundance of several SCFA-producing genera such as Faecalbacterium, Ruminococcus, and Coprococcus increases compared to the chronic phase.

Q165: In the context of Alzheimer's disease mouse models, consider the sequence of events following administration of Buyang Huanwu Decoction (BYHWD). Which of the following events occur after BYHWD treatment and are temporally downstream in the regulatory cascade involving the gut-brain axis and the C/EBPβ/AEP signaling pathway, ultimately leading to improved cognitive function?
Options:
A: Initial improvement in cognitive function, which then leads to reduced pathological Aβ plaque deposition.
B: Restoration of gut microbiota balance, which precedes suppression of the C/EBPβ/AEP pathway in the hippocampus.
C: Transplantation of fecal microbiota from BYHWD-treated mice to germ-free mice, which subsequently ameliorates cognitive deficits and AD-like pathology.
D: Suppression of the C/EBPβ/AEP signaling pathway, resulting in diminished tau hyperphosphorylation and inhibition of pro-inflammatory cytokine release.

Q166: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors to Alzheimer's disease (AD) mice, and are involved in the subsequent improvement of learning and memory abilities through gut-brain axis signaling?
Options:
A: An increase in short-chain fatty acids (SCFAs) in the gut, leading to activation of free fatty acid receptors FFAR2 and FFAR3.
B: Direct modulation of genetic risk factors for Alzheimer's disease before any changes in microbial composition.
C: Activation of the transport protein MCT1, which participates in signaling to the brain to mitigate inflammation.
D: Immediate restoration of normal synaptic plasticity in the hippocampus prior to any changes in gut metabolites.

Q167: Considering the temporal sequence of immune and microbial events in multiple sclerosis (MS) pathogenesis, which of the following processes are likely to occur after gut microbiota dysbiosis but before the appearance of clinical benefits from microbiota-targeted interventions, according to the context provided?
Options:
A: Normalization of gut microbial homeostasis through dietary therapies
B: Identification of gut microbiota alterations as biomarkers for early diagnosis
C: Elevation of pro-inflammatory cytokines and disruption of the gut-brain axis
D: Altered T-cell balance and immune homeostasis influenced by the microbiota

Q168: In the context of Negr1 knockout (KO) mice exhibiting anxiety- and depression-like behaviors, which of the following events occur after the early-life reduction of Akkermansia spp. in the gut microbiota, and are subsequently reversed following daily administration of Akkermansia isolated from wild-type mice? Select all that apply.
Options:
A: Amelioration of anxiety- and depression-like behaviors prior to any microbiota intervention.
B: Immediate upregulation of genes involved in T cell activation and immune homeostasis in the colon before Akkermansia supplementation.
C: Upregulation of mitochondrial genome-encoded genes in the nucleus accumbens and hippocampus.
D: Reduced dendritic arborization and spine density in the nucleus accumbens and dentate gyrus.

Q169: Based on the described studies, consider the sequence of molecular and cellular events following administration of short-chain fatty acids (SCFAs) in delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) rats. Which of the following events are likely to occur after SCFA treatment, and which must precede improvements in cognitive function and anxiety symptoms, according to the reported pathway involving GPR41/GPR43 and inflammatory cytokines?
Options:
A: Reduction of IL-1β, IL-6, and TNF-α in the hippocampus occurs prior to the restoration of dopamine and norepinephrine levels.
B: Improvements in cognitive function and anxiety symptoms occur before the reduction of hippocampal inflammatory cytokines.
C: SCFAs increase the expression of GPR41 and GPR43 in the hippocampus before reducing IL-1β, IL-6, and TNF-α levels.
D: Restoration of dopamine and norepinephrine in the hippocampus occurs before the increase in GPR41 and GPR43 expression.

Q170: Considering the temporal sequence of events described in the context of XiaoYao San (XYS) intervention in a maternal immune activation (MIA) mouse model, which of the following processes are likely to occur after the initial structural remodeling of the gut microbiota, but before the restoration of cerebral glutamate-GABA balance? Select all that apply.
Options:
A: Enrichment of Bacteroides spp., including B. uniformis, within the gut microbiota
B: Downregulation of intestinal amino acid transporters
C: Attenuation of core behavioral deficits such as enhanced social interaction
D: Structural remodeling of gut microbiota with specific enrichment of Odoribacter

Q171: Considering the temporal sequence of events described in Negr1 knockout (KO) mice, which of the following processes occur after the early-life reduction in Akkermansia spp. but before the behavioral improvement observed with Akkermansia supplementation? Select all that apply.
Options:
A: Reduced dendritic arborization and spine density in the nucleus accumbens and dentate gyrus
B: Upregulation of mitochondrial genome-encoded genes in the nucleus accumbens and hippocampus
C: Downregulation of mitochondrial genes in the nucleus accumbens and hippocampus following Akkermansia supplementation
D: Amelioration of anxiety- and depression-like behaviors in Negr1 KO mice

Q172: Based on the described studies, consider the sequence of events following a disruption of the gut barrier in neurodegenerative or brain injury models. Which of the following events are reported to occur subsequently or in association, and which are part of the regulatory cascade linking gut microbiota changes to astrocyte biology and neuroinflammation?
Options:
A: Changes in astrocyte GFAP expression precede any alterations in gut microbiota composition.
B: Compromised gut barrier integrity is linked to increased GFAP expression in astrocytes, indicating neuroinflammation.
C: An increase in the Bacteroidetes/Firmicutes ratio is observed before or alongside compromised gut barrier integrity.
D: Altered gut microbiota composition directly leads to immediate changes in rodent behavior without affecting astrocyte biology.

Q173: Considering the temporal sequence of events in diabetic retinopathy (DR) as described in the context, which of the following processes occur after a decrease in circulating short-chain fatty acids (SCFAs) and before the observation of retinal morphological changes in diabetic mice? Select all that apply.
Options:
A: Immune dysregulation with altered cytokine expression closely correlated with SCFA levels
B: Immediate improvement of intestinal barrier function without any prior intervention
C: Epigenetic changes in retinal DNA methylation, including downregulation of vascular endothelial growth factor and nuclear factor-kappa B pathways
D: Increased frequency of CD45+ CD11b+ cells and F4/80+ CD206+ CD11c- cells indicating an overactive immune system in the diabetic retina

Q174: Considering the temporal sequence of events following probiotic (PP) administration in the context of traumatic brain injury (TBI), which of the following changes are observed at distinct time points, and how do these events reflect the progression from early to late phases of neuroprotection and recovery?
Options:
A: Microglial activation is only reduced at 35 days post-injury, with no significant changes observed at earlier time points.
B: Reduction in lesion volume and cell death is observed at 3 days post-injury, representing an early neuroprotective effect of PP treatment.
C: Increased SCFA levels are found at 35 days post-injury, reflecting a later phase metabolic adaptation associated with prolonged PP administration.
D: Elevated levels of short-chain fatty acids (SCFAs) are detected at 3 days post-injury, indicating immediate metabolic changes following TBI.

Q175: Considering the temporal sequence of events in gastrointestinal inflammation and cancer, which of the following processes occur after the initial infection by Helicobacter pylori or Epstein-Barr virus but before the establishment of a tumor-promoting microenvironment, according to the described molecular mechanisms and hierarchical interactions?
Options:
A: Induction of chronic gastritis and disruption of host immune responses by H. pylori virulence factors
B: Epigenetic changes and immune modulation mediated by EBV in infected cells
C: Synergistic amplification of inflammatory signaling due to EBV and H. pylori co-infection
D: Development of targeted interventions for infection-driven GI malignancies

Q176: During the progression of herpes simplex encephalitis (HSE) caused by HSV-1 infection, several temporally ordered events occur involving the gut microbiota, microglial activation, and neuroinflammation. Based on the described mechanistic pathway, which of the following events would be expected to occur after HSV-1-induced gut microbiota dysbiosis but before the restoration of microglial homeostasis by exogenous nicotinamide n-oxide (NAMO) administration?
Options:
A: Restoration of NAD+-dependent mitophagy and prevention of HSV-1 early infection in neuronal cells
B: Suppression of HSE progression by gut microbial metabolite-induced mitophagy
C: Activation of microglia and increased production of proinflammatory cytokines
D: Microglial antiviral immune response and mitochondrial dysfunction leading to impaired mitophagy

Q177: Considering the temporal sequence of events in neurodegenerative diseases such as Alzheimer's and Parkinson's, which of the following processes are described as occurring after gut microbiota dysregulation but before the manifestation of cognitive or motor deficits, according to the context provided?
Options:
A: Initial genetic mutations predisposing to disease
B: Disruption of intestinal and blood-brain barrier integrity leading to neuroinflammation
C: Clinical application of standardized fecal microbiota transplantation protocols
D: Inflammation-induced epigenetic alterations affecting neuronal health

Q178: Considering the temporal sequence of events in the development of neurodegenerative diseases, which of the following processes must occur prior to the establishment of chronic inflammation and abnormal excitatory/inhibitory balance that contribute to amyotrophic lateral sclerosis (ALS) pathogenesis, according to the described neonatal microbiome context?
Options:
A: Establishment of persistent dysbiosis in the neonatal microbiome
B: Manifestation of neural excitation as a result of abnormal excitatory/inhibitory balance
C: Onset of chronic inflammation in adulthood
D: Maturation and colonization of the infant microbiome during the first 1000 days

Q179: Considering the multi-step processes described in the context, which of the following events would most likely occur after gut microbiota metabolize dietary polyphenols, and before the observed protection of murine microglia against LPS-induced inflammation? Select all that apply.
Options:
A: Polyphenol microbial metabolites (PMMs) exhibit increased permeability through artificial gut and blood-brain barriers compared to their parent compounds.
B: BV-2 microglia are exposed to lipopolysaccharide (LPS) to induce inflammation.
C: Lignan-derived PMMs, such as equol and enterolactone, exert protective effects against nitric oxide production and pro-inflammatory cytokines in BV-2 microglia.
D: Parent polyphenols are directly detected in systemic circulation in their intact forms.

Q180: Based on the provided context, which of the following molecular effects are directly associated with Akkermansia muciniphila (AKK) or its metabolite propionic acid in ARDS mouse models?
Options:
A: AKK decreases microglial activation.
B: Propionic acid inhibits the Toll-like receptor 4/nuclear factor κB signaling pathway.
C: AKK upregulates the Toll-like receptor 4/nuclear factor κB signaling pathway.
D: Propionic acid increases neuronal inflammation.

Q181: Based on the provided context, which of the following molecular effects are directly attributed to fermentation-derived metabolites from dairy products on gut physiology?
Options:
A: Suppression of host enterotype specificity
B: Upregulation of tight-junction proteins to reinforce epithelial barrier integrity
C: Enhancement of microbial diversity in the gut
D: Direct inhibition of neurodegeneration by exopolysaccharides

Q182: Based on the context, which of the following describes direct molecular effects of gut microbiota or their metabolites on brain function or disease progression?
Options:
A: Gut microbiota-derived short-chain fatty acids influence brain immune responses.
B: Gut microbiota directly synthesize neurotransmitters in the brain.
C: Microbial metabolites produced by gut microbiota regulate tumour progression in brain cancers.
D: Brain cancer cells alter the composition of gut microbiota through direct secretion of cytokines.

Q183: Based on the provided context, which of the following molecular effects are directly associated with time-restricted feeding (TRF) in the mitigation of Alzheimer's disease-related cognitive impairments?
Options:
A: TRF enhances the production of propionic acid in the gut.
B: TRF increases the abundance of Bifidobacterium pseudolongum in the gut microbiota.
C: TRF suppresses the expression of all genes involved in AD pathogenesis.
D: TRF directly inhibits amyloid-beta deposition through an unknown mechanism.

Q184: Based on the provided context, which of the following molecular effects are directly associated with gut pathology in autism spectrum disorders?
Options:
A: Butyrate-producing genera increase in individuals with ASD.
B: Insulin-like growth factor 1 (IGF-1) directly increases heavy metal absorption.
C: Heavy metal exposure disrupts zinc homeostasis in the gut.
D: Dysbiosis contributes to increased intestinal permeability.

Q185: Based on the provided context, which of the following statements describe direct molecular or compositional effects involving the gut mycobiome or microbiota that may influence health or disease?
Options:
A: Fungal dysbiosis in the gut is linked to various diseases, including inflammatory bowel disease and metabolic disorders.
B: Exercise directly increases the abundance of gut fungi by upregulating fungal gene expression.
C: The gut mycobiome directly inhibits the function of the microbiota-gut-brain axis.
D: Microecologics can influence the composition and function of the gut microbiota, thereby affecting the central nervous system.

Q186: Based on the context provided, which of the following statements describe direct molecular or cellular effects attributed to Bifidobacterium infantis or Bifidobacterium breve in neurodegenerative disease models?
Options:
A: Bifidobacterium infantis administration has neuroprotective effects that may delay disease progression.
B: Bifidobacterium breve directly increases dopamine (DA) levels in Parkinson's disease models.
C: Bifidobacterium infantis directly inhibits the formation of pathogenic microbiota in all tissues.
D: Bifidobacterium breve administration has neuroprotective effects that may delay disease progression.

Q187: Based on the context, which molecular effects are directly caused by short-chain fatty acids (SCFAs) in the mechanism of improved learning and memory in Alzheimer's disease mice following fecal microbiota transplantation from methionine-restricted diet donors?
Options:
A: Activation of free fatty acid receptor FFAR3
B: Inhibition of APP/PS1 gene expression
C: Suppression of Bacteroidetes phylum abundance
D: Activation of free fatty acid receptor FFAR2

Q188: Based on the provided context, which of the following molecular effects are directly associated with atorvastatin treatment in the context of ischemic stroke via the gut-brain axis?
Options:
A: Inhibition of the NF-κB pathway
B: Suppression of microglia activation
C: Activation of the NLRP3 inflammasome
D: Upregulation of PLA2G7 gene expression

Q189: Based on the provided context, which of the following statements correctly describe direct molecular effects involving matrix metalloproteinases (MMPs) and the gut microbiota?
Options:
A: Methanobrevibacter directly inhibits matrix metalloproteinase (MMP) activity.
B: Microbiome-targeted approaches can modulate matrix metalloproteinase (MMP) levels.
C: Matrix metalloproteinases (MMPs) regulate extracellular matrix (ECM) remodeling.
D: Dysbiosis leads to the upregulation of dopaminergic therapy in Parkinson’s disease.

Q190: Based on the context, which of the following describes direct molecular effects of gut microbiota or their metabolites on host physiology relevant to MASLD and osteoporosis?
Options:
A: Gut microbiota metabolites, such as short-chain fatty acids, affect hepatic fat accumulation.
B: Gut microbiota produce neuroactive substances that can affect brain function.
C: Gut microbiota directly increase estrogen production in the liver.
D: Gut microbiota suppress the vagus nerve activity.

Q191: Based on the context, which of the following molecular factors are produced by microorganisms and can contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's?
Options:
A: LPS
B: Bacteroides
C: IL-6
D: Curli proteins

Q192: Based on the provided context, which of the following molecular effects are directly modulated by Polygoni Multiflori Radix Praeparata polysaccharides (PMP) in the gut or brain tissues of ischemic stroke rats?
Options:
A: PMP directly inhibits the abundance of Bacteroidaceae in the gut microbiota.
B: PMP lowers the levels of inflammatory cytokines such as TNF-α and IL-1β.
C: PMP suppresses the production of beneficial amino acids in the intestine.
D: PMP boosts tight junction protein expression in both brain and intestinal tissues.

Q193: Based on the provided context, which of the following molecular effects are directly attributed to the gut microbiota in relation to brain function or neurodegenerative diseases?
Options:
A: The gut microbiota suppresses all immune responses in the brain.
B: The gut microbiota directly inhibits the formation of amyloid plaques.
C: The gut microbiota influences synaptogenesis.
D: The gut microbiota affects neuroplasticity processes.

Q194: Based on the context, which of the following statements describe direct molecular effects of probiotic-derived extracellular vesicles (PEVs) or tauopathy on host or microbiota composition?
Options:
A: The presence of tauopathy alters the composition of gut microbiota.
B: Tauopathy directly increases the secretion of PEVs from probiotics.
C: PEVs directly increase the number of Lactobacillus spp. in the gut.
D: PEVs can carry exogenous or parental active molecules to distal organs to play their roles.

Q195: Based on the context, which of the following molecular effects are directly stimulated by short-chain fatty acids (SCFAs) in the gut-brain axis?
Options:
A: SCFAs stimulate the release of glucagon-like peptide 1 by enteroendocrine cells.
B: SCFAs inhibit the production of amyloid in the brain.
C: SCFAs directly suppress blood-brain barrier permeability.
D: SCFAs stimulate the release of serotonin by enteroendocrine cells.

Q196: Based on the provided context, which of the following molecular effects are directly associated with neuroinflammation in Parkinson's disease?
Options:
A: Activation of microglia cells
B: Heightened production of proinflammatory cytokines
C: Suppression of dopaminergic neuron loss
D: Upregulation of gut-brain axis signaling

Q197: Based on the context, which molecular effects are directly induced by short-chain fatty acids (SCFAs) in the gut of Alzheimer's disease model mice after methionine-restricted fecal microbiota transplantation?
Options:
A: Suppression of CD4(+)Foxp3(+) regulatory T cell differentiation
B: Activation of free fatty acid receptor FFAR2
C: Activation of free fatty acid receptor FFAR3
D: Inhibition of the transport protein MCT1

Q198: Based on the provided context, which of the following statements describe direct molecular effects involving the gut microbiota or the endocannabinoid system in relation to steroidogenesis or immune regulation?
Options:
A: The endocannabinoid system is a key regulator of immune and metabolic homeostasis.
B: The endocannabinoid system directly increases the synthesis of corticosteroids in the adrenals.
C: The gut microbiota is involved in steroid production.
D: Progesterone is synthesized exclusively by the gonads.

Q199: Based on the provided context, which of the following molecular mechanisms are directly involved in the pathophysiology of depression or neuropsychiatric disorders?
Options:
A: Short-chain fatty acids directly regulate estrogen metabolism
B: Dysregulated tryptophan metabolism is implicated in mental health disorders
C: Microbial remodeling of immune checkpoint inhibitor responses causes blood-brain barrier dysfunction
D: Microbiota-derived lipopolysaccharide activates microglia

Q200: Based on the provided context, which of the following molecular effects are exhibited by lignan-derived polyphenol microbial metabolites (PMMs) in murine BV-2 microglia exposed to lipopolysaccharide-induced inflammation?
Options:
A: They exhibit protective effects against pro-inflammatory cytokines IL-6 and TNF-α.
B: They exhibit protective effects against nitric oxide production.
C: They inhibit the permeability of the blood-brain barrier.
D: They upregulate the production of pro-inflammatory cytokines IL-6 and TNF-α.

Q201: Based on the context, which of the following molecular entities are directly influenced or modified by short-chain fatty acids (SCFAs) within the microbiota-gut-brain axis?
Options:
A: Microglia function
B: Neuronal function
C: Astrocyte function
D: Dopamine receptor expression

Q202: Based on the provided context, which molecular mechanisms are directly modulated by the gut microbiome or bariatric surgery to influence host physiology?
Options:
A: Bariatric surgery increases the secretion of ghrelin, leading to enhanced hunger.
B: The gut microbiome regulates brain cell functions through DNA methylation and histone modifications.
C: Extrinsic factors directly suppress the production of short-chain fatty acids by the gut microbiome.
D: Bariatric surgery increases glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY), enhancing satiety.

Q203: Based on the context provided, which of the following statements describe direct molecular effects involving the gut microbiota or its metabolites on brain or immune function?
Options:
A: Alcohol consumption directly activates peroxisome proliferator-activated receptors (PPARs) in the brain.
B: Short-chain fatty acids (SCFAs) can modify the blood-brain barrier (BBB).
C: The gut microbiota directly increases synaptic structure in the brain.
D: Metabolites of certain probiotics can affect peroxisome proliferator-activated receptors (PPARs).

Q204: Based on the context, which molecular effects are directly attributed to gut microbiota metabolites or interventions on the gut-liver-brain axis in relation to immune or neurological regulation?
Options:
A: Short-chain fatty acids (SCFAs) regulate immune function.
B: Lipopolysaccharides (LPSs) activate inflammatory pathways.
C: Probiotics can restore neurotransmitter balance.
D: Tau protein post-translational modifications increase synaptic plasticity.

Q205: Based on the context, which of the following molecular targets are inhibited by food-related products and medicinal plants in the prevention of neurodegenerative disorders?
Options:
A: β-site amyloid precursor protein (APP) cleaving enzyme 1 (BACE1)
B: Butyrylcholinesterase (BChE)
C: Acetylcholinesterase (AChE)
D: Glucagon-like peptide-1 receptor (GLP-1R)

Q206: Based on the provided context, which of the following molecular effects are directly mediated by specific strains of Lactobacillus or Bifidobacterium in relation to neuroinflammation or neuroprotection?
Options:
A: Suppression of the vagal pathway by Bifidobacterium species.
B: Direct inhibition of the hypothalamic-pituitary-adrenal (HPA) axis by Lactobacillus reuteri.
C: Down-regulation of pro-inflammatory factors such as IL-6 and TNF-α by Lactobacillus reuteri.
D: Upregulation of neurotrophic factors such as brain-derived neurotrophic factor by Lactobacillus and Bifidobacterium species.

Q207: Based on the context, which of the following statements describe direct molecular effects of gut microbiota dysregulation on host physiology or disease progression?
Options:
A: Dysregulation of gut microbiota impairs intestinal barrier function, exacerbating systemic chronic inflammation.
B: Gut microbiota directly causes estrogen deficiency in metabolic dysfunction-associated steatotic liver disease.
C: Central nervous system activation directly increases gut microbiota diversity.
D: Abnormal microbial metabolites from gut microbiota stimulate different physiologic reactions in the host body.

Q208: Based on the provided context, which of the following statements describe direct molecular effects attributed to Bifidobacterium infantis or Bifidobacterium breve in neurodegenerative diseases such as Alzheimer's disease or Parkinson's disease?
Options:
A: Bifidobacterium infantis directly inhibits oxidative stress enzymes in the brain.
B: Bifidobacterium breve administration has neuroprotective effects that may delay disease progression.
C: Bifidobacterium infantis administration has neuroprotective effects that may delay disease progression.
D: Bifidobacterium breve directly increases dopamine synthesis in neurons.

Q209: Based on the provided context, which of the following molecular effects are directly modulated after bariatric surgery or in the context of gut-brain axis dysfunction?
Options:
A: Bariatric surgery reduces the hormone ghrelin, leading to decreased hunger.
B: Dysbiosis decreases gut permeability, reducing systemic inflammation.
C: Dysregulation of the kynurenine pathway leads to decreased production of neurotoxic metabolites.
D: Bariatric surgery increases glucagon-like peptide-1 (GLP-1), enhancing satiety.

Q210: Based on the provided context, which of the following molecular effects are directly induced by probiotic (PP) treatment after traumatic brain injury in mice?
Options:
A: PP treatment directly activates the PI3K/Akt/mTOR pathway in neurons.
B: PP treatment increases the abundance of Lactobacillaceae in the gut microbiome.
C: PP treatment elevates short-chain fatty acid (SCFA) levels in the gut.
D: PP treatment increases microglial activation in the brain.

Q211: Based on the context, which of the following statements describe direct molecular effects or associations involving metabolites or the gut microbiota in relation to disease or aging?
Options:
A: Dysbiosis is characterized by alterations in microbial composition and diversity.
B: Alteration of metabolites in the TCA cycle is associated with Parkinson's disease.
C: Metabolites in the pentose phosphate pathway inhibit gut microbiota diversity.
D: Gut microbiota directly upregulate the TCA cycle in neurons.

Q212: Based on the context, which molecular effects are associated with the pathogenesis of bullous pemphigoid and pemphigus vulgaris in relation to the microbiota composition and diversity?
Options:
A: Higher relative abundance of Firmicutes might contribute to the pathogenesis of both diseases.
B: Depletion of probiotics/beneficial species might contribute to the pathogenesis of both diseases.
C: Suppression of microbial diversity in the oral cavity prevents the formation of blisters.
D: Upregulation of autoantibodies against basement membrane proteins directly increases probiotic abundance.

Q213: Based on the context, which molecular effects are directly attributed to the gut microbiota in regulating human physiology and disease risk?
Options:
A: The gut microbiota modulates the immune response.
B: The gut microbiota upregulates insulin secretion.
C: The gut microbiota directly inhibits viral replication.
D: The gut microbiota regulates the intestinal barrier.

Q214: Based on the context, which molecular effects are directly associated with fecal microbiota transplantation (FMT) in neurological disorders such as Alzheimer's and Parkinson's disease?
Options:
A: FMT inhibits the expression of TLR4 and NF-κB in Parkinson's disease.
B: FMT increases the expression of IL-17 and IFN-γ in post-stroke conditions.
C: FMT decreases Bcl-2 expression in ischemic injury.
D: FMT upregulates synaptic marker (PSD-95, synapsin-1) expression in Alzheimer's disease.

Q215: Based on the context, which of the following statements describe direct molecular effects of the gut microbiota on host physiology or communication along the microbiota-gut-brain axis?
Options:
A: Gut microbiota communicate with the host by producing hormonal intermediates.
B: Neuroimmune-mediated disorders directly inhibit the gut microbiota.
C: Gut microbiota produce metabolites that shape host homeostasis.
D: PET tracers directly activate the gut-brain axis.

Q216: Based on the provided context, which molecular mechanisms involve the gut microbiota directly impacting host tryptophan metabolism through modulation of specific metabolic pathways?
Options:
A: The gut microbiota shapes both Kynurenine and Serotonin pathways in tryptophan metabolism.
B: The gut microbiota suppresses all tryptophan metabolic routes simultaneously.
C: The gut microbiota directly inhibits the Kynurenine pathway in host tryptophan metabolism.
D: The gut microbiota is responsible for Indole metabolites production from tryptophan.

Q217: Based on the provided context, which of the following molecular effects are directly associated with upregulated LRRK2 expression in the brain of the dual-hit mouse model?
Options:
A: Increase in Occludin levels
B: Activation of NF-κB pathway
C: Inhibition of Nrf2 pathway
D: Upregulation of ZO-1 expression

Q218: Based on the provided context, which of the following statements best integrate the roles of short-chain fatty acids (SCFAs) in both metabolic syndrome and neurodegenerative diseases, considering their mechanisms of action and therapeutic potential across different organ systems?
Options:
A: The beneficial effects of SCFAs are restricted to the maintenance of cartilage integrity in osteoarthritis and do not involve modulation of neuroinflammation or metabolic processes.
B: By modulating immune-inflammatory responses and improving metabolic parameters, SCFAs may serve as adjunctive treatments for both osteoarthritis and neurodegenerative diseases through their systemic and central actions.
C: SCFAs, produced by gut microbial fermentation, can ameliorate chronic inflammation in metabolic syndrome and also cross the blood-brain barrier to exert anti-inflammatory effects in neuroinflammatory conditions such as Alzheimer's disease.
D: SCFAs are only effective in the gut and have no influence on distant organs, thus their therapeutic potential is limited to gastrointestinal diseases.

Q219: Based on the provided context, which of the following statements best illustrate how interventions targeting the gut microbiota may have cross-system effects in both metabolic and neurodevelopmental disorders, requiring integration of mechanisms and outcomes from different sections?
Options:
A: Psilocybin’s effects are limited to the central nervous system and do not involve interactions with the gut microbiota or the gut-brain axis.
B: Gut dysbiosis can contribute to both insulin resistance and autism spectrum disorder by increasing intestinal permeability and systemic inflammation, suggesting that microbiota modulation could benefit both metabolic and neurodevelopmental outcomes.
C: Fecal microbiota transplantation is only effective for gastrointestinal symptoms in autism spectrum disorder and has no impact on behavioral symptoms or microbial diversity.
D: Intermittent fasting may improve metabolic dysfunction-associated steatotic liver disease by altering gut microbiota composition, which in turn affects the gut-liver axis and hepatic function.

Q220: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota-derived metabolites influence both neurological and immune outcomes in disease models, considering the roles of SCFAs, indoles, and gut barrier integrity?
Options:
A: Both Polygoni Multiflori Radix Praeparata polysaccharides and acetate supplementation improve neurological or retinal outcomes by enhancing gut barrier function and modulating immune responses through increased SCFA levels.
B: Indoles produced by gut microbiota directly increase the abundance of Bifidobacterium and Lactobacillus, which in turn prevent vessel loss in diabetic retinopathy.
C: Microbiota-derived indoles alleviate neuroinflammation in Alzheimer's disease models by activating the aryl hydrocarbon receptor and inhibiting NF-κB signaling, paralleling the immune regulatory effects observed with SCFA supplementation in diabetic retinopathy.
D: The negative correlation between Peptostreptococcaceae and SCFA levels is responsible for the restoration of synaptic plasticity in Alzheimer's disease models.

Q221: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and immune or neural pathways in the modulation of neuroinflammation or neurodevelopmental disorders, and are supported by evidence from multiple sections of the text?
Options:
A: Short-chain fatty acids (SCFAs) produced by gut microbiota can cross the blood-brain barrier, where they may exert anti-inflammatory effects and improve neuroinflammatory conditions, as seen in both Alzheimer's disease and delayed encephalopathy after carbon monoxide poisoning.
B: Pycnogenol’s therapeutic effects in neurodevelopmental disorders are solely due to its direct antioxidant activity in the brain, independent of any changes in gut microbiota composition or metabolites.
C: Alterations in gut microbiota can influence both immune tolerance via regulatory T cells and neuroinflammatory responses in the brain, highlighting a cross-talk between intestinal immune regulation and central nervous system inflammation.
D: Intermittent theta burst stimulation (iTBS) improves cognitive dysfunction in delayed encephalopathy after carbon monoxide poisoning exclusively by increasing SCFA levels in the serum.

Q222: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and immune or inflammatory mechanisms in both metabolic syndrome and Alzheimer’s disease pathogenesis, highlighting potential therapeutic implications?
Options:
A: Bile acids produced by gut microbiota are the primary mediators of both improved lipid metabolism in metabolic syndrome and reduced amyloid-beta aggregation in Alzheimer’s disease.
B: The only mechanism by which gut microbiota influence Alzheimer’s disease is through the regulation of tau hyperphosphorylation, independent of immune or inflammatory pathways.
C: Short-chain fatty acids produced by gut microbiota can ameliorate immuno-inflammation in metabolic syndrome and also modulate microglial activation, thereby influencing neuroinflammation in Alzheimer’s disease.
D: Therapeutic strategies targeting the gut microbiota, such as probiotics or prebiotics, may reduce neuroinflammation in Alzheimer’s disease and also offer novel approaches to modulate short-chain fatty acids for metabolic syndrome management.

Q223: Based on the provided context, which of the following statements best integrate the roles of the ketogenic diet and gut microbiome in neurodegenerative diseases, particularly in relation to neuroinflammation and cognitive decline?
Options:
A: The presence of bacterial amyloid in the gut always leads to improved neuroprotection in Alzheimer’s disease by increasing beneficial bacterial clades.
B: Increasing carbohydrate intake above 50 g/day in the ketogenic diet directly enhances the synthesis of short-chain fatty acids by the gut microbiome, thereby preventing cognitive decline.
C: Both the ketogenic diet’s immunomodulatory effects and the gut microbiome’s influence on neurotransmitter synthesis are implicated in the development or prevention of cognitive impairment in aging and Alzheimer’s disease.
D: The ketogenic diet’s generation of ketone bodies may reduce neuroinflammation, while gut microbiome dysbiosis can increase proinflammatory bacterial species, both influencing the progression of neurodegenerative diseases.

Q224: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and immune signaling in the pathogenesis or potential treatment of neurodegenerative and neurodevelopmental disorders, such as Alzheimer's disease and neurodevelopmental disorders?
Options:
A: Pycnogenol, by increasing the abundance of butyric acid-producing bacteria in the gut, may influence the gut-brain axis and provide a therapeutic strategy for neurodevelopmental disorders through modulation of microbial metabolites and immune pathways.
B: Short-chain fatty acids (SCFAs) produced by gut microbiota can cross the blood-brain barrier and decrease inflammatory cytokine secretion by microglia-like cells, suggesting a mechanism by which gut-derived metabolites may modulate neuroinflammation implicated in Alzheimer's disease.
C: Trimethylamine N-oxide (TMAO), a gut microbiota-derived metabolite, reduces neuroinflammation and inhibits amyloid-beta aggregation, thereby protecting against Alzheimer's disease progression.
D: NF-κB signaling is only activated by genetic mutations in neurodevelopmental disorders and is not influenced by gut microbiota-derived metabolites or their downstream effects.

Q225: Based on the provided context, which of the following statements best integrate findings regarding the modulation of gut microbiota, its impact on barrier function, and implications for inflammatory or neurodegenerative diseases, as demonstrated by both nanotherapeutic and microplastic exposure studies in mice?
Options:
A: Oral administration of gold nanospheres in mice with rheumatoid arthritis not only enriched beneficial gut bacteria but also restored intestinal barrier function by upregulating tight junction proteins, paralleling findings that microplastics from polypropylene cutting boards impaired barrier function and induced inflammation.
B: Probiotic therapy and gold nanosphere administration both directly decrease the abundance of Desulfobacterota in the gut, thereby preventing neuroinflammation and intestinal inflammation in mice.
C: Exposure to microplastics from polyethylene cutting boards in mice led to significant intestinal inflammation and upregulation of tight junction proteins, which is similar to the effect of gold nanospheres in reducing inflammation in rheumatoid arthritis.
D: Both gold nanosphere treatment in rheumatoid arthritis and microplastic exposure from polypropylene cutting boards in mice demonstrated that modulation of gut microbiota and barrier function can influence systemic inflammation, supporting the gut-joint and gut-intestine axes.

Q226: Based on the provided context, which of the following statements best integrate evidence regarding the gut microbiome’s influence on Alzheimer’s disease pathogenesis and the potential for therapeutic intervention, considering both microbial metabolites and host responses?
Options:
A: The only mechanism by which the gut microbiome affects Alzheimer’s disease is through the modulation of microRNAs, independent of neuroinflammation or blood-brain barrier changes.
B: Alterations in the gut microbiome that increase proinflammatory bacterial species and reduce neurotransmitter synthesis capacity are associated with severe cognitive impairment, suggesting that microbiome-targeted strategies could help prevent cognitive decline.
C: Probiotics may mitigate neuroinflammatory responses in Alzheimer’s disease by restoring gut microbiome homeostasis and reinforcing intestinal barrier integrity, which in turn can influence blood-brain barrier permeability and neurodegeneration.
D: Elevated levels of short-chain fatty acids produced by proinflammatory gut bacteria are directly responsible for increased amyloid-beta aggregation in Alzheimer’s disease.

Q227: Based on the provided context, which of the following statements best illustrate how gut microbiota dysbiosis can influence both neurological and non-neurological chronic diseases, and how integrated resources or interventions may address these effects?
Options:
A: Gut microbiota dysbiosis is only relevant to neurological disorders, and there is no evidence in the context that it plays a role in chronic diseases like diabetes or cancer.
B: Resources like the BGMDB integrate experimentally validated associations between gut microbiota, neurotransmitters, and brain diseases, and also allow exploration of genetic data linking microbiota to neuroanatomical changes, thereby facilitating the development of novel microbiota-targeted therapies for neurological disorders.
C: Dysbiosis of gut microbiota is implicated in both neurological disorders (such as Alzheimer's disease and multiple sclerosis) and non-neurological chronic diseases (such as type 2 diabetes and cancer), with interventions like fecal microbiota transplantation and probiotics being explored to restore microbial balance and improve outcomes in both domains.
D: Bariatric surgery has no effect on gut microbiota profiles or neurological outcomes, and thus is not relevant to the study of gut-brain interactions.

Q228: Based on the provided context, which of the following statements best integrate the roles of short-chain fatty acids (SCFAs), gut microbiota, and their impact on neuroinflammation and cognitive or behavioral outcomes in neurodegenerative or neuropathic conditions?
Options:
A: SCFAs produced by gut microbes can cross the blood-brain barrier, decrease inflammatory cytokine secretion by microglia-like cells, and are implicated in the mitigation of neuroinflammation relevant to Alzheimer's disease.
B: Fecal microbiota transplantation from methionine-restricted diet mouse donors improves Alzheimer's learning and memory abilities by increasing SCFA levels, which activate FFAR2/3 and MCT1 to signal the brain and mitigate inflammation.
C: Gingerol-enriched ginger supplementation in neuropathic pain models increases gut microbiome diversity and upregulates all neuropathology genes in the amygdala, leading to reduced pain behaviors.
D: In progressive multiple sclerosis, increased levels of Alistipes and most fecal metabolites are associated with improved cognition and quality of life due to enhanced SCFA production.

Q229: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota alterations and external interventions (such as microecologics, exercise, or microplastics) can influence central nervous system (CNS) diseases or neuroinflammation, considering both immune and metabolic pathways?
Options:
A: Gut microbial dysbiosis can lead to increased endotoxin production and decreased beneficial metabolites, which may disrupt intestinal and blood-brain barrier permeability, thereby aggravating neuroinflammation and neurodegeneration.
B: Exposure to microplastics from polyethylene cutting boards induces intestinal inflammation and directly increases neuroinflammation by activating microglia in the brain.
C: Combined interventions of microecologics and exercise may more effectively improve CNS diseases by modulating the microbiota-gut-brain axis, which is implicated in both neuroimmune regulation and metabolic pathways.
D: Natural compounds from Chinese herbs improve CNS diseases solely by altering gut microbiota composition, without affecting microglial polarization or neuroinflammation.

Q230: Based on the provided context, which of the following statements best integrate the mechanistic roles of gut microbiota in both cancer and metabolic-associated fatty liver disease (MAFLD), considering their influence on disease progression and potential as therapeutic targets?
Options:
A: The presence of Firmicutes as a highly abundant phylum is uniquely associated with improved outcomes in both breast cancer chemotherapy and MAFLD, indicating a protective role.
B: Alterations in the gut microbiota are only relevant to metabolic diseases like MAFLD and do not impact cancer progression or treatment outcomes.
C: Dysbiosis of the gut microbiota can contribute to both brain cancer progression and MAFLD by altering microbial metabolites such as short-chain fatty acids, which in turn influence immune responses and inflammation.
D: Microbial metabolites produced by the gut microbiota, including bile acids and short-chain fatty acids, play regulatory roles in both tumor progression and hepatic inflammation, making the microbiome a potential target for therapeutic intervention in these diseases.

Q231: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence immune regulation and the pathogenesis or therapy of autoimmune and inflammatory diseases, such as multiple sclerosis and rheumatoid arthritis?
Options:
A: Gold nanospheres directly suppress synovial inflammation in rheumatoid arthritis by acting as anti-inflammatory agents in the joint, independent of any effects on gut microbiota or their metabolites.
B: Short-chain fatty acids and tryptophan metabolites produced by commensal gut bacteria can induce regulatory T-cells and suppress inflammatory responses, with their secretion being influenced by dietary factors such as long-chain fatty acids or salt.
C: Orally administered gold nanospheres ameliorate rheumatoid arthritis by enriching probiotic bacteria, increasing indole-3-propionic acid and indole-3-acetic acid production, which activate the aryl hydrocarbon receptor pathway and suppress NF-κB activation in synovial tissues.
D: Gut microbiota dysbiosis only affects the gut-liver axis and does not play a role in immune dysregulation or the pathogenesis of autoimmune diseases.

Q232: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota interventions, such as probiotics-derived extracellular vesicles (PEVs) and fecal microbiota transplantation (FMT), may influence neurological outcomes through modulation of inflammation and neuroimmune pathways?
Options:
A: PEVs and FMT are only effective in treating gastrointestinal symptoms and have no demonstrated impact on neuroimmune or cognitive functions.
B: Both PEVs and FMT can modulate host immunity and inflammation, with PEVs acting as postbiotics to regulate intestinal inflammation and FMT restoring microbial composition to suppress neuroinflammation in neurological disorders.
C: PEVs and FMT directly increase the expression of neurotoxic cytokines in the brain, thereby worsening neurodegenerative outcomes.
D: FMT improves cognitive function in Alzheimer's disease by lowering amyloid-β accumulation and upregulating synaptic markers, while PEVs maintain organ immunity and may influence distal organs through their loading capacity.

Q233: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota modulation and neurological or psychiatric outcomes, considering both mechanistic pathways and therapeutic implications discussed across the sections?
Options:
A: The relationship between gut microbiota and recurrent spontaneous abortion is well established, with clear therapeutic protocols already standardized and widely implemented in clinical practice.
B: Oral antibiotic administration in the TMEV model of multiple sclerosis consistently improves neurological outcomes by altering gut microbiota and increasing anti-viral immune responses.
C: Targeting the gut microbiota, either through psychobiotics or by restoring intestinal barrier function via the autophagy-lysosomal pathway, has shown potential in alleviating symptoms or delaying progression in neurodegenerative and psychiatric disorders.
D: The gut-brain axis enables bidirectional communication, and interventions that influence gut microbiota—such as psychobiotics or ALP-targeted therapies—can modulate neuroinflammation and neurotransmitter levels, impacting both neurodegeneration and mental health.

Q234: Based on the provided context, which of the following statements best illustrate how advances in understanding immune cell involvement and gut microbiota modulation are converging to inform novel therapeutic strategies for Alzheimer's disease and other neurodegenerative disorders?
Options:
A: Therapies targeting neuroinflammation in Alzheimer's disease are being developed by integrating knowledge of both central and peripheral immune cell interactions and the modulatory effects of gut microbiota on neuroinflammatory responses.
B: The primary focus of current Alzheimer's disease therapies is on correcting genetic mutations using gene-editing tools, without considering the role of immune cells or gut microbiota.
C: In vitro models of host-microbiota interactions are only relevant for studying gastrointestinal diseases and have no application in neurodegenerative disease research.
D: Caloric restriction mimetics are promising for managing age-related neurodegenerative disorders because they enhance beneficial gut bacteria, which in turn can influence neuroinflammation and physiological conditions relevant to disease progression.

Q235: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites in both immune regulation and systemic disease outcomes, such as multiple sclerosis and metabolic dysfunction-associated steatotic liver disease?
Options:
A: Intermittent fasting may improve steatotic liver disease by altering gut microbiota composition and metabolite production, which are recognized as mediators of beneficial effects on hepatic function.
B: The formation of intestinal biofilms is solely responsible for the development of metabolic dysfunction-associated steatotic liver disease, independent of gut microbiota metabolites.
C: Alterations in gut microbiota composition only affect local intestinal immunity and have no impact on systemic diseases such as multiple sclerosis or steatotic liver disease.
D: Gut microbiota-derived metabolites can modulate regulatory T cell function to support immune tolerance, and their systemic circulation may influence central nervous system inflammation relevant to multiple sclerosis.

Q236: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota, immune modulation, and neurobehavioral or neurodegenerative outcomes in both OVA-induced food allergy mice and multiple sclerosis, and are supported by the described mechanisms and findings?
Options:
A: In both OVA-induced food allergy mice and individuals with multiple sclerosis, probiotic supplementation has been shown to directly restore neuronal function by increasing GSH levels in the prefrontal cortex.
B: The behavioral abnormalities in OVA-induced food allergy mice are solely due to elevated serum IgE and Th2 cytokines, with no involvement of gut microbiota or metabolic changes.
C: Both OVA-induced food allergy mice and multiple sclerosis patients exhibit gut microbiota dysbiosis that is associated with increased pro-inflammatory responses, which may contribute to neurobehavioral or neurodegenerative changes.
D: Disruption of gut microbiota in OVA-induced food allergy mice is linked to altered amino acid metabolism and increased neuroinflammation, while in multiple sclerosis, vitamin D may help maintain eubiosis and reduce systemic inflammation by acting on the gut-immune axis.

Q237: Considering the interplay between microbiota, immune modulation, and neurological outcomes, which of the following statements best integrates evidence regarding both the mechanisms and therapeutic implications discussed for neurodevelopmental and neurodegenerative disorders in the context provided?
Options:
A: In neuroangiostrongyliasis and mild cognitive impairment, the beneficial effects of Lactobacillus species are solely attributed to changes in short-chain fatty acids and tryptophan metabolites.
B: Exosomes in Alzheimer's disease not only propagate pathological proteins but also mediate the effects of microbiota-derived metabolites, highlighting a link between systemic dysbiosis and neuroinflammation.
C: Both in autism spectrum disorder and Alzheimer's disease, dysbiosis of microbiota can influence neuroinflammatory mechanisms, and interventions targeting microbiota (such as probiotics or microbiome-based therapies) are suggested to improve neurological symptoms.
D: Isorhamnetin's anti-depressive effects are exclusively due to its antioxidative properties, without involvement of immune or microbiota-related pathways.

Q238: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota alterations can influence neurodegenerative disease progression through both immune and metabolic pathways, and how therapeutic interventions may target these processes?
Options:
A: Gut dysbiosis disrupts the intestinal barrier, allowing toxic metabolites to enter systemic circulation, which triggers chronic neuroinflammation and proteinopathies; interventions like probiotics or FMT may help restore gut-brain axis function and mitigate neurodegeneration.
B: Altered gut microbiota composition can increase gut permeability, leading to systemic inflammation and neuroinflammation via the kynurenine pathway, while probiotics may modulate this pathway to reduce neuroinflammation and improve cognitive outcomes.
C: Alpha-synuclein aggregation in Parkinson's disease is solely caused by defective autophagy in the gut, and can be prevented by dietary interventions alone.
D: Gut-derived propionate increases reactive astrocytosis and Aβ plaque accumulation in Alzheimer's disease models by enhancing IL-17 secretion from Th17 cells, suggesting that reducing propionate could be therapeutic.

Q239: Based on the provided context, which of the following statements best integrate findings about the modulation of neuroinflammation and behavioral outcomes in animal models with the role of gut microbiota interventions in neurodegenerative and cancer settings?
Options:
A: Fecal microbiota transplantation and Coriolus versicolor administration each influence neurotransmitter regulation or production, which is associated with improved behavioral or cognitive outcomes in their respective models.
B: Both Coriolus versicolor administration in valproic acid-induced autism models and fecal microbiota transplantation in neurodegenerative disorders demonstrate improvements in behavioral or motor deficits that are linked to reductions in neuroinflammation.
C: Alterations in the gut microbiome during breast cancer chemotherapy are shown to reverse neuroinflammation and restore hippocampal organization in animal models.
D: Intermittent fasting and Coriolus versicolor both directly target the TLR-4/NF-κB signaling pathway to improve cognitive function in neurodegenerative diseases.

Q240: Considering the interplay between gut microbiota, barrier function, and neurodegeneration, which of the following statements best integrates the mechanisms by which interventions such as fecal microbiota transplantation (FMT) or probiotics may influence Alzheimer's disease progression through the gut-brain axis?
Options:
A: FMT and probiotics are only effective in treating gastrointestinal symptoms of Alzheimer's disease, as their influence is limited to the gut and does not extend to the central nervous system.
B: Both FMT and probiotics like Clostridium butyricum may reduce neuroinflammation and cognitive deficits in Alzheimer's disease by restoring gut microbial balance and strengthening gut barrier integrity, thereby modulating neurodegenerative pathways.
C: Restoring gut microbial diversity through FMT has been shown to eliminate the need for further research into the molecular mechanisms underlying Alzheimer's disease progression.
D: The use of Drosophila melanogaster as a model allows researchers to investigate how gut-derived metabolites and glial cell activation, influenced by interventions such as probiotics, contribute to tau protein accumulation and neurocognitive impairment in Alzheimer's disease.

Q241: Based on the integrated findings from the provided studies, which of the following statements best exemplify how gut microbiota and their metabolites or immune interactions contribute to the pathogenesis or treatment of chronic inflammatory or autoimmune diseases, requiring synthesis of both mechanistic and outcome data from multiple sections?
Options:
A: Short-chain fatty acids produced by Lactobacillus johnsonii are responsible for the observed reduction in neuroinflammation and improved survival in neuroangiostrongyliasis-infected mice.
B: Plant-derived polyphenols directly increase the abundance of beneficial gut bacteria, which in turn always leads to the resolution of both obesity and depressive symptoms.
C: The expansion of Ruminococcus gnavus in lupus-prone mice, promoted by dietary tryptophan and host genetics, leads to Treg apoptosis and autoimmune activation, while its depletion increases Treg frequency and reduces disease activity.
D: In endometriosis, gut microbial dysbiosis characterized by reduced beneficial bacteria and increased pro-inflammatory taxa modulates estrogen metabolism and activates the TLR4/NF-κB pathway, thereby exacerbating inflammation and lesion proliferation.

Q242: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between microbiota, systemic inflammation, and neurodegenerative or autoimmune diseases, and the potential for targeted therapeutic interventions?
Options:
A: The anti-inflammatory effects of antidepressants are limited to the central nervous system and do not involve modulation of the gut-brain axis or systemic inflammatory pathways.
B: Restoring gut microbiota balance through interventions such as precision nutrition or microbial transplantation may modulate both retinal disease progression and neurodegeneration, as both the gut-retina and gut-brain axes are implicated in disease pathogenesis.
C: ROCK inhibitors in Alzheimer's disease act solely by reducing amyloid β plaques, without influencing neuroinflammation, synaptic density, or other aspects of disease pathology.
D: Dysbiosis of the gut microbiota can contribute to both neurodegenerative diseases via the gut-brain axis and autoimmune skin diseases such as bullous pemphigoid and pemphigus vulgaris, suggesting that microbiota-targeted therapies may have broad therapeutic potential.

Q243: Based on the provided context, which of the following statements best integrate findings regarding the modulation of neuroinflammation and behavioral outcomes through gut microbiota or their metabolites, as demonstrated in both ischemic stroke and valproic acid-induced autism models?
Options:
A: Atorvastatin treatment in ischemic stroke and Coriolus versicolor administration in valproic acid-induced autism both resulted in improved neurobehavioral outcomes by inhibiting neuroinflammation via modulation of the NF-κB pathway, with gut microbiota changes implicated in both cases.
B: In both ischemic stroke and valproic acid-induced autism models, interventions targeting the gut-brain axis led to reduced activation of neuroinflammatory pathways (such as NLRP3 inflammasome or TLR-4/Myd88/NF-κB), which was associated with improved behavioral outcomes.
C: The studies demonstrated that short-chain fatty acids produced by the gut microbiome were directly responsible for reversing neuroinflammation in both ischemic stroke and valproic acid-induced autism models.
D: Both ischemic stroke and valproic acid-induced autism models showed that antibiotics treatment alone was sufficient to improve neurobehavioral deficits by increasing the abundance of Lachnospiraceae NK4A136.

Q244: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and neuronal health in the context of both diabetes-related wound healing and neurodegenerative or neuropsychiatric disorders, and are supported by the text?
Options:
A: Probiotic supplementation and dietary fiber intervention are proposed strategies to remodel the gut microbiota, which may benefit both wound healing in diabetes and neuronal mitochondrial function in depression.
B: Bile acids produced by gut microbiota are directly responsible for reducing Aβ levels and inhibiting microglial activation in Alzheimer's disease models.
C: Hydrogen sulfide and tryptophan metabolites from gut microbiota are the primary mediators of memory improvement in 5×FAD mice treated with medium-chain triglycerides.
D: Short-chain fatty acids, as gut microbiota-derived metabolites, are implicated in both promoting wound healing in diabetes and improving neuronal mitochondrial function relevant to depression.

Q245: Based on the provided context, which of the following statements best integrate evidence regarding the gut-brain axis, neuroinflammation, and the role of the gut microbiome in neurological disorders, including both disease mechanisms and potential therapeutic approaches?
Options:
A: The presence of microbial DNA in cerebrospinal fluid directly causes neurodevelopmental deficits in fetal alcohol spectrum disorder by disrupting the glymphatic system.
B: Alterations in the gut microbiome can promote neuroinflammation and cognitive impairment, as seen in both fetal alcohol spectrum disorder and cerebral small vessel disease, highlighting the gut-brain axis as a key mediator.
C: Lifestyle factors such as sleep have no impact on the composition or function of the gut microbiota in relation to neurological health.
D: Intestinal Lactobacillus johnsonii can improve neuroinflammation and survival in neuroangiostrongyliasis through immune modulation, even though these benefits are not linked to changes in microbiome-derived metabolites.

Q246: Based on the provided context, which of the following statements best integrate evidence regarding the gut microbiome’s role in both neurodegenerative and neuroinflammatory diseases, and the therapeutic implications of targeting specific microbial populations or pathways?
Options:
A: The only evidence for gut microbiome involvement in brain disorders comes from correlational analyses, and no functional or mechanistic studies have been conducted in animal models or humans.
B: Causal links between the gut microbiome and both tauopathies and ischemic stroke are supported by studies showing that manipulating gut bacteria can alter disease outcomes and neuroinflammation via pathways such as NF-κB and NLRP3.
C: Therapeutic interventions targeting the gut microbiome, such as atorvastatin in ischemic stroke, have demonstrated improved neurological outcomes by increasing beneficial bacteria like Lachnospiraceae NK4A136, which are associated with reduced inflammation and inhibition of the Akt/NF-κB/NLRP3 pathway.
D: Current treatments for Parkinson’s disease and Alzheimer’s disease are neuroprotective because they directly target the gut microbiome to prevent protein aggregation in the brain.

Q247: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and antioxidants in the modulation of neurodegenerative disease progression, specifically considering both molecular pathways and the gut-brain axis?
Options:
A: Antioxidants can reduce neuroinflammation and oxidative damage in neurodegenerative diseases by modulating gut microbiota composition, which in turn influences the production of short-chain fatty acids that attenuate neuroinflammation via key molecular pathways such as NF-κB and Nrf2.
B: Dysbiosis-induced reduction in beneficial gut bacteria can exacerbate oxidative stress and neuroinflammation in neurodegenerative diseases, but targeted antioxidant delivery by probiotics and prebiotics may restore microbial homeostasis and support neuronal survival.
C: Gut microbiota-derived tryptophan metabolites directly increase oxidative stress in the brain, and antioxidants are unable to influence this process through modulation of the gut-brain axis.
D: Short-chain fatty acids produced by gut microbiota have no impact on neuroinflammation or oxidative stress, and antioxidant interventions are ineffective in altering these outcomes.

Q248: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota in both autoimmune and neurological diseases, and the implications for therapeutic interventions and disease outcomes?
Options:
A: Dysbiosis, characterized by altered gut microbiota composition, is implicated in both autoimmune bullous skin diseases and neurological disorders such as ischemic stroke, and targeting the microbiome may offer novel adjuvant treatment strategies for these conditions.
B: The gut microbiome only influences pediatric diseases during early life and has no established role in adult-onset autoimmune or neurological disorders according to current evidence.
C: Lifestyle factors like diet and exercise affect the gut microbiome, but there is no evidence linking these changes to the pathogenesis or treatment of autoimmune or neurological diseases.
D: Therapeutic interventions such as probiotics, prebiotics, and fecal microbiota transplantation have been supported by evidence to modulate immune responses and improve outcomes in both ischemic stroke and autoimmune bullous skin diseases, highlighting the gut microbiome as a modifiable risk factor.

Q249: Based on the provided context, which of the following statements best illustrate how gut microbiota-targeted interventions may influence both neurological and oncological disease outcomes through integrated mechanisms involving immune modulation and signaling pathways?
Options:
A: Microbiota-based interventions, including probiotics, have the potential to restore microbial balance, thereby reducing systemic inflammation in type 2 diabetes and modulating oxidative stress and immune evasion mechanisms in CNS tumors.
B: Probiotic administration and fecal microbiota transplantation can modulate gut microbiota composition, which in turn may regulate neuroinflammation in Alzheimer's disease and influence immune responses and signaling pathways such as NF-κB and PI3K/Akt/mTOR in glioma.
C: Antibiotic use universally improves cognitive function in all neurodegenerative diseases by directly targeting β-amyloid metabolism, independent of gut microbiota composition.
D: Dietary modifications alone are sufficient to prevent both autoimmune disorders and CNS tumors by directly eliminating dysbiosis without the need for additional therapeutic strategies.

Q250: Based on the provided context, which of the following statements best integrate the mechanistic roles of gut microbiota, metabolic dysfunction, and neuroinflammation in the pathogenesis or management of neurodevelopmental and neurodegenerative disorders such as ASD and Alzheimer's disease?
Options:
A: Leptin directly alters gut microbiota composition, which in turn prevents neuropsychiatric symptoms in Alzheimer's disease by reducing insular inflammation.
B: Both ASD and Alzheimer's disease involve gut microbiota dysbiosis that can modulate neuroinflammation and metabolic dysfunction, with microbial metabolites such as SCFAs and LPS influencing brain pathology through immune and metabolic pathways.
C: Dietary interventions, including the Mediterranean diet and bioactive compounds like prebiotics and polyphenols, may exert neuroprotective effects in Alzheimer's disease by modulating gut microbiota and reducing neuroinflammation, suggesting a potential for microbiota-targeted therapies in neurodegeneration.
D: Traditional Chinese Medicine (TCM) acts solely on neurological pathways in Alzheimer's disease, independent of any interaction with the gut microbiota.

Q251: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, their metabolites, and dietary interventions in the prevention or management of neurodegenerative disorders, considering both mechanistic and therapeutic perspectives?
Options:
A: Dysbiosis of gut microbiota can increase the permeability of the gastrointestinal and blood-brain barriers, facilitating the movement of microbial molecules to the brain and contributing to neurodegenerative disease pathogenesis, which supports the rationale for dietary and microbiota-modulating interventions.
B: The only effective strategy for neurodegenerative disease prevention is the use of pharmaceutical agents, as dietary and microbiota-based interventions have not shown any mechanistic relevance.
C: Secondary bioactive metabolites from plant-based foods directly inhibit α-synuclein accumulation in neurons, thereby preventing Parkinson’s disease without involvement of gut microbiota or metabolic pathways.
D: Targeting gut microbiota-derived metabolites such as TMAO through dietary, nutraceutical, and microbiota-modulating strategies represents a promising approach to mitigate both cardiovascular and neurodegenerative disease progression.

Q252: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived metabolites and inflammatory pathways in the development or mitigation of neurological and metabolic disorders, such as Alzheimer's disease and metabolic dysfunction-associated steatotic liver disease?
Options:
A: Gut microbiota exclusively affect neurological disorders by modulating the vagus nerve, without involvement of immune or metabolic pathways.
B: Dysregulation of gut microbiota can impair intestinal barrier function, leading to increased systemic inflammation and altered metabolic homeostasis, thereby accelerating both steatotic liver disease and osteoporosis through the action of microbial metabolites such as short-chain fatty acids.
C: Gut microbiota-derived short-chain fatty acids can influence microglia activity in the central nervous system, and dysbiosis may exacerbate neuroinflammation through altered inflammasome activation, contributing to Alzheimer's disease progression.
D: The abundance of Vescimonas in wild-type mice directly prevents osteoporosis by increasing acetylcholine production in the gut, which is then transported to bone tissue.

Q253: Based on the provided context, which of the following statements best integrate information about the use of metabolomics in neurodegenerative disease research and the mechanisms by which medium-chain triglycerides (MCT) may exert neuroprotective effects in Alzheimer's disease models?
Options:
A: Metabolomics enables the detection of metabolites related to mitochondrial function in body fluids, and MCT administration in 5×FAD mice leads to changes in brain metabolites, including increased short-chain fatty acids, which may serve as potential biomarkers of neuroprotection.
B: Proteomic approaches using plasma or CSF are currently the only reliable method for assessing neuroprotection in Alzheimer's and Parkinson's disease clinical trials.
C: Although there is a lack of established neuroprotection markers, advances in metabolomics allow for the identification of differentially concentrated metabolites, and MCT treatment in 5×FAD mice is associated with both reduced Aβ levels and improved gut homeostasis, suggesting a link between metabolic changes and neuroprotection.
D: PET imaging is sufficient to correlate disease progression with neuroprotective efficacy in Alzheimer's disease, making metabolomics unnecessary for biomarker discovery.

Q254: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota modulation in both neuroprotection and immune regulation, considering the mechanisms and outcomes described across different disease models?
Options:
A: Antibiotic use in livestock and berberine administration in epileptic mice both disrupt the gut-brain axis by reducing short-chain fatty acid production, resulting in worsened neurological symptoms.
B: Depletion of anaerobic gut bacteria in lupus-prone mice and antibiotic-induced dysbiosis in livestock both directly increase regulatory T cell frequency and reduce neuroinflammation.
C: The expansion of Ruminococcus gnavus in lupus-prone mice and the increase of Bifidobacterium pseudolongum in Alzheimer's disease models are each promoted by specific dietary or environmental factors, leading to disease-relevant immune or cognitive outcomes.
D: Both berberine treatment in epileptic mice and time-restricted feeding in Alzheimer's disease models confer neuroprotection by altering gut microbiota composition and associated metabolites, which in turn impact brain function.

Q255: Based on the provided context, which of the following statements best integrate the roles of gut microbiota composition, microbial metabolites, and their impact on neurological or psychiatric disease outcomes, specifically considering both mechanistic pathways and therapeutic interventions across different disorders?
Options:
A: Probiotic supplementation and fecal microbiota transplantation are discussed as potential interventions for both ischaemic stroke and PTSD, targeting gut microbial composition to modulate inflammatory and neurological outcomes.
B: Semen Cuscutae flavonoids exert antidepressant effects solely by increasing Bacteroides abundance, without affecting metabolic pathways or other microbial taxa.
C: Short-chain fatty acids produced by gut microbiota can strengthen the blood-brain barrier in ischaemic stroke and also regulate tumour progression in brain cancers, highlighting their cross-disease mechanistic influence.
D: Elevated TMAO levels from gut microbiota are beneficial in both ischaemic stroke and brain cancer by reducing inflammation and supporting cognitive function.

Q256: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota interventions may influence both cognitive impairment and immune ageing, and what are the implications for therapeutic strategies targeting the gut-brain axis?
Options:
A: Vitamin D supplementation alone, without considering gut microbiota modulation, is sufficient to delay immune ageing and prevent neurodegenerative diseases.
B: Restoring gut microbial diversity through dietary modifications is only effective for gastrointestinal health and has no impact on cognitive or immune functions.
C: The interplay between gut microbiota and vitamin D can be leveraged to enhance immune resilience and reduce systemic inflammation, suggesting that combined modulation of both may help mitigate immunosenescence and age-related cognitive decline.
D: Targeting the gut microbiota with interventions such as probiotics or fecal microbiota transplantation can modulate microbial metabolites and reduce neuroinflammation, which is relevant for both cognitive decline and neurodegenerative diseases.

Q257: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota composition and immune-metabolic interactions influence Alzheimer's disease progression, and how interventions such as fecal microbiota transplantation (FMT) may modulate these processes?
Options:
A: FMT universally improves neurodegenerative disease outcomes by restoring gut barrier integrity, regardless of donor microbiota composition or the presence of pro-inflammatory pathways.
B: The interplay between lipid metabolism and immune response in Alzheimer's disease is exacerbated by gut microbiota dysbiosis, as shown by increased pro-inflammatory cytokines and neurotoxic metabolites in mice receiving FMT from colitis-associated donors, leading to worsened cognitive deficits.
C: Gut microbiota dysbiosis in Alzheimer's disease is solely responsible for gut barrier disruption, which directly causes neuroinflammation and cognitive decline, regardless of immune or metabolic factors.
D: FMT from healthy donors in APP/PS1 mice leads to improved cognitive function and reduced amyloid-beta pathology, which is associated with enrichment of beneficial microbial taxa producing anti-inflammatory metabolites and normalization of pro-inflammatory cytokines in both gut and brain tissues.

Q258: Based on the provided context, which options best illustrate how manipulation of gut microbiota composition can influence both neurodegenerative and autoimmune disease outcomes, considering the mechanisms and therapeutic implications discussed across different disease models?
Options:
A: Periodontal bacteria directly cause schizophrenia by altering neurotransmitter synthesis, independent of gut microbiota or systemic inflammation.
B: High Clostridium and low Bacteroides levels in female BWF1 mice are consistently associated with suppression of lupus, regardless of cecal transplant source or housing conditions.
C: Transplantation of male cecal microbiota into female lupus-prone mice suppressed kidney disease and improved survival, paralleling the use of Drosophila models to study gut-derived metabolites that affect tau protein accumulation and neurocognitive impairment in Alzheimer’s disease.
D: Restoration of microbial balance through probiotics or fecal microbiota transplantation is proposed as a therapeutic strategy for schizophrenia, similar to how Drosophila models are used to test probiotics for Alzheimer’s disease by targeting gut-brain axis mechanisms.

Q259: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota or their metabolites influence neurological or renal outcomes, requiring synthesis of information from multiple sections of the text?
Options:
A: Viral infections after neurosurgery primarily cause cognitive impairment by increasing the abundance of Akkermansia and reducing intestinal permeability.
B: Dysbiosis of gut microbiota contributes to diabetic nephropathy through immune and inflammatory pathways, and microbial metabolites are implicated in both glomerular and renal tubule pathology.
C: Honokiol short-chain fatty acid esters directly prevent glomerular sclerosis and renal tubule injury in diabetic nephropathy by inhibiting gut bacterial dysbiosis.
D: Medium-chain triglycerides from coconut oil ameliorate memory deficits in 5×FAD mice by both promoting neurite outgrowth and maintaining gut homeostasis, as evidenced by increased Akkermansia abundance and elevated brain short-chain fatty acids.

Q260: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota-derived metabolites and their impact on neurodegenerative or neuroinflammatory disease progression and therapeutic strategies, considering both animal models and human studies?
Options:
A: Probiotic supplementation with Lactobacillus strains has been conclusively shown to reverse cognitive decline in Alzheimer's disease by directly restoring neuronal survival in the cortex, as demonstrated in both animal and human studies.
B: Alterations in gut microbiota composition and their metabolites, such as short-chain fatty acids, are implicated in both the modulation of immune responses in neurodegenerative diseases and the regulation of cognitive function, as evidenced by studies in Huntington's disease mouse models and clinical trials in Alzheimer's disease.
C: Psychological stress improves inflammatory bowel disease symptoms by enhancing the homeostasis of the intestinal flora and strengthening the microbiota-gut-brain axis, as supported by current evidence.
D: Short-chain fatty acids, produced by gut microbiota, can exert mild anti-inflammatory effects in the central nervous system of Huntington's disease mouse models, but do not prevent neuronal loss or clinical progression, suggesting that while microbial metabolites may modulate inflammation, they are insufficient alone for disease modification.

Q261: Based on the provided context, which of the following statements best integrates the mechanisms by which gut microbiota and viral infections can contribute to neurological and cognitive impairments, considering both immune and neuroinflammatory pathways?
Options:
A: Disruption of the blood-brain barrier during neurosurgery increases susceptibility to viral infections, which trigger neuroinflammation and cognitive decline; similarly, gut microbiota dysregulation can influence neuroinflammatory processes via immune modulation, impacting CNS disorders.
B: B lymphocytes only regulate gut microbiota composition and have no role in autoimmune or neuroinflammatory processes affecting the brain.
C: Both viral infections after neurosurgery and gut microbiota dysregulation can lead to neuroinflammation through activation of immune cells and cytokine release, resulting in impaired synaptic function and long-term cognitive deficits.
D: Gut microbiota solely affect cognitive function by altering nutrient absorption, without involvement in immune or neuroinflammatory pathways.

Q262: Based on the provided context, which of the following statements best illustrate how gut microbiota and their metabolites can influence both neurological and metabolic diseases through integrated mechanisms involving signaling pathways, immune modulation, and metabolite production?
Options:
A: Gut microbiota can modulate immune responses and oxidative stress in the CNS, influencing glioma progression, while also producing short-chain fatty acids that improve learning and memory in Alzheimer's disease models.
B: Alterations in gut microbiota composition can affect metabolic pathways such as glucose and lipid metabolism, contributing to obesity, while also impacting neuroinflammation and therapy resistance in CNS tumors via pathways like NF-κB and PI3K/Akt/mTOR.
C: Methionine restriction in the diet leads to increased intestinal permeability, which is the primary mechanism by which gut microbiota influence both Alzheimer's disease and autism spectrum disorders.
D: Heavy metal exposure directly increases the abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus, thereby preventing both autism spectrum disorders and obesity.

Q263: Based on the provided context, which of the following statements best integrate the roles of gut dysbiosis, immune response, and metabolite alterations in the progression of neurodegenerative diseases such as Parkinson's disease and multiple sclerosis?
Options:
A: In multiple sclerosis, vitamin D may help maintain eubiosis and reduce intestinal permeability, thereby potentially preventing systemic inflammation that is linked to neurodegeneration.
B: The gut-brain axis only affects neurodevelopmental disorders and has no role in neurodegenerative disease progression.
C: Alterations in the TCA cycle metabolites alone are sufficient to explain the onset of neurodegenerative diseases without involvement of gut microbiota or immune dysregulation.
D: Gut dysbiosis can disrupt the intestinal barrier, allowing toxic metabolites to enter systemic circulation, which may contribute to neuroinflammation and the progression of neurodegenerative diseases like Parkinson's disease.

Q264: Based on the provided context, which of the following statements best integrate the roles of peripheral metabolic dysfunction, neuroinflammation, and gut-brain-liver axis interventions in the pathogenesis and treatment of neurological disorders such as Alzheimer's disease and depression?
Options:
A: Vagus nerve stimulation is primarily effective in treating neuropsychiatric symptoms by directly inhibiting leptin production in adipose tissue.
B: Imbalances in gut microbiota can promote inflammation and increase gut permeability, which, together with peripheral adipokine release, may contribute to neuroinflammatory processes underlying both depression and Alzheimer's disease.
C: Small molecule-based inhibition of protein aggregation in Parkinson's disease directly reduces gut barrier permeability, thereby preventing neuroinflammation and cognitive decline.
D: Leptin-mediated inflammation in the insula links adiposity to neuropsychiatric symptoms in Alzheimer's disease, suggesting that targeting adipose-derived inflammatory pathways could be a promising intervention for neuropsychiatric symptoms.

Q265: Based on the provided context, which of the following statements best integrate information about the interplay between metabolism, immune cell function, and disease progression in cancer and neurodegenerative disorders, and are supported by the text?
Options:
A: Metabolic reprogramming in the tumor microenvironment can influence the formation of follicular helper T cells and germinal centers, thereby promoting tertiary lymphoid structure formation and enhancing antitumor immunity.
B: Proteomic approaches using plasma or CSF are currently the only reliable method to assess neuroprotection in clinical trials for Alzheimer's and Parkinson's diseases.
C: Microglia and CNS-associated macrophages, which are influenced by the gut microbiota, play a key role in Alzheimer's disease progression by clearing amyloid beta through phagocytosis.
D: Psychological stress improves the severity of inflammatory bowel disease by restoring the balance of the microbiota-gut-brain axis and enhancing intestinal immunity.

Q266: Based on the integrated findings from studies on pediatric obesity, menopause-related neuroinflammation, and gut-brain axis interventions, which of the following statements best illustrate how dietary patterns and gut microbiota interact to influence inflammation and cognitive or metabolic outcomes across different populations?
Options:
A: Interventions that restore gut microbiota balance, such as the combined use of Polygala tenuifolia and Magnolia officinalis, can alleviate cognitive impairment by reducing inflammation and protecting both the blood-brain and intestinal barriers, similar to how dietary modulation of gut microbiota in pediatric obesity can improve inflammatory and metabolic outcomes.
B: The effectiveness of dietary interventions in modulating gut microbiota and reducing inflammation is well established in both pediatric and menopausal populations, with long-term benefits confirmed in all reviewed studies.
C: Alterations in gut microbiota due to dietary changes are only relevant to cognitive impairment in animal models and do not impact metabolic or inflammatory status in human populations.
D: Dietary interventions such as symbiotic supplementation or adherence to Mediterranean diet patterns can modulate gut microbiota, leading to reduced inflammation and improved metabolic profiles in obese children, paralleling how unhealthy dietary habits during menopause may worsen inflammation and increase neurodegenerative risk in women.

Q267: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota alterations, neuroinflammation, and neurodegenerative or neurodevelopmental outcomes in both rodent models and human disease, and highlight the potential for therapeutic intervention?
Options:
A: Both neurodegenerative diseases and leukodystrophies demonstrate that gut microbiota composition can influence neurological outcomes through mechanisms involving neuroinflammation and redox homeostasis, suggesting that targeting the microbiota may offer novel therapeutic strategies.
B: Early ethanol exposure in pregnancy leads to permanent restoration of gut microbiota and prevents neurodevelopmental deficits, as supported by evidence from both rodent and human studies.
C: Therapeutic administration of antibiotics in a viral model of multiple sclerosis consistently prevents neuroinflammation and demyelination by restoring gut microbiota balance, as shown in both animal and human studies.
D: Alterations in gut microbiota composition following early ethanol exposure in rodent models are associated with neuroinflammation and cognitive impairment, paralleling findings that gut dysbiosis and neuroinflammation are linked in pediatric-onset leukodystrophies.

Q268: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, neuroinflammation, and metabolic changes in the development or treatment of neurodegenerative and psychiatric disorders, and are supported by evidence from multiple sections of the text?
Options:
A: Neuroinflammation in depression is exclusively caused by glial cell activation and does not involve peripheral immune responses or systemic stress.
B: Dysbiosis of gut microbiota can contribute to both brain cancer progression and age-related cognitive decline by disrupting homeostatic cognitive functioning and promoting chronic systemic inflammation.
C: Medium-chain triglycerides from coconut oil improve memory in 5×FAD mice solely by increasing ketone production, without affecting gut microbiota or neuroinflammation.
D: Alterations in gut microbiota and their metabolites, such as short-chain fatty acids, can influence neuroinflammatory processes implicated in both depression and neurodegenerative diseases.

Q269: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota modulation and inflammatory pathways contribute to neurological outcomes in Alzheimer’s disease and ischemic stroke, considering both therapeutic interventions and mediators involved?
Options:
A: Atorvastatin improves neurobehavioral deficits in ischemic stroke by increasing specific gut bacteria, which in turn suppresses microglia activation and inhibits the Akt/NF-κB/NLRP3 pathway, demonstrating a gut-brain axis mechanism.
B: Clostridium butyricum directly prevents Alzheimer’s disease by acting only on microglia without involving gut microbiota or metabolite regulation.
C: Leptin links adipose tissue dysfunction to neuropsychiatric symptoms in Alzheimer’s disease by promoting insular neuroinflammation, as shown by its correlation with BMI and TSPO-PET imaging results.
D: Traditional Chinese Medicine treats Alzheimer’s disease solely by direct action on neuronal cells, without any involvement of gut microbiota as a mediator or target.

Q270: Based on the integrated findings from studies on polyphenols, gut microbiota, and neurodegenerative diseases, which of the following statements best illustrate how interventions targeting both dietary components and gut microbial composition could synergistically influence neuroinflammation and cognitive decline in aging populations?
Options:
A: Polyphenols can modulate key signaling pathways involved in neuroprotection, while age- and sex-specific gut microbiota signatures, such as increased Bifidobacterium spp. in younger females, may further enhance cognitive resilience against dementia-related brain pathologies.
B: Increasing Bacteroides spp. abundance in elderly individuals is directly associated with improved neuroprotection and reduced risk of dementia-related brain pathologies.
C: Polyphenols alone, without any influence from gut microbiota composition, are sufficient to prevent all forms of neurodegenerative diseases in elderly males.
D: Lactiplantibacillus plantarum strains promote eubiosis and beneficial metabolite production, which, when combined with the anti-inflammatory and antioxidant effects of polyphenols, may help mitigate neuroinflammation and support cognitive function in neurodegenerative disorders.

Q271: Based on the provided context, which of the following statements best integrate the mechanisms by which gut-derived factors influence neuroinflammation and cognitive function in neurodegenerative and metabolic diseases, and also relate to therapeutic interventions discussed?
Options:
A: Obesity-induced changes in gut flora, including increased intestinal permeability and neuroinflammation, are mechanistically linked to cognitive decline, and early lifestyle interventions targeting gut flora may improve neurological outcomes.
B: Rubusoside supplementation in Parkinson's disease models directly prevents dopaminergic neuron loss by restoring the gut mycobiome to its normal composition.
C: Antifungal therapies have been conclusively shown to reverse metabolic disorders by restoring gut homeostasis and preventing neurodegeneration.
D: Short-chain fatty acids, such as propionate, can mildly reduce central nervous system inflammation in Huntington's disease models by down-regulating inflammatory markers, but do not prevent neuronal loss or clinical progression.

Q272: Based on the provided context, which of the following statements best integrates evidence regarding the interplay between gut microbiota-derived metabolites and disease prevention or progression in both colorectal cancer and neurodegenerative disorders?
Options:
A: Short-chain fatty acids produced by gut microbiota directly increase the risk of both colorectal cancer and neurodegenerative disorders by promoting pro-inflammatory bacteria.
B: Alterations in gut microbiota that reduce beneficial metabolite production are linked to both compromised gut barrier integrity in neurological disease models and increased risk of colorectal cancer, supporting the therapeutic potential of microbiota modulation in both contexts.
C: Restoring gut microbial short-chain fatty acid levels through microbiota modulation may prevent colorectal cancer by improving epithelial barrier function and immunity, while similar microbiota-targeted interventions like fecal microbiota transplantation are suggested to enhance cognitive performance in neurodegenerative disorders.
D: Gut microbiota interventions are only effective in preventing colorectal cancer and have no demonstrated impact on neurological or cognitive health according to the context.

Q273: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence neuroinflammation and neurodegenerative disease progression, considering both microbial amyloids and short-chain fatty acids (SCFAs)? Select ALL that apply.
Options:
A: Akkermansia muciniphila abundance is positively correlated with depression phenotypes in ARDS, and its metabolite propionic acid increases microglial activation through the TLR4/NF-κB pathway.
B: Reduced levels of SCFAs in Alzheimer's disease models are associated with altered gut microbial metabolism and systemic inflammation, which correlates with increased microglial and astrocyte activity in memory-related brain regions.
C: Bacterial amyloids produced by gut-colonizing microbes can cross-seed human amyloidogenic proteins, and persistent inflammation may compromise the blood-brain barrier, allowing these amyloids and inflammatory molecules to enter the brain and exacerbate neurodegeneration.
D: Molecular chaperones and heat shock proteins are sufficient to prevent all neuronal damage caused by bacterial amyloids, regardless of genetic variations in chaperone genes.

Q274: Based on the provided context, which of the following statements best integrate information about metabolic or microbial influences on disease mechanisms or outcomes across different disorders, requiring synthesis of both mechanistic and outcome-related details?
Options:
A: Women with both IBS and chronic fatigue syndrome display distinct gut microbiota and altered tryptophan metabolite profiles, with higher urinary levels of neuroactive kynurenine derivatives correlating with increased fatigue severity.
B: Neuroinflammation in Alzheimer's disease, Parkinson's disease, and multiple sclerosis is exclusively caused by the same molecular aggregates and does not involve any shared signaling pathways or immune mediators.
C: In early-life, transient changes in the gut microbiome due to environmental factors are only associated with short-term health outcomes and do not impact immunological or metabolic responses later in life.
D: Metabolic reprogramming in the tumor microenvironment can promote the formation of follicular helper T cells and germinal centers, which are components of tertiary lymphoid structures associated with improved antitumor immunity and prognosis.

Q275: Based on the provided context, which of the following statements best integrate the mechanisms by which antidepressants and probiotics may influence neuroinflammation and neurological health, considering the roles of the gut-brain axis, immune modulation, and molecular mediators?
Options:
A: Both antidepressants and probiotics can modulate neuroinflammation through immune pathways, with antidepressants acting via mechanisms such as NF-κB and NLRP3 inflammasome, and probiotics influencing inflammation through PPARs as molecular mediators.
B: The gut-brain axis serves as a bidirectional communication system, allowing both antidepressants and probiotics to impact neurological diseases by modulating immune responses and neuroinflammation through distinct but potentially overlapping molecular targets.
C: Probiotics and antidepressants only affect the central nervous system independently, without any influence on peripheral immune or gut-related pathways.
D: Antidepressants and probiotics exert their effects on neurological health exclusively through direct neurotransmitter modulation, without involvement of immune or gut-brain axis pathways.

Q276: Based on the provided context, which of the following statements best integrate information about the roles of gut microbiota-derived metabolites and neuropeptide signaling in neurodegenerative or CNS-related diseases, requiring synthesis of mechanisms and outcomes across different disease models?
Options:
A: Microbiota-derived Indoles can modulate neuroinflammation in APP/PS1 mice by activating the aryl hydrocarbon receptor pathway and inhibiting NF-κB signaling, demonstrating a mechanism by which gut microbial metabolites influence CNS pathology.
B: Alterations in the gut microbiota composition are only relevant to ocular diseases and do not impact neurodegenerative or CNS-related disorders according to current evidence.
C: Dysregulation of gut neuropeptide signaling, which can be influenced by microbial metabolites and immune factors, is associated with pathological effects in Parkinson’s disease animal models, highlighting the integration of gut-brain communication and neuroimmune pathways.
D: Phages, as the most abundant viral component of the gut microbiota, have been shown to directly regulate gut neuropeptide signaling and thereby prevent α-synuclein aggregation in Parkinson’s disease models.

Q277: Based on the provided context, which interventions demonstrate both modulation of gut microbiota composition and improvement of neurological outcomes through changes in metabolite levels, and what mechanisms are involved in these effects?
Options:
A: Lactobacillus rhamnosus directly increases serum indoleacetic acid (IAA) levels to prevent retinal ganglion cell loss in glaucoma by activating the RAGE/NF-κB pathway.
B: Firmicutes abundance in the gut is solely responsible for motor function recovery in spinal cord injury patients, independent of SCFA production or other bacterial genera.
C: Bacteroides fragilis supplementation restores AhR activation and suppresses microglial inflammation in glaucoma by increasing IAA levels and reversing gut dysbiosis.
D: Polygoni Multiflori Radix Praeparata polysaccharides (PMP) improve neurological function in ischemic stroke by increasing SCFAs and beneficial amino acids, reversing gut dysbiosis, and enhancing gut barrier integrity.

Q278: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, the kynurenine pathway, and dietary polyphenols in modulating neuroinflammation and neurodegeneration through the gut-brain axis?
Options:
A: The kynurenine pathway exclusively produces neuroprotective compounds, and dietary polyphenols have no impact on gut-brain axis functions.
B: Alterations in gut microbiota composition can increase gut permeability and trigger inflammation, which, via the kynurenine pathway, contributes to neuroinflammation; dietary polyphenols can modulate gut microbial diversity and biochemical changes in the brain, potentially mitigating these effects.
C: Probiotics can modulate the kynurenine pathway to reduce neuroinflammation, while polyphenols biotransformed by gut microbiota can influence neurotransmitter levels and cerebrovascular function, together offering therapeutic potential for neuropsychiatric and neurodegenerative disorders.
D: Gut microbiota does not interact with the immune system, and changes in its composition are unrelated to neurodegenerative disease progression.

Q279: Based on the provided context, which of the following statements best integrate information about the role of microbiota and inflammation in both neurodegenerative and psychological disorders, and their implications for therapeutic strategies?
Options:
A: The Mediterranean diet is specifically recommended for the treatment of both retinal and neurodegenerative diseases due to its direct anti-inflammatory effects on the gut microbiota.
B: Dysbiosis and the resulting chronic inflammation are implicated in the pathogenesis of both Parkinson's disease and retinal disorders, supporting the exploration of microbiota-targeted therapies such as probiotics and nutritional interventions.
C: PTSD and age-related macular degeneration share the same underlying mechanism of dopaminergic neuron loss, making L-dopa therapy a promising treatment for both conditions.
D: Both Parkinson's disease and PTSD are associated with inflammation and immune dysregulation, and targeting these processes through microbiota modulation or anti-inflammatory interventions is suggested as a potential therapeutic strategy.

Q280: Based on the provided context, which of the following statements best integrate findings regarding the modulation of neuroinflammation and cognitive outcomes through gut microbiota-targeted interventions and their mechanisms in both delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) and Alzheimer's disease models?
Options:
A: Both SCFAs (acetate and propionate) in DEACMP rats and GV-971 in Alzheimer's disease mouse models improve neuroinflammatory profiles by altering gut microbiota composition and reducing pro-inflammatory cytokines.
B: GV-971 reduces cerebral amyloidosis and reactive microglia in a sex-specific manner, while SCFAs in DEACMP rats improve cognitive dysfunction and anxiety symptoms by modulating inflammation and neurotransmitter levels.
C: GV-971 and iTBS both directly increase hippocampal dopamine and norepinephrine levels in their respective models, leading to improved cognitive function.
D: Both iTBS and GV-971 act primarily by increasing the abundance of beneficial bacterial species, which directly correlates with increased GPR41 and GPR43 expression in the hippocampus.

Q281: Based on the integrated evidence from the context, which of the following statements best illustrate how gut microbiota alterations can contribute to both neuropsychiatric and neurodegenerative disorders, considering mechanisms involving metabolite signaling, immune modulation, and brain region-specific effects?
Options:
A: Stress-induced changes in gut microbiota, such as increased Muribaculaceae and butanoate metabolism, can alter GABAergic synaptic transmission in the prefrontal cortex, linking social status loss to brain disorders.
B: Gut microbiota dysbiosis can activate microglia via lipopolysaccharide signaling and alter neurotransmitter balance through disrupted tryptophan metabolism, thereby contributing to both neurodegenerative and psychiatric disorders.
C: Alzheimer’s disease pathogenesis is solely determined by amyloid-beta accumulation, independent of any microbial or gut-brain axis involvement.
D: Changes in gut microbiota composition only affect metabolic diseases by regulating insulin sensitivity, without influencing brain function or neuropsychiatric outcomes.

Q282: Based on the provided context, which of the following statements best integrate the mechanisms and outcomes described for gut microbiota-derived short-chain fatty acids (SCFAs) in both colorectal cancer and neuroinflammatory disease models, and how their modulation may influence disease progression or prevention?
Options:
A: SCFA supplementation in Huntington’s disease mice leads to complete prevention of neurodegeneration and clinical symptoms, and also directly eliminates colorectal cancer cells by modifying DNA methylation.
B: Gut microbiota-derived SCFAs universally prevent all forms of inflammation and neurodegeneration, regardless of disease context or underlying genetic mutations.
C: Restoring SCFA levels in the colon through microbiota modulation can enhance gut barrier function and immunity, thereby reducing colorectal cancer risk, while propionate supplementation in Huntington’s disease mice mildly down-regulates CNS inflammatory markers but does not prevent neuronal loss.
D: SCFAs produced by gut microbiota can influence both colorectal cancer progression via epigenetic modifications and neuroinflammatory processes in Huntington’s disease by reducing specific inflammatory markers, though their effects on clinical outcomes differ between these diseases.

Q283: Based on the provided context, which of the following statements best integrate evidence regarding the gut microbiome’s influence on neurological disorders and the potential for therapeutic interventions that target both metabolic and mitochondrial pathways?
Options:
A: Butyrate produced by gut microbiota can enhance neuronal mitochondrial biosynthesis via the AMPK-PGC1α pathway, and dietary fiber interventions may support this process, providing a theoretical basis for novel antidepressant therapies targeting gut-brain interactions.
B: The presence of pro-inflammatory bacteria in the gut microbiome is solely responsible for the onset of all neurological disorders, making anti-inflammatory bacterial supplementation sufficient as a universal therapy.
C: The gut microbiome can compensate for metabolic deficiencies in Alzheimer’s disease by producing metabolites such as acetyl-CoA and succinate, while interventions like probiotics and fecal microbial transplantation may further enhance neurological function by remodeling the flora-mitochondrial axis.
D: Altered gut microbiota after bariatric surgery always results in improved neurological outcomes due to increased anti-inflammatory bacteria, regardless of the type of neurological disorder.

Q284: Considering the multifactorial mechanisms underlying neurodevelopmental and neurodegenerative disorders, which of the following statements best integrates the roles of gut microbiota, immune signaling, and neuropeptides in both disease pathogenesis and therapeutic strategies as discussed in the context?
Options:
A: Pycnogenol’s therapeutic potential in neurodevelopmental disorders is attributed to its ability to modulate gut microbial composition, which in turn influences immune signaling pathways such as NF-κB and PI3K/AKT/mTOR, thereby impacting cognitive and behavioral outcomes.
B: Viral infections after neurosurgery only cause cognitive impairment through direct neuronal damage, and do not involve neuroinflammatory responses or blood-brain barrier disruption.
C: Gut neuropeptide dysregulation in Parkinson’s disease is solely a consequence of central nervous system α-synuclein aggregation, without any involvement of microbial metabolites or immune pathway alterations.
D: Alterations in gut microbiota can affect neurodevelopmental and neurodegenerative disorders by modulating neurotransmitter systems, immune responses, and neuropeptide signaling, which together influence both cognitive function and disease progression.

Q285: Considering the temporal progression of Alzheimer's disease pathology, which of the following events are supported by the context as occurring after the administration of sodium oligomannate (GV-971) at the onset or plateau of Aβ deposition, and are linked to subsequent changes in the microbiota-microglia-amyloid axis?
Options:
A: Reduction in cerebral amyloidosis primarily in male mice, independent of strain.
B: Immediate restoration of all gut microbiota species to baseline levels prior to treatment.
C: Complete elimination of amyloid-beta plaques in both male and female mice regardless of treatment timing.
D: Dampening of astrocyte and microglia activation, with decreased plaque-associated reactive microglia and increased homeostatic microglia in male mice.

Q286: Considering the temporal sequence of events following therapeutic interventions targeting the gut microbiota in neurodegenerative diseases, which of the following processes are likely to occur after the initial restoration of microbial balance, and before the manifestation of improved cognitive or motor function, according to the context provided?
Options:
A: Regulation of neurotransmitter production and reinstatement of microbial diversity
B: Reduction of neuroinflammation and strengthening of gut barrier integrity
C: Onset of donor selection complexities and uncertainties about long-term safety
D: Immediate reversal of all neurodegenerative symptoms

Q287: Considering the temporal sequence of molecular and cellular events described in the treatment of delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) in rats, which of the following events are likely to occur after the administration of short-chain fatty acids (SCFAs) such as acetate and propionate, but before the improvement of cognitive dysfunction and anxiety symptoms? Select all that apply.
Options:
A: Immediate restoration of cognitive function as measured by the Morris water maze.
B: Normalization of dopamine and norepinephrine levels in the hippocampus.
C: Reduction in hippocampal inflammatory factors such as IL-1β, IL-6, and TNF-α.
D: Increased activation of GPR41 and GPR43 receptors in the hippocampus.

Q288: Considering the temporal progression of gut microbiota changes in patients with spinal cord injury (SCI), which of the following statements accurately describe the sequential alterations in the abundance of short-chain fatty acid (SCFA)-producing bacteria from the subacute to the chronic phase, and their potential implications for gut dysbiosis and motor function recovery?
Options:
A: Gut dysbiosis is only present in the chronic phase of SCI, as the subacute phase is characterized by a stable and healthy gut microbiota composition.
B: The genus of potential SCFA-producing bacteria is lower in the chronic phase of SCI than in the subacute phase, suggesting a temporal decline in beneficial microbial populations associated with gut dysbiosis.
C: Firmicutes and Lactobacillus both increase in abundance from the subacute to the chronic phase of SCI, indicating improved gut microbial balance over time.
D: In the subacute phase of SCI, the relative abundance of several SCFA-producing genera such as Faecalbacterium, Ruminococcus, and Coprococcus increases, while in the chronic phase, these genera show a lower relative abundance.

Q289: Considering the multi-step progression of colorectal cancer (CRC), which of the following events would most likely occur after a decrease in gut microbial short-chain fatty acid (SCFA) production, and before the initiation of tumor metastasis, according to the described temporal and hierarchical mechanisms?
Options:
A: Altered intestinal epithelial barrier function and immune changes linked to CRC development
B: Complete prevention of CRC risk without further intervention
C: Immediate restoration of SCFA levels through microbiota modulation
D: Epigenetic modifications such as DNA methylation and histone changes affecting tumor initiation

Q290: Considering the temporal sequence of events following bariatric surgery, which of the following changes are observed as part of the multi-step pathway leading to improved long-term metabolic health, and which occur earlier in the cascade? Select all that apply: (A) An increase in Akkermansia muciniphila abundance in the gut microbiota, (B) Upregulation of mitochondrial genome-encoded genes in the hippocampus, (C) Reduction in appetite-regulating hormone ghrelin, (D) Enhanced satiety and decreased caloric intake due to increased GLP-1 and PYY levels.
Options:
A: An increase in Akkermansia muciniphila abundance in the gut microbiota.
B: Upregulation of mitochondrial genome-encoded genes in the hippocampus.
C: Enhanced satiety and decreased caloric intake due to increased GLP-1 and PYY levels.
D: Reduction in appetite-regulating hormone ghrelin.

Q291: Considering the temporal sequence of events in neuroangiostrongyliasis as described, which of the following occur after the initial infection with Angiostrongylus cantonensis in BALB/c mice, and are associated with subsequent modulation of disease progression by intestinal Lactobacillus johnsonii? Select all that apply.
Options:
A: Immediate normalization of short-chain fatty acid, tryptophan, and bile acid levels following L. johnsonii inoculation.
B: An increase in the abundance of different Lactobacillus species in the gut, correlated with disease severity.
C: Improvement in neuroinflammation and prolonged survival after L. johnsonii administration, mediated by immune modulation.
D: A decrease in the initial infection rate of Angiostrongylus cantonensis due to L. johnsonii presence.

Q292: Considering the temporal sequence of events following addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage and contribute to subsequent changes in brain function and behavior? Select all that apply.
Options:
A: Systemic inflammatory responses and immune imbalances develop after harmful substances and bacteria cross the damaged intestinal barrier.
B: Reshaping the gut-brain axis and adjusting gut microbiota composition can alleviate withdrawal symptoms after dependence has developed.
C: Dysbiosis resulting from gut barrier damage activates immune cells and releases inflammatory factors, which then affect brain function.
D: Gut barrier damage directly leads to altered mood and cognitive function without involvement of immune activation.

Q293: Considering the temporal sequence of events described in the context of kainic acid-induced acute epileptic seizures in mice, which of the following processes are reported to occur after berberine administration and are involved in its neuroprotective effect, according to the described studies on gut microbiota and metabolite changes?
Options:
A: Immediate restoration of normal Racine scores before any metabolic changes are detected
B: Regulation of short-chain fatty acids (SCFAs) following alterations in gut microbiota
C: A reduction in hippocampal neuron damage prior to any changes in gut microbiota composition
D: An increase in the abundance of Bacteroidetes and Alloprevotella in the gut microbiota

Q294: In the context of morphine self-administration in rodents, which of the following statements accurately describe the temporal sequence of biological changes observed from baseline through acute and chronic phases, and the hierarchical relationship between gut and brain alterations as supported by the study findings?
Options:
A: The study supports that gut changes temporally precede brain changes, with the striatum and thalamus acting as key mediators in gut-brain communication during morphine exposure.
B: Early changes in gut microbiota diversity and abundance are detectable in the acute phase and persist into the chronic phase, preceding detectable MRI changes in the brain.
C: Alterations in MRI diffusivity indices in the striatum and thalamus are observed before any measurable changes in gut microbiota composition during morphine self-administration.
D: MRI and gut microbiota changes occur simultaneously, with no evidence for a temporal hierarchy between gut and brain alterations during morphine self-administration.

Q295: Considering the temporal sequence of events in APP/PS1 mice subjected to early social isolation, which of the following changes occur after the onset of social isolation and before the therapeutic intervention with oxytocin, and which changes are observed following oxytocin administration? Select all that apply.
Options:
A: Social isolation leads to decreased oxytocin levels and upregulated oxytocin receptor expression prior to oxytocin intervention.
B: Oxytocin intervention restores gut microbiota homeostasis and mitigates AD-related pathological damage after social isolation.
C: Increased Aβ plaque deposition and aberrant microglial proliferation occur after social isolation and before oxytocin treatment.
D: Oxytocin intervention induces initial social cognitive impairments in APP/PS1 mice before any pathological changes are observed.

Q296: Considering the temporal sequence of events in colorectal cancer (CRC) development, which of the following processes occur after a decrease in gut microbial short-chain fatty acid (SCFA) production, and before the manifestation of tumor initiation and metastasis, according to the described mechanistic pathway?
Options:
A: Exposure to environmental carcinogens
B: Alterations in intestinal epithelial barrier function and immunity
C: Epigenetic modifications such as DNA methylation and histone changes
D: Restoration of SCFA levels through microbiota modulation

Q297: Considering the multi-step pathway by which the gut microbiome influences reactive astrocytosis during Aβ amyloidosis, which of the following events occur after an increase in gut-derived propionate, and before the reduction in Aβ plaque accumulation, according to the described sequence of molecular and cellular changes?
Options:
A: Decrease in peripheral Th17 (RORγt+ CD4+) cells and IL-17 secretion
B: Initial administration of antibiotics leading to gut microbiome perturbation
C: Accumulation of Aβ plaques in the brain
D: Reduction in reactive astrocytosis and increased expression of neurotrophic genes in astrocytes

Q298: Considering the temporal progression of gut microbiota changes after spinal cord injury (SCI), which of the following statements accurately describe the sequential alterations in the abundance of short-chain fatty acid (SCFA)-producing bacteria from the subacute to the chronic phase, and their hierarchical impact on gut dysbiosis?
Options:
A: In the chronic phase of SCI, the average proportion of Bifidobacterium, Bacteroides, and Blautia is lower than in non-SCI persons, indicating a complete recovery of the gut microbiota.
B: Firmicutes and Lactobacillus both increase in abundance from the subacute to the chronic phase of SCI, contributing to improved gut homeostasis over time.
C: Gut dysbiosis is present in both the subacute and chronic phases of SCI, but the genus of potential SCFA-producing bacteria is lower in the chronic phase than in the subacute phase.
D: In the subacute phase of SCI, the relative abundance of SCFA-producing genera such as Faecalbacterium, Ruminococcus, and Coprococcus increases, while in the chronic phase, these genera show a lower relative abundance.

Q299: Considering the temporal sequence of molecular events described in APP/PS1 mice, which of the following steps occur after the gut microbiota-derived Indoles upregulate aryl hydrocarbon receptor (AhR) production but before the improvement in cognitive and behavioral ability is observed? Select all that apply.
Options:
A: Prevention of Aβ accumulation and Tau hyperphosphorylation
B: Reduction in the release of inflammatory cytokines such as TNF-α, IL-6, IL-1β, and IL-18
C: Inhibition of the NF-κB signaling pathway and formation of the NLRP3 inflammasome
D: Restoration of synaptic plasticity

Q300: Considering the temporal sequence of events in the gut microbiota–CNS disease axis, which of the following processes are likely to occur after an initial alteration in gut microbiota composition, but before the manifestation of CNS disease symptoms or therapeutic response, according to the context provided?
Options:
A: Direct genetic editing of CNS neurons by gut microbiota without involvement of metabolic or immune pathways.
B: Modulation of immune responses and oxidative status by the altered gut microbiota, influencing neuroinflammation.
C: Activation of signaling pathways such as NF-κB, MAPK, or PI3K/Akt/mTOR in the CNS microenvironment, contributing to tumor progression or therapy resistance.
D: Immediate reversal of CNS disease symptoms without intermediary molecular or cellular changes.

Q301: In the dual-hit mouse model combining DSS-induced colitis and MPTP-induced Parkinson's disease, which of the following events occur sequentially after the initial upregulation of LRRK2 expression in both the colon and brain, and are temporally linked to exacerbated neuroinflammation and dopaminergic neuron loss?
Options:
A: Increased Iba-1 expression and significant loss of dopaminergic neurons occur after LRRK2 upregulation and NF-κB activation.
B: Reduction in LRRK2 expression in the colon leads to decreased inflammatory cytokines and improved barrier integrity.
C: Restoration of ZO-1 and Occludin levels in the colon precedes the increase in inflammatory cytokines.
D: Activation of the NF-κB pathway and inhibition of the Nrf2 pathway in the brain follow the upregulation of LRRK2.

Q302: Based on the described studies of morphine self-administration in rodents, which of the following statements accurately reflect the temporal sequence of biological changes observed in the gut-brain axis, and which events are reported to occur earlier or persist throughout the process?
Options:
A: Early changes in gut microbiota diversity and abundance are observed during the acute phase and persist into the chronic phase of morphine self-administration.
B: MRI and gut microbiota changes occur simultaneously, with no evidence of one preceding the other during morphine self-administration.
C: Alterations in MRI diffusivity indices in the striatum and thalamus are detected before any changes in gut microbiota are observed.
D: Gut changes are posited to precede the effects observed in MRI, suggesting that gut alterations may occur before detectable brain changes.

Q303: Considering the temporal sequence of events following perinatal chlorpyrifos (CPF) exposure, which of the following processes occur after the initial disruption of gut microbiota in offspring, and are subsequently mitigated by inulin supplementation according to the described experimental timeline?
Options:
A: Bacterial translocation to the spleen and liver occurs after gut dysbiosis and is reduced by inulin.
B: Increased abundance of Bifidobacterium and Lactobacillus precedes CPF-induced gut dysbiosis.
C: Decreased expression of tight junction genes in brain microvessels follows CPF-induced gut dysbiosis and is restored by inulin.
D: CPF exposure first increases tight junction gene expression, which is then decreased by inulin supplementation.

Q304: Considering the temporal sequence of molecular events described in neurodegenerative diseases, which of the following processes are likely to occur after the initial gut microbiota dysbiosis but before the manifestation of neuronal integrity loss, according to the context provided? Select all that apply.
Options:
A: Downregulation of the microbial metabolite DHPS, leading to increased hydrogen sulfide and promotion of inflammation and oxidative stress.
B: Direct improvement of learning and memory processes before any changes in neurotrophin signaling or synaptic function.
C: Increased production of pro-inflammatory cytokines and subsequent generation of Th17 cells following gut microbiota alterations.
D: Immediate restoration of neuronal integrity through stem cell replacement prior to any immune dysregulation.

Q305: Considering the temporal sequence of events in the microbiota-gut-brain axis, which of the following processes would most likely occur after the restoration of microbial composition and functionality by fecal microbiota transplantation (FMT) in a patient with a neurological disorder, but before improvements in cognitive function are observed?
Options:
A: A decrease in IL-17 and IFN-γ expression, indicating reduced neuroinflammation
B: Suppression of neuroinflammation through modulation of the neuroimmune axis
C: Lowering of amyloid-β accumulation in the brain
D: Immediate upregulation of synaptic markers such as PSD-95 and synapsin-1

Q306: Considering the temporal sequence of molecular and cellular events in Alzheimer's disease, which of the following processes are likely to occur after the initial dysbiosis of the gut microbiota but before the manifestation of cognitive deterioration, according to the described pathways involving neuroinflammation and glial cell activation?
Options:
A: Restoration of microbial composition and functionality via fecal microbiota transplantation
B: Progressive deterioration of nervous system structure and function characteristic of neurodegenerative diseases
C: Activation of astrocytes and microglia leading to neuroinflammation
D: Accumulation of beta-amyloid protein forming neuritic plaques

Q307: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes are reported to occur after the initial disruption of the gut microbiome, and are subsequently modulated by Pectin-Zein-IPA nanoparticle treatment to promote functional recovery and reduce neuroinflammation?
Options:
A: Immediate restoration of normal intestinal flora composition prior to any neuroinflammatory response
B: Direct enhancement of Parasutterella abundance before any changes in neuroinflammation or autophagy
C: Activation of oxidative stress and inhibition of axonal regeneration, which are later alleviated by Pectin-Zein-IPA NPs
D: Accumulation of L-methionine in the intestinal flora, which is subsequently reduced by Pectin-Zein-IPA NPs to alleviate neuroinflammation

Q308: Considering the temporal sequence of molecular and cellular events described in Negr1 knockout (KO) mice, which of the following occur after the early-life reduction in Akkermansia spp. and before the behavioral improvements observed with Akkermansia supplementation? Select all that apply.
Options:
A: Reduced dendritic arborization and spine density in the nucleus accumbens and dentate gyrus.
B: Upregulation of mitochondrial genome-encoded genes in the nucleus accumbens and hippocampus.
C: Downregulation of mitochondrial genes in the nucleus accumbens and hippocampus following Akkermansia supplementation.
D: Amelioration of anxiety- and depression-like behaviors in Negr1 KO mice.

Q309: Considering the multi-step pathway described in the context, which of the following events would most likely occur after the identification of strong binding affinities between NFKB1 and bile acid derivatives in the computational drug screening process for erectile dysfunction, but before clinical validation of these findings? Select all that apply.
Options:
A: Genome-wide association study (GWAS) summary statistics are collected to identify associations between gut microbiota and erectile dysfunction.
B: Top-ranking drug-gene pairs are validated by assessing their binding free energies and interaction stability.
C: Preclinical or clinical studies are conducted to translate computational findings into therapeutic applications.
D: Molecular docking is performed to confirm the stability and binding free energies of the predicted drug-gene interactions.

Q310: Considering the temporal sequence of events described in the context of Alzheimer's disease continuum, which of the following steps occur after an increase in body mass index (BMI) but before the manifestation of neuropsychiatric symptoms (NPS), according to the path analysis involving leptin and neuroinflammation?
Options:
A: Higher plasma leptin significantly predicts increased (11)C-DPA-713 binding potential in the insula, indicating neuroinflammation.
B: Cognitive function is measured using the Alzheimer's Disease Assessment Scale-Japanese Cognitive Subscale (ADAS-J cog).
C: Elevated plasma leptin concentration positively correlates with increased BMI.
D: Interventions targeting leptin and adipose tissue dysfunction are implemented to manage NPS.

Q311: Considering the temporal sequence of events in ischemic stroke, which of the following processes occur after the initial activation of microglia, and are directly involved in the subsequent regulation of neuroinflammation and tissue repair? Select all that apply.
Options:
A: Immediate restoration of blood-brain barrier integrity before cytokine release
B: Transition of microglia between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes
C: Release of cytokines by activated microglia contributing to neuroinflammation
D: Promotion of tissue repair through anti-inflammatory responses and regeneration by microglia

Q312: Considering the temporal sequence of events in the development and management of pediatric obesity, which of the following processes occur after the initial onset of gut microbiota dysbiosis but before the establishment of long-term therapeutic effectiveness, according to the reviewed studies on gut microbiota and metabolic outcomes in obese children?
Options:
A: Favorable modulation of gut microbiota and inflammatory parameters following dietary interventions such as symbiotic supplementation or adherence to Mediterranean diet patterns
B: Substantiation of the effectiveness of dietary and microbiota-modifying strategies through robust, long-term studies
C: Alterations in microbial diversity and abundance associated with increased inflammation and adverse metabolic profiles
D: Resolution of all methodological limitations in study design and implementation

Q313: Considering the temporal sequence of molecular and cellular events following cerebral ischaemia, which of the following processes are likely to occur after the initial reduction in blood flow but before the exacerbation of reperfusion-induced damage, according to the described pathophysiology of ischaemic stroke and the influence of gut microbiota?
Options:
A: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB
B: Strengthening of the blood-brain barrier by short-chain fatty acids derived from beneficial gut microbiota
C: Therapeutic intervention with faecal microbiota transplantation resulting in improved patient outcomes in large-scale, randomised trials
D: Compromise of blood-brain barrier integrity due to a pro-inflammatory milieu intensified by oxidative stress

Q314: Based on the provided context, which of the following molecular effects are directly associated with nicotinamide n-oxide (NAMO) in the regulation of microglial activity during herpes simplex virus type 1 (HSV-1) infection?
Options:
A: NAMO restores NAD+-dependent mitophagy in microglia.
B: NAMO enhances the production of proinflammatory cytokines by microglia.
C: NAMO directly inhibits the production of CagA by H. pylori.
D: NAMO restrains microglial over-activation.

Q315: Based on the provided context, which of the following statements describe direct molecular effects of short-chain fatty acids (SCFA) in the context of metabolic syndrome and its complications?
Options:
A: SCFA ameliorates immuno-inflammation, which is a causative factor of metabolic syndrome.
B: SCFA inhibits the bidirectional communication of the microbiota-gut-brain axis.
C: SCFA directly causes sepsis-associated encephalopathy by altering gut flora metabolites.
D: SCFA improves lipid distribution, blood glucose, and body weight levels in animal models of metabolic syndrome.

Q316: Based on the context, which of the following molecular effects are directly associated with gut microbiota or their metabolites in the regulation of neurodegenerative diseases or Parkinson's Disease?
Options:
A: Fecal microbiota transplantation directly increases plasma metabolite levels in Parkinson's Disease patients.
B: Gut microbiota metabolites regulate neural barrier integrity.
C: Elevated plasma metabolites in Parkinson's Disease patients are associated with increased intestinal permeability.
D: Gut microbiota metabolites regulate neuroinflammation.

Q317: Based on the provided context, which of the following molecular effects are directly associated with gut microbiota or their metabolites in the regulation of host physiological or pathological processes?
Options:
A: Short-chain fatty acids regulate insulin sensitivity.
B: Gut microbiota remodel immune checkpoint inhibitor responses.
C: Microbiota-derived lipopolysaccharide activates microglia.
D: Diquat directly increases the production of short-chain fatty acids.

Q318: Based on the provided context, which of the following statements describe direct molecular effects of the gut microbiome on host health or disease development in early life or colorectal cancer?
Options:
A: Sequencing technologies directly alter the metabolites produced by gut bacteria.
B: Manipulating early-life intestinal microbes can ameliorate host's immunological responses.
C: Manipulating early-life intestinal microbes can impair host's metabolic responses.
D: Gut microbiome-based diagnostics directly increase the diversity of gut bacterial taxa.

Q319: Based on the context, which of the following molecular effects are directly caused by a high-fat diet rich in saturated fatty acids on enterocyte signaling pathways?
Options:
A: Activation of enterocyte TLR-4 signaling
B: Activation of enterocyte TLR-2 signaling
C: Suppression of MyD88-NF-κB signaling cascade
D: Downregulation of pro-inflammatory factors

Q320: Based on the provided context, which of the following statements describe direct molecular effects of choline supplementation or gut microbiota on brain or myelin-related processes?
Options:
A: Oligodendrocyte homeostasis is directly regulated by choline oxidase activity.
B: Gut microbiota metabolites directly increase the production of acetylcholine neurotransmitter.
C: Choline supplementation can reduce microgliosis in neurodegenerative disease models.
D: Choline supplementation can reduce amyloid-β deposition in the brain.

Q321: Based on the context, which molecular effects are directly attributed to the gut microbiota or the microbiota-gut-brain axis in the pathogenesis or treatment of autism spectrum disorder?
Options:
A: Restoration of gut microbial composition through dietary intervention strategies
B: Modulation of immune-inflammatory responses by the microbiota-gut-brain axis
C: Inhibition of mitochondrial dysfunction by stem cell strategies
D: Direct activation of gene-editing tools like CRISPR by gut microbiota

Q322: Based on the context, which of the following molecular mechanisms are directly involved in the influence of gut microbiota metabolites on the progression of Parkinson's disease through the gut-brain axis?
Options:
A: Inflammatory signals are transmitted bidirectionally between the gut and brain, affecting disease progression.
B: Protein aggregation is directly inhibited by gut microbiota metabolites in the brain.
C: Dopamine receptor activation by gut microbiota metabolites directly prevents Parkinson's disease.
D: Gut microbiota metabolites modulate inflammatory signals along the gut-brain axis.

Q323: Based on the provided context, which of the following molecular effects are directly associated with probiotic supplementation in non-communicable diseases according to the reviewed studies?
Options:
A: Reduction of tumor necrosis factor-alpha (TNF-α) levels
B: No change in total antioxidant capacity (TAC) levels
C: Reduction of C-reactive protein (CRP) levels
D: Increase in nitric oxide (NO) levels

Q324: Based on the context, which of the following molecular effects are associated with Coriolus versicolor (CV) administration in valproic acid (VPA)-induced mice, particularly regarding the TLR-4/Myd88/NF-κB signaling pathway and neuroinflammation?
Options:
A: CV administration directly activates neuroinflammation in the cerebellum and hippocampus.
B: CV administration significantly improved VPA-induced neuroinflammation via the TLR-4/Myd88/NF-κB signaling cascade.
C: CV administration modulates the TLR-4/Myd88/NF-κB signaling pathway in VPA-induced mice.
D: CV administration upregulates the TLR-4/Myd88/NF-κB signaling pathway in VPA-induced mice.

Q325: Based on the provided context, which of the following molecular effects are directly associated with gut microbiota or microbial infections in the pathogenesis or modulation of autoimmune diseases or Alzheimer's Disease?
Options:
A: B lymphocytes directly degrade amyloid-beta (Aβ) plaques in the brain.
B: Amyloid-beta (Aβ) peptide directly inhibits the formation of brain biofilms.
C: Gut microbiota dysregulation precedes and may promote brain amyloid-beta (Aβ) accumulation.
D: Viral infections such as HSV-1 and SARS-CoV-2 modulate host immune system processes.

Q326: Based on the provided context, which of the following molecular mechanisms are directly implicated in the dysregulation of the gut-brain axis or brain aging, as described in the text?
Options:
A: Impaired cholinergic signaling is involved in the development of age-associated impairments in the brain.
B: Alterations in gut microbiota can modulate gut-brain axis function in non-alcoholic fatty liver disease.
C: Increased intestinal permeability directly enhances the function of the autonomic nervous system.
D: Gender differences in neurodegeneration are caused by changes in the circadian clock.

Q327: Based on the context, which of the following statements describe direct molecular effects involved in host-microbiome interactions or disease diagnostics as discussed in the review?
Options:
A: Natural products mediate microbe-host interactions by acting as small molecule effectors.
B: Fungi in the gut mycobiome directly increase the abundance of bacteria in the gastrointestinal tract.
C: Short-chain fatty acids produced by the gut microbiome are considered novel targets in Parkinson's disease research.
D: Volatile organic compounds universally suppress immune function in the host.

Q328: Based on the context, which of the following molecular effects are directly associated with fecal microbiota transplantation (FMT) in neurological disorders?
Options:
A: FMT increases amyloid-β accumulation.
B: FMT decreases IL-17 expression.
C: FMT inhibits the expression of TLR4.
D: FMT upregulates microglial M1 polarization.

Q329: Based on the context, which of the following molecular effects are directly attributed to the gut microbiota or its metabolites in relation to human health and neurodegeneration?
Options:
A: The gut microbiota produces neurotransmitters that can influence brain function.
B: The gut microbiota always upregulates oxidative stress in neurodegenerative diseases.
C: Polyphenol metabolites produced by the gut microbiota can function as neurotransmitters after crossing the blood-brain barrier.
D: The gut microbiota directly inhibits the immune response in all organ systems.

Q330: Based on the context provided, which of the following statements describe direct molecular effects of the gut microbiota on signaling pathways or molecular processes relevant to CNS tumors or schizophrenia?
Options:
A: The gut microbiota influences oxidative status in the central nervous system.
B: The gut microbiota always suppresses the MAPK pathway in glioma.
C: The gut microbiota directly increases the synthesis of all neurotransmitters in the brain.
D: The gut microbiota modulates immune responses in the central nervous system.

Q331: Based on the provided context, which of the following molecular effects are directly associated with sodium butyrate supplementation in patients with active ulcerative colitis?
Options:
A: Sodium butyrate supplementation increases the HADS anxiety score.
B: Sodium butyrate supplementation increases the partial Mayo score.
C: Sodium butyrate supplementation decreases the neutrophil-to-lymphocyte ratio (NLR).
D: Sodium butyrate supplementation decreases the erythrocyte sedimentation rate (ESR).

Q332: Based on the provided context, which of the following molecular effects are directly mediated by propionate in the regulation of reactive astrocytosis and Aβ amyloidosis in APPPS1-21 mice?
Options:
A: Propionate decreases peripheral Th17 (Rorγt+ CD4+) cells.
B: Propionate reduces IL-17 release.
C: Propionate upregulates proinflammatory gene expression in astrocytes.
D: Propionate increases IL-17 secretion.

Q333: Based on the context, which of the following molecular effects are directly caused by nicotinamide n-oxide (NAMO) in microglia during HSV-1 infection?
Options:
A: NAMO promotes proinflammatory cytokine production in microglia.
B: NAMO restrains microglial over-activation.
C: NAMO impairs mitochondrial function in microglia.
D: NAMO restores NAD+-dependent mitophagy in microglia.

Q334: Based on the provided context, which of the following statements describe direct molecular or cellular effects involving the ketogenic diet or gut microbiota in modulating immune or inflammatory responses?
Options:
A: Alterations in the gut microbiota are associated with systemic inflammation in type 2 diabetes mellitus.
B: The ketogenic diet directly increases carbohydrate accumulation as energy reserves.
C: The ketogenic diet leads to the generation of ketone bodies, which play a pivotal role in its effects.
D: Dysbiosis of the gut microbiota directly increases the diversity of microbial species.

Q335: Based on the provided context, which of the following molecular effects are directly attributed to gut microbiota or their metabolites in the regulation of distant organ function or disease pathogenesis?
Options:
A: Microbiota-derived lipopolysaccharide activates microglia in neurodegenerative diseases.
B: Short-chain fatty acids produced by gut microbiota regulate insulin sensitivity.
C: Gut microbiota directly upregulate pulmonary surfactant protein expression in the lungs.
D: Gut microbiota directly inhibit dopamine receptor expression in the brain.

Q336: Based on the provided context, which of the following molecular effects are directly attributed to the gut microbiota in regulating human health and disease?
Options:
A: The gut microbiota modulates the immune response.
B: The gut microbiota produces neurotransmitters.
C: The gut microbiota directly inhibits cardiovascular disease enzymes.
D: The gut microbiota upregulates all human metabolic genes.

Q337: Based on the provided context, which of the following molecular effects are directly associated with the gut microbiota-targeted intervention in hyperlipidemia using Monascus-fermented ginseng or fecal microbiota transplantation?
Options:
A: Upregulation of lipogenic regulators
B: Enhancement of cholesterol excretion
C: Suppression of short-chain fatty-acid-producing microbes
D: Promotion of primary-to-secondary bile acid conversion

Q338: Based on the provided context, which molecular mechanisms are directly activated or modulated by gut microbiota or their components in the pathogenesis of endometriosis?
Options:
A: Lipopolysaccharides (LPS) from Gram-negative bacteria activate the TLR4/NF-κB signaling pathway.
B: Gut microbiota modulate estrogen metabolism via the estrobolome, contributing to increased systemic estrogen levels.
C: Bifidobacterium directly increases the prevalence of pro-inflammatory taxa.
D: Lactobacillus directly inhibits the TLR4/NF-κB signaling pathway.

Q339: Based on the provided context, which of the following statements accurately describe direct molecular effects of gut microbiota-derived metabolites on neurological or metabolic functions relevant to Alzheimer’s disease?
Options:
A: Gut microbiota synthesize short-chain fatty acids that signal through the autonomic nervous system to influence neurological conditions.
B: Gut microbiota directly increase the abundance of Vescimonas in APP/PS1 mice to prevent Alzheimer’s disease.
C: Traditional Chinese Medicine directly increases acetylcholine levels in the brain by bypassing the gut microbiota.
D: Gut microbiota produce succinate, which can cross the blood-brain barrier and impact central nervous system functions.

Q340: Based on the context, which of the following molecular effects are directly attributed to dietary component interventions on gut microbiota and their downstream impact on host physiology?
Options:
A: Dietary component interventions directly activate neurotransmitter receptors in the brain.
B: Dietary component interventions inhibit the synthesis of all volatile organic compounds in the host.
C: Dietary component interventions modulate gut microbiota composition.
D: Dietary component interventions enhance anticancer immune responses via gut microbiota modulation.

Q341: Based on the provided context, which of the following molecular effects are directly attributed to plant polyphenols in relation to neurotrophin signaling and brain health?
Options:
A: Upregulation of neurotrophins such as brain-derived neurotrophic factor (BDNF)
B: Direct inhibition of sympathetic nervous system activation
C: Suppression of the Renin-Angiotensin-Aldosterone (RAAS) axis in the heart
D: Activation of intracellular cascades such as the cAMP response element-binding protein (CREB)

Q342: Based on the provided context, which of the following molecular effects are directly supported as mechanisms by which leptin or Lactobacillus may influence inflammation or neuropsychiatric symptoms?
Options:
A: Bacteroides directly activates the hypothalamic-pituitary-adrenal (HPA) axis.
B: Specific strains of Lactobacillus may alleviate inflammatory responses by down-regulating the expression of IL-6 and TNF-α.
C: Leptin directly downregulates the expression of TNF-α in the brain.
D: Leptin significantly predicts increased TSPO-PET binding potential in the insula, indicating a role in neuroinflammation.

Q343: Based on the provided context, which of the following molecular effects are directly associated with dysbiosis or viral infection in the pathogenesis of chronic diseases or cognitive impairment?
Options:
A: Viral infections after neurosurgery activate neuroinflammatory responses involving microglia and astrocytes.
B: Prebiotics directly suppress the production of carcinogenic metabolites in the gut.
C: Dysbiosis disrupts immune homeostasis, leading to sustained inflammation.
D: Fecal microbiota transplantation directly inhibits cytokine release from microglia.

Q344: Based on the context provided, which of the following molecular effects are directly associated with the gut microbiota's influence on the host in the microbiota-gut-brain axis?
Options:
A: Gut microbiota suppress the HPA axis without affecting inflammation.
B: Gut microbiota produce hormonal intermediates that communicate with the host.
C: Gut microbiota produce metabolites that shape host homeostasis.
D: Gut microbiota directly increase hippocampal neuron number.

Q345: Based on the provided context, which of the following molecular effects are associated with severe cognitive impairment in long-term care residents as related to the gut microbiome?
Options:
A: Enhanced synthesis of short-chain fatty acids by the gut microbiome
B: Increased abundance of proinflammatory bacterial species such as Methanobrevibacter smithii
C: Increased relative abundance of beneficial bacterial clades
D: Reduced microbial capacity for synthesis of neurotransmitters glutamate and gamma-aminobutyric acid

Q346: Based on the context, which of the following molecular effects are directly involved in the pathogenesis of Alzheimer's disease or colorectal cancer as described?
Options:
A: Lipid metabolism has no role in the regulation of β-amyloid clearance in Alzheimer's disease.
B: Short-chain fatty acids directly increase the production of β-amyloid in Alzheimer's disease.
C: Alterations in gut microbiome can lead to decreased production of short-chain fatty acids in the colon.
D: Prolonged activation of immune cells can trigger chronic neuroinflammation in Alzheimer's disease.

Q347: Based on the provided context, which of the following molecular effects are directly associated with the action of SSRIs, SNRIs, esketamine, or ketamine in the treatment of depression?
Options:
A: Suppression of insulin secretion by pancreatic beta cells
B: Reduction of pro-inflammatory cytokines in serum or specific brain regions
C: Enhancement of anti-inflammatory cytokines in the hippocampus and prefrontal cortex
D: Direct activation of the gut microbiota to increase serotonin production

Q348: Based on the provided context, which of the following molecular effects are directly regulated by gut microbiota or their metabolites in the context of neurodegenerative diseases?
Options:
A: Gut microbiota regulate neuroinflammation.
B: Gut microbiota metabolites regulate neurogenesis.
C: Gut microbiota directly inhibit MRI signal changes.
D: Gut microbiota directly activate opioid receptors.

Q349: Based on the provided context, which of the following molecular effects are directly attributed to fermented dairy products or vitamin D on gut or immune function?
Options:
A: Fermented dairy products upregulate tight-junction proteins to reinforce epithelial barrier integrity.
B: Fermented dairy products downregulate the production of active vitamin D metabolites.
C: Vitamin D modulates gut microbiota diversity and composition.
D: Vitamin D directly inhibits the synthesis of short-chain fatty acids in the gut.

Q350: Based on the context, which of the following molecular effects are directly promoted by obesity-induced pro-inflammatory mediators in the central nervous system?
Options:
A: Suppression of gut-brain axis communication
B: Induction of insulin resistance in the brain
C: Promotion of mitochondrial dysfunction in neurons
D: Direct upregulation of microbial diversity in the gut

Q351: Based on the provided context, which of the following molecular effects are directly attributed to the gut microbiota in the pathophysiology of heart failure or Alzheimer's Disease?
Options:
A: Gut microbiota influences inflammatory pathways in heart failure.
B: Gut microbiota directly repairs neuronal damage in Alzheimer's Disease.
C: Gut microbiota impacts amyloid metabolism in Alzheimer's Disease.
D: Gut microbiota directly increases neuroimaging biomarker levels in Alzheimer's Disease.

Q352: Based on the context, which of the following molecular effects are directly associated with the ketogenic diet or gut microbiota in relation to the gut-brain axis and neurological health?
Options:
A: Short-chain fatty acid-producing bacteria suppress the central nervous system directly.
B: The gut-brain axis inhibits the production of ketone bodies.
C: Restoring balance to the gut microbiome can reduce inflammation.
D: The ketogenic diet induces the production of ketone bodies from fat.

Q353: Based on the provided context, which of the following molecular mechanisms are directly involved in modulating neuroinflammation or neurodegeneration in depression or Alzheimer's disease?
Options:
A: Bioactive compounds such as polyphenols reduce neuroinflammation by modulating gut microbiota.
B: Short-chain fatty acids directly increase amyloid-β pathology in Alzheimer's disease.
C: Activation of glial cells contributes to neuroinflammation in depression.
D: The hypothalamic-pituitary-adrenal (HPA) axis directly inhibits blood-brain barrier integrity.

Q354: Based on the provided context, which molecular effects are directly associated with the modulation of neuroinflammation in Alzheimer's disease models following fecal microbiota transplantation?
Options:
A: Transplantation from healthy donors upregulates amyloid-beta plaque burden in the brain.
B: Transplantation from healthy donors downregulates pro-inflammatory cytokine expression in brain tissues.
C: Transplantation from DSS-treated donors upregulates anti-inflammatory cytokine expression in gut tissues.
D: Transplantation from DSS-treated donors upregulates pro-inflammatory cytokine levels in both gut and brain tissues.

Q355: Based on the provided context, which of the following molecular effects are directly associated with upregulated LRRK2 expression in the brain of mice with Parkinson's disease and colitis?
Options:
A: Reduction of IL1-β levels
B: Upregulation of ZO-1 expression
C: Activation of NF-κB pathway
D: Inhibition of Nrf2 pathway

Q356: Based on the provided context, which of the following molecular mechanisms are directly involved in modulating neuroinflammatory responses or disease severity in the gut-brain or lung-brain axis?
Options:
A: Lung-derived immune mediators induce neuroinflammation by traversing the blood-brain barrier.
B: Probiotics directly upregulate TLR4 expression in the lung-brain axis.
C: Mechanical ventilation directly activates the vagus nerve.
D: Probiotics mitigate neuroinflammatory responses via the gut-brain axis.

Q357: Based on the provided context, which molecular effects are directly attributed to the gut microbiota in the pathogenesis or treatment of neurodegenerative disorders and breast cancer?
Options:
A: Gut microbiota directly synthesizes chemotherapeutic agents for breast cancer treatment.
B: Gut microbiota modulates inflammatory pathways involved in neurodegenerative processes.
C: Gut microbiota influences immune responses relevant to breast cancer progression.
D: Gut microbiota universally suppresses all forms of neurodegeneration.

Q358: Based on the context, which molecular effects are directly attributed to gut microbiota in the pathogenesis of neurodegenerative or metabolic diseases?
Options:
A: Gut microbiota directly suppresses amyloid-β plaque formation in Alzheimer's disease.
B: Microbiota-derived lipopolysaccharide activates microglia in neurodegenerative diseases.
C: Short-chain fatty acids from gut microbiota regulate insulin sensitivity in metabolic diseases.
D: Gut microbiota directly inhibits neurofibrillary tangle formation in Alzheimer's disease.

Q359: Based on the context, which molecular effects are directly attributed to gut microbial metabolites in the modulation of neuroinflammation and blood-brain barrier integrity?
Options:
A: Gut microbial metabolites preserve blood-brain barrier integrity.
B: Gut microbial metabolites modulate neuroinflammation.
C: Gut microbial metabolites suppress neurotransmitter generation.
D: Gut microbial metabolites inhibit the enteric nervous system.

Q360: Based on the context, which molecular effects are directly mediated by nicotinamide n-oxide (NAMO) in microglia during HSV-1 infection?
Options:
A: NAMO impairs mitochondrial function in microglia.
B: NAMO restores NAD+-dependent mitophagy in microglia.
C: NAMO promotes proinflammatory cytokine production in microglia.
D: NAMO restrains microglial over-activation.

Q361: Based on the provided context, which of the following molecular effects are directly attributed to natural compounds or gut microbiota in the regulation of neurological diseases?
Options:
A: Natural compounds from Chinese herbs upregulate amyloid-β protein aggregation.
B: Gut microbiota influences the cAMP-PKA signaling pathway through its metabolites.
C: Gut microbiota directly inhibits the activation of microglia via the cAMP-PKA pathway.
D: Natural compounds from Chinese herbs suppress microglia-mediated detrimental inflammatory response.

Q362: Based on the context, which of the following molecular effects are directly attributed to short-chain fatty acids (SCFAs) produced by gut microbiota in relation to colorectal cancer and neuropsychiatric disorders?
Options:
A: SCFAs modify epigenetic mechanisms such as DNA methylation and histone modifications.
B: SCFAs inhibit the production of environmental carcinogens in the gut.
C: SCFAs influence non-coding RNA functions affecting tumor initiation and metastasis.
D: SCFAs directly increase the number of immune cells in the colon.

Q363: Based on the provided context, which of the following statements describe direct molecular effects of gut microbiota composition on host characteristics such as inflammation or brain pathology risk?
Options:
A: Blautia spp. directly suppresses Bacteroidia.
B: Increased abundance of Bacteroides spp. is associated with inflammation.
C: Bacteroides spp. is linked to a higher risk of dementia-related brain pathologies.
D: Bifidobacterium spp. directly increases the abundance of Bacteroides spp.

Q364: Based on the context, which of the following molecular effects are associated with severe cognitive impairment in long-term care residents in relation to the gut microbiome?
Options:
A: Enhanced neuroprotective lysosomal activity due to increased amino acid synthesis
B: Upregulation of short-chain fatty acid synthesis by the gut microbiome
C: Reduced microbial capacity for synthesis of neurotransmitters glutamate and gamma-aminobutyric acid
D: Increased abundance of proinflammatory bacterial species

Q365: Based on the context, which of the following statements describe direct molecular or compositional effects involving the gut microbiome in Alzheimer's disease pathology?
Options:
A: Psilocybin inhibits gut microbial pathways involved in inflammatory-related disorders.
B: Gut microbiome composition differs between individuals with Alzheimer's disease dementia and cognitively unimpaired individuals.
C: Psilocybin directly activates the hypothalamic-pituitary axis.
D: Differentially abundant gut microbiome features are associated with cerebrospinal fluid biomarkers of Alzheimer's disease.

Q366: Based on the context, which of the following molecular effects are directly associated with gut microbiota in the setting of radiation-induced injury or the gut-brain axis?
Options:
A: Gut microbiota directly inhibit the function of circulating cell-derived microparticles.
B: Gut microbiota directly upregulate the glymphatic system in the brain.
C: Alterations in microbiota-derived metabolites can occur due to changes in gut microbiota.
D: Activation of inflammatory responses within the intestine can be triggered by changes in gut microbiota.

Q367: Based on the provided context, which of the following molecular effects are directly modulated by gut microbiota or their components in the pathogenesis of endometriosis?
Options:
A: Flavanones directly inhibit the TLR4/NF-κB signaling pathway in endometriosis.
B: Lipopolysaccharides (LPS) from Gram-negative bacteria activate the TLR4/NF-κB signaling pathway.
C: Gut microbiota modulate estrogen metabolism via the estrobolome, contributing to increased systemic estrogen levels.
D: Bifidobacterium directly increases the production of estrogen in endometriosis.

Q368: Based on the provided context, which of the following molecular effects are directly attributed to gut microbiota in the pathogenesis of neurodegenerative or metabolic diseases?
Options:
A: Short-chain fatty acids from gut microbiota regulate insulin sensitivity.
B: Gut microbiota directly upregulates dopamine synthesis in neurons.
C: Gut microbiota directly inhibits immune checkpoint inhibitor responses in cancer.
D: Microbiota-derived lipopolysaccharide activates microglia.

Q369: Based on the provided context, which of the following statements best integrate information about the role of the gut microbiota and its metabolites in both neurological and psychiatric disorders, considering their influence on immune signaling and potential therapeutic strategies?
Options:
A: Alterations in gut microbiota composition, along with changes in inflammatory cytokines such as IL-6 and TNF-α, are linked to both stroke severity and PTSD pathology, suggesting that interventions targeting gut microecology may benefit these conditions.
B: Short-chain fatty acids produced by the gut microbiota can influence microglia activity, and targeting this pathway is considered a potential pharmacological strategy for neurological diseases.
C: The prevalence of Pseudomonadota in the gut microbiota is associated with improved outcomes in both ischemic stroke and PTSD due to its anti-inflammatory properties.
D: Insulin resistance in severe stroke patients is primarily caused by decreased levels of butyrate and IL-10, which are both pro-inflammatory metabolites.

Q370: Based on the integrated findings from studies on gut microbiota, discuss how both lifestyle interventions and disease states such as periodontitis and ME/CFS can influence systemic health outcomes through changes in microbial composition and metabolite profiles. Which of the following statements are supported by the CONTEXT?
Options:
A: Circadian rhythm disruption and periodontitis both directly increase the abundance of short-chain fatty acid producers in the gut, leading to reduced systemic inflammation.
B: Interventions targeting the gut microbiome, such as specific diets and moderate exercise, may help reduce neuropsychiatric symptoms in ME/CFS by modulating gut-brain axis pathways and improving microbial diversity.
C: High-fiber diets and healthy gut microbiota, both associated with increased short-chain fatty acid producers, are linked to improved metabolic and immune health, while periodontitis patients show reduced abundance of these bacteria and altered serum metabolites.
D: Periodontal therapy alone is sufficient to restore both salivary and gut microbiota to healthy profiles, thereby normalizing systemic metabolite levels and reducing disease risk.

Q371: Based on the provided context, which of the following statements best integrate the roles of gut microbiota modulation and immune regulation in the improvement of cognitive or neurodevelopmental disorders, and are supported by evidence from multiple sections of the text?
Options:
A: Therapeutic strategies targeting the gut-brain axis, such as DOFF and PYC, involve both the regulation of intestinal microbial communities and the suppression of pro-inflammatory factors, thereby alleviating neuroinflammation and cognitive dysfunction.
B: Both Dendrobium officinale Kimura & Migo flower flavonoids (DOFF) and pycnogenol (PYC) improve cognitive or neurodevelopmental outcomes by regulating the abundance of beneficial gut bacteria such as Akkermansia, which in turn modulates inflammation and enhances synaptic or neural function.
C: The improvement in cognitive function observed with DOFF and PYC is exclusively due to their antioxidant properties, without any involvement of gut microbiota or immune modulation.
D: DOFF and PYC exert their effects on cognitive function solely by increasing the expression of synaptic proteins in the hippocampus, independent of any changes in gut microbiota or immune signaling.

Q372: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence neurodegenerative or neuroregenerative outcomes, considering both experimental and clinical insights across spinal cord injury and neurodegenerative diseases?
Options:
A: Dysbiosis of the gut microbiota can increase gastrointestinal and blood-brain barrier permeability, facilitating the movement of microbial molecules to the brain and contributing to neurodegenerative disease pathogenesis via immune and endocrine pathways.
B: Morphine self-administration in rodents leads to increased tryptophan metabolite production by the gut microbiota, which directly prevents maladaptive changes in the striatum and thalamus.
C: Probiotic-induced enrichment of Bacillota and Clostridia in the gut can enhance tryptophan metabolite production, which in turn activates anti-inflammatory and neuroregenerative gene pathways in the spinal cord, supporting structural and functional recovery after injury.
D: TMAO, produced by gut microbiota, directly repairs spinal cord tissue by increasing the abundance of Lactobacillus species and upregulating neuroprotective genes in the spinal cord.

Q373: Based on the provided context, which of the following statements best integrate findings about gut microbiota metabolites, their measurement, and their relevance to neurodegenerative or neuropsychiatric disease progression and potential therapeutic strategies?
Options:
A: Peripheral immune cell recruitment to the CNS is the primary mechanism by which gut microbiota metabolites influence the progression of mood disorders, as evidenced by urinary metabolite profiling.
B: Altered levels of gut microbiota metabolites, such as increased succinic acid and decreased TMAO in Parkinson's disease, highlight the mechanistic role of the gut-liver-brain axis in neurodegeneration and support the rationale for microbiome-targeted therapies.
C: Urinary measurement of gut-derived metabolites such as succinic acid and TMAO using GC-MS and LC-MS/MS can provide non-invasive biomarkers for Parkinson's disease progression, supporting the clinical potential of microbiome-targeted interventions discussed for neuropsychiatric disorders.
D: The efficacy of levodopa treatment in Parkinson's disease can be directly improved by increasing TMAO levels through dietary interventions, as shown by the positive association between TMAO and disease severity.

Q374: Based on the provided context, which of the following statements best integrate the mechanisms by which organ-specific changes (such as in the gut or lung) can influence brain pathology or function, and how these changes may be targeted therapeutically?
Options:
A: Mechanical ventilation in heart failure patients increases gut microbiome diversity, which in turn reduces neuroinflammation by downregulating TLR4 and ACE2 protein markers in the brain.
B: Alterations in gut microbiota composition and their metabolites, as seen after ginger polyphenol administration in neuropathic pain models, are associated with changes in amygdala neuropathology gene expression, suggesting that targeting the gut microbiome can modulate brain molecular signatures.
C: Immune mediators originating from the lung can traverse the blood-brain barrier and induce neuroinflammation, while microbiome engineering and immunomodulation are emerging as therapeutic strategies to target this lung-brain crosstalk.
D: The activation of the Renin-Angiotensin-Aldosterone axis in heart failure directly leads to upregulation of amygdala neuropathology genes, which can be reversed by dietary interventions targeting the lung-brain axis.

Q375: Considering the interplay between host-microbiome interactions and disease, which of the following statements best integrates the roles of microbial metabolites, analytical advances, and disease diagnostics or management as described in the context?
Options:
A: The use of probiotics in early life universally prevents all forms of neuroinflammation by directly eliminating chronic systemic inflammation, as shown by mass spectrometry-based studies.
B: Microbiome-derived small molecules, identified through advanced analytical techniques, contribute to both mental health modulation via the gut-brain axis and the development of non-invasive biomarkers for neurological diseases.
C: Short-chain fatty acids are exclusively produced by the host and are not relevant to either Parkinson’s disease diagnostics or mental health interventions.
D: Mass spectrometry-based detection of volatile organic compounds, including short-chain fatty acids produced by the gut microbiome, enables non-invasive monitoring of Parkinson’s disease by linking microbial metabolism to disease pathophysiology.

Q376: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota alterations, metabolic or neurobehavioral outcomes, and the potential for therapeutic intervention across different disease models discussed?
Options:
A: Intermittent fasting directly reduces neuroinflammation in the prefrontal cortex of OVA-induced food allergy mice by restoring amino acid metabolism.
B: Disruption of gut microbiota composition is linked to both neurobehavioral impairments in OVA-induced food allergy mice and to the pathogenesis of Alzheimer's and Parkinson's diseases through mechanisms involving inflammation and epigenetic changes.
C: The beneficial effects of intermittent fasting on MASLD are solely due to changes in hepatic function, independent of gut microbiota or metabolite alterations.
D: Plant-derived bioactive compounds that modulate gut-brain axis pathways may offer therapeutic benefits for obesity comorbid with depression, similar to how gut microbiota-targeted interventions are proposed for Alzheimer's and Parkinson's diseases.

Q377: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, gut permeability, and immune mechanisms in the development or progression of neurological disorders such as Alzheimer's and Parkinson's disease?
Options:
A: The only way gut microbiota influence neurological disorders is by altering nutrient absorption, without any involvement in immune or inflammatory pathways.
B: Changes in gut microbiota can modulate the kynurenine pathway, leading to the production of neurotoxic metabolites that exacerbate neuroinflammation and neuronal damage, processes implicated in both Parkinson's and Alzheimer's diseases.
C: Dysbiosis-induced increases in gut permeability can facilitate systemic inflammation, which, through the gut-brain axis, contributes to neuroinflammation and the recruitment of peripheral immune cells into the CNS, thereby influencing the progression of Alzheimer's disease.
D: Alterations in the gut microbiota composition directly cause the accumulation of amyloid plaques in the brain, which is the sole mechanism underlying Alzheimer's disease pathogenesis.

Q378: Based on the provided context, which of the following statements best integrate the roles of gut microbiota and their metabolites in both metabolic and neuropsychiatric disorders, and are supported by evidence from multiple sections of the text?
Options:
A: The only effect of gut microbiota is on glucose metabolism, with no evidence for their involvement in neuropsychiatric disorders or immune modulation.
B: Gut microbiota and their metabolites can influence both obesity and PTSD by modulating immune responses and inflammatory markers, as well as affecting metabolic and neuropsychiatric pathways.
C: Specific strains of beneficial bacteria, such as Lactobacillus, are implicated in improving both metabolic disorders like obesity and neuropsychiatric conditions like PTSD, partly through their anti-inflammatory effects.
D: Gut microbiota are exclusively involved in the development of autoimmune diseases and have no role in metabolic or neuropsychiatric disorders.

Q379: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota, inflammation, and neurodegenerative or autoimmune diseases, specifically highlighting mechanisms that involve both peripheral (gut/skin) and central (brain) processes?
Options:
A: Oxytocin intervention in socially isolated Alzheimer's disease mice only restores gut microbiota homeostasis without affecting behavioral or pathological impairments in the brain.
B: Type-2 diabetes and high-fat diet are implicated in Alzheimer's disease solely through direct effects on brain neurons, independent of gut microbiota or systemic inflammation.
C: Gut dysbiosis, characterized by altered microbial composition, can contribute to both autoimmune skin diseases like bullous pemphigoid and neurodegenerative conditions such as Alzheimer's disease by promoting systemic inflammation and barrier dysfunction.
D: In Parkinson's disease models, increased LRRK2 expression due to chronic colitis is associated with both reduced intestinal barrier proteins and enhanced neuroinflammation via NF-κB activation and Nrf2 inhibition.

Q380: Based on the provided context, which of the following statements best illustrate how gut microbiota-derived short-chain fatty acids (SCFAs) and systemic inflammation are interconnected with neuroinflammation and cognitive impairment in neurodegenerative disease models, requiring integration of findings from both Alzheimer's and Huntington's disease mouse studies?
Options:
A: In Huntington's disease mouse models, propionate supplementation completely prevents neuronal loss and fully restores motor abilities by eliminating all central nervous system inflammation.
B: Reduced SCFA levels in Alzheimer's disease mice are associated with increased systemic pro-inflammatory cytokines and neuroinflammation, suggesting that gut dysbiosis may contribute to brain microstructural damage and memory impairment.
C: Alpha diversity of gut microbiota is significantly increased in Alzheimer's disease mice, directly leading to improved cognitive function and reduced neuroinflammation.
D: Short-chain fatty acids can exert mild anti-inflammatory effects in the central nervous system, as shown by reduced inflammatory markers in Huntington's disease mice, but do not halt neurodegeneration or clinical progression.

Q381: Based on the provided context, which of the following statements best integrate the mechanisms by which gut-targeted interventions modulate disease outcomes in both rheumatoid arthritis and Parkinson's disease, considering the roles of gut microbiota, barrier function, and downstream signaling pathways?
Options:
A: Oral administration of gold nanospheres in rheumatoid arthritis not only enriches beneficial gut bacteria but also restores intestinal barrier function, leading to suppression of NF-κB activation in synovial tissues via increased production of tryptophan metabolites.
B: In Parkinson's disease models, increased LRRK2 expression due to chronic colitis is associated with reduced intestinal barrier proteins and heightened inflammatory cytokines, which together contribute to NF-κB activation and Nrf2 inhibition in the brain.
C: Inhibition of levodopa metabolism by honokiol-SCFA conjugates in Parkinson's disease is achieved solely through direct suppression of brain inflammation without involvement of gut microbial modulation.
D: The therapeutic effects of gold nanospheres in rheumatoid arthritis are exclusively due to their direct anti-inflammatory action on synovial tissues, independent of any changes in gut microbiota or metabolite production.

Q382: Based on the provided context, which of the following statements best integrate the roles of gut microbiota metabolites or virulence factors with neurodegenerative or autoimmune disease mechanisms, considering both the modulation of immune responses and the impact on neurological function?
Options:
A: Virulence factors produced by gut microbiota, including LPS and amyloidogenic proteins, can be transported via bacterial outer membrane vesicles, enabling distal communication that impacts neurodegenerative diseases such as Alzheimer's and Parkinson's through immune modulation.
B: Microbial metabolites such as sphingolipids and phospholipids can regulate neuroinflammation and β-amyloid metabolism in Alzheimer's disease, while virulence factors from gut microorganisms may worsen neurodegenerative conditions by increasing intestinal permeability and affecting immune cells.
C: Antibiotic use alone is sufficient to restore intestinal ecology and prevent both autoimmune and neurodegenerative diseases by eliminating all harmful microbial metabolites and virulence factors.
D: RG2 expansion in lupus-prone mice leads to increased Treg cell frequency and reduced autoantibody production, which in turn protects against neurodegenerative diseases by stabilizing the microbiota-gut-brain axis.

Q383: Based on the provided context, which of the following statements best illustrate how gut microbiota can influence both neuropsychiatric and inflammatory diseases through integrated mechanisms involving immune modulation, gene expression, and microbial composition?
Options:
A: Altered gut microbiota composition can contribute to neuroinflammation and blood-brain barrier permeability via dysregulation of the gut-brain axis, while also promoting systemic inflammation in diseases like psoriatic arthritis by affecting the intestinal barrier and immune responses.
B: Gut microbiota can modulate host gene expression through epigenetic mechanisms such as DNA methylation and histone modification, influencing brain cell function and potentially contributing to both neurodegenerative and age-related inflammatory diseases.
C: The gut microbiome exclusively affects only gastrointestinal disorders and does not play a role in neuropsychiatric or inflammatory joint diseases.
D: Changes in the gut microbiota are solely determined by host genetics and do not interact with environmental or extrinsic factors such as diet or medication.

Q384: Based on the provided context, which of the following statements best illustrate how modulation of microbiota in one body site can influence neurological or respiratory disease outcomes through multi-organ signaling pathways, and are supported by evidence integrating both mechanistic and therapeutic findings?
Options:
A: The only effective way to treat neurological disorders is through direct brain-targeted therapies, as modulation of gut or oral microbiota has not shown any impact on neurological outcomes.
B: Clinical interventions that alter gut microbiota composition can modulate immune responses and metabolic function, thereby influencing susceptibility to pulmonary infections and offering new approaches for pneumonia prevention and treatment.
C: Oral microbiota dysbiosis is solely a consequence of cognitive decline, with no evidence supporting its contribution to the pathogenesis of dementia or its modulation as a therapeutic strategy.
D: Buyang Huanwu Decoction improves cognitive function in Alzheimer's disease mice by restoring gut microbiota balance, which in turn suppresses the C/EBPβ/AEP signaling pathway in the hippocampus, demonstrating a gut-brain axis mechanism.

Q385: Based on the provided context, which of the following statements best illustrate how interventions targeting gut microbiota can have therapeutic implications across both inflammatory and neurocognitive disorders, requiring integration of mechanisms and outcomes from different sections?
Options:
A: Fecal microbiota transplantation has shown promise in both alleviating neurological symptoms in disorders like Parkinson’s disease and in modulating gut microbiota to reduce symptoms in psoriatic arthritis.
B: Probiotics and prebiotics are discussed as interventions that can reshape gut microbiota to mitigate both radiation-induced intestinal injury and neurocognitive disorders by restoring microbial balance.
C: Antibiotic use in livestock directly improves the gut-joint axis in psoriatic arthritis by increasing beneficial bacteria.
D: The gut microbiota-brain axis is only relevant to neurodegenerative disorders and does not influence systemic inflammation in other diseases.

Q386: Based on the provided context, which of the following statements best integrate the roles of gut microbiota-derived short-chain fatty acids (SCFAs) and natural compounds in modulating both neurological and intestinal health, particularly in the context of neurodegenerative diseases and ischemic stroke?
Options:
A: The modulation of gut microbiota and SCFA production can influence neurodegenerative disease progression by affecting inflammatory responses and neurotransmitter regulation, highlighting the gut-brain axis as a therapeutic target.
B: Restoring SCFA levels in the colon is only relevant for colorectal cancer prevention and has no impact on neurological or intestinal health in the context of ischemic stroke.
C: Polyphenols directly increase the abundance of Bifidobacterium and Lactobacillus in the gut, which is the primary mechanism for their neuroprotective effects in neurodegenerative diseases.
D: Polygoni Multiflori Radix Praeparata polysaccharides enhance gut health and neurological recovery after ischemic stroke by increasing SCFA levels and beneficial gut microbiota, which in turn improve both intestinal barrier integrity and brain function.

Q387: Based on the integrated information from the context, which of the following statements best describe how polyphenols may exert therapeutic effects in neurodegenerative diseases by interacting with neuroinflammatory processes and cellular signaling pathways?
Options:
A: Polyphenols primarily act by directly altering estradiol metabolism in the gut microbiota, thereby preventing all forms of neurodegeneration regardless of inflammatory status.
B: Polyphenols can reduce neuroinflammation and neuronal death by modulating pro-inflammatory gene activity and influencing key signaling pathways such as Akt, Nrf2, STAT, and MAPK, which are implicated in neurodegenerative disease progression.
C: The neuroprotective effects of polyphenols involve both the regulation of inflammatory responses and the enhancement of synaptic plasticity and cognitive function through modulation of cellular signaling pathways.
D: Polyphenols are effective in treating neurodegenerative diseases solely by acting as antibiotics within the brain-liver-gut axis, independent of their antioxidant or anti-inflammatory properties.

Q388: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota alterations can contribute to neurodegenerative disease progression and the potential for therapeutic intervention across the gut-brain and gut-liver-brain axes?
Options:
A: Obesity-induced gut dysbiosis exacerbates neuroinflammation via a leaky intestinal barrier, leading to cognitive decline and motor deficits; strategies to alter gut dysbiosis, including dietary supplementation and lifestyle changes, are discussed as therapeutic approaches.
B: Neurodegenerative diseases are solely caused by hepatic dysfunction, and the gut microbiota plays no role in their progression or treatment.
C: The gut microbiota only affects neurodegeneration through direct modulation of neurotransmitter levels, and therapeutic interventions are limited to pharmacological agents derived from natural sources.
D: Gut dysbiosis can increase intestinal permeability, allowing microbial byproducts to enter the liver and brain, thereby activating inflammatory pathways that contribute to neurodegeneration; interventions such as probiotics and fecal microbiota transplantation are highlighted as potential strategies to restore eubiosis and mitigate disease severity.

Q389: Considering the interplay between immune, metabolic, and gut microbiota factors described in the context, which of the following statements best integrates mechanisms and outcomes across different disease models and interventions, such as type 1 diabetes, hyperlipidemia, and CNS diseases?
Options:
A: Microecologics and exercise are only effective in CNS diseases when used as single interventions, as combined approaches have not shown any theoretical or clinical promise.
B: Both the Endocannabinoidome-Microbiota (ECBoM) model in type 1 diabetes and Monascus-fermented ginseng intervention in hyperlipidemia highlight the therapeutic potential of targeting gut microbiota to modulate metabolic and immune dysfunction.
C: Macrophage polarization is exclusively regulated by pathogen-associated molecular patterns and does not interact with metabolic or gut-derived signals in disease contexts.
D: The normalization of gut microbiota composition, as seen with Monascus-fermented ginseng in hyperlipidemia, and the modulation of the endocannabinoid system in type 1 diabetes, both suggest that multi-omics approaches could identify disease-specific therapeutic targets.

Q390: Based on the provided context, which options best illustrate how interventions targeting the gut microbiota can influence neuroinflammatory or neurodegenerative disease outcomes through integrated mechanisms involving both metabolic and immune pathways?
Options:
A: Short-chain fatty acids in the diet fully reverse all neurodegenerative symptoms in Huntington’s disease by eliminating microglial activation and restoring normal motor abilities.
B: Propionate supplementation in the R6/2 mouse model of Huntington’s disease completely prevents neuronal loss and clinical disease progression by directly increasing BDNF mRNA expression in the striatum.
C: Fecal microbiota transplantation from methionine-restricted diet mouse donors improves Alzheimer’s learning and memory abilities by increasing short-chain fatty acids, which activate free fatty acid receptors and transport proteins, thereby signaling to the brain to mitigate inflammation.
D: Probiotic supplementation with Lactobacillus and Bifidobacterium strains in Alzheimer’s and mild cognitive impairment patients shows beneficial effects on cognitive function, which are associated with altered gut microbiota composition and positive changes in metabolic biomarkers.

Q391: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, immune modulation, and epigenetic mechanisms in the development or treatment of neuropsychiatric disorders, considering the involvement of both the gut-microbiota-brain axis and therapeutic interventions?
Options:
A: The interaction between the gut microbiota and the immune system can alter epigenetic pathways, and interventions like methyl-rich diets and medications may target these mechanisms to impact neuropsychiatric disorder outcomes.
B: Gut microbes and their metabolites can influence immune cell activity and brain function through epigenetic mechanisms, and therapeutic strategies such as prebiotics and probiotics may modulate this axis for neuropsychiatric disorder prevention or treatment.
C: Steroidogenesis in the gut is unrelated to the gut microbiota or neuropsychiatric disorder pathogenesis, and thus cannot be considered in therapeutic strategies.
D: The gut microbiota only affects neuropsychiatric disorders through direct neural signaling, without involvement of immune or epigenetic pathways.

Q392: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota modulation can influence both neurological and metabolic diseases, and suggest potential therapeutic strategies that target these pathways?
Options:
A: Increasing sodium absorption via gut microbiota modulation is the primary mechanism by which heart failure can be prevented and treated.
B: Therapeutic strategies targeting the gut-brain axis, such as microbiota modulation and neuroprotective interventions, may mitigate non-alcoholic fatty liver disease progression by addressing dysregulation involving gut microbiota, intestinal permeability, and neuroinflammation.
C: Restoring gut microbiota solely through dietary fiber intake is sufficient to prevent both colorectal cancer and heart failure by directly eliminating systemic inflammation.
D: Modulating gut microbiota can alleviate kainic acid-induced epileptic seizures by increasing Bacteroidetes and Alloprevotella, which regulate short-chain fatty acids and lipid metabolism in both the colon and hippocampus.

Q393: Based on the provided context, which of the following statements best integrate the mechanisms by which honokiol-SCFA conjugates and the microbiota-gut-brain axis may influence neurodegenerative disease outcomes, particularly in relation to Parkinson's disease and the therapeutic potential of microbiota-targeted interventions?
Options:
A: Honokiol-SCFA esters inhibit Enterococcus faecalis growth, thereby reducing levodopa metabolism in the gut and potentially enhancing Parkinson's disease therapy by modulating the microbiota-gut-brain axis.
B: Flavobacterium prevalence in the blood microbiome is a specific biomarker for improved neurological outcomes in patients treated with honokiol-SCFA esters.
C: Both honokiol-SCFA conjugates and probiotics represent microbiota-targeted interventions that may modulate neurodegenerative disease progression by influencing gut microbial composition and metabolite production.
D: The abundance of Firmicutes in the blood microbiome is consistently increased in all neurodegenerative and cardiovascular diseases, directly improving the efficacy of levodopa in Parkinson's disease.

Q394: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between microbiota composition, systemic disease risk, and potential therapeutic strategies, requiring synthesis of information from multiple sections?
Options:
A: Therapeutic strategies targeting gut microbiota and their metabolites, such as bile acid derivatives interacting with genes like NFKB1, may offer novel interventions for conditions like erectile dysfunction, paralleling the potential for microbiota modulation in other systemic diseases discussed in the context.
B: Neuroinflammaging is exclusively caused by age-related genetic mutations, and there is no evidence that environmental factors or microbiota influence epigenetic modulation of neuroinflammatory responses.
C: Both the oral-gut microbiome axis and the gut–skin axis suggest that dysbiosis in microbial communities can contribute to the pathogenesis of systemic diseases such as Alzheimer disease and autoimmune bullous skin diseases, highlighting the importance of maintaining microbial homeostasis for disease prevention.
D: The presence of autoantibodies in bullous pemphigoid and pemphigus vulgaris is solely determined by genetic factors, with no influence from environmental or microbial factors according to current evidence.

Q395: Based on the provided context, which of the following statements best illustrate how gut microbiota-derived metabolites can influence disease progression by integrating both immune and metabolic pathways across different organ systems?
Options:
A: Gold nanospheres ameliorate rheumatoid arthritis by enriching Ligilactobacillus, which increases indole-3-propionic acid and indole-3-acetic acid, activating the AhR pathway and suppressing NF-κB-mediated synovial inflammation.
B: In adolescent depression, increased Faecalibacterium directly enhances glycolysis and gluconeogenesis, leading to reduced pro-inflammatory cytokine production and improved mood.
C: Short-chain fatty acids produced by gut microbiota directly prevent schizophrenia by blocking all neurotransmitter disruptions in the brain.
D: Nicotinamide n-oxide, produced by gut Lactobacillus species, restores NAD+-dependent mitophagy in microglia, thereby restraining neuroinflammation and mitigating herpes simplex encephalitis progression.

Q396: Based on the provided context, which of the following statements best integrate information about the interplay between immune cell interactions, microbiota, and neurodevelopmental or neurodegenerative outcomes, particularly in relation to BDNF production and the gut-brain axis during early life?
Options:
A: The interaction between monocytes and platelets, when exposed to bacterial antigens, is a major source of BDNF in peripheral blood, and such immune-blood cell complex activity during early-life microbial stimulation may influence the gut-brain axis and subsequent brain development.
B: Neurodevelopmental outcomes in early life are unaffected by the plasticity or dysbiosis of the neonatal microbiome, as only genetic factors play a role in determining brain health.
C: BDNF production in PBMC cultures is solely determined by the presence of platelets, independent of any microbial stimulation or immune cell interactions.
D: Early-life gut microbiota maturation, influenced by maternal and environmental factors, can affect immune modulators and neurotransmitter production, which are critical for brain development and may impact the risk of later neurodegenerative diseases such as ALS.

Q397: Based on the provided context, which of the following statements best integrate the roles of gut microbiota in both neurodegenerative diseases and immune regulation, and also consider the implications for therapeutic interventions targeting the gut microbiota?
Options:
A: Radiation-induced injury to the gut is solely mediated by direct changes in the gut microbiota, without involvement of immune responses or systemic effects.
B: The beneficial effects of Lactobacillus johnsonii in neuroangiostrongyliasis are entirely dependent on changes in microbiome-related metabolites such as short-chain fatty acids and bile acids.
C: Gut microbiota dysbiosis can contribute to neuroinflammation in neurodegenerative diseases by disrupting immune cell interactions, and therapeutic strategies targeting the microbiota may help alleviate these neuroinflammatory processes.
D: Microbial-derived metabolites and structural components influence regulatory T cell function, and dysbiosis can compromise immune tolerance, suggesting that microbiota-based interventions could restore immune balance in inflammatory and neurodegenerative conditions.

Q398: Based on the provided context, which of the following statements best integrate the roles of the gut microbiota, immune system, and brain function in the context of neurodegenerative disorders and inflammatory bowel disease, and are supported by evidence from multiple sections of the text?
Options:
A: The only pathway by which the gut microbiota influences brain function is through direct neuronal signaling, without involvement of the immune system or neuroendocrine mechanisms.
B: Therapeutic interventions targeting the gut microbiota, such as probiotics or psychobiotics, have the potential to improve both cognitive function in neurodegenerative diseases and quality of life in inflammatory bowel disease by modulating the microbiota-gut-brain axis.
C: Alterations in gut microbiota composition can contribute to both neuroinflammation in neurodegenerative disorders and exacerbation of inflammatory bowel disease by disrupting immune system communication along the gut-brain axis.
D: Psychological stress has no impact on the gut microbiota or the severity of inflammatory bowel disease, as the microbiota-gut-brain axis is not involved in stress responses.

Q399: Based on the provided context, which options best illustrate how interventions targeting gut microbiota can influence both neuroinflammatory and neuropsychiatric outcomes by integrating changes in microbial composition, metabolite production, and host gene expression?
Options:
A: Increasing Firmicutes abundance in chronic spinal cord injury patients directly leads to improved motor function and reduced neuroinflammation by enhancing SCFA production.
B: Clostridium butyricum administration in Alzheimer’s disease models exerts anti-neuroinflammatory effects by regulating the gut microbiota and metabolites such as butyrate, thereby influencing the gut-brain axis.
C: Decreased Lactobacillus in the subacute phase of spinal cord injury is solely responsible for the development of neurodegenerative disorders, independent of other microbial changes.
D: Supplementation with Akkermansia in Negr1 knockout mice reverses neuronal atrophy and modulates anxiety- and depression-like behaviors by altering gut microbiota composition and downregulating mitochondrial genes in the brain.

Q400: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence neurodegenerative diseases, and how model organisms and therapeutic interventions are used to study and potentially treat these conditions?
Options:
A: Drosophila melanogaster is used to study how gut-derived metabolites, such as lactate and acetate, activate glial cells and affect tau protein dynamics, providing insights into Alzheimer's disease progression and informing potential probiotic therapies.
B: Genetic background alone determines the risk and progression of neurodegenerative diseases, with no influence from gut microbiota or its metabolites.
C: Gut dysbiosis can lead to neuroinflammation by activating microglia and peripheral immune cells, and fecal microbiota transplantation is being researched as a therapeutic intervention targeting the gut-brain axis in neurodegenerative diseases including Alzheimer's and Parkinson's.
D: The neonatal microbiome is not involved in neurodevelopmental processes, and its composition has no impact on later-life neurodegenerative diseases such as ALS.

Q401: Considering the multi-step regulatory cascades described in Alzheimer's disease, which of the following events would most likely occur after microbiota-derived Indoles upregulate aryl hydrocarbon receptor (AhR) production, but before the restoration of synaptic plasticity and cognitive ability in APP/PS1 mice? Select all that apply.
Options:
A: Accumulation of beta-amyloid protein and tau hyperphosphorylation
B: Recruitment of peripheral immune cells such as T cells and B cells to the CNS
C: Inhibition of the NF-κB signal pathway and formation of the NLRP3 inflammasome
D: Reduction in the release of inflammatory cytokines including TNF-α, IL-6, IL-1β, and IL-18

Q402: Based on the described studies, when GV-971 is administered to mouse models of Alzheimer's disease at a time point when Aβ burden is already detectable or near maximal, which sequential biological events are observed in male mice following treatment, and what changes occur in the microbiota-microglia-amyloid axis over time?
Options:
A: GV-971 treatment first alters gut microbiota composition, which is followed by increased amino acid production and modulation of the tryptophan pathway.
B: GV-971 treatment in female mice leads to the same transcriptome changes in the cerebral cortex as observed in male mice.
C: GV-971 treatment immediately reduces plaque-associated reactive microglia before any changes in gut microbiota are detected.
D: After GV-971-induced microbiome changes, there is a subsequent reduction in cerebral amyloidosis and dampening of astrocyte and microglia activation in male mice.

Q403: Based on the described temporal sequence of events in neurodegenerative diseases, which of the following processes are likely to occur after the onset of gut dysbiosis but before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Disruption of the intestinal barrier leading to the ingress of pathobionts and toxic metabolites into systemic circulation
B: Chronic neuroinflammation via dysregulated immune activation
C: Therapeutic intervention with prebiotics, probiotics, or fecal microbial transplantation
D: Altered cognitive functioning due to established proteinopathies

Q404: Considering the progression of neurodegenerative diseases such as Alzheimer's, which of the following events occurs before the accumulation of neurotoxic misfolded proteins in and around CNS cells, and which events are part of the subsequent vicious cycle that perpetuates neurodegeneration according to the described temporal and hierarchical sequence involving gut dysbiosis, immune activation, and autophagy impairment?
Options:
A: Defective autophagy-mediated proteinopathies develop before gut dysbiosis alters the immune response.
B: Gut dysbiosis disrupts the intestinal barrier, allowing toxic metabolites to enter systemic circulation prior to chronic neuroinflammation.
C: Chronic neuroinflammation via dysregulated immune activation precedes the accumulation of neurotoxic misfolded proteins in CNS cells.
D: Therapeutic modulation of gut dysbiosis with prebiotics or probiotics occurs before the onset of gut-brain axis dysregulation.

Q405: Considering the temporal sequence of molecular and cellular events described in the context of Alzheimer's disease mouse models, which of the following occur after antibiotic-induced changes in the gut microbiome but before the reduction of Aβ plaque accumulation, and are directly linked to the regulation of reactive astrocytosis?
Options:
A: Immediate reduction of Aβ plaques without changes in immune cell populations
B: An increase in plasma propionate levels followed by decreased peripheral Th17 cells and IL-17 secretion
C: Reduced expression of proinflammatory genes and increased expression of neurotrophic genes in astrocytes
D: Direct administration of IL-17 monoclonal antibody prior to any changes in gut microbiota

Q406: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbiota composition (dysbiosis) but before the manifestation of cognitive or psychological symptoms in neurological or metabolic disorders, according to the context provided?
Options:
A: Activation of the hypothalamic-pituitary-adrenal (HPA) axis and subsequent neural signaling via the vagus nerve
B: Immediate reversal of disease severity without changes in inflammatory or metabolic markers
C: Direct improvement in cognitive function without intermediary molecular or cellular changes
D: Modulation of immune mediators such as chemokines and cytokines, leading to neuroinflammation or systemic inflammation

Q407: Considering the multi-step biological pathways described, which of the following events occur after the oral administration of medium-chain triglycerides (MCT) in 5×FAD mice and contribute to the prevention of Alzheimer's disease progression? Select all that apply. Your answer should reflect the temporal sequence from MCT intake to molecular and cellular changes, as supported by the context.
Options:
A: Elevation of short-chain fatty acid concentrations in the brain, which is associated with protection against Aβ25-35-induced apoptosis and promotion of neurite regeneration.
B: Immediate inhibition of acetylcholinesterase activity in the brain prior to any changes in gut microbiota composition.
C: Direct activation of microglia and astroglia leading to increased neuronal loss before any dietary intervention.
D: An increase in the relative abundance of Akkermansia in the gut microbiota, followed by reduced intestinal permeability.

Q408: Considering the multi-step regulatory cascades described, which of the following events are likely to occur after a decrease in short-chain fatty acid (SCFA) levels in diabetic retinopathy patients, and before the manifestation of retinal vessel loss? Select all that apply. Your answer should reflect the temporal progression from molecular changes to tissue pathology, as supported by the context.
Options:
A: Immediate improvement of intestinal barrier function
B: Benign modulation of gut microbiota by manual acupuncture
C: Immune dysregulation with altered cytokine expression correlated to SCFA levels
D: Epigenetic changes in retinal DNA methylation, including downregulation of vascular endothelial growth factor and nuclear factor-kappa B pathways

Q409: Considering the temporal sequence of events in the microbiota-gut-brain axis, which of the following changes would most likely occur after psychological stress initiates alterations in the hypothalamic-pituitary-adrenal (HPA) axis, and before improvements in IBD symptoms are observed following interventions targeting the microbiota-gut-brain axis?
Options:
A: Immediate restoration of normal intestinal immunity and permeability
B: Alterations in the balance between the sympathetic nervous system and vagus nerves
C: Disruption of the homeostasis of the intestinal flora and metabolites
D: Long-term improvement in both physical and psychological well-being

Q410: Considering the temporal sequence of events following postnatal valproic acid (VPA) exposure in mice, which of the following processes are likely to occur before the observed improvement in behavioral alterations when Coriolus versicolor (CV) is administered daily from day 14 to day 40? Select all that apply.
Options:
A: Modulation of the TLR-4/Myd88/NF-κB signaling pathway in the brain
B: Initial VPA-induced neuroinflammation and disorganization of the cerebellum and hippocampus
C: Restoration of behavioral performance in motor skill and anxiety tests
D: Alteration in gamma-amino butyric acid (GABA) production detected by Western blot analysis

Q411: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after the ingestion of flavanone-rich citrus fruits but before observable improvements in cognitive performance, according to the described gut-brain axis pathway?
Options:
A: Modulation of gut microbiota composition, fostering a balance between beneficial and pathogenic bacteria
B: Extensive metabolic transformation of flavanones into active metabolites
C: Long-term reduction in the risk of neurodegenerative disorders
D: Direct inhibition of acetylcholinesterase in the brain by unmodified flavanones

Q412: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes occur after the initial disruption of gut microbiota (dysbiosis) and before the manifestation of disease phenotypes such as neuroinflammation or impaired barrier function? Select all that apply.
Options:
A: Activation of immune responses, including increased proinflammatory cytokine production.
B: Immediate restoration of tight junction protein expression in the intestinal barrier.
C: Altered production of microbiota-derived metabolites that modulate host signaling pathways.
D: Changes in the abundance of specific gut microbial species correlated with clinical symptoms.

Q413: Considering the temporal sequence of events following cerebral ischemia/reperfusion (I/R) injury in the context of ischemic stroke, which of the following processes are reported to occur after administration of Polygoni Multiflori Radix Praeparata polysaccharides (PMP), and contribute to the subsequent improvement in both neurological and intestinal outcomes according to the described mechanisms?
Options:
A: Immediate restoration of neuronal function prior to any changes in gut microbiota composition or metabolite levels.
B: A reversal of gut dysbiosis, characterized by increased abundance of beneficial bacteria such as Bifidobacterium and Lactobacillus, which precedes improvements in SCFA and amino acid metabolism.
C: An increase in intestinal short-chain fatty acid (SCFA) levels, which is temporally followed by enhanced gut barrier integrity and reduced inflammatory cytokines.
D: A decrease in the family Bacteroidaceae and genus Bacteroides, leading directly to reduced SCFA production before any neurological improvement is observed.

Q414: Considering the temporal sequence of events following morphine self-administration in rodents, which of the following statements accurately describe the order and progression of changes observed in the gut-brain axis, particularly regarding the timing of gut microbiota alterations relative to brain MRI findings during the acute and chronic phases?
Options:
A: Gut microbiota changes are evident as early as the acute phase, and these changes continue into the chronic phase, with brain MRI alterations emerging subsequently.
B: Early changes in gut microbiota diversity and abundance are detected during the acute phase and persist into the chronic phase, preceding detectable alterations in brain MRI indices.
C: Brain MRI and gut microbiota changes occur simultaneously, with no clear temporal precedence of one over the other.
D: Alterations in brain MRI diffusivity indices in the striatum and thalamus are observed before any significant changes in gut microbiota diversity occur.

Q415: Considering the temporal sequence of events in Alzheimer's disease progression as influenced by gut microbiota, which of the following events would be expected to occur after fecal microbiota transplantation (FMT) from healthy wild-type donors, but before the normalization of pro-inflammatory cytokine expression in both gut and brain tissues? Select all that apply.
Options:
A: Elevation of pro-inflammatory cytokine levels in both gut and brain tissues.
B: Improvement in spatial memory and exploratory behavior in APP/PS1 transgenic mice.
C: Bloom of pathogenic genera such as Erysipelatoclostridium and Enterobacteriaceae in the gut microbiota.
D: Reduction in amyloid-beta (Aβ) plaque burden in the brain.

Q416: Considering the temporal progression of stress-induced sleep dysregulation, which of the following events are likely to occur sequentially after chronic stress exposure, ultimately contributing to neurodegenerative and psychiatric disorders? Select all that apply: (1) Astrocyte-mediated disruption of adenosine signaling and glymphatic clearance, (2) Microglial activation leading to neuroinflammation, (3) Impairment of synaptic processes such as neurotransmitter balance and synaptic plasticity, and (4) Exacerbation of brain dysfunction.
Options:
A: Microglial activation and neuroinflammation occur after astrocyte dysfunction, leading to subsequent impairment of synaptic processes.
B: Astrocyte-mediated disruption of adenosine signaling and glymphatic clearance occurs early, followed by microglial activation and neuroinflammation.
C: Impairment of synaptic processes is the initial event, followed by astrocyte and microglial activation.
D: Exacerbation of brain dysfunction precedes impairment of synaptic processes such as neurotransmitter balance and synaptic plasticity.

Q417: Considering the temporal sequence of events in the pathogenesis of epilepsy-depression comorbidity (EDC), which of the following processes are likely to occur after the initial inflammatory response, ultimately leading to synaptic dysfunction and neuroimmune imbalance, according to the described mechanisms in the context?
Options:
A: Direct neuroimmune imbalance as the earliest event, preceding glial cell activation
B: Glial cell activation and cytokine release, followed by pyroptosis and oxidative damage
C: Pyroptosis and oxidative damage, which subsequently contribute to synaptic dysfunction
D: Immediate synaptic dysfunction prior to any inflammatory or oxidative changes

Q418: Considering the timeline of morphine self-administration in rodents, which of the following events occur during the progression from baseline to the acute and chronic phases, and what is the temporal relationship between gut microbiota changes and MRI-detected brain alterations in the striatum and thalamus?
Options:
A: Early changes in gut microbiota diversity and abundance are observed in the acute phase and persist into the chronic phase.
B: MRI alterations in diffusivity indices in the striatum and thalamus are detected before any changes in gut microbiota.
C: Gut changes precede the effects observed in MRI, with the striatum and thalamus emerging as crucial links in gut-brain communication.
D: No concurrent changes are observed in the brain and gut during morphine self-administration.

Q419: Considering the temporal sequence of events in gut dysbiosis-associated neurodegeneration, which of the following processes would most likely occur after an increase in gut permeability but before the manifestation of neurodegenerative symptoms, according to the described gut-brain axis mechanisms and biomarker studies?
Options:
A: Immediate improvement in cognitive function due to increased polyphenol intake
B: Normalization of the Firmicutes/Bacteroidetes ratio without any intervention
C: Activation of the kynurenine pathway leading to increased production of neuroactive and neurotoxic metabolites
D: Elevation of inflammatory biomarkers such as sCD14 and antibodies against bacterial endotoxins in the bloodstream

Q420: Considering the temporal sequence of events following perinatal chlorpyrifos (CPF) exposure in rats, which of the following processes occur after the initial disruption of gut microbiota, and are subsequently mitigated by inulin supplementation, according to the described experimental findings?
Options:
A: Decreased gene expression of tight junction markers in brain microvessels follows CPF-induced gut dysbiosis and is restored by inulin.
B: Increased expression of tight junction genes in brain microvessels precedes CPF-induced gut dysbiosis.
C: Restoration of gut microbiota composition by inulin occurs before CPF exposure.
D: Bacterial translocation from the gut to the spleen and liver occurs after gut dysbiosis and is reduced by inulin.

Q421: Considering the sequence of biological events described in the context, which of the following processes occur after berberine administration in kainic acid-induced epileptic mice and contribute to its neuroprotective effect, specifically through temporal changes in gut microbiota and associated lipid metabolism in the colon and hippocampus?
Options:
A: Identification of candidate metabolites in the colon and hippocampus that are possibly involved in the protective effect against acute seizures.
B: Immediate restoration of hippocampal neuron structure prior to any changes in gut microbiota composition.
C: Direct inhibition of kainic acid activity in the brain without involvement of gut microbiota.
D: An increase in the abundance of Bacteroidetes and Alloprevotella, followed by regulation of short-chain fatty acids.

Q422: Considering the temporal sequence of events in the development of depressive symptoms as discussed in the context, which of the following changes in gut-derived biomarkers are observed before or during the progression of depressive symptoms, and what do these changes indicate about the underlying biological processes over time?
Options:
A: A significant decrease in sCD14 levels, reflecting reduced inflammatory response to bacterial endotoxins.
B: A marked reduction in antibodies against bacterial endotoxins, implying diminished immune activation during depressive symptom progression.
C: An increase in zonulin levels, indicating early disruption of intestinal tight junctions and increased gut permeability.
D: An elevation in I-FABP levels, suggesting acute intestinal epithelial damage occurring alongside depressive symptoms.

Q423: Considering the temporal sequence of events in the pathogenesis of cerebral small vessel disease (CSVD) as described in the context, which of the following processes are likely to occur after microbial dysbiosis but before the manifestation of cognitive decline, according to the regulatory cascade involving the microbiota-gut-brain axis?
Options:
A: Promotion of neuroinflammation and vascular dysfunction in the brain
B: Impaired waste clearance in the brain due to glymphatic system dysfunction
C: Initial colonization of the gut by commensal bacteria in early life
D: Onset of cognitive decline and vascular dementia symptoms

Q424: Considering the temporal progression of neuroinflammaging, which involves chronic up-regulation of inflammatory responses in the brain, and the sequential epigenetic modifications induced by environmental exposures, which of the following events would likely occur before the sustained neuroinflammatory phenotype is established in age-related neurodegenerative disorders?
Options:
A: Long-term maintenance of a proinflammatory state contributing to neurodegenerative pathology
B: Epigenetic modifications of DNA methylome, histone fold proteins, and nucleosome positioning due to environmental factors
C: Combination and interaction of epigenetic modifiers during the life course to model epigenome dynamics
D: Use of diagnostic biomarkers to tailor therapeutic strategies in patients with neurodegenerative diseases

Q425: Considering the sequence of molecular and cellular events described in neuroangiostrongyliasis, which of the following changes would be expected to occur after the administration of intestinal Lactobacillus johnsonii in Angiostrongylus cantonensis-infected mice, and which would be expected to precede changes in microbiome-related metabolites, according to the context provided?
Options:
A: A significant alteration in short-chain fatty acids, tryptophan metabolites, and bile acids immediately following L. johnsonii administration.
B: A direct improvement in neuroinflammation and prolonged survival prior to any observed change in gut microbiome composition.
C: An increase in IL-10 levels in the brain, reflecting an early immune-modulatory effect of L. johnsonii.
D: A reduction in IL-2, IL-4, IL-5, and MCP-1 levels in the brain as part of the immune response modulation by L. johnsonii.

Q426: Considering the temporal sequence of molecular and cellular events following spinal cord injury (SCI), which of the following processes are likely to occur after administration of Pectin-Zein-IPA nanoparticles, and before the final improvement in motor function recovery, according to the described mechanistic pathway?
Options:
A: Formation of autoantibodies against basement membrane proteins
B: Activation of the AKT/Nrf-2 signaling pathway
C: Initial impairment of gut microbiome balance
D: Reduction in intestinal flora metabolite accumulation of L-methionine

Q427: Considering the temporal sequence of events during menopause, which of the following processes occur after the initial decline in ovarian estrogen production, and subsequently contribute to the development of postmenopausal health disorders according to the context provided?
Options:
A: A decrease in gut microbiota diversity leading to reduced microbial decomposition and lower circulating estrogen levels.
B: A gradual onset of disorders such as lipid metabolism abnormalities, cognitive decline, and osteoporosis following decreased estrogen reabsorption.
C: An immediate increase in ovarian estrogen synthesis to compensate for hormonal loss.
D: A direct restoration of estrogen levels by the ovaries without involvement of the gut microbiota.

Q428: Considering the temporal progression of diabetic retinopathy (DR) in the context of gut microbiota-derived short-chain fatty acids (SCFAs), which of the following events are likely to occur after a sustained period of acetate supplementation in a streptozotocin-induced diabetic mouse model, and before the observed downregulation of vascular endothelial growth factor and nuclear factor-kappa B pathways in retinal DNA methylation?
Options:
A: Upregulation of pro-inflammatory cytokine expression in the retina
B: Decrease in the frequency of CD45+ CD11b+ cells and F4/80+ CD206+ CD11c- cells in the diabetic retina
C: Improvement of intestinal barrier function and alleviation of retinal thinning
D: Elevation of circulating butyric and iso-valeric acid levels above those of non-DR controls

Q429: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after an initial alteration in gut microbiota composition (dysbiosis) and before the manifestation of chronic disease phenotypes such as diabetes, autoimmune disorders, or cancer? Select all that apply.
Options:
A: Decreased microbial diversity associated with systemic inflammation and insulin resistance in type 2 diabetes mellitus.
B: Production of carcinogenic metabolites and chronic inflammation contributing to cancer onset.
C: Immediate restoration of microbial balance through dietary modifications.
D: Sustained inflammation and aberrant immune responses resulting from disrupted immune homeostasis.

Q430: Considering the multi-step mechanisms involved in Alzheimer's disease progression, which of the following events must occur before the implementation of CRISPR-Cas9-mediated genome editing or neural stem cell transplantation as therapeutic strategies, according to the reviewed molecular findings and therapeutic innovations?
Options:
A: Identification of molecular targets arising from mechanisms such as Aβ plaque accumulation, glymphatic pathways, and autophagy alterations
B: Review and exploration of novel areas including the gut-brain axis, vascular dysfunction, and oral health to inform therapeutic approaches
C: Immediate combination therapy without consideration of underlying mechanisms
D: Direct administration of disease-modifying drugs without prior molecular characterization

Q431: In the context of neurodegenerative diseases and cognitive impairment, consider the sequence of molecular and cellular events following gut microbiota dysbiosis. Which of the following events are likely to occur in the subsequent phases, leading to neurological dysfunction, according to the described temporal and hierarchical mechanisms in the context?
Options:
A: Polyphenol-induced upregulation of neurotrophins occurs prior to the mitigation of neuroinflammatory responses.
B: Upregulation of tight junction proteins in the intestinal barrier occurs before the onset of gut dysbiosis.
C: Activation of the NF-κB pathway and increased oxidative stress follow the reduction of SCFA-producing bacteria in the gut.
D: Increased abundance of LPS-producing bacteria precedes elevated pro-inflammatory cytokine expression in serum or hippocampal tissue.

Q432: Considering the temporal sequence of events in endometriosis pathogenesis, which of the following processes would most likely occur after microbial dysbiosis but before the proliferation of endometriotic lesions, according to the described hierarchical and regulatory cascades involving the gut microbiota, immune modulation, and estrogen metabolism?
Options:
A: Activation of the TLR4/NF-κB signaling pathway by lipopolysaccharides from Gram-negative bacteria, leading to exacerbated inflammation
B: Clinical manifestation of endometriosis symptoms due to lesion proliferation
C: Modulation of estrogen metabolism by the estrobolome, resulting in increased systemic estrogen levels
D: Initial reduction in beneficial bacteria such as Lactobacillus and Bifidobacterium within the gut microbiota

Q433: Based on the described studies, consider the sequence of events in Alzheimer's disease (AD) mouse models treated with Buyang Huanwu Decoction (BYHWD). After BYHWD administration, which of the following events are expected to occur in the subsequent temporal order, leading to improved cognitive function, and are explicitly supported by the context provided?
Options:
A: Reduced Aβ plaque deposition and diminished tau hyperphosphorylation occur before suppression of the C/EBPβ/AEP signaling pathway.
B: Restoration of gut microbiota balance precedes suppression of the C/EBPβ/AEP signaling pathway in the hippocampus.
C: Suppression of the C/EBPβ/AEP signaling pathway leads to reduced Aβ plaque deposition and diminished tau hyperphosphorylation.
D: Suppression of the C/EBPβ/AEP signaling pathway in the hippocampus occurs before restoration of gut microbiota balance.

Q434: During the progression of herpes simplex encephalitis (HSE) caused by HSV-1 infection, several sequential events occur involving the gut microbiota, microglial activation, and neuroinflammation. Based on the described temporal cascade, which of the following events are expected to occur after HSV-1 infection but before the administration of exogenous nicotinamide n-oxide (NAMO)?
Options:
A: HSV-1 infection induces gut microbiota dysbiosis, leading to impaired mitophagy and activation of microglia.
B: NAMO restores NAD+-dependent mitophagy, restraining microglial over-activation and preventing early HSV-1 infection in neuronal cells.
C: Depletion of gut microbiota by oral antibiotics results in hyperactivated microglia and exacerbated HSE pathology.
D: HSV-1 infection causes mitochondrial dysfunction in microglia, promoting proinflammatory cytokine production.

Q435: Considering the temporal sequence of events in Alzheimer's disease pathogenesis, which of the following processes occur after the initial immune cell recognition and clearance of β-amyloid (Aβ) aggregates, and contribute to the subsequent progression of the disease through feedback mechanisms or hierarchical molecular changes?
Options:
A: Prolonged or excessive activation of immune cells leading to chronic neuroinflammation and accelerated neuronal damage
B: Disruption of lipid metabolism that further exacerbates immune dysregulation and accelerates AD progression
C: Initial aggregation of β-amyloid (Aβ) forming senile plaques in the extracellular space
D: Early microglial phagocytic clearance of Aβ aggregates, reducing plaque formation

Q436: Considering the temporal sequence of events following ischemic stroke (IS) and subsequent intervention with Polygoni Multiflori Radix Praeparata polysaccharides (PMP), which of the following processes are expected to occur after PMP administration, and which are likely to precede improvements in neurological function? Select all that apply.
Options:
A: Proliferation of beneficial gut microbiota, such as Bifidobacterium and Lactobacillus, is an early event that precedes the improvement of intestinal barrier function.
B: The reversal of disrupted carbohydrate and amino acid metabolism in the intestine is a direct consequence of improved neurological function.
C: Enhancement of short-chain fatty acid (SCFA) and amino acid metabolism in the gut microbiota occurs before the observed improvement in neurological function.
D: Reduction of inflammatory cytokines such as TNF-α and IL-1β in both brain and intestinal tissues is a late event that follows the restoration of gut barrier integrity.

Q437: Considering the temporal sequence of events in Alzheimer's disease mouse models, which of the following changes are observed as the disease progresses from 6 months to 12 months of age, and how do these changes relate to the hierarchical interplay between gut microbiota, systemic inflammation, and brain microstructure?
Options:
A: Decreased pro-inflammatory cytokine levels in serum are seen at 12 months, following improvements in gut microbiota composition.
B: An increase in alpha diversity of gut microbiota is detected at 12 months, preceding changes in neuroinflammation.
C: A diminished Firmicutes/Bacteroidetes (F/B) ratio is specifically noted at 12 months, temporally associated with advanced AD pathology.
D: A reduction in short-chain fatty acids (SCFAs) is observed at both 6 and 12 months, indicating persistent disruption in gut microbial metabolism over time.

Q438: Based on the described sequence of events in neurodegenerative disease pathogenesis, which of the following processes occur after gut dysbiosis disrupts intestinal barrier integrity but before the accumulation of neurotoxic misfolded proteins in CNS cells? Select all that apply.
Options:
A: Ingress of pathobionts and toxic metabolites into the systemic circulation
B: Chronic neuroinflammation via dysregulated immune activation
C: Upregulation of proliferation pathways in astrocytes
D: Neuronal death in the central nervous system

Q439: Considering the temporal sequence of events in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD), which of the following processes occur after gut microbiota dysbiosis but before the development of hepatic inflammation, according to the described gut-liver axis mechanisms?
Options:
A: Influence of microbial metabolites such as short-chain fatty acids and bile acids on hepatic function and immune responses
B: Enhanced intestinal permeability allowing translocation of bacterial products like lipopolysaccharide (LPS) into systemic circulation
C: Initial disruption of gut microbiota composition due to lifestyle and dietary factors
D: Accumulation of hepatic lipids leading directly to liver fibrosis without prior inflammation

Q440: Considering the sequence of events following postnatal valproic acid (VPA) exposure in mice, which of the following processes occur after the initial behavioral impairment and neuroinflammation, and are subsequently modulated by daily administration of Coriolus versicolor (CV) through the TLR-4/Myd88/NF-κB signaling cascade, as described in the context?
Options:
A: Behavioral testing is performed before VPA exposure and prior to any neuroinflammatory changes.
B: Reversal of disorganization in the cerebellum and hippocampus occurs after behavioral alterations and is improved by CV administration.
C: Significant improvement of VPA-induced neuroinflammation via modulation of the TLR-4/Myd88/NF-κB pathway is observed after CV treatment.
D: Biochemical analyses of glutathione, malondialdehyde, and nitric oxide are conducted before any behavioral changes are assessed.

Q441: Considering the temporal sequence of events during the first 1000 days of life, which of the following processes must occur before the establishment of chronic inflammation and abnormal excitatory/inhibitory balance that contribute to later-life neurodegenerative diseases such as ALS? Select all that apply.
Options:
A: Maturation and colonization of the infant microbiome and its production of metabolites such as neurotransmitters and immune modulators
B: Persistent dysbiosis of the neonatal microbiome that continues into adulthood
C: Development of chronic inflammation and abnormal excitatory/inhibitory balance resulting in neural excitation
D: Formation of functioning neuronal circuits during early brain development

Q442: Considering the temporal sequence of events in herpes simplex encephalitis (HSE) as described in the context, which of the following processes occur after HSV-1 infection but before the administration of exogenous nicotinamide n-oxide (NAMO), and are directly involved in the progression of neuroinflammation via the gut microbiota-microglia axis?
Options:
A: Mitochondrial dysfunction and impaired mitophagy activate microglia and promote proinflammatory cytokine production.
B: Exogenous NAMO restores NAD+-dependent mitophagy to restrain microglial over-activation.
C: HSV-1 infection induces gut microbiota dysbiosis and microglial antiviral immune response.
D: NAMO administration prevents HSV-1 early infection in neuronal cells.

Q443: Considering the temporal sequence of molecular and cellular events described in the context of glaucoma, which of the following processes would be expected to occur after the restoration of AhR activation by indoleacetic acid (IAA) or Bacteroides fragilis, but before the preservation of visual function in the disease model?
Options:
A: Attenuation of RAGE/NF-κB pathway activation via AhR-dependent signaling
B: Suppression of microglial activation and reduction in the release of pro-inflammatory mediators throughout the retina
C: Initial depletion of tryptophan-metabolizing bacteria such as B. fragilis in the gut microbiota
D: Behavioral assays demonstrating preserved visual function in mice

Q444: Considering the temporal sequence of events described in Alzheimer's disease (AD) and the effects of time-restricted feeding (TRF), which of the following processes are reported to occur after the initial alteration of gut microbiota composition, and are linked to subsequent improvements in cognitive function according to the context provided?
Options:
A: Direct modulation of microglial activation in the brain before any changes in gut microbiota or metabolite levels
B: Increased production of propionic acid (PA) by gut microbiota, leading to its penetration of the blood-brain barrier
C: Activation of key genes in AD pathogenesis modulated by B. pseudolongum and PA following TRF
D: Immediate reversal of tau tangle formation prior to any changes in gut microbiota

Q445: Based on the described temporal sequence of events in neurodegenerative disease pathogenesis, which of the following processes occur after gut dysbiosis but before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Disruption of the intestinal barrier leading to ingress of pathobionts and toxic metabolites into systemic circulation
B: Chronic neuroinflammation via dysregulated immune activation
C: Initial alteration in gut microbiota composition (increase in pathobionts, decrease in symbionts)
D: Neuronal death in the central nervous system

Q446: Considering the temporal sequence of events following addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage but before the manifestation of altered mood and cognitive function, according to the described gut-brain axis mechanisms?
Options:
A: Appropriately selected supplements are used to support cognitive function in neurodegenerative diseases.
B: Exercise and microecologics synergistically improve CNS disease symptoms through the microbiota-gut-brain axis.
C: Harmful substances and bacteria cross the intestinal barrier into the circulatory system, leading to systemic inflammatory responses.
D: Dysbiosis develops, activating immune cells and leading to the release of inflammatory factors.

Q447: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbiota composition but before the manifestation of neurodegenerative or psychiatric symptoms, according to the described mechanisms and regulatory cascades in the context?
Options:
A: Changes in microbial metabolite production that influence neurotransmitter synthesis or immune signaling
B: Direct genetic mutation in neuronal DNA caused by gut microbes
C: Modulation of intestinal and blood-brain barrier integrity by gut microbiota-derived factors
D: Immediate onset of neurodegenerative symptoms without intermediary molecular changes

Q448: Considering the temporal sequence of events in Alzheimer's disease (AD) neuroinflammation, which of the following processes occur after gut microbiota dysbiosis but before the modulation of neuroinflammatory responses by microbiota-derived metabolites? Select all that apply.
Options:
A: Increased intestinal permeability leading to translocation of endotoxins like lipopolysaccharides (LPS) into the bloodstream
B: Microbiota-derived short-chain fatty acids (SCFAs) and amyloid peptides crossing the blood-brain barrier
C: Activation of the brain's toll-like receptor 4 (TLR4) pathways by circulating endotoxins
D: Alteration of microglial activation and cytokine production due to changes in oral microbiota

Q449: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) from male to female BWF1 mice, which of the following changes in gut microbiota composition are observed during periods when disease suppression occurs, and which events must precede the reemergence of the protective phenotype after the colony's relocation?
Options:
A: A decrease in Clostridium in female mice occurs only after the protective phenotype has fully reemerged post-relocation.
B: Periods of high Bacteroides/Clostridium ratio in female mice receiving male cecal transplants are temporally associated with disease suppression.
C: The reemergence of the protective phenotype after two years in the new facility is independent of any changes in gut microbiota composition.
D: An increase in Bacteroides and presence of Alistipes in female mice must precede the suppression of kidney disease after male cecal transplant.

Q450: Considering the temporal sequence of events following bacterial antigen exposure in human peripheral blood mononuclear cell (PBMC) cultures, which of the following steps would occur after the initial bacterial stimulation but before the observed increase in BDNF levels, and which would be expected to occur later in the regulatory cascade involving monocyte-platelet aggregates and BDNF secretion?
Options:
A: Alteration of BDNF levels in PBMC cultures is the earliest event immediately following bacterial antigen exposure.
B: Reduction of monocyte-platelet aggregates by positive magnetic separation of monocytes occurs before bacterial stimulation.
C: Elevated platelet counts, when combined with bacterial antigen exposure, lead to a later and more pronounced increase in BDNF levels.
D: Formation of monocyte-platelet aggregates occurs after bacterial antigen exposure and precedes the significant increase in BDNF levels.

Q451: Considering the temporal sequence of events in delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) in rats, which of the following occur after the initial increase in hippocampal inflammatory factors (IL-1β, IL-6, and TNF-α) and decreased SCFAs, and are subsequently improved following treatment with either iTBS or SCFAs (acetate and propionate) over a two-week period?
Options:
A: Immediate normalization of SCFA levels prior to any intervention
B: Permanent reduction of inflammatory factors without any intervention
C: Improvement in cognitive dysfunction and anxiety symptoms as assessed by behavioral tests
D: Restoration of dopamine and norepinephrine levels in the hippocampus after SCFA treatment

Q452: Considering the temporal sequence of events in the gut microbiota-brain axis, which of the following processes would most likely occur after a dysbiosis-induced disturbance in the gut microbial composition, and before the manifestation of neurodegenerative disease symptoms, according to the described mechanisms in the context?
Options:
A: Regulation of neurotransmitters by the gut microbiota affecting neural pathways
B: Immediate reversal of neurodegenerative disease symptoms through dietary intervention
C: Permanent eradication of all pathogenic bacteria from the gut microbiome
D: Production of neuroactive substances and inflammatory responses modulated by the altered gut microbiota

Q453: In the context of mild chronic colitis exacerbating intracerebral inflammation in Parkinson's disease (PD) mice, which of the following events occur sequentially after the induction of colitis and contribute to the progression of brain inflammation, as supported by the observed regulatory cascade involving LRRK2, NF-κB, and Nrf2 pathways?
Options:
A: Activation of NF-κB and inhibition of Nrf2 in the brain follow the upregulation of LRRK2 expression, contributing to dopaminergic neuron loss.
B: Increased Iba-1 expression in the brain precedes the upregulation of LRRK2 in the colon.
C: Reduction in intestinal barrier proteins ZO-1 and Occludin occurs after the increase in inflammatory cytokines IL1-β and TNF-α in the colon.
D: Upregulation of LRRK2 expression in both the colon and brain precedes NF-κB activation and Nrf2 inhibition in the brain.

Q454: Considering the temporal sequence of events in APP/PS1 mice, which of the following changes occur after a decrease in short-chain fatty acids (SCFAs) and precede the improvement observed with manual acupuncture or probiotics? Select all that apply.
Options:
A: A decrease in FFAR3 expression and impaired intestinal barrier integrity
B: An increase in cognitive ability and restoration of SCFAs levels
C: Benign modulation of gut microbiota dysbiosis by manual acupuncture
D: An increase in NF-κB expression and elevated intestinal IL-1β and TNF-α levels

Q455: Considering the temporal sequence of events in OVA-induced food allergy mice, which of the following processes are observed to occur after the initial immune sensitization and are associated with subsequent neurobehavioral changes, according to the described multi-step pathway involving gut microbiota, metabolic disruption, and neural inflammation?
Options:
A: Elevated levels of TNF-α, IL-1β, and IL-6 in the prefrontal cortex, along with microglial activation, following changes in gut microbiota and amino acid metabolism.
B: Immediate improvement in spatial memory and social behavior prior to any alteration in gut microbiota composition.
C: Disruption of amino acid metabolism, particularly carboxylic acids and derivatives, correlated with altered gut microbiota abundance after OVA sensitization.
D: Suppression of Th2 signature cytokine levels and allergy-related antibodies before the onset of anaphylactic symptoms.

Q456: Based on the described molecular cascade in APP/PS1 mice, which of the following events occur after the gut microbiota-derived Indoles upregulate aryl hydrocarbon receptor (AhR) production, but before the restoration of synaptic plasticity and cognitive function? Select all that apply.
Options:
A: Initial accumulation of Aβ and Tau hyperphosphorylation
B: Promotion of Indoles-producing bacterial populations in the gut
C: Reduction in the release of inflammatory cytokines such as TNF-α, IL-6, IL-1β, and IL-18
D: Inhibition of the NF-κB signaling pathway and suppression of NLRP3 inflammasome formation

Q457: Considering the temporal sequence of events following long-term exposure (12 weeks) to microplastics (MPs) released from polypropylene (PP) cutting boards in mice, which of the following changes are observed as downstream consequences after the initial increase in serum LPS and inflammatory cytokines, and which occur later in the biological hierarchy, such as at the level of intestinal barrier function or gene expression?
Options:
A: Elevated levels of IL-1β, TNF-α, MDA, SOD, and MLCK in the ileum and colon tissues
B: A significant decrease in the relative expression of Occludin and Zonula occludens-1 in the ileum and colon
C: A rapid increase in fecal and liver metabolites within hours of MP exposure
D: An immediate alteration in the relative abundance of Firmicutes and Desulfobacterota in the gut microbiota

Q458: Considering the temporal sequence of molecular and cellular events described in the context of glaucoma, which of the following processes occur after gut dysbiosis leads to reduced tryptophan-metabolizing bacteria, and before the preservation of visual function in experimental models? Select all that apply.
Options:
A: Dietary interventions, such as symbiotic supplementation, directly increase retinal ganglion cell (RGC) survival in glaucoma models.
B: Lower systemic indoleacetic acid (IAA) levels are observed following fecal microbiota transplantation from glaucoma patients.
C: Restoration of AhR activation and suppression of microglial activation occur after administration of B. fragilis or IAA.
D: Genetic variations in chaperone genes immediately precede the reduction of retinal inflammation in glaucoma.

Q459: Considering the temporal sequence of events during morphine self-administration in rodents, which of the following statements accurately describes the progression from baseline through acute and chronic phases, particularly regarding the relationship between gut microbiota changes and brain MRI findings?
Options:
A: Early changes in gut microbiota diversity and abundance are detectable in the acute phase and persist into the chronic phase.
B: MRI and gut microbiota changes occur simultaneously, with no evidence of one preceding the other during morphine self-administration.
C: Alterations in brain MRI diffusivity indices in the striatum and thalamus are observed before any changes in gut microbiota.
D: Gut microbiota changes precede the MRI-detectable effects in the brain, suggesting a temporal order in the gut-brain axis response.

Q460: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after gut dysbiosis leads to increased gut permeability, but before the onset of neuroinflammation and progression of neurological disorders such as Alzheimer's disease, according to the context provided?
Options:
A: Increased production of neurotoxic metabolites via the dysregulated kynurenine pathway
B: Translocation of toxins and bacteria into systemic circulation, triggering widespread inflammation
C: Restoration of microbial balance through dietary interventions and probiotics
D: Amyloid deposition and tauopathy in the central nervous system

Q461: Considering the multi-step processes described in the context, which of the following events would most likely occur after microbiota-released extracellular vesicles (MEVs) cross the intestinal barrier but before they influence brain functionality, and which would occur after MEVs reach the brain? Select all that apply.
Options:
A: MEVs are endocytosed by Caco-2 and hCMEC/D3 cells following their paracellular transport across host barriers.
B: MEVs directly alter the expression of genes related to intestinal barrier integrity before crossing the intestinal barrier.
C: MEVs deliver neuroactive metabolites to the brain after traversing the blood-brain barrier, potentially influencing mental and behavioral outcomes.
D: MEVs are released by Bacteroides finegoldii with high GABA content prior to any interaction with host cellular barriers.

Q462: Considering the temporal sequence of events following cerebral ischemia/reperfusion (I/R) injury in the rat model, which of the following processes are reported to occur after the initial brain injury and are subsequently modulated by Polygoni Multiflori Radix Praeparata polysaccharides (PMP) intervention, according to the described gut-brain axis mechanisms?
Options:
A: Initial improvement in tight junction protein expression in the intestine before any changes in the brain are detected.
B: Altered intestinal short-chain fatty acid (SCFA) and amino acid metabolism following I/R injury, with subsequent normalization after PMP administration.
C: Immediate restoration of beneficial gut microbiota abundance prior to any observable neurological improvement.
D: Disruption of the gut barrier and increased inflammatory cytokines in both brain and intestinal tissues, which are later alleviated by PMP treatment.

Q463: Based on the described studies, which of the following events occur after the administration of gingerol-enriched ginger (GEG) in the spinal nerve ligation (SNL) model of neuropathic pain in female rats, and are temporally downstream of changes in gut microbiome composition? Select all that apply.
Options:
A: Mitigation of pain-associated behaviors, such as decreased mechanical hypersensitivity and anxiety-like behavior.
B: Initial decrease in gut microbiome diversity before any behavioral or molecular changes are observed.
C: Immediate upregulation of neuropathology genes in the amygdala prior to any changes in gut microbiota.
D: Altered levels of specific fecal metabolites, including increased hydrophilic positive metabolites and decreased hydrophilic negative metabolites.

Q464: Considering the multi-step processes described in the context, which of the following sequences accurately reflects the temporal and hierarchical progression by which gut microbiota-derived extracellular vesicles (MEVs) may influence brain function, starting from their release in the gut to their potential impact on neural pathways?
Options:
A: MEVs are released by gut microbiota, cross host cellular barriers, are endocytosed by epithelial and brain endothelial cells, and deliver GABA and other neuroactive compounds to distant organs including the brain.
B: MEVs are released by gut microbiota, immediately induce apoptosis in intestinal epithelial cells, and are degraded before reaching systemic circulation.
C: MEVs are released by gut microbiota, directly alter gene expression related to intestinal barrier integrity, and remain localized within the gut.
D: MEVs are released by gut microbiota, cross the intestinal barrier, enter systemic circulation, traverse the blood-brain barrier, and deliver neuroactive metabolites to the brain.

Q465: Considering the temporal sequence of events described in rodent models of morphine self-administration, which of the following statements accurately reflect the order and progression of changes observed in the gut-brain axis, particularly regarding the timing of gut microbiota alterations and brain MRI findings during acute and chronic phases?
Options:
A: Gut microbiota changes occur prior to the main MRI-detected effects in the striatum and thalamus during morphine self-administration.
B: MRI and gut microbiota changes occur simultaneously at the baseline (naïve, nondrug state) before morphine exposure.
C: Alterations in brain MRI diffusivity indices in the striatum and thalamus are observed before any changes in gut microbiota are detected.
D: Early changes in gut microbiota diversity and abundance are detected during the acute phase and persist into the chronic phase.

Q466: Considering the temporal sequence of events in the gut microbiota-immune system-brain axis, which of the following processes would most likely occur after a shift in gut microbial composition but before the manifestation of neuropsychiatric or neurodegenerative symptoms, according to the described regulatory cascades and feedback mechanisms?
Options:
A: Immediate reversal of established neurobehavioral deficits without intermediary molecular changes
B: Epigenetic modifications in neural or immune cells influenced by gut-derived metabolites
C: Onset of clinical neuropsychiatric symptoms as the initial event in the cascade
D: Altered production of microbial metabolites that modulate immune cell activity and neuroinflammation

Q467: Considering the temporal sequence of events in APP/PS1 mice subjected to early social isolation, which of the following changes are observed prior to the therapeutic intervention with oxytocin, and which are subsequently mitigated following oxytocin administration, according to the described experimental timeline and mechanistic findings?
Options:
A: Increased Aβ plaque deposition and aberrant microglial proliferation are observed only after oxytocin intervention.
B: Early social isolation leads to decreased oxytocin levels and upregulated oxytocin receptor expression before oxytocin intervention.
C: Social isolation-induced changes in gut microbiota composition occur before oxytocin intervention and are partially restored after oxytocin treatment.
D: Oxytocin intervention precedes the onset of anxiety-like behaviors and depression-like phenotypes in APP/PS1 mice.

Q468: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an acute administration of cannabis essential oil (CEO) but before the potential cognitive impairment associated with chronic CEO use, according to the described regulatory cascades and feedback mechanisms?
Options:
A: Reduction of gut inflammation and decreased gut permeability due to CEO’s acute effects
B: Immediate restoration of cognitive function following CEO administration
C: Alteration of gut microbiota composition resulting from chronic CEO exposure
D: Modulation of cannabinoid receptors (CBR1 and CBR2) affecting gut motility and neurotransmission

Q469: In the dual-hit mouse model combining DSS-induced colitis and MPTP-induced Parkinson's disease, which of the following events occur sequentially after the initial upregulation of LRRK2 expression in both the colon and brain, and how do these events contribute to the exacerbation of intracerebral inflammation over time?
Options:
A: Rapid recovery of dopaminergic neurons in the substantia nigra following LRRK2 upregulation.
B: Immediate restoration of intestinal barrier integrity through increased ZO-1 and Occludin expression.
C: Elevation of inflammatory cytokines such as IL1-β and TNF-α, correlating with reduced barrier proteins and increased brain inflammation.
D: Activation of NF-κB pathway and inhibition of Nrf2 pathway in the brain, leading to increased inflammation.

Q470: Based on the described studies, which of the following events are likely to occur sequentially after the initiation of time-restricted feeding (TRF) in Alzheimer's disease models, ultimately leading to improved cognitive function? Consider the temporal progression from gut microbiota modulation to molecular and behavioral outcomes as supported by the context.
Options:
A: TRF increases B. pseudolongum abundance, which elevates propionic acid production, subsequently activating FFAR3 and resulting in cognitive improvement.
B: TRF first reduces amyloid-beta deposition in the brain, which then alters gut microbiota composition, leading to increased propionic acid production.
C: TRF directly enhances FFAR3 expression in the brain, which then increases B. pseudolongum abundance in the gut, leading to higher propionic acid levels.
D: Oral supplementation with B. pseudolongum or propionic acid mimics the effects of TRF by increasing propionic acid levels, which cross the blood-brain barrier and contribute to cognitive benefits.

Q471: Considering the temporal sequence of events in the context of fecal microbiota transplantation (FMT) for neurological disorders, which of the following changes are expected to occur after the restoration of microbial composition and functionality, and before the improvement of cognitive function or suppression of neuroinflammation in post-stroke or Alzheimer's disease models?
Options:
A: Immediate upregulation of synaptic markers such as PSD-95 and synapsin-1 prior to any changes in inflammation
B: Increase in Bcl-2 expression and decrease in Bax expression as part of neuroprotective mechanisms
C: Accumulation of amyloid-β in the brain as an early effect of FMT
D: Amelioration of inflammatory responses through decreased IL-17 and IFN-γ expression

Q472: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an increase in gut permeability but before the manifestation of neuropsychiatric symptoms, according to the described mechanisms involving the kynurenine pathway and inflammation?
Options:
A: Resolution of neuropsychiatric symptoms through dietary intervention
B: Immediate restoration of gut microbiome balance by short-chain fatty acid-producing bacteria
C: Triggering of systemic inflammation and subsequent neuroinflammation
D: Activation of the kynurenine pathway leading to increased production of neuroactive and neurotoxic metabolites

Q473: Considering the temporal sequence of events following bariatric surgery, which of the following changes are expected to occur in the early post-surgical phase and subsequently contribute to long-term metabolic health improvements through hierarchical regulation involving gut microbiota, hormone modulation, and brain function?
Options:
A: A reduction in ghrelin levels occurs early, leading to enhanced satiety and decreased caloric intake.
B: An increase in beneficial gut microbiota species such as Akkermansia muciniphila influences metabolic pathways via short-chain fatty acid production and bile acid metabolism.
C: Long-term metabolic health improvements are achieved before any modulation of appetite-regulating hormones takes place.
D: Structural and functional changes in brain regions involved in reward processing precede any alterations in gut microbiota composition.

Q474: Considering the temporal progression of gut microbiota changes after spinal cord injury (SCI), which of the following statements accurately describe the sequence of microbial abundance shifts from the subacute to the chronic phase, and their potential impact on short-chain fatty acid (SCFA) production over time?
Options:
A: Firmicutes abundance increases from the subacute to the chronic phase of SCI.
B: The chronic phase of SCI is characterized by a lower abundance of potential SCFA-producing bacteria compared to the subacute phase.
C: In the subacute phase of SCI, the relative abundance of SCFA-producing genera such as Faecalbacterium and Ruminococcus is higher than in the chronic phase.
D: Gut dysbiosis is only present in the chronic phase of SCI and not in the subacute phase.

Q475: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after a disruption in gut microbiota composition (dysbiosis) but before the manifestation of chronic inflammation-related metabolic disorders, according to the described hierarchical and regulatory pathways?
Options:
A: Restoration of microbial balance through probiotic or prebiotic intervention
B: Increased intestinal permeability and compromised epithelial barrier integrity
C: Altered levels and activity of inflammatory biomarkers such as CRP, IL-6, and LPS due to dysbiosis
D: Clinical diagnosis of type 2 diabetes or non-alcoholic fatty liver disease

Q476: Considering the temporal sequence of events in APP/PS1 mice, which of the following changes are observed after manual acupuncture (MA) intervention, and which of these changes occur prior to the improvement in cognitive ability? Select all that apply.
Options:
A: An increase in short-chain fatty acids (SCFAs) and FFAR3 expression in the intestine.
B: A significant reduction in the expression of NF-κB and levels of intestinal IL-1β and TNF-α.
C: Alleviation of destruction of the intestinal mucosal barrier.
D: Initial decrease in cognitive ability compared to control mice.

Q477: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after the initial onset of gut microbiota dysbiosis but before the manifestation of neurodegenerative symptoms such as cognitive decline or motor dysfunction in diseases like Alzheimer's or Parkinson's?
Options:
A: Clinical implementation of non-invasive urinary metabolite profiling for disease monitoring
B: Restoration of microbial homeostasis through antioxidant delivery by probiotics
C: Increased intestinal permeability and production of virulence factors by gut microorganisms
D: Accumulation of oxidative damage and neuroinflammation in the central nervous system

Q478: Considering the temporal sequence of events in the development of ARDS-related depression, which of the following steps must occur before the alleviation of depressive-like behaviors by Akkermansia muciniphila or its metabolite propionic acid, according to the described mechanistic pathway in the context?
Options:
A: Alterations in gut microbiota composition and reduction in Akkermansia muciniphila abundance
B: Immediate restoration of intestinal barrier function prior to any changes in gut microbiota
C: Microglial activation and increased neuronal inflammation following fecal transplantation from ARDS patients
D: Direct improvement of depressive-like behaviors without changes in microglial activation

Q479: Considering the temporal sequence of events in herpes simplex encephalitis (HSE) as described in the context, which of the following processes occur after HSV-1 infection but before the administration of exogenous nicotinamide n-oxide (NAMO), and are directly involved in the progression of neuroinflammation via the microbiota-gut-brain axis?
Options:
A: Mitochondrial dysfunction and impaired mitophagy activate microglia and promote proinflammatory cytokine production.
B: NAMO restores NAD+-dependent mitophagy to restrain microglial over-activation.
C: HSV-1 infection causes gut microbiota dysbiosis and microglial antiviral immune response.
D: Exogenous administration of NAMO significantly suppresses HSE progression.

Q480: Considering the temporal sequence of events in the gut-brain axis as described in the context, which of the following processes would most likely occur after an initial disruption in gut microbiota composition, and before the manifestation of cognitive or behavioral symptoms in neuropsychiatric or neurodegenerative disorders?
Options:
A: Immediate restoration of microbial balance through dietary intervention
B: Alteration of neurotransmitter synthesis and signaling in the brain
C: Activation of immune and inflammatory pathways leading to neuroinflammation
D: Onset of clinical symptoms such as cognitive decline or behavioral impairments

Q481: Considering the temporal sequence of events in rodents trained to self-administer morphine, which of the following statements accurately reflects the order and persistence of changes observed in the gut microbiota and brain, as measured by MRI and 16s rDNA analysis, from baseline through acute and chronic phases?
Options:
A: Gut microbiota changes precede the MRI-detected effects in the striatum and thalamus during morphine self-administration.
B: Early changes in gut microbiota diversity and abundance are detected in the acute phase and persist into the chronic phase.
C: Alterations in MRI diffusivity indices in the striatum and thalamus are observed before any changes in gut microbiota are detected.
D: MRI and gut microbiota changes occur simultaneously at the baseline (naïve, nondrug) state.

Q482: Considering the temporal sequence of events described in the context, which of the following processes would occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors to Alzheimer's disease (AD) mice, but before the observed improvement in learning and memory abilities? Select all that apply.
Options:
A: An increase in short-chain fatty acids (SCFAs) levels in the gut of recipient AD mice.
B: A reduction in the secretion of interleukin (IL)-1β and tumor necrosis factor (TNF)-α by immune-stimulated microglia-like cells in vitro.
C: Activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1 in the recipient AD mice.
D: The reversal of the reduction in SCFAs induced by AD in the recipient mice.

Q483: Considering the temporal sequence of events in Parkinson's disease pathogenesis, which of the following processes are likely to occur after perturbations in gut microbiota composition but before the progressive loss of dopaminergic neurons in the substantia nigra? Select all that apply.
Options:
A: Neuroinflammation involving microglial activation
B: Restoration of microbiota-gut-brain axis functions through modulation of tryptophan metabolite levels
C: Activation of microglia cells and heightened production of proinflammatory cytokines
D: Differential abundance of gut microbiome features associated with cerebrospinal fluid biomarkers for Alzheimer's disease

Q484: Based on the context, which of the following molecular effects are directly associated with Polygoni Multiflori Radix Praeparata polysaccharides (PMP) intervention in ischemic stroke models?
Options:
A: PMP lowers the levels of inflammatory cytokines such as TNF-α and IL-1β.
B: PMP directly inhibits the abundance of Bifidobacterium in the gut microbiota.
C: PMP increases the levels of short-chain fatty acids (SCFAs) such as butyrate and propionate in the intestine.
D: PMP reduces the abundance of beneficial amino acids in the intestine.

Q485: Based on the context, which of the following molecular effects are directly modulated by dysbiosis in relation to inflammatory biomarkers and intestinal barrier integrity?
Options:
A: Dysbiosis directly modulates the levels and activity of C-reactive protein (CRP).
B: Dysbiosis directly modulates the levels and activity of interleukin-6 (IL-6).
C: Dysbiosis directly upregulates the synthesis of histone fold proteins in neurons.
D: Dysbiosis directly inhibits the production of short-chain fatty acids (SCFAs) by microglia.

Q486: Based on the provided context, which of the following molecular effects are directly associated with short-chain fatty acid (SCFA) administration in the context of Japanese encephalitis virus (JEV) infection in mice?
Options:
A: Downregulation of inflammatory cytokines such as TNF-α, MCP-1, IL-6, and IFN-Υ
B: Upregulation of phospho-NF-kB (P-NF-kB) and iba1 in SCFA-supplemented JEV-infected mice compared to JEV-infected controls
C: Reduced glial activation as indicated by decreased microglial counts in SCFA-supplemented JEV-infected mice
D: Increased caspase-3 expression in SCFA-supplemented JEV-infected mice compared to JEV-infected controls

Q487: Based on the provided context, which of the following statements correctly describe direct molecular effects involving gut microbiota, steroids, or metabolites in the gut-microbiota-brain axis or Parkinson's disease?
Options:
A: Gut microbiota is involved in the production of steroids in the gastrointestinal tract.
B: Trimethylamine N-oxide (TMAO) directly activates dopamine synthesis in Parkinson's disease patients.
C: Gut microbiota functions like a virtual endocrine organ and is involved in steroid metabolism.
D: Succinic acid directly inhibits the synthesis of corticosteroids in the adrenal glands.

Q488: Based on the context, which of the following statements describe direct molecular effects of short-chain fatty acids (SCFA) or gut microbiota on host physiology or disease processes?
Options:
A: SCFA ameliorates immuno-inflammation, which is a causative factor of metabolic syndrome.
B: Gut microbiota composition is shaped by diet, lifestyle, genetics, and environment.
C: Gut microbiota influences the host's nervous system development through neurotransmitters, immune modulation, and metabolic pathways.
D: SCFA directly causes cardiovascular diseases by altering blood pressure.

Q489: Based on the context, which of the following molecular effects are directly caused by Akkermansia muciniphila or its metabolite propionic acid in ARDS mouse models?
Options:
A: Upregulation of gut dysbiosis
B: Activation of microglial cells leading to increased neuronal inflammation
C: Decrease in microglial activation
D: Inhibition of the Toll-like receptor 4/nuclear factor κB signaling pathway

Q490: Based on the provided context, which of the following statements describe direct molecular effects of gut microbiome alterations on systemic inflammation or immune responses in pulmonary arterial hypertension or heart failure?
Options:
A: Gut microbiome changes directly upregulate endothelial dysfunction in heart failure.
B: Alterations in the gut microbiome may modify systemic immune responses in pulmonary arterial hypertension.
C: Alterations of the gut microbiome may induce inflammation associated with heart failure.
D: Gut microbiome dysbiosis directly increases the activation of the Renin-Angiotensin-Aldosterone (RAAS) axis.

Q491: Based on the context, which of the following statements correctly describe direct molecular effects involving matrix metalloproteinases (MMPs) or gut microbiota on host processes?
Options:
A: B lymphocytes directly upregulate matrix metalloproteinase (MMP) expression in the gut.
B: Gut microbiota directly inhibit matrix metalloproteinase (MMP) activity in all tissues.
C: Matrix metalloproteinases (MMPs) regulate extracellular matrix (ECM) remodeling.
D: Matrix metalloproteinases (MMPs) contribute to compromised barrier integrity during dysbiosis.

Q492: Based on the context, which of the following statements describe direct molecular effects of gut microbiota or their metabolites on neurodegenerative disorder pathology?
Options:
A: Gut microbiota dysbiosis leads to changes in the production of short-chain fatty acids (SCFAs).
B: Differentially abundant gut microbiome features are associated with cerebrospinal fluid biomarkers of Alzheimer's disease.
C: Alzheimer's disease pathology is caused solely by changes in gut microbiome composition.
D: Short-chain fatty acids (SCFAs) always inhibit the gut-brain axis communication.

Q493: Based on the context, which of the following statements describe direct molecular or microbial effects involved in the modulation of disease or neuro-cancer interactions by gut microbiota or their metabolites?
Options:
A: Gut microbiota composition with high Bacteroides and low Clostridium is associated with suppression of kidney disease in female BWF1 mice.
B: Indoles and polyamines are novel metabolites from gut microbiota with potential implications for neurobiology and cancer.
C: Short-chain fatty acids (SCFAs) are key metabolites produced by gut microbiota that modulate systemic processes influencing brain health and tumorigenesis.
D: Dietary changes directly increase the abundance of Alistipes in the gut microbiota of all mice.

Q494: Based on the context, which of the following molecular effects are directly attributed to alterations in gut microbiota composition within the gut-brain axis?
Options:
A: Alterations in gut microbiota composition can increase gut permeability.
B: Alterations in gut microbiota composition can trigger inflammation.
C: Alterations in gut microbiota composition directly inhibit the central nervous system.
D: Alterations in gut microbiota composition suppress the kynurenine pathway.

Q495: Based on the context, which of the following molecular effects are directly associated with upregulated LRRK2 expression in the brain of mice with Parkinson's disease and colitis?
Options:
A: Inhibition of Nrf2 pathway
B: Increase in serotonin production in the gut
C: Upregulation of ZO-1 expression
D: Activation of NF-κB pathway

Q496: Based on the provided context, which of the following molecular effects are directly attributed to polyphenol microbial metabolites (PMMs) in murine BV-2 microglia exposed to lipopolysaccharide-induced inflammation?
Options:
A: PMMs exhibit protective effects against pro-inflammatory cytokines (IL-6 and TNF-α) in BV-2 microglia.
B: PMMs exhibit protective effects against nitric oxide production in BV-2 microglia.
C: PMMs inhibit the permeability of the blood-brain barrier.
D: PMMs increase the production of pro-inflammatory cytokines IL-6 and TNF-α in BV-2 microglia.

Q497: Based on the provided context, which of the following molecular mechanisms are directly involved in the progression of neurodegenerative diseases related to biofilm-associated amyloid proteins?
Options:
A: Bile acids directly upregulate the production of α-synuclein in neurons.
B: Bacterial amyloids accelerate the misfolding and aggregation of human amyloidogenic proteins.
C: Short-chain fatty acids directly inhibit the formation of biofilm-associated amyloid proteins.
D: Bacterial amyloids can overwhelm molecular chaperones and heat shock proteins, worsening neuronal damage.

Q498: Based on the context, which of the following molecular factors are described as virulence factors produced by microorganisms that can contribute to neurodegenerative diseases such as Alzheimer's and Parkinson's?
Options:
A: Curli proteins
B: Short-chain fatty acids (SCFAs)
C: LPS
D: Vagus nerve signaling

Q499: Based on the context provided, which of the following molecular entities are directly modulated by alterations in the gut microbiota, particularly in relation to inflammatory responses and intestinal barrier integrity?
Options:
A: Acetylcholinesterase
B: Interleukin-6 (IL-6)
C: Dopamine receptors
D: C-reactive protein (CRP)

Q500: Based on the context, which of the following molecular effects are directly associated with alterations in gut microbiota composition on astrocyte biology and neuroinflammation?
Options:
A: Altered gut microbiota can increase GFAP expression in astrocytes.
B: Altered gut microbiota directly suppresses tryptophan metabolism via the kynurenine pathway.
C: Altered gut microbiota can compromise gut barrier integrity, leading to increased GFAP expression.
D: Altered gut microbiota directly inhibits the production of all neuroprotective kynurenine metabolites.

Q501: Based on the provided context, which of the following statements best integrate the mechanisms by which gut dysbiosis and intestinal barrier damage contribute to both neurodegenerative and psychiatric disorders, and how therapeutic interventions targeting the gut microbiota may impact these conditions?
Options:
A: Damage to the intestinal barrier from addictive substance use disorder has no effect on the gut-brain axis or cognitive function.
B: Altered gut microbiota composition only affects gastrointestinal symptoms and does not influence central nervous system function or psychiatric outcomes.
C: Gut dysbiosis and intestinal barrier damage allow harmful substances and pathobionts to enter the circulation, leading to immune activation and neuroinflammation, which can contribute to both neurodegenerative diseases and mood disorders.
D: Therapeutic strategies such as probiotic supplementation, dietary fiber intervention, and fecal microbial transplantation can remodel the gut microbiota, potentially improving neuronal mitochondrial function and alleviating symptoms in both depression and neurodegenerative diseases.

Q502: Based on the provided context, which options best illustrate how alterations in gut microbiota composition can influence both immune and neurobiological functions, integrating mechanisms described in bariatric surgery and Long COVID, as well as SCFA-mediated microglial regulation?
Options:
A: Long COVID is characterized by increased beneficial short-chain fatty acid-producing bacteria, which directly stimulate appetite-regulating hormones and improve neuroimaging outcomes in brain regions involved in reward processing.
B: Gut dysbiosis in Long COVID leads to decreased SCFA-producing bacteria, resulting in reduced SCFA levels that may impair microglial regulation and contribute to neuroinflammation and altered serum cortisol levels via gut-brain axis dysregulation.
C: Bullous pemphigoid and pemphigus vulgaris are caused exclusively by depletion of Akkermansia muciniphila, which directly increases the secretion of appetite-regulating hormones and causes blisters.
D: Bariatric surgery increases beneficial gut species such as Akkermansia muciniphila, which enhance short-chain fatty acid production, thereby influencing metabolic pathways and potentially modulating microglial immune functions through reduced secretion of pro-inflammatory cytokines.

Q503: Based on the provided context, which options best illustrate how advances in sequencing and metabolite profiling technologies have enabled the development of omics-based diagnostics or interventions that integrate both microbial composition and metabolite changes in disease states such as colorectal cancer and radiation-induced injury?
Options:
A: Sequencing technologies are only useful for identifying bacterial taxa in colorectal cancer, but do not contribute to understanding metabolite changes in radiation-induced injury.
B: In colorectal cancer, advances in sequencing and metabolite profiling have allowed identification of CRC-associated bacterial taxa and their metabolites, which can be used as predictive features for diagnosis, while similar technologies have enabled the recognition of gut microbiota-derived metabolites as biomarkers for radiation injuries.
C: Metabolite profiling is exclusively relevant to colorectal cancer diagnostics and has no application in the context of radiation-induced injury or its interaction with the gut microbiota.
D: Both colorectal cancer and radiation-induced injury benefit from omics approaches that integrate microbial community shifts and metabolite alterations, facilitating the development of diagnostics and interventions such as probiotics and fecal microbiota transplantation.

Q504: Based on the provided context, which of the following statements best integrate information about the role of gut microbiota and its metabolites in both neuroinflammatory and cardiovascular diseases, and the potential for targeted interventions across these conditions?
Options:
A: Alterations in gut microbiota can contribute to both heart failure through inflammatory mechanisms and neuroinflammatory diseases like multiple sclerosis and Alzheimer's disease, suggesting that interventions targeting the microbiome may have cross-disease therapeutic potential.
B: Microbiome homeostasis, influenced by factors such as diet and environment, is important for immune regulation and metabolic product production, which is relevant to both the progression of multiple sclerosis and the inflammatory environment in heart failure.
C: The context supports that gut microbiota interventions are effective exclusively in neurodegenerative diseases and have no relevance to cardiovascular conditions like heart failure.
D: Only dietary modifications, but not probiotics or other microbiota-targeted interventions, have been shown to influence both cognitive impairment and heart failure according to the context.

Q505: Based on the provided context, which of the following statements best illustrate how the interplay between the gut microbiome and systemic inflammation can influence both metabolic-associated fatty liver disease (MAFLD) and neurodegenerative disorders, and how emerging therapeutic strategies may target these mechanisms?
Options:
A: The only effective intervention for both MAFLD and neurodegenerative diseases is the use of nanotechnology-based drug delivery systems to bypass the blood-brain barrier.
B: Gut microbiota dysbiosis can increase intestinal permeability and promote the translocation of bacterial products, leading to liver inflammation in MAFLD and potentially contributing to neuroinflammatory responses implicated in neurodegenerative diseases.
C: Genetic mutations are the sole cause of both MAFLD and neurodegenerative diseases, and gut microbiota has no significant role in their pathogenesis or treatment.
D: Microbiome-targeted therapies, such as fecal microbiota transplantation, are being explored to modulate the gut-brain axis, with the aim of reducing neuroinflammatory responses in neurodegenerative diseases and addressing liver inflammation in MAFLD.

Q506: Based on the provided context, which options best illustrate how gut microbiota-targeted interventions can influence both neuroinflammatory processes and clinical outcomes across different neurological disorders, integrating mechanisms and therapeutic strategies described for schizophrenia and Alzheimer's disease?
Options:
A: Restoring microbial balance through fecal microbiota transplantation from healthy donors can attenuate neuroinflammation and improve cognitive function in both schizophrenia and Alzheimer's disease, as shown by reduced pro-inflammatory cytokines and improved behavioral outcomes.
B: Gut microbiota-targeted therapies are only effective in reducing amyloid-beta pathology in Alzheimer's disease and have no impact on neuroinflammation or clinical symptoms in schizophrenia.
C: Microbiota-targeted interventions, such as probiotics, prebiotics, and dietary changes, can improve clinical outcomes in schizophrenia by modulating neurotransmitter synthesis and immune responses, similar to how fecal transplantation from healthy donors reduces neuroinflammation and cognitive deficits in Alzheimer's disease.
D: Colitis-associated dysbiosis leads to improved cognitive function and reduced neuroinflammation in Alzheimer's disease, which is also observed in schizophrenia when gut microbiota are disrupted.

Q507: Considering the interplay between oxidative stress, gut dysbiosis, and neurodegenerative diseases, which of the following statements best integrates the mechanisms by which antioxidants and gut microbiota-targeted interventions may influence neuroinflammation and neuronal survival in the context of the gut-brain axis?
Options:
A: Antioxidants act solely within the central nervous system to prevent neurodegeneration, independent of any changes in gut microbiota or gut-derived metabolites.
B: Gut dysbiosis only affects gastrointestinal symptoms and does not contribute to neuroinflammation or neurodegenerative disease progression.
C: Antioxidants can reduce neuroinflammation and promote neuronal survival by modulating gut microbiota composition, thereby decreasing oxidative stress and influencing key molecular pathways such as NF-κB and Nrf2 in both the gut and brain.
D: Microbiota-targeted interventions, such as probiotics and prebiotics, can restore microbial homeostasis, leading to increased production of short-chain fatty acids that attenuate neuroinflammation and oxidative damage in neurodegenerative diseases.

Q508: Based on the provided context, which of the following statements best integrate mechanisms and therapeutic potentials involving the gut-brain axis, immune modulation, and neuropsychiatric disorders, demonstrating how interventions may target multiple pathways for improved outcomes?
Options:
A: The immune system does not play a significant role in the communication between the gut microbiota and the brain, and thus is not relevant to neuropsychiatric clinical interventions.
B: SSRIs and SNRIs only exert antidepressant effects through monoamine modulation and do not influence inflammatory pathways or the gut-brain axis.
C: Probiotics and fecal microbiota transplantation, by targeting specific microbial populations and their metabolites, can regulate neuroinflammation and neural barrier integrity, offering individualized treatment options for neurodegenerative diseases.
D: Dietary interventions that restore gut microbial composition in ASD may also modulate immune responses and enhance metabolic function, thereby influencing neurodevelopment and behavioral regulation via the microbiota-gut-brain axis.

Q509: Based on the provided context, which interventions for Alzheimer's disease progression involve both modulation of gut microbiota composition and direct impact on neuroinflammatory or neurodegenerative pathways, and what evidence supports their therapeutic potential?
Options:
A: Antibiotics-induced dysbiosis consistently improves cognitive function in Alzheimer's disease by enhancing beneficial microbial metabolites.
B: Synthetic microbial communities have been conclusively proven to reverse amyloid-β and tau pathology in Alzheimer's disease.
C: Dietary patterns such as the Mediterranean diet can modulate gut microbiota composition and reduce neuroinflammation, offering neuroprotection in Alzheimer's disease.
D: Fecal microbiota transplantation (FMT) restores microbial balance and reduces neuroinflammatory markers, showing promise in alleviating cognitive deficits in Alzheimer's disease.

Q510: Based on the provided context, which interventions demonstrate both mechanistic and outcome-based benefits by modulating gut microbiota to influence neurological or autoimmune disease progression, and what evidence supports their efficacy across different life stages or disease models?
Options:
A: Caloric restriction mimetics improve gut microbiota composition and metabolite production, supporting gut-brain axis function and extending lifespan, particularly benefiting age-related neurodegenerative disorders.
B: Gut microbiota interventions are only effective in early life stages and have no impact on neurodegenerative or autoimmune diseases in adulthood.
C: Male cecal microbiota transplantation into female BWF1 mice suppresses lupus progression, with efficacy linked to specific bacterial populations such as high Bacteroides/Clostridium ratio and presence of Alistipes.
D: Probiotic supplementation with Bifidobacterium and Lactobacillus strains is conclusively proven to cure chronic, treatment-resistant depression by restoring gut microbiota balance.

Q511: Based on the integrated findings from the provided context, which of the following statements best illustrate how targeting both redox homeostasis and gut microbiota could influence neurodegenerative disease progression, and what therapeutic strategies are supported by recent research?
Options:
A: Recent evidence supports that therapies aimed at both redox homeostasis and microbiota modulation may reduce neuroinflammatory responses and offer personalized treatment strategies for neurodegenerative conditions.
B: Focusing solely on antioxidant supplementation without considering gut microbiota or epigenetic factors is sufficient to halt neurodegenerative disease progression.
C: There is no evidence that gut microbiota or epigenetic modifications play any role in the pathogenesis or treatment of neurodegenerative diseases.
D: Modulating gut microbiota composition can influence redox balance, and targeting this interplay is supported as a novel therapeutic avenue for neurodegenerative diseases.

Q512: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota modulation and epigenetic changes can influence neurodegenerative disease progression and therapeutic strategies?
Options:
A: Epigenetic modifications induced by environmental factors, including drugs that modulate gut microbiota, can alter neuroinflammatory responses and thus impact the progression of neurodegenerative diseases.
B: Traditional Chinese medicine exclusively targets the DNA methylome without affecting neuroinflammatory cascades or gut microbiota composition.
C: Gut microbiota modulation through probiotic therapy directly reverses all age-related epigenetic changes in the central nervous system, eliminating neuroinflammaging.
D: Research trends show that both the gut microbiota-neuroinflammation relationship and epigenetic mechanisms are central to developing tailored therapeutic strategies for neurodegenerative diseases.

Q513: Based on the provided context, which strategies for promoting neuroprotection in age-related diseases like Parkinson's and Alzheimer's require integration of both immune system modulation and gut microbiota interventions, and how do these approaches mechanistically link to disease outcomes?
Options:
A: Focusing exclusively on environmental variables and mitochondrial dysfunction in Alzheimer's disease, without integrating gut microbiota or immune modulation.
B: Relying solely on small molecule-based inhibition of protein aggregation in Parkinson's disease without considering gut microbiota or immune system involvement.
C: Utilizing immune cells capable of degrading toxic amyloid deposits in the brain of Parkinson's patients, combined with altering the gut microbiome through probiotics to affect neuroinflammation in Alzheimer's disease.
D: Promoting healthy aging and neuroprotection by combining dietary phytochemicals that nurture a diverse gut microbiota, which in turn produces bioactive metabolites influencing immune function and mitochondrial health.

Q514: Based on the provided context, which options best illustrate how gut microbiota alterations can simultaneously influence both neurological disease progression and therapeutic strategies, requiring integration of mechanisms such as neurotransmitter modulation, epigenetic changes, and metabolite profiles?
Options:
A: Epigenetic modifications driven by gut microbiota and their metabolites can compromise blood-brain barrier integrity, promoting Alzheimer’s and Parkinson’s disease, while dietary and probiotic interventions may target these pathways.
B: Altered gut microbiota after bariatric surgery can mimic profiles seen in neurological disorders, affecting neurotransmitter levels and suggesting that interventions like probiotics may alleviate neurological symptoms.
C: All fecal metabolites increase in progressive multiple sclerosis, indicating an excess of protective factors in the gut.
D: Gut microbiota changes only impact metabolic byproducts in stroke, without influencing immune function or neuroinflammation.

Q515: Based on the integrated information from the context, which of the following statements best describe how gut microbiota and their metabolites can influence both neuroinflammation and systemic immune responses, and how interventions targeting the microbiome may impact diseases such as multiple sclerosis and pulmonary arterial hypertension?
Options:
A: Gut microbiota only affect the central nervous system through direct neural pathways, and do not influence systemic immune responses or diseases like pulmonary arterial hypertension.
B: Alterations in gut microbiota composition can increase gut permeability, leading to systemic inflammation and neuroinflammation, while probiotics may modulate the kynurenine pathway to reduce neuroinflammation.
C: Commensal bacteria and their metabolites can promote regulatory T-cell generation, suppressing inflammation in the CNS, and modifying the gut microbiome may influence the progression of diseases such as multiple sclerosis and pulmonary arterial hypertension.
D: Dietary components have no effect on the secretion of gut microbiota metabolites or on immune regulation in autoimmune diseases.

Q516: Based on the provided context, which options best illustrate how gut microbiome alterations can simultaneously influence neuroinflammation and cognitive or mood outcomes, integrating mechanisms and therapeutic strategies discussed across multiple sections?
Options:
A: Neuroinflammation in neurological disorders is exclusively driven by glial cell activation and is not influenced by gut microbiome composition or metabolites.
B: Therapeutic strategies that modulate the gut microbiota, such as probiotics or immune-modulating therapies, may address both neuroinflammatory processes and neurotransmitter imbalances, offering potential benefits for mood disorders and neurodegenerative conditions.
C: Rubusoside’s anti-inflammatory effects in Parkinson’s disease are limited to reducing microglial activation and do not involve changes in gut microbiota or metabolite composition.
D: An increased abundance of proinflammatory gut bacteria in aged care residents is linked to both heightened neuroinflammation and reduced synthesis of neuroprotective metabolites, suggesting that targeting the microbiome could help prevent cognitive decline.

Q517: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between gut microbiota, redox homeostasis, and neurodegenerative disease progression, and are supported by findings from both systematic reviews and experimental studies?
Options:
A: Therapeutic strategies targeting gut microbiota, such as probiotics or fecal transplantation from healthy donors, can influence both redox balance and cognitive outcomes in neurodegenerative disease models, highlighting the gut-brain axis as a promising intervention point.
B: Epigenetic modifications are the sole determinant of neurodegenerative disease progression, with gut microbiota and oxidative stress playing only minor roles according to the systematic reviews.
C: The primary mechanism by which gut microbiota influences neurodegenerative diseases is through direct repair of neuronal structures, independent of changes in oxidative stress or inflammation.
D: Alterations in gut microbiota composition can modulate oxidative stress and neuroinflammation in neurodegenerative diseases, as shown by both the neuroprotective effects of Bifidobacterium strains and the bidirectional impact of fecal microbiota transplantation on Alzheimer's pathology.

Q518: Based on the provided context, which options best illustrate how microbial virulence factors and gut microbiota composition can influence both neurodegenerative and metabolic diseases through multi-barrier modulation and distal communication mechanisms?
Options:
A: Virulence factors such as LPS and amyloidogenic proteins, when packed into bacterial outer membrane vesicles, can be transported distally, impacting both the blood-brain barrier and contributing to neurodegenerative diseases like Parkinson’s and Alzheimer’s.
B: Alterations in gut microbiota diversity, as seen with intermittent fasting, can influence metabolomic profiles and barrier integrity, which may have implications for both liver health and neurological disorders via the gut-liver and gut-brain axes.
C: Gut microbiota composition only affects metabolic diseases such as MASLD and has no role in neurodegenerative disease progression or barrier function modulation.
D: Virulence factors are exclusively produced by viruses in the gut and do not participate in the modulation of host barrier functions or disease progression.

Q519: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence neurological disorders, and the therapeutic strategies that have been explored to modulate these effects?
Options:
A: Dietary interventions alone are sufficient to fully restore gut microbiota balance and prevent all forms of neuroinflammation in neurological disorders.
B: Manual acupuncture can improve cognitive ability and intestinal barrier function in APP/PS1 mice by modulating gut microbiota dysbiosis, increasing short-chain fatty acids, and downregulating NF-κB-mediated inflammation.
C: The Brain Disease Gut Microbiota Database (BGMDB) only documents associations between gut microbiota and brain diseases without integrating neurotransmitter or genetic data.
D: Pectin-Zein-IPA nanoparticles promote functional recovery after spinal cord injury by altering gut microbiota composition, reducing L-methionine-associated neuroinflammation, and enhancing axonal regeneration via the AKT/Nrf-2 pathway.

Q520: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota alterations can influence both neurodevelopmental and autoimmune skin disorders, and how therapeutic interventions may target these pathways?
Options:
A: Autoantibodies against basement membrane proteins are exclusively linked to gut microbiota composition and do not involve neurobehavioral or cognitive outcomes.
B: The presence of Bacteroides spp. in the gut microbiota is solely associated with the pathogenesis of autoimmune bullous skin diseases and has no relevance to neurobehavioral deficits.
C: Dysbiosis, characterized by reduced beneficial species and increased pro-inflammatory bacteria, is implicated in both neurodevelopmental disorders and autoimmune skin diseases, suggesting that interventions restoring microbial balance may benefit both conditions.
D: Therapeutic strategies such as probiotics or traditional formulations like XiaoYao San can modulate the gut microbiota, leading to improvements in both cognitive function and immune-mediated skin conditions by restoring microbial and metabolic homeostasis.

Q521: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, immune modulation, and therapeutic interventions in neurodegenerative or neurological diseases, specifically highlighting mechanisms that involve both gut and neural outcomes?
Options:
A: Probiotics universally prevent all forms of neurodegeneration by directly increasing the abundance of Bacteroidetes in the adult gut, thereby eliminating proteinopathies in the central nervous system.
B: Vitamin D may help prevent systemic inflammation in multiple sclerosis by supporting regulatory T cell function and maintaining intestinal barrier integrity through its action on the gut microbiota and tight junction proteins.
C: Defective autophagy in neurodegenerative diseases is solely caused by vitamin D deficiency, which directly leads to the accumulation of neurotoxic proteins in the central nervous system.
D: Berberine alleviates kainic acid-induced epileptic seizures in mice by increasing beneficial gut bacteria and regulating short-chain fatty acids, which is associated with changes in both colon and hippocampal lipid metabolism.

Q522: Based on the provided context, which of the following statements best demonstrate how gut microbiota alterations can influence both disease development and therapeutic strategies by integrating mechanisms and outcomes across different physiological systems?
Options:
A: Altered gut microbiota can contribute to impulse control disorders in Parkinson’s disease through changes in specific microbial taxa and metabolic pathways, suggesting microbiome-targeted interventions beyond dopaminergic therapy.
B: The only way gut microbiota affect neurological disorders is by producing neurotransmitters, without involvement of immune or endocrine pathways.
C: Disruptions in gut microbiota composition can impair intestinal anastomotic healing by affecting host immune responses, while targeted microbiota restoration may improve surgical outcomes.
D: Gut microbiota diversity is always higher after menopause, which directly prevents cognitive decline and osteoporosis in women.

Q523: Considering the interplay between gut microbiome composition, neuroinflammation, and neurodegenerative diseases, which of the following statements best integrates mechanisms by which dietary interventions and probiotics may influence brain health and disease outcomes according to the provided context?
Options:
A: Polyphenol-rich diets can upregulate neurotrophin signaling, mitigate neuroinflammatory responses, and enhance synaptic function, while probiotics may exert neuroactive effects via PPAR-mediated regulation of inflammation.
B: Tauopathies are exclusively caused by genetic mutations and are not influenced by changes in the gut microbiome or neuroinflammatory processes.
C: Probiotic interventions targeting gut dysbiosis may restore beneficial short-chain fatty acid-producing bacteria and modulate neuroinflammation through PPARs, potentially alleviating cognitive and mood symptoms associated with neurodegeneration and Long COVID.
D: Long COVID is solely characterized by persistent viral infection in the gut, with no involvement of gut-brain axis dysregulation or changes in microbiome composition.

Q524: Based on the integrated findings from studies of gut microbiota in both autoimmune and neurodegenerative diseases, which of the following statements best reflect how specific changes in microbial composition and targeted interventions can influence disease outcomes and host physiology?
Options:
A: Therapeutic interventions such as microbiome transplantation can restore microbial homeostasis, which is linked to reduced risk of both autoimmune and neurodegenerative diseases due to the microbiota’s role in immune modulation and metabolism.
B: Periods when male cecal transplants suppressed lupus in female BWF1 mice were associated with a high Bacteroides/Clostridium ratio and presence of Alistipes, suggesting that specific bacterial populations can modulate immune-related disease risk.
C: High-fiber diets have been shown to decrease the abundance of beneficial bacteria and are associated with increased risk of metabolic and neurodegenerative diseases.
D: Circadian rhythm disruption consistently increases the abundance of short-chain fatty acid-producing bacteria, which directly suppresses both autoimmune and neurodegenerative diseases.

Q525: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota dysbiosis and systemic inflammation in the progression of neurological and inflammatory diseases, and the potential for therapeutic intervention through microbiota modulation?
Options:
A: Psoriatic arthritis is unrelated to gut microbiota composition, and its treatment does not benefit from any microbiota-based interventions.
B: In both Alzheimer's disease and psoriatic arthritis, gut microbiota dysbiosis is linked to increased systemic inflammation, and interventions such as probiotics or fecal microbiota transplantation are highlighted as potential strategies to modulate disease progression.
C: The bidirectional communication between the gut and brain, involving immune and metabolic pathways, underlies the impact of gut microbiota on both neuroinflammatory responses after stroke and memory impairment in Alzheimer's disease, supporting the use of microbiota-targeted therapies.
D: Alzheimer's disease progression is solely determined by changes in alpha diversity of gut microbiota, without involvement of systemic inflammation or neuroinflammatory markers.

Q526: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, immune modulation, and neurodegenerative disease mechanisms, particularly in relation to Parkinson's disease and potential interventions?
Options:
A: The gut microbiota only affects metabolic disorders and has no documented influence on neurological or immune-related diseases according to the context.
B: Disruptions in gut microbiota composition can lead to neuroinflammation in Parkinson's disease by modulating immune responses, and interventions targeting the microbiota, such as probiotics or rubusoside, may help alleviate these processes.
C: The gut-brain axis demonstrates that gut microbiota can influence both immune system regulation and the progression of neurodegenerative diseases like Parkinson's and Alzheimer's, suggesting that modifying the microbiota could impact disease outcomes.
D: Phages in the gut microbiota are the sole contributors to central nervous system disorders, with no involvement from bacteria or other microorganisms.

Q527: Based on the provided context, which of the following statements best integrate mechanisms involving the gut-brain axis, neuroinflammation, and age-related or drug-induced changes in brain health, highlighting how systemic or lifestyle factors can modulate neurological outcomes?
Options:
A: Current treatments for Parkinson's disease are neuroprotective and directly target the gut-brain axis to prevent neurodegeneration.
B: Microbial dysbiosis can promote neuroinflammation and vascular dysfunction, which, when combined with age-related impairments in signaling pathways, may exacerbate cognitive decline and the risk of cerebral small vessel disease.
C: Dysfunctions of the circadian clock and gut dysbiosis can trigger chronic systemic inflammation, which, together with impaired waste clearance in the brain, contribute to the pathogenic cascades underlying age-associated neurodegeneration.
D: Morphine self-administration leads to changes in the striatum and thalamus, but these changes are independent of any alterations in gut microbiota diversity or abundance.

Q528: Based on the provided context, which of the following statements best integrate the mechanisms by which gut microbiota and their metabolites influence both neurological and intestinal outcomes in the context of disease and intervention, such as radiation injury and ischemic stroke?
Options:
A: Disruption of the gut barrier and altered gut microbiota composition can activate inflammatory responses that contribute to both local intestinal injury and distant neurological dysfunction, as seen in both radiation injury and ischemic stroke models.
B: The only effective strategy for improving cognitive impairment related to gut microbiota is fecal microbiota transplantation, with no evidence supporting dietary or exercise interventions.
C: Interventions that increase beneficial gut microbiota and short-chain fatty acid (SCFA) production, such as Polygoni Multiflori Radix Praeparata polysaccharides, can improve both intestinal barrier integrity and neurological function after ischemic stroke by modulating gut-brain axis signaling.
D: Radiation-induced injury to the gut is solely determined by direct changes in the diversity of gut microbiota, without involvement of immune or inflammatory responses.

Q529: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, dietary interventions, and tryptophan metabolic pathways in modulating neuroinflammation and neurodegenerative disease progression?
Options:
A: Dietary patterns such as the Mediterranean diet can modulate gut microbiota composition, which in turn influences tryptophan metabolism through the kynurenine and indole pathways, ultimately impacting neuroinflammation and cognitive decline.
B: Fecal microbiota transplantation (FMT) is only effective in treating gastrointestinal complaints and has no influence on neuroinflammation or neurodegenerative disease progression.
C: Alterations in gut microbiota can affect gut permeability and inflammation via the kynurenine pathway, and interventions like probiotics or prebiotics may help restore neuroprotective metabolite balance, potentially slowing neurodegenerative processes.
D: The Western diet directly increases serotonin production in the brain, thereby preventing neurodegeneration without involving gut microbiota or tryptophan metabolism.

Q530: Based on the provided context, which of the following statements best integrate findings about the gut microbiome’s role in both neurodegenerative and psychiatric disorders, and the mechanisms by which interventions may influence brain health through the gut-brain axis?
Options:
A: Microbiome-targeted interventions, including probiotics and dietary modifications, have potential to improve both mental health and neurodegenerative disease outcomes by influencing microbial metabolites and inflammatory pathways along the gut-brain axis.
B: Altered gut microbiota diversity and decreased short-chain fatty acid production are implicated in both psychiatric and neurodegenerative disorders, and interventions such as probiotics may alleviate symptoms by modulating neuroinflammation and neurotransmitter regulation.
C: Gut microbiota only affects neurodegenerative diseases through immune responses, and psychiatric disorders are unrelated to gut-brain axis signaling.
D: Changes in the gut microbiome are exclusively a consequence of opioid use and do not precede or influence brain changes in neurodegenerative or psychiatric conditions.

Q531: Based on the provided context, which options best illustrate how gut microbiota alterations can simultaneously influence both central nervous system inflammation and metabolic disorders, considering the interplay of microbial metabolites, immune pathways, and barrier integrity?
Options:
A: Gut microbiota changes only affect gastrointestinal symptoms and have no impact on neurological or metabolic outcomes.
B: Increased abundance of Bacteroides and Akkermansia directly enhances blood-brain barrier integrity and prevents all forms of neuropsychiatric disorders.
C: Altered gut microbiota composition modulates inflammasome activation, resulting in increased intestinal permeability and production of pro-inflammatory cytokines, which are linked to both CNS and metabolic pathologies.
D: Dysbiosis leads to decreased short-chain fatty acids, which disrupt microglia function and energy metabolism, contributing to both neuroinflammation and metabolic disorders such as type 2 diabetes.

Q532: Based on the provided context, which options best illustrate how gut microbiota alterations can simultaneously impact both metabolic and neurological disease pathogenesis, and how interventions targeting the microbiome may offer therapeutic benefits across these conditions?
Options:
A: Pesticide exposure during early life exclusively impacts the liver and spleen, without any effect on the blood-brain barrier or neurological outcomes, so prebiotics are only useful for metabolic health.
B: Gut microbiota only affects metabolic diseases like MAFLD and has no role in neurological disorders such as AD and PD, making microbiome-targeted therapies irrelevant for brain health.
C: Microbial metabolites, including short-chain fatty acids and bile acids, influence hepatic function and immune responses in MAFLD, and also modulate neurological and epigenetic processes in AD and PD; dietary interventions and traditional Chinese medicine may leverage these effects for multi-targeted therapy.
D: Gut dysbiosis contributes to liver inflammation in MAFLD via increased intestinal permeability and translocation of bacterial products, while also promoting blood-brain barrier disruption and neuroinflammation in AD and PD; interventions such as prebiotics and microbiota transplantation may help restore barrier integrity and reduce disease progression.

Q533: Based on the provided context, which of the following statements best integrate the roles of gut microbiota, oxidative stress, and neurodegeneration, highlighting how interventions targeting the gut-brain axis may influence disease outcomes in both ischaemic stroke and neurodegenerative disorders?
Options:
A: Gastrointestinal symptoms in leukodystrophies are unrelated to gut microbiota composition or neurodegeneration, so interventions targeting the gut-brain axis would not affect disease progression.
B: Gut dysbiosis can exacerbate oxidative stress and inflammation in ischaemic stroke, while also contributing to neuroinflammation and neurodegeneration in diseases like Parkinson’s and leukodystrophies, suggesting that restoring microbial balance may benefit both conditions.
C: Therapeutic strategies such as fecal microbiota transplantation and probiotics may modulate gut microbiota, potentially reducing oxidative stress in ischaemic stroke and providing neuroprotective effects in neurodegenerative diseases by influencing neuroinflammation and neuronal regeneration.
D: Oxidative stress is only relevant to ischaemic stroke and does not play a role in neurodegenerative diseases or gut-brain axis dysfunction, so targeting gut microbiota would not impact neurodegeneration.

Q534: Based on the integrated findings from the context, which of the following statements best describe how gut-brain axis dysregulation can contribute to both neurodegenerative and metabolic diseases, and how therapeutic interventions may target these mechanisms?
Options:
A: Therapeutic strategies that restore gut microbiota balance and intestinal barrier function, such as probiotics or ALP-targeted interventions, may mitigate both neurodegenerative progression and metabolic dysfunction.
B: The gut-brain axis only affects neurodegenerative diseases through direct neural pathways, with no involvement of immune or metabolic mechanisms.
C: Microbiota-targeted therapies are effective exclusively for psychiatric disorders and have no demonstrated impact on metabolic or neurodegenerative diseases.
D: Dysregulation of the gut-brain axis can promote both neuroinflammation and increased intestinal permeability, which together exacerbate neurodegeneration and metabolic disorders such as non-alcoholic fatty liver disease.

Q535: Based on the provided context, which options best illustrate how interventions targeting the gut microbiota can influence neurodegenerative disease progression by integrating molecular mechanisms and therapeutic strategies discussed across multiple sections?
Options:
A: Fecal microbiota transplantation (FMT) may provide neuroprotective benefits in Parkinson’s disease by restoring gut microbiota diversity, which can reduce intestinal and neuroinflammation and abnormal α-synuclein aggregation.
B: Synbiotic supplementation can enhance cognitive function and reduce neuroinflammation in neurodegenerative disorders by modulating gut microbiota composition and increasing production of neuroactive compounds such as short-chain fatty acids.
C: Pharmacogenomics-based therapies are primarily effective in neurodegenerative diseases by targeting the gut microbiota to increase bile acid production and thereby reverse mitochondrial dysfunction.
D: Gene-editing tools like CRISPR directly restore gut microbiota diversity, thereby preventing neurodegenerative disease progression by eliminating misfolded proteins in the gut.

Q536: Based on the provided context, which options correctly integrate the roles of gut microbiota composition changes and inflammatory signaling pathways in the pathogenesis or progression of chronic diseases such as endometriosis and chronic kidney disease?
Options:
A: Both endometriosis and chronic kidney disease involve gut microbial dysbiosis that modulates inflammatory signaling pathways, such as NF-κB and TLR4/NF-κB, contributing to disease progression.
B: Gut microbiota changes in endometriosis are limited to estrogen metabolism and do not influence inflammatory signaling pathways or systemic inflammation.
C: In chronic kidney disease, gut microbiota composition changes do not affect metabolite alterations or inflammatory signaling pathways relevant to disease progression.
D: Polyphenols can exert therapeutic effects in chronic kidney disease by modulating gut microbiota and targeting inflammatory pathways, such as NF-κB and TLRs, which are also implicated in endometriosis pathogenesis.

Q537: Based on the provided context, which of the following statements best integrate the mechanistic roles of gut microbiota-derived metabolites and their impact on neurodegenerative and neuropsychiatric disorders, considering both molecular pathways and therapeutic interventions discussed across the sections?
Options:
A: Psilocybin’s therapeutic effects are exclusively mediated by its direct action on the central nervous system, without any involvement of the gut microbiota or peripheral signaling pathways.
B: Dysbiosis-induced increases in gut permeability allow microbial byproducts to activate inflammatory pathways in both the liver and brain, and interventions like probiotics or FMT may help restore eubiosis and mitigate disease severity in both metabolic and neuropsychiatric conditions.
C: Gut microbiota-derived metabolites such as TMAO and SCFAs can influence neuroinflammation and cognitive decline, and targeting these metabolites through microbiome manipulation may offer novel therapeutic strategies for neurodegenerative diseases.
D: The gut microbiota only affects neurological health through direct neuronal signaling, and microbiome-targeted therapies are limited to treating metabolic liver diseases rather than neuropsychiatric disorders.

Q538: Based on the provided context, which of the following statements best integrate the roles of gut microbiota and oxidative stress in ischaemic stroke pathophysiology, and also consider the implications for therapeutic strategies and clinical challenges?
Options:
A: The only effective way to prevent ischaemic stroke is through antioxidant supplementation, as gut microbiota has no significant influence on stroke outcomes or recovery.
B: Dysbiosis can exacerbate oxidative stress and systemic inflammation, worsening ischaemic stroke outcomes, while interventions like probiotics and dietary modulation may target both oxidative pathways and gut microbial balance, though their clinical application is limited by individual variability and lack of large-scale trials.
C: Gut-derived metabolites such as SCFAs may help protect the blood-brain barrier and reduce inflammation after ischaemic stroke, suggesting that strategies to rebalance gut microbiota could mitigate neuronal injury, but further research is needed due to efficacy and safety concerns.
D: Oxidative stress in ischaemic stroke is solely a result of mitochondrial dysfunction, and gut microbiota-based therapies have already been widely adopted in clinical practice due to their proven long-term safety.

Q539: Based on the provided context, which of the following statements best integrate the mechanisms by which obesity-induced changes in gut flora can contribute to neurodegenerative diseases and cognitive dysfunction, and how these insights inform potential therapeutic strategies?
Options:
A: The only pathway by which obesity affects the brain is through increased adipose tissue expression of NUDT2 and AMPH genes, with no involvement of gut flora or neuroinflammation.
B: Altered gut microbiota in obesity can modulate neuroinflammation via the gut-brain axis, impacting both cognitive decline and the progression of neurodegenerative diseases; therefore, microbiome-based diagnostics and individualized treatments are promising approaches.
C: Obesity-induced disruption of gut flora can increase intestinal permeability, allowing endotoxins to enter circulation, which may trigger neuroinflammation and contribute to neurodegenerative processes; thus, interventions like probiotics and dietary modification targeting the microbiota may help improve cognitive function.
D: Obesity primarily affects cognitive function through direct neuronal injury, and gut flora changes are unrelated to neurodegenerative disease mechanisms or therapeutic interventions.

Q540: Based on the provided context, which options best illustrate how gut microbiota-targeted dietary interventions could simultaneously impact both cancer-depression comorbidity and neurodegenerative tauopathies, considering the mechanisms of immune modulation, neurotransmitter homeostasis, and gut-brain axis signaling?
Options:
A: Dietary patterns and probiotics that modulate gut microbiota composition can inhibit abnormal tumor proliferation signals and enhance anticancer immune responses, while also suppressing neuroinflammation and improving mood behaviors via gut-brain axis interactions.
B: Microbiota-derived metabolites, regulated by dietary components, can bidirectionally modulate immune homeostasis and neurotransmitter balance, thereby improving both the tumor microenvironment and depressive-like behaviors, and may also influence tauopathy progression through gut-brain axis signaling.
C: Gut microbiota-targeted dietary interventions only affect cancer progression and have no influence on neurodegenerative tauopathies or mood disorders.
D: Adjusting dietary components to target gut microbiota is effective exclusively for metabolic diseases and does not impact neuropsychiatric or cancer-related outcomes.

Q541: Based on the provided context, which of the following statements best integrate the roles of gut microbiota modulation, neuroinflammation, and neurodegeneration in Alzheimer's disease, and the therapeutic potential of specific probiotic strains in this context?
Options:
A: The use of Bifidobacterium strains has been shown to reverse all neuropathological features of Alzheimer's disease, including neurofibrillary tangles and beta-amyloid plaques, in all clinical trials.
B: Supplementation with Bifidobacterium infantis and Bifidobacterium breve can modulate gut dysbiosis, which is linked to neuroinflammation and the accumulation of neurotoxic misfolded proteins in Alzheimer's disease.
C: Therapeutic strategies targeting gut microbiota, such as prebiotics and probiotics, may help restore physiological microbiota composition and reduce neuroinflammation mediated by astrocytes and microglia in Alzheimer's disease.
D: Gut dysbiosis is only associated with gastrointestinal symptoms and does not contribute to neurodegenerative processes or proteinopathies in Alzheimer's disease.

Q542: Based on the provided context, which options best illustrate how gut microbiota-derived metabolites and extracellular matrix dynamics can jointly influence immune regulation and disease progression across both diabetic retinopathy and neurodegenerative disorders?
Options:
A: Matrix metalloproteinases only affect oral microbiome composition and have no impact on gut-brain or gut-retina axes.
B: Microbiome-targeted therapies, such as prebiotics and probiotics, can modulate matrix metalloproteinase activity and restore gut barrier function, which may alleviate immune dysregulation and reduce the risk of both diabetic retinopathy and neuroinflammatory processes in neurodegenerative diseases.
C: Gut microbiota dysbiosis can disrupt extracellular matrix balance via altered matrix metalloproteinase activity, leading to compromised barrier integrity and increased immune dysregulation, which is mechanistically linked to both diabetic retinopathy and neuroinflammation in neurodegenerative diseases.
D: Short-chain fatty acids produced by gut microbiota directly increase neurotransmitter levels in the brain, thereby preventing both diabetic retinopathy and neurodegenerative diseases.

Q543: Based on the provided context, which options best illustrate how gut microbiome-derived metabolites and the brain-liver-gut axis can be integrated to inform therapeutic strategies for neurological disorders such as Alzheimer's and Parkinson's disease?
Options:
A: Gut microbial metabolites like succinate and short-chain fatty acids can signal through the autonomic nervous system and cross the blood-brain barrier, impacting central nervous system functions; therapies targeting the brain-liver-gut axis, such as probiotics and fecal microbiota transplantation, may leverage these mechanisms to treat neurological disorders.
B: Periodontal bacteria directly cause Alzheimer's disease by colonizing the brain, and thus oral hygiene alone is sufficient to prevent all neurological disorders.
C: Functional analysis of the gut microbiome in AD models reveals that metabolites such as acetyl-CoA, glucose, and choline may alleviate energy deficits and synaptic dysfunction; modulating the brain-liver-gut axis with interventions like vagus nerve stimulation and dietary changes could enhance these compensatory effects.
D: Current treatments for Parkinson's disease are exclusively based on small molecule inhibition of protein aggregation and do not involve immune cells or natural degradation pathways.

Q544: Based on the provided context, which interventions could potentially modulate both neurodegenerative processes in Alzheimer's disease and gastrointestinal disorders by targeting gut microbiota composition and its metabolites, and what mechanisms are involved in these effects?
Options:
A: Dietary modifications such as the Mediterranean diet and bioactive compounds like prebiotics and polyphenols can modulate gut microbiota, leading to reduced neuroinflammation in Alzheimer's disease and improved gastrointestinal health.
B: Antiviral therapies targeting EBV and SARS-CoV-2 directly restore gut microbiota balance and prevent both neurodegeneration and gastrointestinal cancer.
C: Vaccination against H. pylori and EBV is the primary method for modulating gut microbiota and preventing neurodegenerative and gastrointestinal diseases.
D: Microbiome-based therapies including probiotics, prebiotics, and fecal microbiota transplantation (FMT) can restore microbial balance, alleviate GI disease symptoms, and potentially slow Alzheimer's progression by influencing the gut-brain axis.

Q545: Based on the integrated findings from the context, which therapeutic strategies for neurodegenerative diseases and IBD involve both modulation of gut microbiota and molecular-level regulation, and what are their proposed mechanisms of action according to the reviews?
Options:
A: Employing plant-based dietary compounds to improve gut microbiota dysbiosis and regulate signaling pathways such as autophagy and immune responses, leading to reduced IBD severity.
B: Focusing exclusively on direct neuroprotective effects in the central nervous system without addressing gut microbiota or intestinal homeostasis.
C: Targeting the autophagy-lysosomal pathway to restore intestinal barrier function and modulate gut microbiota, thereby delaying neurodegeneration through improved gut-brain axis communication.
D: Using electrical nerve stimulation alone to regulate neural activity in the gut, without considering microbiota or molecular-level interventions.

Q546: Based on the provided context, which statements best illustrate how gut microbiota-targeted therapies could influence both gastrointestinal and neurodegenerative disease outcomes by integrating mechanisms involving the gut-brain axis and neuroimmune modulation?
Options:
A: Dietary modifications are only effective for gastrointestinal diseases and have no impact on neuroinflammatory processes or neurodegenerative disease progression.
B: Microbiome-based interventions such as probiotics and fecal microbiota transplantation can restore microbial balance in GI disorders and may also modulate neuroimmune pathways implicated in Alzheimer's disease via the gut-brain axis.
C: Pharmacogenomics and gene-editing tools are the only approaches capable of altering disease progression in neurodegenerative conditions, with no relevance to gut microbiota modulation.
D: Therapeutic strategies targeting the gut microbiota, including prebiotics and dietary intervention, offer personalized alternatives to conventional therapies for GI diseases and may reduce neuroinflammatory responses linked to neurodegeneration.

Q547: Based on the provided context, which options best illustrate how gut microbiota dysbiosis can contribute to both neurodegenerative and mood disorders through integrated biological mechanisms involving inflammation, neurotransmitter production, and brain structure?
Options:
A: Gut microbiota dysbiosis only affects digestive health and has no impact on brain structure, neurotransmitter production, or inflammatory pathways relevant to mental or neurodegenerative disorders.
B: Gut microbiota dysbiosis can increase gut permeability, allowing endotoxins to enter the bloodstream, which promotes systemic and neuroinflammation, leading to neuronal damage in regions such as the hippocampus and prefrontal cortex, thereby contributing to both depression and Alzheimer's disease pathology.
C: Disruption of gut microbial metabolism, including reduced short-chain fatty acids (SCFAs), can impair blood-brain barrier integrity and modulate neuroinflammation, which is associated with memory impairment in Alzheimer's disease and aggravation of mood disorders.
D: Altered gut microbiota directly increases alpha diversity, which enhances serotonin production and prevents neuroinflammation, thereby protecting against both mood and neurodegenerative disorders.

Q548: Based on the provided context, which options best illustrate how gut microbiota-mediated mechanisms can influence both neurodegenerative and mood disorders, integrating molecular pathways, immune modulation, and therapeutic strategies discussed across different disease models?
Options:
A: The presence of Firmicutes in the gut microbiome is solely responsible for the development of mood disorders and neurodegenerative diseases, independent of immune or metabolic pathways.
B: Modulation of the gut-brain axis through interventions like probiotics, dietary fiber, and fecal microbial transplantation can remodel the flora-mitochondrial axis, thereby providing a theoretical basis for novel antidepressant therapies and also influencing exosome-mediated neuroinflammatory responses relevant to Alzheimer’s disease.
C: Chemotherapy-induced changes in gut microbiome diversity, such as increased Ruminococcus, directly prevent neurodegeneration and mood disorders without involvement of immune or metabolic mechanisms.
D: Gut microbiota-derived metabolites such as butyrate can enhance neuronal mitochondrial biosynthesis via the AMPK-PGC1α pathway, which not only impacts depression by improving energy metabolism and neuroplasticity but also interacts with exosomal signaling to modulate neuroinflammation in Alzheimer’s disease.

Q549: Based on the context provided, which statements best illustrate how advances in analytical instrumentation and multi-omics approaches have enabled the integration of microbiome-derived metabolite research into clinical strategies for neurological and neuro-cancer disorders?
Options:
A: Standardized multi-omics approaches integrating microbiome, neuroscience, and oncology have advanced the understanding of how gut microbiota metabolites modulate neuroinflammation and tumorigenesis, informing personalized therapeutic strategies for neuro-cancer patients.
B: Mass spectrometry-based metabolomics has facilitated the identification of volatile organic compounds and short-chain fatty acids as biomarkers, supporting non-invasive diagnostic strategies for Parkinson's disease and informing personalized disease management.
C: Computational methods have replaced all experimental approaches in the study of host-microbe interactions, making animal models obsolete in neurological research.
D: The use of mass spectrometry has directly led to the development of new antibiotics for neuro-cancer patients by targeting gut microbiota-derived lipopolysaccharides.

Q550: Based on the provided context, which of the following statements best illustrate how interventions targeting the gut microbiota can simultaneously influence both neurological and oncological outcomes, and what mechanisms are involved in these effects?
Options:
A: The only way to improve neurodegenerative disease progression is by directly targeting neuronal cells, as gut microbiota interventions have no effect on neurological health.
B: Dietary interventions that modulate gut microbiota composition can suppress neuroinflammation and abnormal tumor proliferation by altering microbial metabolites, thereby improving both mood behaviors and the tumor microenvironment.
C: Oral probiotics exclusively affect oral health and have no impact on systemic diseases or neurological conditions, regardless of their influence on the oral microbiome.
D: Probiotics and prebiotics targeting gut microbiota can enhance anticancer immune responses and regulate neurotransmitter homeostasis, leading to improved outcomes in both cancer and depression through gut-brain axis interactions.

Q551: Based on the provided context, which of the following statements best integrate evidence regarding the role of gut microbiota and its metabolites in modulating neurological or psychiatric symptoms, and the potential for therapeutic intervention through microbiome-targeted strategies?
Options:
A: The lack of significant differences in gut microbiome alpha and beta diversity between Parkinson’s disease patients with and without impulse control disorders suggests that gut microbiota composition is not relevant to neurological symptom modulation.
B: The absence of significant differences in LPS-binding protein and alpha-1 antitrypsin levels between depressive patients and controls indicates that gut permeability biomarkers are not useful for understanding psychiatric disorders.
C: The observed mitigation of pain-associated behaviors and reversal of amygdala neuropathology gene expression in rats treated with gingerol-enriched ginger, along with changes in gut microbiome composition and metabolites, demonstrates that dietary modulation of the microbiome can influence both behavioral and molecular neurological outcomes.
D: The enrichment of specific gut microbial taxa and metabolic pathways in Parkinson’s disease patients with impulse control disorders, together with evidence that gut microbiota can modulate central signaling pathways such as cAMP-PKA, supports the potential for microbiome-targeted interventions in non-dopaminergic neurological symptoms.

Q552: Based on the provided context, which of the following statements best integrate the roles of gut microbiota metabolites, dietary components, and neurodegenerative disease mechanisms, particularly in relation to immune regulation and the gut-brain axis?
Options:
A: Polyphenols, when biotransformed by gut microbiota, can modulate microbial diversity and influence brain biochemistry, thereby linking dietary intake, gut microbial metabolites, and neurodegenerative disease management.
B: Short-chain fatty acids produced by commensal gut bacteria can induce regulatory T-cells, and their secretion may be impaired by excess dietary long-chain fatty acids, thereby influencing neuroinflammatory processes relevant to neurodegeneration.
C: Metabolic reprogramming in the tumor microenvironment only affects cancer immunotherapy outcomes and has no relevance to immune regulation or neurodegenerative disease mechanisms.
D: The formation of amyloid β plaques in Alzheimer's disease is solely dependent on the direct neuroprotective effects of the autophagy-lysosomal pathway, without involvement of gut microbiota or immune modulation.

Q553: Based on the provided context, which of the following statements best integrate the roles of gut microbiota modulation and immune cell involvement in the pathogenesis or treatment of neurodegenerative diseases such as Alzheimer's disease?
Options:
A: Gut microbiota modulation is only relevant for skin and joint inflammation in psoriatic arthritis and has no demonstrated impact on neurodegenerative disease mechanisms or outcomes.
B: The interplay between central and peripheral immune cells in Alzheimer's disease pathogenesis highlights the potential of gut microbiota-targeted therapies, such as probiotics, to modulate neuroinflammation by influencing both gut and brain immune environments.
C: Bifidobacterium infantis and Bifidobacterium breve are only effective in treating neurodegenerative diseases when combined with Lactiplantibacillus plantarum, as they do not influence immune responses or neuroinflammation on their own.
D: Lactiplantibacillus plantarum strains may benefit neurodegenerative diseases by promoting eubiosis and supporting gut-brain axis homeostasis, which is relevant since gut dysbiosis is linked to neuroinflammation and immune cell activation in Alzheimer's disease.

Q554: Based on the provided context, which of the following statements best integrate the mechanistic links between gut microbiome dysbiosis, neurodegenerative disease pathology, and the role of matrix metalloproteinases (MMPs) in systemic disease progression, as well as the potential for therapeutic intervention?
Options:
A: Restoring gut microbiome diversity alone is sufficient to prevent all forms of neurodegenerative disease, regardless of ECM or MMP involvement.
B: Gut microbiome dysbiosis can disrupt extracellular matrix (ECM) balance via altered MMP activity, leading to compromised barrier integrity and facilitating immune-mediated neurodegeneration through the gut-brain axis.
C: Therapeutic strategies targeting both the microbiome (e.g., prebiotics, probiotics) and MMP activity may help mitigate neurodegenerative disease progression by addressing both barrier integrity and neuroimmune dysregulation.
D: Changes in the gut microbiome only affect local gastrointestinal health and have no impact on distant organs or systemic disease processes.

Q555: Based on the provided context, which options best illustrate how interventions targeting the gut microbiota can influence both neuroinflammation and CNS tumor progression through integrated mechanisms involving immune modulation, barrier integrity, and signaling pathways?
Options:
A: Short-chain fatty acids produced by the gut microbiota only affect metabolic diseases and have no impact on neuroinflammation or CNS tumor progression.
B: Microbiota-based therapies, including probiotics, can modulate systemic inflammation and oxidative stress via pathways such as NF-κB and PI3K/Akt/mTOR, thereby influencing both neuroinflammation and glioma progression.
C: Manual acupuncture directly increases neurotransmitter production in the CNS, which leads to reduced glioma proliferation and improved cognitive function.
D: Manual acupuncture and probiotics can restore gut microbiota balance, increase SCFAs and FFAR3 expression, reduce NF-κB activation, and thereby improve intestinal barrier integrity and decrease neuroinflammation in APP/PS1 mice.

Q556: Based on the integrated findings from the provided context, which of the following statements best illustrate how gut microbiota-derived metabolites and matrix metalloproteinase (MMP) activity can jointly influence neuroinflammation and neurodegenerative disease risk through the gut-brain axis?
Options:
A: Gut dysbiosis can disrupt extracellular matrix (ECM) regulation by altering MMP activity, which compromises barrier integrity and, together with reduced beneficial microbial metabolites, increases neuroinflammation and risk for Alzheimer's disease.
B: MMP inhibitors alone are sufficient to restore gut-brain axis communication and prevent depression, independent of any changes in the gut microbiome or dietary intake.
C: Polyphenol microbial metabolites (PMMs) directly inhibit MMP expression in the gut, thereby preventing all forms of neurodegeneration regardless of dietary patterns.
D: Dietary interventions that enhance beneficial gut microbiota can increase production of neuroprotective microbial metabolites and indirectly modulate MMP activity, reducing systemic and neuroinflammation via improved barrier function.

Q557: Based on the provided context, which of the following statements best integrate the roles of gut microbiota modulation and its impact on both inflammatory bowel disease (IBD) and neurological conditions such as Alzheimer's disease, considering the mechanisms and outcomes described?
Options:
A: Psychological stress only affects IBD severity through immune system changes and does not involve any alterations in gut microbiota or brain function.
B: Plant-based dietary compounds can improve IBD by modulating gut microbiota composition and function, which is relevant since gut microbiome alterations are also associated with Alzheimer's disease pathology.
C: High-throughput cultivation and characterization of gut microbiota strains with anti-inflammatory and brain-important metabolite production can provide insights into both IBD treatment and gut-brain axis communication relevant to neurological disorders.
D: The gut microbiome composition is unrelated to cerebrospinal fluid biomarkers in Alzheimer's disease and does not differ between AD and cognitively unimpaired individuals.

Q558: Based on the provided context, which of the following statements best integrate evidence regarding the interplay between microbiota dysbiosis, inflammatory markers, and neuropsychiatric or neurodegenerative outcomes, and how interventions targeting microbiota may influence these processes?
Options:
A: There is no evidence that microbiota-targeted interventions can influence either inflammatory markers or neuropsychiatric outcomes, as all studies reviewed failed to show any therapeutic effect.
B: Both oral and gut microbiota dysbiosis are associated with neurodegenerative and neuropsychiatric conditions, and interventions that restore microbial balance, such as oral health measures or probiotics, have shown potential to improve cognitive or psychiatric outcomes.
C: Alterations in microbiota composition can modulate inflammatory biomarkers such as zonulin and sCD14, which are linked to both depressive symptoms and metabolic disorders, suggesting that microbiota-targeted therapies may have cross-cutting benefits for mental and metabolic health.
D: Only gut microbiota dysbiosis, but not oral microbiota changes, has been linked to neurodegenerative diseases, and interventions targeting the oral microbiome have not demonstrated any effect on cognitive decline.

Q559: Based on the provided context, which options best illustrate how gut microbiota modulation can influence both neuroinflammatory and metabolic outcomes through integrated mechanisms involving microbial composition, metabolite production, and signaling pathways across different disease models?
Options:
A: Psilocybin’s therapeutic effects on stress-related disorders are solely mediated by changes in the hypothalamic-pituitary axis, independent of gut microbiota or peripheral signaling.
B: Dietary interventions in pediatric obesity directly increase serotonin levels in the spinal cord without altering gut microbiota composition or inflammatory status.
C: Microbiome homeostasis in murine models of multiple sclerosis is linked to differences in predicted gene expression related to amino acid and metabolite metabolism, which may contribute to variations in neuroinflammatory disease progression.
D: Probiotic treatment in spinal cord injury models enhances gut microbiota diversity and tryptophan metabolite production, which activates anti-inflammatory and neuroregenerative signaling pathways in the spinal cord.

Q560: Based on the provided context, which options best illustrate how therapeutic interventions targeting the gut microbiota can influence both neuroinflammatory processes and central nervous system disorders, requiring integration of mechanisms and outcomes described across multiple sections?
Options:
A: Therapies such as berberine can alleviate acute epileptic seizures by remodeling gut microbiota-associated lipid metabolism, which in turn may impact neuroinflammatory responses and neuronal protection.
B: Neuroinflammatory processes are exclusively regulated by glial cell interactions and cannot be influenced by changes in gut microbiota or its metabolites.
C: Modulating gut microbiota composition through interventions like probiotics or fecal transplantation can influence the production of neuroactive metabolites, thereby affecting both neuroinflammation and the development or treatment of neurological disorders.
D: Dietary interventions targeting the gut microbiota are only effective for mood disorders and have no influence on neuroinflammatory mechanisms or central nervous system diseases.

Q561: Based on the provided context, which options best illustrate how dietary interventions can influence neuroinflammation and mental health by integrating mechanisms involving metabolic changes, immune modulation, and the gut-brain axis?
Options:
A: Alcohol use disorder is primarily managed by increasing carbohydrate intake, which directly strengthens the blood-brain barrier and prevents neuroinflammation without involving gut microbiota.
B: Menopause-related mood disturbances in women are solely caused by hormonal changes and are not affected by dietary habits or inflammation.
C: The ketogenic diet reduces neuroinflammation by inducing ketogenesis, which generates ketone bodies that modulate immune responses in the central nervous system, potentially offering therapeutic benefits for neurodegenerative diseases.
D: Psychobiotics can alleviate psychiatric symptoms by influencing neurotransmitter levels, regulating the HPA axis, and improving gut barrier function through short-chain fatty acids, thereby impacting the microbiota-gut-brain axis and mental health.

Q562: Based on the provided context, which therapeutic strategies for intestinal or neuropsychiatric disorders demonstrate an integrated approach by simultaneously targeting both microbial composition and neural or immune signaling, and what are their proposed clinical benefits?
Options:
A: Electrical nerve stimulation techniques alone are sufficient to restore gut microbiota composition and resolve neuroinflammation in schizophrenia without the need for microbiota-targeted interventions.
B: An integrated therapeutic framework for IBD/IBS may include molecular-level modulation of neurotransmitters, systemic neural regulation, and ecological reprogramming of gut microbiota, offering a translational pathway to personalized clinical interventions.
C: Diquat toxicity can be fully reversed by dietary therapies alone, without the need for antioxidants or probiotics, as these are not mentioned as effective interventions in the context.
D: Microbiota-targeted therapies such as probiotics, prebiotics, and fecal microbiota transplantation are proposed to restore microbial balance and improve clinical outcomes in both multiple sclerosis and schizophrenia by modulating immune and neural pathways.

Q563: Based on the provided context, which options best illustrate how modulation of gut microbiota can influence both neurodegenerative and inflammatory diseases through metabolite production and immune regulation, and what therapeutic strategies emerge from these interactions?
Options:
A: Amyloid-beta accumulation in Alzheimer's disease is solely caused by genetic mutations, and gut microbiota modulation has no impact on disease progression or immune regulation.
B: Plant-based dietary compounds can modulate gut microbiota, resulting in increased anti-inflammatory cytokines and improved barrier function in IBD, while similar microbiota-targeted interventions like probiotics upregulate neurotrophic factors and reduce oxidative stress in neurodegenerative diseases.
C: Probiotics and fecal microbiota transplantation can restore gut microbial balance, leading to reduced neuroinflammation and improved cognition in neurodegenerative diseases, while also influencing metabolite production that regulates immune cells in inflammatory bowel disease.
D: Ocrelizumab treatment in multiple sclerosis patients has no effect on tryptophan metabolism or gut microbiota, and dietary interventions are ineffective in modulating disease outcomes.

Q564: Based on the provided context, which options best illustrate how gut microbiota-derived metabolites and dietary interventions can influence both immune regulation in diabetes and neurological health, requiring integration of mechanisms and outcomes from multiple sections?
Options:
A: Lower levels of short-chain fatty acids produced by gut microbiota are associated with increased diabetic retinopathy risk due to immune dysregulation, while plant-based diets rich in secondary bioactive metabolites can synergistically prevent neurodegenerative disorders by modulating oxidative stress and brain health.
B: Secondary bioactive metabolites from plant foods have no impact on immune regulation or neurological health and are only relevant for cancer prevention.
C: Gut microbiota only affects metabolic functions in diabetes and does not play a role in neurological disorders or immune regulation.
D: Altered gut microbiota profiles, as seen after bariatric surgery, can influence neurotransmitter levels and neurological disorders, while interventions like probiotics and fecal microbiota transplantation may alleviate both neurological and immune symptoms by restoring microbial balance.

Q565: Based on the provided context, which options best illustrate how gut microbiota dysregulation can simultaneously influence both metabolic and neuropsychiatric disease progression through interconnected mechanisms involving inflammation, metabolite signaling, and barrier function?
Options:
A: Altered gut microbiota composition directly increases estrogen levels, thereby preventing both osteoporosis and breast cancer without affecting inflammatory or metabolic pathways.
B: Gut microbiota dysregulation impairs intestinal barrier function, leading to systemic chronic inflammation that accelerates both hepatic fat accumulation in MASLD and microglial activation in neurodegenerative diseases.
C: Gut microbiota changes only affect gastrointestinal symptoms and have no impact on systemic inflammation or neuropsychiatric outcomes.
D: Microbiota-derived metabolites such as short-chain fatty acids regulate insulin sensitivity in metabolic diseases and modulate neurotransmitter balance in mental health disorders, linking metabolic and neuropsychiatric pathogenesis.

Q566: Based on the provided context, which options best illustrate how gut microbiota dysbiosis and biofilm-associated amyloid proteins can interact to influence the progression of neurodegenerative diseases, considering both gastrointestinal and neurological mechanisms?
Options:
A: Persistent gut dysbiosis and bacterial infections can compromise the blood-brain barrier, allowing inflammatory molecules and bacterial amyloids to enter the brain, which perpetuates neurodegeneration and is linked to both GI symptoms and neurological decline.
B: Gut dysbiosis can promote the production of biofilm-associated amyloid proteins by gut-colonizing bacteria, which may cross-seed human amyloidogenic proteins and accelerate neurodegeneration, while also contributing to gastrointestinal symptoms that impact patient quality of life.
C: Gut microbiota dysbiosis directly increases the abundance of beneficial bacteria, thereby preventing the formation of biofilm-associated amyloid proteins and halting neurodegenerative disease progression.
D: Biofilm-associated amyloid proteins produced by gut bacteria are always neutralized by molecular chaperones and heat shock proteins, preventing any impact on neurodegenerative disease progression.

Q567: Based on the provided context, which options best illustrate how gut microbiome-targeted interventions can simultaneously impact both neurological and metabolic health through integrated mechanisms involving microbial metabolites, barrier integrity, and immune modulation?
Options:
A: Fecal microbiota transplantation exclusively improves cognitive function by increasing neurotransmitter synthesis, without affecting metabolic or immune pathways.
B: Probiotics can restore gut microbiome homeostasis, reinforce intestinal barrier integrity, and mitigate neuroinflammatory responses via the gut-brain axis, which is significant in both Alzheimer’s disease and metabolic dysfunction.
C: Microbiome-targeted therapies such as probiotics, prebiotics, and FMT can restore gut eubiosis, regulate immune function, and reduce neuroinflammation, thereby mitigating both metabolic and neuropsychiatric disease severity.
D: Short-chain fatty acids produced by the gut microbiome only influence lipid metabolism and have no role in neurological or immune regulation.

Q568: Based on the provided context, which of the following statements best integrate the roles of gut microbiota in both neurodegenerative diseases and metabolic disorders, highlighting their mechanisms and potential therapeutic implications?
Options:
A: Probiotics like Bifidobacterium infantis and Bifidobacterium breve may provide neuroprotective effects in neurodegenerative diseases, while beneficial bacteria such as Bifidobacterium can also prevent obesity by enhancing the intestinal barrier and improving insulin sensitivity.
B: Gut microbiota can influence both neurodegenerative diseases and obesity by regulating metabolic processes such as glucose and lipid metabolism, and by affecting the central nervous system through the gut-brain axis.
C: Gut microbiota is unrelated to the development of metabolic or neuropsychiatric diseases, as their effects are limited to nutrient absorption in the intestine.
D: The only effect of gut microbiota on health is through the secretion of β-glucuronidase, which is limited to estrogen regulation in menopausal women.

Q569: Based on the provided context, which of the following statements best integrate the roles of gut neuropeptides, microbiome alterations, and immune responses in the pathogenesis or modulation of Parkinson's disease and other neurological disorders?
Options:
A: Dysregulation of gut neuropeptide signaling, such as substance P and neuropeptide Y, can be influenced by microbial metabolite and immune changes, potentially affecting α-synuclein aggregation and neuroimmune pathways in Parkinson's disease.
B: Microbiome-targeted therapies are only effective in treating cardiometabolic disorders and have no relevance to neurological diseases such as Parkinson's disease.
C: Gut neuropeptides directly prevent the formation of Lewy bodies in the substantia nigra by restoring dopaminergic neuron function, independent of microbiome or immune system involvement.
D: Alterations in the gut microbiome, driven by diet or inflammation, may modulate gut neuropeptide signaling and thereby impact both local gut barrier function and central nervous system symptoms in Parkinson's disease.

Q570: Based on the provided context, which options best illustrate how alterations in microbiota and metabolic pathways can contribute to neurodegenerative or autoimmune disease pathogenesis through integrated mechanisms involving immune or metabolic responses?
Options:
A: In Alzheimer’s disease, disruptions in lipid metabolism interact with immune dysregulation, as microglia clear pathological aggregates but chronic activation accelerates neurodegeneration, showing that metabolic and immune pathways are intertwined in disease progression.
B: In Parkinson’s disease with probable REM sleep behavior disorder, distinctive gut microbiota and metabolites are associated with phenylalanine and vitamin B6 metabolism, suggesting that metabolic changes linked to microbiota alterations may influence disease mechanisms.
C: B cells have no influence on gut microbiota communities and do not play any role in autoimmune disease regulation.
D: Alzheimer’s disease progression is solely determined by the extracellular aggregation of β-amyloid, without any involvement of immune or lipid metabolic mechanisms.

Q571: Considering the temporal sequence of events in Alzheimer's disease pathogenesis as described in the context, which of the following processes occur early and which occur later in the disease progression? Select all options that correctly reflect the order or timing of these events, such as immune cell activity in clearing aggregates versus the development of chronic neuroinflammation and neuronal damage.
Options:
A: Disruptions in lipid metabolism only occur after the onset of chronic neuroinflammation.
B: Prolonged or excessive activation of immune cells leads to chronic neuroinflammation, which accelerates neuronal damage at a later stage.
C: Chronic neuroinflammation, resulting from prolonged immune cell activation, occurs before microglia begin to clear Aβ aggregates.
D: Early in Alzheimer's disease, microglia identify and clear pathological aggregates like β-amyloid (Aβ).

Q572: Based on the described studies, which of the following events are likely to occur sequentially following an increase in gut permeability due to dysbiosis, and how might these events contribute to the progression of neurological disorders such as Parkinson's disease? Select all that apply.
Options:
A: Neuroinflammation caused by gut-derived factors is resolved before any systemic inflammation develops.
B: Dysregulation of the kynurenine pathway in the context of inflammation leads to the production of neurotoxic metabolites, such as quinolinic acid, which contribute to neuronal damage.
C: Elevated plasma metabolites associated with Parkinson's disease are detected before any changes in intestinal inflammation or permeability are observed.
D: Increased gut permeability allows translocation of toxins and bacteria into systemic circulation, which then triggers widespread inflammation impacting neurological health via the gut-brain axis.

Q573: Considering the temporal sequence of events described in the context of HIV-associated neurocognitive disorder (HAND), which of the following events are likely to occur after a reduction in SCFA-producing gut bacteria, and before the manifestation of cognitive impairment, according to the study findings?
Options:
A: A rise in pro-inflammatory cytokine levels
B: An increase in anti-inflammatory cytokine levels
C: An improvement in cognitive function
D: A decrease in plasma short-chain fatty acids (SCFAs)

Q574: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after the ingestion of flavanone-rich citrus fruits and before the observed improvement in cognitive performance, according to the hierarchical pathway involving gut microbiota and the gut-brain axis?
Options:
A: Direct modulation of neuronal gene expression by unmodified dietary flavanones in the brain.
B: Production of short-chain fatty acids and neurotransmitters by the gut microbiota, influencing the gut-brain axis.
C: Immediate reduction of neurodegenerative pathology without intermediary metabolic or microbial steps.
D: Extensive metabolic transformation of flavanones by the gut microbiota, leading to changes in microbial composition.

Q575: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an increase in gut permeability due to altered gut microbiota composition, and before the manifestation of neuropsychiatric symptoms? Select all that apply.
Options:
A: Direct upregulation of amygdala neuropathology genes without changes in gut microbiota or metabolites.
B: Modulation of neuroactive and neurotoxic kynurenine metabolites affecting brain function.
C: Activation of systemic inflammation leading to neuroinflammation via the kynurenine pathway.
D: Immediate improvement in cognitive development due to increased gut permeability.

Q576: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after a disruption in gut microbiota composition but before the manifestation of neuroinflammatory responses in the central nervous system? Select all that apply.
Options:
A: Direct infiltration of peripheral immune cells into the central nervous system without any preceding changes in gut metabolites.
B: Increased intestinal permeability leading to elevated levels of inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6).
C: Altered production of short-chain fatty acids (SCFAs) by the gut microbiota, affecting microglial activation.
D: Restoration of microbial balance and correction of metabolic disturbances by administration of probiotics or prebiotics.

Q577: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) in APP/PS1 transgenic mice, which of the following outcomes are observed after transplantation from healthy wild-type donors, and which occur after transplantation from DSS-induced colitis donors, in relation to changes in cognitive function, amyloid-beta pathology, and pro-inflammatory cytokine levels over time?
Options:
A: Heightened amyloid-beta deposition and increased pro-inflammatory cytokine levels occur after FMT from DSS-induced colitis donors.
B: Elevated pro-inflammatory cytokine levels and exacerbated cognitive deficits occur after FMT from healthy wild-type donors.
C: Improved spatial memory and reduced amyloid-beta plaque burden occur after FMT from healthy wild-type donors.
D: Reduced exploratory behavior and normalized cytokine expression occur after FMT from DSS-induced colitis donors.

Q578: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted diet mouse donors to Alzheimer's disease (AD) mice, but before the observed improvement in learning and memory abilities? Select all that apply.
Options:
A: Immediate restoration of cognitive function in AD mice without intermediary metabolic changes.
B: An increase in short-chain fatty acids (SCFAs) in the gut of recipient AD mice.
C: Activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1 in the gut following elevated SCFAs.
D: Initial reduction in amyloid-beta (Aβ) plaque burden prior to any changes in gut microbiota composition.

Q579: Considering the temporal progression of metabolic and microbial changes in multiple sclerosis (MS) patients treated with ocrelizumab, which of the following events are likely to occur after six months of treatment, based on comparative mass spectrometry profiling of tryptophan-related pathways and their metabolites?
Options:
A: Ocrelizumab treatment has no impact on the host microbiota or tryptophan metabolism over time.
B: After six months of ocrelizumab treatment, MS patients show a metabolite pattern across tryptophan pathways that resembles the health state for various metabolites.
C: Ocrelizumab treatment immediately restores all tryptophan pathway metabolites to levels identical to healthy controls within days.
D: MS patients treated with ocrelizumab exhibit concurrent alterations in tryptophan-related metabolic pathways compared to untreated MS patients.

Q580: Based on the described multi-step interactions, which of the following sequences correctly reflects the temporal progression from dietary intake to neuroprotection, and which steps are supported as contributing to improved cognitive function or reduced neuroinflammation according to the context? Select all that apply.
Options:
A: Ingestion of polyphenols → Microbial metabolism to polyphenol microbial metabolites (PMMs) → Increased gut and blood-brain barrier permeability of PMMs → Protection of microglia against inflammation
B: Alteration of gut microbiota by antibiotics → Immediate increase in beneficial bacterial populations → Enhanced cognitive function
C: Ingestion of flavanones → Metabolic transformation by gut microbiota → Modulation of gut microbiota composition → Production of beneficial metabolites → Improvement in cognitive performance
D: Ingestion of polyphenols → Direct absorption of parent compounds into the brain → Immediate neuroprotection without microbial involvement

Q581: Considering the multi-step biological pathways described in the context, which of the following events would most likely occur after the restoration of gut microbiota composition by probiotic or prebiotic supplementation in neurodegenerative disease models, and before the improvement of cognitive function? Select all that apply.
Options:
A: Modulation of glial cell activity, including astrocytes and microglia, leading to changes in neuroinflammatory markers.
B: Regulation of neuroinflammation through altered microbial metabolite production, such as short-chain fatty acids and tryptophan derivatives.
C: Immediate reversal of neuritic plaque formation in the brain.
D: Direct enhancement of cholinergic synaptic transmission without intermediary molecular changes.

Q582: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes are likely to occur in the progression from acute injury to chronic dysfunction, specifically involving the gut-brain axis and nutritional status, as described in the context above?
Options:
A: Immediately after SCI, dietary interventions fully restore gut microbiota composition and prevent all metabolic complications.
B: SCI leads to gut dysbiosis, which then exacerbates metabolic disturbances and impedes neurological recovery over time.
C: Nutritional alterations following SCI are closely associated with neurogenic gut dysfunction, which further interacts with gut dysbiosis in a progressive manner.
D: Gut-brain axis involvement is limited to the acute phase of SCI and does not influence chronic neurological recovery.

Q583: Based on the described studies, which of the following events occur after modulation of gut microbiota-derived metabolites, such as short-chain fatty acids or indole derivatives, and precede observable improvements in disease phenotypes like reduced retinal vessel loss or ameliorated arthritis severity? Select all that apply.
Options:
A: Immediate reversal of all disease-associated epigenetic changes prior to any immune modulation
B: Upregulation of tight junction proteins and improvement of intestinal barrier function
C: Direct restoration of normal organ morphology without intermediate molecular changes
D: Alteration of immune cell populations and cytokine expression in affected tissues

Q584: Considering the temporal progression of obesity-related disorders, which of the following events are likely to occur after initial alterations in gut microbiome composition, and subsequently contribute to the development or persistence of obesity and its metabolic consequences? Select all that apply.
Options:
A: Direct reversal of obesity solely by altering gut microbiome composition, without involvement of epigenetic mechanisms.
B: Immediate improvement of metabolic health without further molecular changes.
C: Epigenetic modifications in adipocytes leading to cellular memory and predisposition to weight regain.
D: Induction of inflammatory pathways in the liver following epigenetic changes.

Q585: Considering the temporal sequence of events in the pathogenesis of neurodegenerative diseases, which of the following processes are likely to occur after gut microbiota dysbiosis but before the manifestation of clinical symptoms, according to the described gut microbiota-gut-brain axis and its impact on neurodegeneration?
Options:
A: Immediate restoration of gut microbiota diversity and function through fecal microbiota transplantation (FMT).
B: Increased intestinal permeability and neuroinflammation, contributing to abnormal protein aggregation and oxidative stress.
C: Resolution of neurodegenerative disease symptoms through dietary polyphenol intervention.
D: Altered production of microbial metabolites such as short-chain fatty acids (SCFAs) that can cross the intestinal barrier and influence the brain.

Q586: Considering the temporal progression of neuroinflammatory responses following neurosurgical procedures, which of the following events are likely to occur sequentially after the blood-brain barrier is compromised, leading to both immediate and long-term cognitive impairments according to the context provided?
Options:
A: Impairment of synaptic function and connectivity due to inflammation, contributing to cognitive dysfunction in both the acute postoperative period and over time.
B: Direct improvement in cognitive function as a result of viral infection-induced inflammation.
C: Immediate restoration of blood-brain barrier integrity, preventing any neuroinflammatory response.
D: Activation of microglia and astrocytes, followed by the release of cytokines such as TNF-alpha and interleukin-1, resulting in neuronal damage.

Q587: Considering the temporal progression of neurodegenerative diseases, which of the following events typically occur in sequence following gut dysbiosis, as described in the context? Select all that apply: First, gut dysbiosis disrupts intestinal barrier integrity, then pathobionts and toxic metabolites enter systemic circulation, and subsequently, chronic neuroinflammation and accumulation of neurotoxic misfolded proteins in CNS cells occur. Which steps are part of this cascade?
Options:
A: Disruption of intestinal barrier integrity occurs early, allowing pathobionts and toxic metabolites to enter systemic circulation.
B: Defective autophagy and proteinopathies are the initial events preceding gut dysbiosis.
C: Neurotoxic misfolded proteins accumulate in CNS cells before any disruption of the intestinal barrier.
D: Chronic neuroinflammation via dysregulated immune activation follows the ingress of toxic metabolites into systemic circulation.

Q588: Considering the multi-step regulatory cascades described in the context, which of the following events would most likely occur after the restoration of microbial balance through probiotic or synbiotic intervention in the gut-brain axis, and which events would precede the improvement of cognitive function in Alzheimer's disease? Select all that apply.
Options:
A: Reduction in systemic and neuroinflammation would follow restoration of microbial balance.
B: Blood-brain barrier permeability would increase prior to the restoration of microbial balance.
C: Amyloid deposition and tauopathy would immediately decrease before any change in microbial populations.
D: Enhanced gut-brain communication would occur after dietary interventions that restore microbial diversity.

Q589: Considering the temporal sequence of events in the regulation of blood pressure by dietary fiber, which of the following steps must occur before the central nervous system can receive information from the gut microbiome, and which steps are involved in the subsequent signaling cascade leading to blood pressure modulation via the gut-brain axis?
Options:
A: The central nervous system directly senses dietary fiber in the gut before any microbial or hormonal processing occurs.
B: Binding of gut-derived hormones to their receptors on peripheral nervous system nerves occurs before the production of SCFAs by the gut microbiome.
C: Production of short-chain fatty acids (SCFAs) by the gut microbiome following a high-fibre diet precedes the release of gut hormones by enteroendocrine cells.
D: Stimulation of enteroendocrine cells by SCFAs to release neurotransmitters and hormones is an early event that precedes the relaying of information to the brain.

Q590: Considering the multi-step regulatory cascade described in glaucoma pathogenesis, which of the following events would be expected to occur after the restoration of AhR activation by indoleacetic acid (IAA) or Bacteroides fragilis, and which events must precede the preservation of visual function in the timeline of neuroprotection?
Options:
A: Suppression of microglial activation and inhibition of pro-inflammatory mediator release throughout the retina
B: Fecal microbiota transplantation (FMT) from glaucoma patients leading to lower systemic IAA levels in mice
C: Depletion of tryptophan-metabolizing bacteria such as B. fragilis and reduced serum IAA levels
D: Reduction of retinal ganglion cell (RGC) loss

Q591: Considering the temporal sequence of events in colorectal cancer (CRC) development, which of the following processes occur after alterations in the gut microbiome lead to decreased production of short-chain fatty acids (SCFAs), but before the manifestation of CRC progression? Select all that apply.
Options:
A: Epigenetic modifications such as DNA methylation and histone modifications influenced by SCFAs.
B: Manifestation of colorectal cancer progression and metastasis.
C: Changes in intestinal epithelial barrier function and immunity associated with reduced SCFA levels.
D: Restoration of SCFA levels in the colon through microbiota modulation.

Q592: Considering the sequence of molecular and cellular events described in the dual-hit (DSS+MPTP) mouse model, which of the following processes occur after the initial upregulation of LRRK2 expression in both the colon and brain, and contribute to the progression of Parkinson's disease pathology in this model?
Options:
A: Significant gain of dopaminergic neurons in the striatum
B: Increase in inflammatory cytokines such as IL1-β and TNF-α in the colon
C: Restoration of intestinal barrier integrity through increased ZO-1 and Occludin levels
D: Activation of NF-κB pathway and inhibition of Nrf2 pathway in the brain

Q593: Considering the temporal sequence of events in the pathogenesis of Alzheimer's and Parkinson's diseases as described in the context, which of the following processes occur after gut microbiota dysregulation but before the manifestation of clinical neurodegenerative symptoms? Select all that apply.
Options:
A: Initial genetic mutations predisposing to disease
B: Protein misfolding and aggregation linked to disease pathogenesis
C: Dietary interventions with probiotics and microbiota transplantation
D: Inflammation-induced epigenetic alterations that promote disease development

Q594: Considering the temporal sequence of events in neurodegenerative diseases such as Alzheimer's and Parkinson's, which of the following processes occur after gut microbiota dysbiosis but before the manifestation of cognitive decline or motor dysfunction, according to the described molecular and cellular pathways?
Options:
A: Production of short-chain fatty acids by beneficial gut bacteria that attenuate neuroinflammation
B: Immediate restoration of neuronal function through antioxidant supplementation
C: Increased oxidative stress and neuroinflammation mediated by disrupted gut-brain axis signaling
D: Activation of molecular pathways such as NF-κB and MAPK leading to elevated inflammatory cytokine expression

Q595: Considering the multi-step biological pathways involved in Alzheimer's disease (AD), which of the following events would most likely occur after the activation of glial cells by gut-derived metabolites, and before the onset of cognitive deterioration? Select all that apply. Base your answer on the described cellular and molecular mechanisms, including neuroinflammation and protein accumulation.
Options:
A: Acute increase in cholinergic synaptic transmission
B: Immediate restoration of cognitive function due to probiotic supplementation
C: Accumulation of beta-amyloid protein leading to neuritic plaque formation
D: Hyperphosphorylation of tau protein resulting in neurofibrillary tangles

Q596: Based on the described sequence of molecular and cellular events following oral administration of gold nanospheres (GNS) for rheumatoid arthritis therapy, which of the following events would be expected to occur after the enrichment of Ligilactobacillus in the gut but before the reduction of synovial hyperplasia and inflammatory infiltration? Select all that apply.
Options:
A: Suppression of NF-κB activation in synovial tissues
B: Reduction in disease severity and synovial inflammation in collagen-induced arthritis (CIA) mice
C: Upregulation of tight junction proteins Claudin-1 and ZO-1, restoring intestinal barrier function
D: Increased production of indole-3-propionic acid (IPA) and indole-3-acetic acid (IAA) in the gut

Q597: Considering the multi-step regulatory cascades described, which of the following events would most likely occur after an increase in gut-derived propionate in the plasma of APPPS1-21 mice, and which events would precede the reduction of Aβ plaques? Select all that apply.
Options:
A: Reduced expression of proinflammatory genes and increased expression of neurotrophic genes in astrocytes.
B: Direct modulation of neurotransmitter levels in the brain independent of gut microbiota changes.
C: Immediate restoration of blood-brain barrier integrity without changes in astrocyte gene expression.
D: A decrease in peripheral Th17 cells and IL-17 secretion, leading to reduced reactive astrocytosis.

Q598: Considering the temporal sequence of events in OVA-induced food allergy mice, which of the following processes are likely to occur after the initial elevation of Th2 signature cytokines and allergy-related antibodies, but before the manifestation of extensive behavioral impairments? Select all that apply.
Options:
A: Increased activation of microglia and elevated TNF-α, IL-1β, and IL-6 levels in the prefrontal cortex.
B: Disruption of amino acid metabolism, particularly involving carboxylic acids and derivatives, correlated with altered gut microbiota.
C: Extensive impairment of behaviors such as anxiety-like, depression-like, and repetitive behaviors.
D: Establishment of the food allergy mouse model with OVA sensitization and evaluation of anaphylactic symptoms.

Q599: Considering the temporal progression of metabolic-associated fatty liver disease (MAFLD), which of the following events are likely to occur sequentially after gut microbiota dysbiosis, and before the development of hepatic inflammation, according to the described gut-liver axis mechanisms?
Options:
A: Immediate resolution of hepatic inflammation without intervention
B: Enhanced intestinal permeability allowing translocation of bacterial products such as lipopolysaccharide (LPS) into systemic circulation
C: Direct genetic mutation in hepatocytes independent of microbial or metabolic factors
D: Influence of microbial metabolites, including short-chain fatty acids and bile acids, on hepatic function and immune responses

Q600: Considering the temporal sequence of events in the pathogenesis of neurodegenerative diseases, which of the following processes are described as occurring after gut dysbiosis disrupts the intestinal barrier but before the accumulation of neurotoxic misfolded proteins in the CNS? Select all that apply.
Options:
A: Ingress of pathobionts and toxic metabolites into the systemic circulation causing gut-brain axis dysregulation
B: Chronic neuroinflammation via dysregulated immune activation
C: Clinical manifestation of gastrointestinal symptoms several years before neurological symptoms
D: Therapeutic intervention with prebiotics, probiotics, or fecal microbial transplantation

Q601: Considering the temporal sequence of events following neurosurgical procedures, which of the following processes occur after the disruption of the blood-brain barrier (BBB) and contribute to both immediate and long-term cognitive impairments, as described in the context? Select all that apply.
Options:
A: Activation of neuroinflammatory responses involving microglia and astrocytes
B: Initial compromise of the blood-brain barrier during surgery
C: Exposure of cerebrospinal fluid to pathogens prior to BBB disruption
D: Release of cytokines such as tumor necrosis factor-alpha and interleukin-1 leading to neuronal damage

Q602: In the context of chronic unpredictable mild stress (CUMS)-induced depression in mice, after the administration of Semen Cuscutae flavonoids (SCFs), which of the following sequential events occur in the timeline following confirmation of antidepressant efficacy, specifically regarding the gut microbiota and metabolome? Select all that apply.
Options:
A: Fecal metabolomics analysis after SCFs treatment reveals modulation of metabolic pathways, including aldosterone synthesis and secretion, arachidonic acid metabolism, and primary bile acid biosynthesis.
B: SCFs treatment immediately restores hippocampal metabolic disturbances before any changes in gut microbiota composition are observed.
C: SCFs treatment leads to an increase in the Firmicutes/Bacteroidota ratio and elevates the abundance of Firmicutes, Lactobacillus, Limosilactobacillus, and Actinobacteria in the gut microbiota.
D: SCFs treatment causes a reduction in the abundance of Firmicutes and an increase in Bacteroidota in CUMS-treated mice.

Q603: Considering the multi-step regulatory cascades described in the context, which of the following events would most likely occur after gut microbiota dysbiosis in the progression of multiple sclerosis or brain cancer, and which events would precede the appearance of clinical symptoms or behavioral changes? Select all that apply.
Options:
A: Immediate improvement of clinical symptoms due to increased levels of Akkermansia muciniphila in the gut.
B: Altered production of microbial metabolites, such as short-chain fatty acids, influencing tumor progression in brain cancer after dysbiosis.
C: Disruption of immune homeostasis and elevation of pro-inflammatory cytokines following gut microbiota dysbiosis in multiple sclerosis.
D: Direct manifestation of neurobehavioral changes in mice prior to any changes in gut microbiota composition or metabolite levels.

Q604: Considering the sequential events described in the context, which of the following processes occur after the modification of gut microbiota composition and subsequently contribute to the progression or alleviation of central nervous system (CNS) inflammation in diseases such as multiple sclerosis or ARDS? Select all that apply.
Options:
A: Periodontal therapy immediately restores gut microbiota composition and reverses systemic metabolite profile changes.
B: Ultra-processed foods directly induce protein misfolding in neurons without involvement of the gut microbiota.
C: Altered gut microbiota influences immune cell priming in the periphery, leading to dysregulation of immune responses and neuroinflammatory processes in the CNS.
D: Commensal bacteria and their metabolites promote the generation of regulatory T-cells, contributing to immune suppression and protection against CNS inflammation.

Q605: Based on the described effects of honokiol short-chain fatty acid (HNK-SCFA) derivatives on Enterococcus faecalis and levodopa metabolism, which of the following events would be expected to occur sequentially after administration of HNK-SCFA esters in the gut, and which would be observed before a potential enhancement of levodopa's therapeutic efficacy in Parkinson's disease?
Options:
A: Direct increase in dopamine levels in the brain without any intermediate steps
B: Inhibition of E. faecalis growth by HNK-SCFA esters in a dose-dependent manner
C: Immediate and permanent elimination of E. faecalis from the gut microbiota
D: Temporary period during which levodopa remains intact and unmetabolized due to reversible modulation of bacterial metabolism

Q606: Based on the described studies, which of the following events occur after the administration of sodium oligomannate (GV-971) in mouse models of Alzheimer's disease, and which processes are temporally linked to subsequent reductions in cerebral amyloidosis and neuroinflammation? Select all that apply.
Options:
A: Dampening of astrocyte and microglia activation, including decreased plaque-associated reactive microglia, follows GV-971-induced changes in the gut microbiome.
B: Sex-specific changes in cerebral cortex transcriptome profiles occur before any observed changes in gut microbiota composition.
C: Alteration of gut microbiota composition and metabolism, including increased amino acid production and changes in the tryptophan pathway, precedes reductions in peripheral pro-inflammatory cytokines.
D: Reductions in Aβ amyloidosis are observed prior to any alterations in the gut microbiota or peripheral immune profiles.

Q607: Considering the temporal progression of glioma development and therapy response, which of the following events are supported by the context as occurring after gut microbiota dysbiosis and before the enhancement of immunotherapies such as checkpoint inhibitors? Select all that apply.
Options:
A: Activation of critical signaling pathways such as NF-κB, MAPK, PI3K/Akt/mTOR, and Kynurenine/AhR driving tumor proliferation and immune evasion.
B: Modulation of systemic inflammation and oxidative stress contributing to tumorigenesis and CNS tumor progression.
C: Immediate restoration of CNS homeostasis through dietary interventions.
D: Direct enhancement of immunotherapies without prior modulation of the tumor microenvironment.

Q608: Based on the described studies, which of the following events are likely to occur sequentially in the progression from nonalcoholic fatty liver disease (NAFLD) to neuroinflammation, considering the temporal and hierarchical flow of chronic systemic inflammation and its impact on the central nervous system?
Options:
A: Neuroinflammation in the brain initiates, which subsequently causes NAFLD in the liver.
B: Chronic systemic inflammation develops in NAFLD, leading to the release of circulating inflammatory mediators.
C: Circulating inflammatory mediators from the periphery travel to the central nervous system and affect glial cells.
D: Neuroinflammation resolves first, followed by the onset of chronic systemic inflammation in NAFLD.

Q609: Considering the temporal progression of neurodegenerative diseases such as Alzheimer's and Parkinson's, which of the following events are likely to occur after the initial increase in oxidative stress and neuroinflammation, but before the restoration of microbial homeostasis through antioxidant-based interventions targeting the gut microbiota?
Options:
A: Activation of molecular pathways such as NF-κB and MAPK that regulate inflammatory cytokine expression
B: Exacerbation of neuronal damage and cognitive decline due to sustained oxidative damage
C: Immediate restoration of synaptic marker expression and reduction of amyloid-β accumulation
D: Acute normalization of gut-derived metabolite production by beneficial bacteria

Q610: Considering the temporal sequence of events in neurodegenerative disease progression, which of the following processes can occur as a result of early gut microbiota dysbiosis, and which may subsequently contribute to later neurodegeneration via the gut-brain axis? Select all that apply.
Options:
A: Activation of microglia and astrocytes in response to chronic stress, resulting in impaired sleep and exacerbation of brain dysfunction.
B: Immediate restoration of gut microbiome balance following the onset of neurodegeneration.
C: Direct production of BDNF by platelets interacting with monocytes after bacterial antigen exposure, independent of gut-brain axis involvement.
D: Disruption of intestinal homeostasis due to autophagy-lysosomal pathway dysfunction, leading to chronic neuroinflammation.

Q611: Considering the sequential events described in Alzheimer's disease mouse models, which of the following processes occur after fecal microbiota transplantation (FMT) from healthy wild-type donors, and precede the observed improvements in spatial memory and exploratory behavior? Select all that apply.
Options:
A: Normalization of pro-inflammatory cytokine expression (IL-6, IL-1β, TNF-α) in both gut and brain
B: Exacerbation of cognitive deficits and heightened Aβ deposition
C: Increase in pathogenic genera such as Erysipelatoclostridium in the gut microbiota
D: Reduction in amyloid-beta (Aβ) plaque burden in brain tissue

Q612: Considering the temporal sequence of events described in the context of neurodegenerative diseases, which of the following processes are likely to occur after gut dysbiosis disrupts the intestinal barrier but before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Ingress of pathobionts and toxic metabolites into the systemic circulation
B: Chronic neuroinflammation via dysregulated immune activation
C: Neuronal death in the central nervous system
D: Initial colonization of the gut microbiota at birth

Q613: Considering the temporal sequence of events in Alzheimer's disease (AD) as described in the context, which of the following processes are likely to occur after gut microbiota dysbiosis but before the manifestation of severe cognitive decline, according to the described hierarchical and time-dependent mechanisms linking the gut microbiome to neuroinflammation and cognitive impairment?
Options:
A: Complete reversal of cognitive impairment without intervention
B: Activation of brain toll-like receptor 4 (TLR4) pathways by circulating endotoxins
C: Increased intestinal permeability leading to translocation of endotoxins like LPS into the bloodstream
D: Immediate restoration of beneficial bacterial clades in the gut microbiota

Q614: Considering the temporal sequence of events in the neuroprotective mechanism against glaucoma described in the context, which of the following events would occur after the restoration of AhR activation by indoleacetic acid (IAA) or Bacteroides fragilis, but before the preservation of visual function in mice? Select all that apply.
Options:
A: Reduction of retinal ganglion cell (RGC) loss.
B: Depletion of tryptophan-metabolizing bacteria such as B. fragilis in the gut microbiota.
C: Lower systemic IAA levels in mice receiving FMT from glaucoma patients.
D: Suppression of inflammation by inhibiting microglial activation and the release of pro-inflammatory mediators throughout the retina.

Q615: Considering the temporal progression of gut microbiota-driven neuroinflammation in Alzheimer's disease, which of the following events are likely to occur after gut dysbiosis disrupts gut barrier integrity, but before the implementation of microbiota-targeted therapeutic interventions such as probiotics or fecal microbiota transplantation?
Options:
A: Systemic inflammation is promoted, exacerbating neuroinflammatory responses and accelerating Alzheimer's disease progression.
B: Randomized controlled trials conclusively validate the clinical efficacy of microbiota-targeted therapies in Alzheimer's disease.
C: Gut microbiota-derived metabolites, such as short-chain fatty acids and lipopolysaccharides, directly influence microglial activation and amyloid-beta aggregation.
D: Long-term sustainability of dietary interventions for depression is established through mechanistic studies.

Q616: Considering the temporal sequence of events in Alzheimer's disease, which of the following processes can occur after exosomes reflect the molecular state of the central nervous system, and may subsequently influence the progression of AD through the gut-brain axis or serve as a basis for early diagnosis?
Options:
A: Gut microbiota composition remains static and does not interact with exosomal pathways.
B: Exosomes promote the propagation of pathological proteins, contributing to disease progression.
C: Exosomes immediately reverse neuroinflammation without any intermediate steps.
D: Exosomes serve as non-invasive biomarkers detectable in peripheral fluids, enabling early diagnosis.

Q617: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes occur after the initial impairment of gut microbiome balance, and contribute to the progression or recovery of SCI according to the described studies? Select all that apply.
Options:
A: Aggravation of inflammation in the injured areas, which further inhibits axonal regeneration.
B: Permanent accumulation of L-methionine in the intestinal flora, regardless of any treatment.
C: Immediate restoration of gut microbiome balance, leading to spontaneous axonal regeneration without intervention.
D: Pectin-Zein-IPA nanoparticle treatment improves motor function recovery and inhibits activation of oxidative stress after SCI.

Q618: Considering the sequence of biological events described in the context, which of the following processes occur after the administration of Polygoni Multiflori Radix Praeparata polysaccharides (PMP) in the treatment of ischemic stroke, and which are part of the subsequent cascade leading to improved neurological outcomes? Select all that apply.
Options:
A: PMP administration immediately lowers the levels of inflammatory cytokines, such as TNF-α and IL-1β, without affecting gut barrier proteins.
B: PMP administration directly reverses the abundance of Bifidobacterium, Muribaculaceae, and Lactobacillus before any changes in metabolite levels.
C: PMP administration increases intestinal levels of short-chain fatty acids (SCFAs) and beneficial amino acids.
D: PMP administration promotes intestinal health and barrier integrity, thereby relieving ischemia/reperfusion injury in both brain and intestine.

Q619: Considering the temporal sequence of events described in OVA-induced food allergy mice, which of the following processes are likely to occur after the initial elevation of serum IgE and Th2 cytokines, but before the manifestation of extensive behavioral impairments? Select all that apply.
Options:
A: Activation of microglia and increased levels of TNF-α, IL-1β, and IL-6 in the prefrontal cortex.
B: Disruption of amino acid metabolism, particularly involving carboxylic acids and derivatives, correlated with altered gut microbiota.
C: Extensive impairment of behaviors such as anxiety-like, depression-like, and repetitive behaviors.
D: Initial sensitization with OVA and development of anaphylactic symptoms.

Q620: Based on the described temporal and hierarchical processes in the microbiota-gut-brain axis, which of the following events would most likely occur after gut microbiota dysbiosis but before the manifestation of neurological symptoms such as depression or anxiety? Consider the sequence involving metabolite release, immune activation, and CNS effects.
Options:
A: Alteration in the release of specific microbial metabolites into the bloodstream
B: Direct colonization of the central nervous system by gut microorganisms
C: Immediate improvement in psychological symptoms following butyrate supplementation
D: Activation of innate and adaptive immunity by the gastrointestinal microbiota

Q621: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes occur after the upregulation of LRRK2 expression in the colon and brain during the progression from mild chronic colitis to exacerbated neuroinflammation in Parkinson's disease mouse models? Select all that apply.
Options:
A: Activation of NF-κB pathway and inhibition of Nrf2 pathway in the brain
B: Elevation of inflammatory cytokines such as IL1-β and TNF-α in both colon and striatum
C: Initial increase in ZO-1 and Occludin expression in the colon
D: Restoration of dopaminergic neurons in the substantia nigra

Q622: Considering the temporal sequence of events in neurodegenerative diseases, which of the following processes are likely to occur after the initial disruption of redox homeostasis but before the manifestation of severe cognitive and motor deficits, according to the described hierarchical and regulatory cascades in the context?
Options:
A: Epigenetic modifications influencing redox balance and modulating oxidative stress
B: Immediate restoration of neuronal function and reversal of neurodegeneration
C: Activation of microglia and astrocytes in response to protein aggregation or immune attack
D: Complete prevention of neuronal loss by short-chain fatty acid supplementation

Q623: Considering the temporal progression of neurodegenerative disorders such as Alzheimer's disease, which of the following events are likely to occur after an initial gut microbiome imbalance, according to the described gut-brain axis pathways and feedback mechanisms? Select all that apply.
Options:
A: Increased neuroinflammatory responses mediated by altered gut microbiome metabolites.
B: Rapid reversal of amyloid pathology independent of gut microbiome composition.
C: Impaired intestinal barrier integrity leading to changes in blood-brain barrier permeability.
D: Immediate restoration of cognitive function due to compensatory neurotransmitter synthesis.

Q624: Based on the temporal progression of gut microbiota changes in patients with spinal cord injury (SCI), which of the following statements accurately describe the sequential alterations in the abundance of specific bacterial genera or phyla from the subacute to the chronic phase, and their potential implications for short-chain fatty acid (SCFA) production and gut dysbiosis?
Options:
A: In the subacute phase of SCI, the relative abundance of potential SCFA-producing genera such as Faecalbacterium, Ruminococcus, and Coprococcus is higher than in the chronic phase.
B: Gut dysbiosis is only present in the chronic phase of SCI and not in the subacute phase.
C: Firmicutes abundance increases from the subacute to the chronic phase of SCI.
D: The chronic phase of SCI is characterized by a lower abundance of potential SCFA-producing bacteria compared to the subacute phase, indicating a temporal decline in these beneficial genera.

Q625: Considering the temporal sequence of events in the pathogenesis of Alzheimer's Disease (AD) as described in the context, which of the following processes are reported to occur prior to the accumulation of amyloid-beta (Aβ) in the brain, and which interventions are shown to subsequently reduce Aβ accumulation and improve cognition in preclinical models? Select all that apply.
Options:
A: Fecal microbiota transplantation (FMT) restores gut microbial balance, reduces Aβ accumulation, and improves cognition in preclinical models.
B: Aβ accumulation in the brain occurs before any changes in the gut microbiota.
C: Antiviral therapies targeting HSV-1 are the first intervention before gut-brain signaling changes.
D: Gut microbiota dysregulation precedes brain Aβ accumulation.

Q626: In the experimental model of Japanese encephalitis described, mice were first administered a short-chain fatty acid (SCFA) mixture for 7 days before viral infection. Considering the sequence of molecular and cellular events following this prophylactic intervention, which of the following changes would be expected to occur after JEV infection, and which would be observed prior to the reduction in cellular death within brain tissue?
Options:
A: Reduced glial activation, as evidenced by lower microglial counts in brain tissue sections of SCFA-supplemented mice
B: Downregulation of inflammatory cytokines such as TNF-α, MCP-1, IL-6, and IFN-Υ in the SCFA-treated group compared to controls
C: Immediate restoration of normal weight in all JEV-infected mice regardless of SCFA supplementation
D: Upregulation of caspase-3 to levels higher than those seen in JEV-infected controls

Q627: Considering the temporal sequence of events described in the context of diabetic retinopathy (DR), which of the following processes occur after a reduction in circulating short-chain fatty acids (SCFAs) and before the manifestation of retinal morphological changes? Select all that apply.
Options:
A: Alleviation of retinal thinning and prevention of vessel loss in diabetic mice
B: Immune dysregulation with altered cytokine expression closely correlated with SCFA levels
C: Significant changes in retinal DNA methylation, including downregulation of key pathways
D: Improvement of intestinal barrier function following acetate supplementation

Q628: Considering the temporal progression of neurodegenerative diseases, which of the following events are likely to occur sequentially after autophagy-lysosomal pathway (ALP) dysfunction in the gut, based on the described gut-brain axis mechanisms? Select all that apply: (A) Promotion of gut microbiota dysbiosis, (B) Immediate restoration of intestinal barrier function, (C) Triggering of chronic neuroinflammation, (D) Acceleration of neurodegeneration.
Options:
A: Immediate restoration of intestinal barrier function
B: Triggering of chronic neuroinflammation
C: Acceleration of neurodegeneration
D: Promotion of gut microbiota dysbiosis

Q629: Considering the temporal sequence of events in ARDS-related depression, which of the following steps occur after the initial alteration in gut microbiota composition but before the alleviation of depressive-like behaviors in mouse models? Select all that apply.
Options:
A: Initial alteration in gut microbiota composition directly results in the complete prevention of depressive-like behaviors.
B: Oral administration of propionic acid immediately restores gut microbiota composition to baseline levels.
C: Fecal transplantation from ARDS patients into naive mice leads to microglial activation and intestinal barrier destruction.
D: Colonization of Akkermansia muciniphila or administration of its metabolite propionic acid decreases microglial activation and neuronal inflammation.

Q630: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after the ingestion of flavanones and before the observed improvement in cognitive function, specifically involving the gut-brain axis and molecular mediators produced by the gut microbiota?
Options:
A: Production of short-chain fatty acids (SCFAs), neurotransmitters, and anti-inflammatory cytokines by the gut microbiota, influencing the gut-brain axis.
B: Direct modulation of neuronal gene expression by unmodified dietary flavanones without involvement of the gut microbiota.
C: Immediate enhancement of cognitive function prior to any metabolic or microbial changes.
D: Metabolic transformation of flavanones by gut microbiota, leading to changes in the composition of beneficial and pathogenic bacterial populations.

Q631: Following neurosurgical procedures, a sequence of events can lead to both immediate and long-term cognitive impairments. Based on the described temporal and hierarchical processes, which of the following events occur after the initial compromise of the blood-brain barrier (BBB) and contribute to the progression of cognitive dysfunction in these patients?
Options:
A: Immediate restoration of BBB integrity preventing further neuronal damage
B: Release of cytokines such as tumor necrosis factor-alpha and interleukin-1 causing neuronal damage
C: Activation of neuroinflammatory responses involving microglia and astrocytes
D: Permanent resistance of the brain to viral infections due to surgery-induced immune enhancement

Q632: Considering the multi-step molecular pathways described in the context, which of the following events would most likely occur after a high-fat diet induces activation of enterocyte TLR-2 and TLR-4 signaling in obese mice, and before the onset of neuroinflammation and brain damage? Select all that apply.
Options:
A: Loss of integrity of the intestinal mucosa and increased intestinal permeability, allowing endotoxins into the blood circulation.
B: Immediate improvement in cognitive function due to increased tight junction proteins in the colon.
C: Direct reversal of obesity-induced changes in the gut flora without dietary intervention.
D: Alteration of the downstream MyD88-NF-κB signaling cascade and up-regulation of pro-inflammatory factors and lipopolysaccharide (LPS) levels.

Q633: Considering the multi-step regulatory cascades described in the context, which of the following events would most likely occur after dietary interventions modulate gut microbiota composition, and before improvements in depressive-like behaviors in cancer patients? Select all that apply.
Options:
A: Direct suppression of neuroinflammation in the central nervous system without involvement of microbial metabolites.
B: Immediate improvement of mood behaviors prior to any changes in gut microbiota composition.
C: Enhancement of immune homeostasis and intestinal barrier function by regulated gut microbiota.
D: Bidirectional modulation of microbial metabolites via systemic circulation and the gut-brain axis.

Q634: Considering the temporal sequence of events in the pathogenesis of Long COVID, which of the following processes are described as occurring after the initial SARS-CoV-2 infection and contribute to the chronic phase of the syndrome through gut-brain axis dysregulation and immune activation? Select all that apply.
Options:
A: Acute activation of the mTOR pathway resulting in increased AMP secretion and improved gut barrier function.
B: Translocation of pathogens or lipopolysaccharide into circulation, causing the release of pro-inflammatory cytokines.
C: Decreased production of short-chain fatty acids leading to impaired enteroendocrine cell function and increased gut leakiness.
D: Immediate restoration of beneficial short-chain fatty acid-producing bacteria such as Faecalibacterium and Bifidobacterium.

Q635: Considering the temporal progression of neurological diseases such as Alzheimer's disease and multiple sclerosis, which of the following events or interventions occurs prior to the restoration of neurotransmitter balance or improvement in cognition, according to the described microbiota-gut-brain axis mechanisms and therapeutic strategies? Select all that apply.
Options:
A: Reduction in systemic inflammation via gut-brain axis interventions
B: Restoration of neurotransmitter balance in the brain
C: Improvement in cognitive function and quality of life in patients
D: Modulation of gut microbiota composition through probiotic, prebiotic, or synbiotic administration

Q636: Considering the multi-step pathway by which gut microbial short-chain fatty acids (SCFAs) influence colorectal cancer (CRC) development, which of the following events would occur after a diet-induced reduction in SCFA production, and which would precede tumor initiation? Select all that apply.
Options:
A: Epigenetic modifications such as DNA methylation and histone changes influenced by reduced SCFA levels.
B: Restoration of SCFA levels in the colon through microbiota modulation as a preventive strategy.
C: Metastasis of colorectal cancer cells to distant organs.
D: Alterations in intestinal epithelial barrier function and immunity following decreased SCFA levels.

Q637: Considering the temporal progression of gut microbiota alterations and their downstream effects, which of the following events are likely to occur after the onset of dysbiosis and increased gut permeability, but before the manifestation of neuroinflammatory symptoms in the gut-liver-brain axis? Select all that apply.
Options:
A: Upregulation of synaptic marker expression in Alzheimer's disease following FMT.
B: Activation of immune and inflammatory pathways in the liver and brain due to increased permeability.
C: Restoration of microbial composition and functionality through fecal microbiota transplantation.
D: Entry of microbial byproducts such as lipopolysaccharides into the liver and brain, activating inflammatory pathways.

Q638: Considering the multi-step biological pathway described in the context, which of the following events would most likely occur after the oral administration of medium-chain triglycerides (MCT) in 5×FAD mice, and before the observed mitigation of memory decline? Select all that apply.
Options:
A: Elevation of short-chain fatty acid concentrations in the brain following improved gut homeostasis.
B: Increase in the relative abundance of Akkermansia in the gut microbiota.
C: Immediate reduction in Aβ levels in the brain prior to any changes in gut microbiota.
D: Direct promotion of neurite outgrowth without any alteration in intestinal permeability.

Q639: Considering the sequence of biological events described in the context, which of the following steps occur after fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors into Alzheimer's disease (AD) mice, and are temporally downstream of initial gut microbiota changes, ultimately leading to improved learning and memory abilities in AD mice?
Options:
A: Direct modulation of neuroplasticity-related gene expression in peripheral blood before any changes in gut microbiota composition.
B: Signaling to the brain via transport protein MCT1, resulting in mitigation of inflammation and enhancement of cognitive functions.
C: Activation of free fatty acid receptors FFAR2 and FFAR3 in the brain following increased short-chain fatty acids (SCFAs) production.
D: Immediate reversal of amyloid-β (Aβ) accumulation in the brain prior to any gut microbiota changes.

Q640: Considering the temporal progression of Alzheimer's disease (AD) pathology and therapeutic interventions, which of the following events or strategies occur after the initial formation of amyloid β (Aβ) plaques and neurofibrillary tangles, and are part of later-stage regulatory cascades or feedback mechanisms in AD as described in the context?
Options:
A: Microgliosis, astrocytosis, and synaptic loss as subsequent pathological events following Aβ and p-tau formation
B: Activation or inhibition of Ras homolog (Rho)-associated kinases (ROCKs) leading to changes in dendritic/synaptic structures and inflammation
C: Initial deposition of amyloid β (Aβ) plaques in the brain
D: Early onset of cognitive decline prior to any molecular pathology

Q641: Based on the described temporal and hierarchical interactions between the gut microbiota and the cAMP-PKA signaling pathway, which of the following events could occur sequentially after gut microbiota-derived metabolites activate the vagus nerve, ultimately influencing the progression of neurological diseases? Select all that apply.
Options:
A: Direct alteration of genetic background independent of gut microbiota or signaling pathways.
B: Modulation of immune and neuroendocrine systems, leading to changes in neurotransmitter release and behavioral traits.
C: Microglial activation and oxidative stress, contributing to the onset and progression of neurodegenerative diseases.
D: Immediate reversal of amyloid-β protein aggregation without involvement of signaling cascades.

Q642: Considering the temporal sequence of events in the pathogenesis of obesity as described in the context, which of the following processes occur after changes in gut microbiota composition but before the clinical manifestation of metabolic diseases? Select all that apply.
Options:
A: Onset of metabolic disorders mediated by microbial metabolites
B: Clinical diagnosis of obesity and related metabolic diseases
C: Initial alteration in the abundance of Bifidobacterium and Lactobacillus
D: Development of insulin resistance and adipose tissue accumulation

Q643: Considering the temporal sequence of events described in the context, which of the following processes occur after the disruption of the blood-brain barrier (BBB) during neurosurgical procedures and contribute to both immediate and long-term cognitive impairments through neuroinflammation?
Options:
A: Sustained neuroinflammatory responses that impair synaptic function and connectivity, resulting in cognitive dysfunction over time.
B: Restoration of BBB integrity before any neuroinflammatory processes can begin.
C: Activation of microglia and astrocytes leading to the release of pro-inflammatory cytokines such as tumor necrosis factor-alpha and interleukin-1.
D: Initial compromise of the BBB and exposure of cerebrospinal fluid to pathogens prior to any inflammatory response.

Q644: Considering the temporal sequence of events following gut microbiome dysbiosis, which of the following processes are likely to occur before the onset of chronic neurodegenerative disorders, and which may subsequently aggravate disease progression through hierarchical regulatory cascades involving inflammation, barrier dysfunction, and protein misfolding?
Options:
A: Impaired blood-brain barrier permeability occurs prior to changes in gut microbial metabolite profiles and precedes enteric neuronal dysfunction.
B: Defective protein clearance in the CNS initiates changes in gut microbiota composition, which then leads to increased production of beneficial metabolites.
C: Altered gut microbial composition leading to increased endotoxin production and immune cell activation precedes disruption of intestinal barrier permeability and neuroinflammation.
D: Pathogenic transformation of microbial composition triggers immune cell activation, which then disrupts intestinal barrier permeability and aggravates systemic pro-inflammatory states.

Q645: Considering the sequential biological events described in the context, which of the following processes occur after the administration of fermented dairy products and contribute to host health outcomes over time? Select all that apply. Your answer should reflect the timeline from initial microbial modulation to downstream effects on metabolic and immune parameters, as supported by mechanistic and clinical evidence in the context.
Options:
A: Permanent engraftment of all probiotic strains regardless of host genetics or intervention duration.
B: Immediate reversal of all neurodegenerative disease symptoms without further intervention.
C: Modulation of immune signaling leading to reductions in systemic inflammation markers.
D: Upregulation of tight-junction proteins in the intestinal epithelium, reinforcing barrier integrity.

Q646: Considering the multi-step regulatory cascades described in the context, which of the following events would most likely occur after a pathological shift in gut microbiota composition, and before the manifestation of neuropsychological disorders such as major depressive disorder or autism spectrum disorder? Select all that apply.
Options:
A: Altered secretion of metabolites and signaling molecules by the gut microbiota.
B: Direct improvement of cognitive functions and mood stabilization.
C: Immediate onset of neuropsychological disorders without intermediary biological changes.
D: Modulation of the immune system and function of tissue barriers such as the blood-brain barrier.

Q647: Based on the described studies, which of the following events are likely to occur after the administration of sodium oligomannate (GV-971) in male mice during the phase when amyloid-β (Aβ) deposition is already detectable or near maximal levels, considering the temporal progression from gut microbiota alteration to neuroinflammatory changes and transcriptomic responses?
Options:
A: After GV-971-induced microbiota and metabolite changes, there is a reduction in peripheral pro-inflammatory cytokine profiles and decreased plaque-associated reactive microglia in male mice.
B: GV-971 treatment in female mice consistently results in the same transcriptomic changes in the cerebral cortex as observed in male mice.
C: GV-971 administration immediately increases plaque-associated reactive microglia before any changes in gut microbiota are observed.
D: GV-971 treatment leads to significant changes in gut microbiota composition, followed by increased amino acid production and modulation of the tryptophan pathway.

Q648: Considering the temporal progression of gut microbiota colonization from birth to three years of age, which of the following events or interventions can occur during this critical window and subsequently influence both short-term and long-term health outcomes, including the risk of developing pediatric diseases or metabolic disorders later in life?
Options:
A: Environmental factors transiently reprogram the early-life gut microbiome, leading to functional changes that may impact health into adulthood.
B: Manipulation of the early-life intestinal microbes after the age of three has no effect on immunological or metabolic responses.
C: Gut microbiota composition remains static and unaffected by environmental factors during the first three years of life.
D: Interventions targeting the early-life gut microbiota, such as probiotics or prebiotics, can ameliorate or impair host immunological and metabolic responses, affecting overall health conditions later in life.

Q649: Considering the temporal progression of Alzheimer's disease (AD) pathogenesis, which of the following events or interventions are supported by the context as occurring after gut microbiota dysregulation but before the development of effective, personalized AD therapies? Select all that apply.
Options:
A: Initiation of clinical trials targeting AD-associated neuroinflammation.
B: Immediate restoration of cognitive function through standardized microbiome-based therapies.
C: Accumulation of amyloid-beta (Aβ) in the brain following gut-brain axis signaling pathways.
D: Universal efficacy of Aβ-targeted therapies in all AD patients.

Q650: Based on the described cellular and molecular pathways, which of the following events are likely to occur sequentially after dysbiosis in the gut microbiota, ultimately contributing to neurodegeneration in Alzheimer's disease? Consider the temporal progression from gut changes to glial cell activation and neuroinflammation.
Options:
A: Neurofibrillary tangles form in neurons before any changes in gut microbiota composition are observed.
B: Cholinergic synaptic decrease occurs prior to any involvement of glial cells in the neurodegenerative process.
C: Altered gut microbiota composition leads to compromised gut barrier integrity, which is then associated with increased GFAP expression in astrocytes.
D: Increased Bacteroidetes/Firmicutes ratio in the gut is temporally linked to subsequent activation of astrocytes and increased neuroinflammatory markers.

Q651: Considering the sequence of biological events following cerebral ischemia/reperfusion (I/R) injury in rats, which of the following processes occur after the initial brain injury and are subsequently modulated by Polygoni Multiflori Radix Praeparata polysaccharides (PMP) intervention, ultimately leading to improved neurological outcomes? Select all that apply.
Options:
A: Elevation of intestinal short-chain fatty acids (SCFAs) and beneficial amino acids following PMP administration.
B: Disruption of the gut barrier and reduction in tight junction proteins in both brain and intestinal tissues.
C: Immediate increase in the abundance of Bifidobacterium, Muribaculaceae, and Lactobacillus prior to I/R injury.
D: Lowering of inflammatory cytokines such as TNF-α and IL-1β in both brain and intestinal tissues after PMP treatment.

Q652: Considering the temporal progression of sepsis-associated encephalopathy (SAE), which of the following events are likely to occur sequentially as the microbiota-gut-brain axis (MGBA) is targeted for therapeutic intervention? Select all that apply: First, alterations in intestinal microbiota composition are observed, followed by changes in neuroendocrine signaling and immune responses, and finally, relief of cognitive impairments is achieved. Which steps in this timeline are explicitly supported by the context?
Options:
A: Relief of cognitive impairments occurs prior to changes in intestinal microbiota composition.
B: Alterations in compositional and quantitative intestinal microbiota profiles occur before changes in neuroendocrine signaling and immune responses.
C: Changes in neuroendocrine signaling and immune responses precede the relief of cognitive impairments in SAE.
D: Cognitive dysfunction is the initial event before any microbiota changes in SAE.

Q653: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of Dendrobium officinale Kimura & Migo flower flavonoids (DOFF) in D-galactose-induced aging mice, and contribute to the improvement of cognitive dysfunction through hierarchical regulation from gut microbiota to neuronal function?
Options:
A: DOFF up-regulates the expression of ZO-1, improving colonic tissue injury and enhancing intestinal barrier integrity.
B: DOFF directly increases the expression of synaptic proteins in the hippocampus without affecting gut microbiota composition.
C: DOFF intervention regulates the relative abundance of intestinal flora, including Akkermansia, and down-regulates the Firmicutes/Bacteroidetes ratio.
D: DOFF induces microglial activation and increases the production of pro-inflammatory cytokines in the hippocampus.

Q654: Considering the temporal sequence of events in ischemic stroke (IS) models treated with atorvastatin, which of the following processes occur after atorvastatin administration and before the observed improvement in neurobehavioral deficits, according to the described regulatory cascade involving the gut-brain axis and inflammation?
Options:
A: Suppression of microglia activation and inhibition of the NF-κB pathway
B: Reduction in the release of inflammatory cytokines such as IL-1β and IL-18
C: Initial induction of bilateral common carotid artery occlusion (BCCAO) to establish the IS model
D: Recruitment of IS patients and collection of fecal samples for gut microbiota assessment

Q655: Considering the sequential biological events described in the context, which of the following processes occur after the administration of propionate in the APPPS1-21 Alzheimer's disease mouse model, and are temporally linked to the reduction of Aβ plaques via modulation of immune and astrocytic responses?
Options:
A: Elevation of peripheral IL-17 levels, resulting in increased neuroinflammation.
B: Reduced expression of proinflammatory genes and increased expression of neurotrophic genes in astrocytes following propionate treatment.
C: Decrease in peripheral Th17 (Rorγt+ CD4+) cells and IL-17 secretion, leading to reduced reactive astrocytosis.
D: Immediate increase in Aβ plaque accumulation due to enhanced astrocyte activation.

Q656: Considering the temporal sequence of events in Alzheimer's disease pathogenesis as described in the context, which of the following processes are likely to occur after gut microbiome perturbations but before the manifestation of neuroinflammatory responses, according to the gut-brain axis model and probiotic intervention studies?
Options:
A: Restoration of gut microbiome homeostasis following probiotic administration as the initial event
B: Influence on blood-brain barrier permeability mediated by microbial metabolites
C: Impairment of intestinal barrier stability due to altered gut microbiome composition
D: Direct reduction of neuroinflammation by antioxidants in the brain without gut involvement

Q657: Considering the temporal sequence of events in the pathogenesis and treatment of inflammatory bowel disease (IBD), which of the following processes are likely to occur after the administration of plant-based dietary compounds, based on their effects on gut microbiota and downstream immune regulation as described in the context?
Options:
A: Regulation of signaling pathways such as TGF-β/Smad and TLR4/NF-κB/MAPK, subsequently leading to improved barrier function and reduced oxidative stress.
B: An improvement in gut dysbiosis, followed by an increase in anti-inflammatory cytokines and a decrease in pro-inflammatory cytokines.
C: A direct increase in harmful microbiota populations prior to any modulation of immune responses.
D: Immediate reduction of IBD symptoms without any changes in gut microbiota composition or immune signaling pathways.

Q658: Considering the temporal sequence of events described in Alzheimer's disease models, which of the following processes are likely to occur after gut microbiota dysbiosis but before the manifestation of memory impairments, according to the context provided? Select all that apply.
Options:
A: Significant changes in alpha diversity of gut microbiota in AD mice at 12 months of age.
B: Elevated levels of pro-inflammatory cytokines in the serum associated with increased activity of microglia and astrocytes in brain regions critical for memory.
C: Reduction in short-chain fatty acids (SCFAs) at both 6 and 12 months, indicating disruption in gut microbial metabolism.
D: Behavioral assessments revealing significant memory impairments in AD mice at both assessed ages.

Q659: Considering the temporal sequence of events following bariatric surgery, which of the following changes are likely to occur after the initial modulation of appetite-regulating hormones, and subsequently contribute to long-term metabolic health through the gut-brain axis? Select all that apply.
Options:
A: Structural and functional changes in brain regions involved in reward processing and cognitive control, leading to altered food choices.
B: Immediate restoration of all pre-surgical gut microbiota species to baseline levels.
C: Acute onset of neurodegenerative symptoms directly after surgery.
D: Increase in beneficial gut microbiota species such as Akkermansia muciniphila, influencing metabolic pathways via short-chain fatty acid production and bile acid metabolism.

Q660: Considering the temporal sequence of events in the gut microbiota-gut-brain axis, which of the following processes are likely to occur after an initial dysbiosis in gut microbial composition, and before the manifestation of cognitive or behavioral symptoms in neurodegenerative or neurodevelopmental disorders, according to the context provided?
Options:
A: Immediate restoration of cognitive function without intervention
B: Modulation of immune-inflammatory responses and neuroinflammation
C: Alterations in gut permeability and dysregulated microbial metabolite production
D: Direct upregulation of neurotrophic factors prior to any changes in gut barrier integrity

Q661: Considering the temporal sequence of events in neurodegenerative disease progression, which of the following processes are described as occurring prior to or influencing later pathological outcomes, such as neuroinflammation or amyloid-beta accumulation, according to the context provided? Select all that apply.
Options:
A: Proteomic approaches using plasma or CSF to assess efficacy after neurodegeneration is established.
B: The use of PET imaging to estimate the extent of lesions after disease progression has already occurred.
C: Gut microbiota dysregulation preceding brain amyloid-beta accumulation in transgenic mouse models.
D: Alterations in gut microbiota composition that trigger neuroinflammatory pathways and affect systemic immunity.

Q662: Considering the temporal sequence of events in ARDS-related depression, which of the following processes occur after fecal transplantation from ARDS patients into naive mice and before the alleviation of deficits by Akkermansia muciniphila (AKK) or propionic acid administration? Select all that apply.
Options:
A: Microglial activation and intestinal barrier destruction in recipient mice
B: Decrease in microglial activation and neuronal inflammation via inhibition of the Toll-like receptor 4/nuclear factor κB pathway
C: Development of depressive-like behaviors in recipient mice
D: Alleviation of ARDS-related deficits by AKK or propionic acid

Q663: Considering the multi-step biological pathways described, which of the following events must occur before the cognitive benefits of time-restricted feeding (TRF) are observed in Alzheimer's disease patients, and which events are part of the sequential mechanism linking TRF to improved cognition? Select all that apply.
Options:
A: Propionic acid (PA) crosses the blood-brain barrier and interacts with FFAR3 to mediate TRF's protective effects.
B: TRF directly reduces amyloid-beta deposition without involvement of gut microbiota or metabolites.
C: Knockdown of the free fatty acid receptor 3 (FFAR3) amplifies the cognitive benefits of TRF.
D: TRF enhances the production of propionic acid (PA) by modulating gut microbiota, specifically increasing B. pseudolongum abundance.

Q664: Following bariatric surgery, a sequence of neurobiological and gut microbiota changes occurs that influences hunger, appetite, and long-term metabolic health. Which of the following events are likely to occur after the initial reduction in ghrelin levels, considering the temporal progression and hierarchical regulation of appetite and metabolism described in the context?
Options:
A: Acute onset of neurodegenerative disease symptoms directly following surgery.
B: Immediate restoration of pre-surgical gut microbiota composition without further metabolic changes.
C: Structural and functional changes in brain regions involved in reward processing and cognitive control, contributing to reduced cravings and altered food choices.
D: An increase in glucagon-like peptide-1 (GLP-1) and peptide tyrosine-tyrosine (PYY) leading to enhanced satiety and decreased caloric intake.

Q665: Considering the multi-step biological pathways and temporal progression described in the context, which of the following events would most likely occur after the administration of SSRIs or SNRIs in patients with depression, and which events would precede observable changes in mood or cognition? Select all that apply.
Options:
A: Reduction of pro-inflammatory cytokines in serum or specific brain regions such as the hippocampus and prefrontal cortex.
B: Modulation of inflammatory pathways including NF-κB and NLRP3 inflammasome before behavioral changes are observed.
C: Direct alteration of gut microbiota composition as the first step in antidepressant action.
D: Immediate improvement in mood and cognition without any preceding molecular changes.

Q666: Considering the temporal sequence of events described in Alzheimer's disease mouse models treated with Buyang Huanwu Decoction (BYHWD), which of the following processes occur after the restoration of gut microbiota balance and suppression of the C/EBPβ/AEP pathway, ultimately leading to improved cognitive function? Select all that apply.
Options:
A: Onset of gut microbiota dysbiosis in 3×Tg mice
B: Reduction in pathological amyloid-beta (Aβ) plaque deposition
C: Initial activation of the C/EBPβ/AEP signaling pathway in the hippocampus
D: Diminished tau hyperphosphorylation and inhibition of pro-inflammatory cytokine release

Q667: Considering the temporal progression of gut microbiota interventions in neurological disorders, which of the following events are likely to occur after the initial administration of probiotics or fecal microbiota transplantation in individuals with autism spectrum disorder or Alzheimer's disease, according to the context provided?
Options:
A: Complete elimination of neuroinflammation and restoration of the gut-brain axis after a single intervention.
B: Immediate and definitive conclusions about the efficacy of probiotics in Alzheimer's disease based on current randomized controlled trials.
C: Enhancement of microbial diversity and mitigation of gastrointestinal and behavioral symptoms in autism spectrum disorder.
D: Altered gut microbiota composition and positive effects on metabolic biomarkers in Alzheimer's disease patients following probiotic supplementation.

Q668: Considering the sequential events in the pathogenesis of functional constipation (FC), which of the following processes must occur before impaired gut motility can be observed in FC patients, and which processes are likely to follow changes in microbiota composition over time according to the described study? Select all that apply.
Options:
A: Alterations in the abundance of key intestinal bacteria such as Alistipes, Akkermansia, and Oscillibacter precede changes in metabolite profiles including short-chain fatty acids and bile acids.
B: Differentially abundant metabolites, such as butyric acid and nor-deoxycholic acid, are observed after shifts in microbiota composition and are correlated with specific bacterial taxa.
C: Clinical symptoms of constipation are resolved prior to the identification of significant microbiota-metabolite correlations.
D: Impaired gut motility occurs before any detectable changes in the composition of the intestinal microbiota.

Q669: Considering the temporal progression of Alzheimer's disease pathogenesis, which of the following events occur early and which are observed later in the disease cascade? Select all options that correctly describe the sequence, including the initial immune response to β-amyloid aggregates and the subsequent chronic neuroinflammation that accelerates neuronal damage.
Options:
A: Prolonged or excessive activation of immune cells leads to chronic neuroinflammation and accelerates neuronal damage at later stages.
B: Chronic neuroinflammation due to prolonged immune cell activation occurs before microglia clear β-amyloid aggregates.
C: Early in Alzheimer's disease, microglia identify and clear pathological β-amyloid aggregates.
D: Neuronal damage precedes the initial immune response to β-amyloid aggregates in Alzheimer's disease.

Q670: Considering the temporal progression of gut microbiome colonization from birth through the first three years of life, which of the following events or interventions can occur during this critical window and subsequently influence long-term health outcomes, including the risk of pediatric diseases and neurodevelopmental disorders, as described in the context?
Options:
A: Manipulation of the adult gut microbiome after the age of three to alter pediatric disease risk.
B: Environmental factors leading to transient microbial reprogramming and functional changes in the early-life gut microbiome.
C: Exclusive reliance on genetic predisposition without considering microbiome changes during early life.
D: Interventions that modify the composition and function of the gut microflora during the first 1000 days, impacting neurodevelopment and later-life disease risk.

Q671: Considering the temporal sequence of events described in the context, which of the following processes occur after dietary component interventions modulate gut microbiota composition, and subsequently contribute to improved cancer-depression comorbidity outcomes through multi-step biological pathways involving immune and neurobehavioral regulation?
Options:
A: Direct genetic modification of host cells by dietary components without intermediary microbial changes.
B: Enhanced anticancer immune responses and inhibition of abnormal proliferation signals in the tumor microenvironment.
C: Immediate reversal of all depressive symptoms without involvement of microbial metabolites.
D: Modulation of neurotransmitter homeostasis and suppression of neuroinflammation via gut-brain axis interactions mediated by microbial metabolites.

Q672: Considering the temporal progression of neurodegenerative diseases such as Parkinson's and Alzheimer's, which of the following events are likely to occur sequentially following gut microbiota dysbiosis, based on the described regulatory cascades and feedback mechanisms involving immune and metabolic pathways?
Options:
A: Immediate restoration of cognitive function due to increased production of short-chain fatty acids by gut bacteria.
B: Altered production of microbial metabolites, such as short-chain fatty acids, influencing inflammatory cytokine levels and cognitive impairment.
C: Activation of microglia and peripheral immune cells leading to neuroinflammation within the central nervous system.
D: Direct reversal of neurodegeneration without modulation of immune or metabolic pathways.

Q673: During the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's, which of the following events are temporally linked in the gut-brain axis pathway, specifically involving gut microbiota-derived metabolites and their downstream effects on the central nervous system? Consider the sequence from gut dysbiosis to molecular changes in the brain, including the role of TMAO and miRNAs, and select all correct options that reflect this multi-step, time-dependent process as described in the context.
Options:
A: Gut dysbiosis leads to increased production of TMAO, which subsequently crosses the blood-brain barrier and promotes amyloid and tau aggregation in the brain.
B: Elevated TMAO levels modulate the expression of specific miRNAs, which then regulate neuroinflammation and neuronal death over time.
C: Altered gut microbiome composition immediately results in neuronal death without involvement of intermediate molecular pathways.
D: Neurodegeneration in the brain precedes any changes in gut microbiome composition or function.

Q674: Considering the sequential progression of Parkinson's disease (PD) as described in the context, which of the following events or interventions would most likely occur after the initial alteration of gut microbiota composition, and before the emergence of motor and non-motor symptoms? Select all that apply.
Options:
A: Production of neurotoxic microbial metabolites that may exacerbate neuronal damage.
B: Increased intestinal permeability and chronic inflammation resulting from dysbiosis.
C: Implementation of large-scale, randomized placebo-controlled trials for microbiota-based therapies.
D: Loss of dopaminergic neurons leading to motor and non-motor symptoms.

Q675: Considering the sequential biological events described in the context, which of the following processes would most likely occur after an increase in gut permeability due to microbiota imbalance, and before the manifestation of depressive symptoms? Select all that apply. Your answer should reflect the temporal progression from gut microbiota changes to neuroinflammation and neurotransmitter alterations, as outlined in the context.
Options:
A: Endotoxins enter the bloodstream, contributing to neuroinflammation.
B: Elevated cortisol levels directly cause neuronal damage in the hippocampus.
C: Behavioral evaluations reveal improvements in locomotor recovery after spinal cord injury.
D: Neuroinflammation alters neurotransmitter production, including serotonin.

Q676: Considering the temporal sequence of events in gut microbiome dysbiosis-mediated neurodegeneration, which of the following processes are likely to occur after the initial alteration in gut microbial composition but before the manifestation of clinical neurodegenerative symptoms, according to the described mechanistic pathways?
Options:
A: Complete reversal of neurodegenerative pathology solely by dietary interventions after clinical symptoms have fully developed.
B: Disruption of intestinal barrier permeability, aggravation of systemic pro-inflammatory state, and impairment of blood-brain barrier permeability.
C: Immediate restoration of brain homeostasis through intrinsic brain mechanisms without peripheral involvement.
D: Increased endotoxin production and reduction in beneficial metabolites, leading to immune cell activation and enteric neuronal dysfunction.

Q677: Considering the temporal progression of Alzheimer's disease (AD) pathology, which of the following events are likely to occur after early microglial clearance of β-amyloid (Aβ) aggregates, and contribute to the chronic phase of neurodegeneration according to the described immune and metabolic cascades?
Options:
A: Immediate restoration of normal lipid metabolism and complete resolution of neuroinflammation.
B: Disruption of lipid metabolism further exacerbating immune dysregulation and advancing AD progression.
C: Prolonged or excessive activation of immune cells leading to chronic neuroinflammation and accelerated neuronal damage.
D: Permanent suppression of microglial activity preventing any further immune response.

Q678: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of medium-chain triglycerides (MCT) to 5×FAD mice and contribute to the mitigation of memory deficits? Select all that apply.
Options:
A: Immediate reduction of memory decline before any changes in gut microbiota composition.
B: Hyperactivation of microglia and astroglia prior to MCT administration.
C: An increase in the relative abundance of Akkermansia in the gut microbiota.
D: Elevation of short-chain fatty acid concentrations in the brain following changes in gut microbiota.

Q679: Considering the multi-step biological pathways described, which of the following events would most likely occur after the administration of Berberine in mice with kainic acid-induced acute epileptic seizures, and which events would precede the observed neuroprotection? Select all that apply. Base your answer on the temporal sequence involving gut microbiota remodeling, metabolite changes, and neuronal outcomes as described in the context.
Options:
A: An increase in the abundance of Bacteroidetes and Alloprevotella in the gut microbiota occurs before the identification of candidate metabolites in the colon and hippocampus.
B: Neuroprotection against hippocampal neuron damage is observed prior to the regulation of short-chain fatty acids (SCFAs) by Berberine.
C: Remodeling of gut microbiota-associated lipid metabolism in the colon and hippocampus follows the initial alleviation of acute epileptic seizures.
D: Alterations in gut microbiota and metabolites are detected before the reduction of acute epileptic seizures in KA-induced mice.

Q680: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted diet mouse donors to Alzheimer's disease (AD) mice, and subsequently lead to improved learning and memory abilities? Select all that apply.
Options:
A: Direct modulation of neurotransmitter levels in the brain prior to any changes in gut microbiota composition.
B: An increase in short-chain fatty acids (SCFAs) in the recipient mice’s gut, followed by activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1.
C: Mitigation of brain inflammation as a downstream effect of SCFA signaling to the brain after FMT.
D: Immediate restoration of normal cognitive function in AD mice without changes in gut metabolites or receptor activation.

Q681: Considering the temporal progression of events following valproic acid (VPA) exposure in mice, which of the following processes occur after the initial behavioral impairment and neuroinflammation, and are subsequently modulated by daily administration of Coriolus versicolor (CV) from day 14 to 40, as evidenced by biochemical and histopathological analyses?
Options:
A: Permanent reduction in self-harming behavior before VPA exposure and CV administration.
B: Immediate restoration of normal motor skill growth prior to any behavioral testing or CV administration.
C: Significant improvement of VPA-induced neuroinflammation via modulation of the TLR-4/Myd88/NF-κB signaling cascade after CV treatment.
D: Reversal of cerebellum and hippocampus disorganization following CV administration after VPA-induced neuroinflammation.

Q682: Considering the multi-step biological pathways described, which of the following events would be expected to occur after vitamin D binds to the Vitamin D receptor (VDR) in intestinal epithelial cells, and before the prevention of systemic inflammation in Multiple Sclerosis patients? Select all that apply.
Options:
A: Decrease in microbial diversity within the gut microbiota
B: Support of regulatory T cell functions by suppressing Th1 and Th17 activity
C: Increase in pro-inflammatory gut microbial species
D: Regulation of tight junction proteins leading to reduced intestinal permeability

Q683: Based on the described mechanisms in the lung-brain axis, which of the following events would most likely occur after lung-derived immune mediators traverse the blood-brain barrier, and which event would typically precede cognitive decline in this temporal cascade? Select all that apply.
Options:
A: Induction of neuroinflammation following entry of immune mediators into the brain
B: Immediate improvement in cognitive function due to immune activation
C: Reduction of oxidative stress prior to hypoxemia-induced cerebral injury
D: Cognitive decline as a consequence of neuroinflammation triggered by lung-derived mediators

Q684: Considering the temporal progression of events following bariatric surgery, which of the following changes are observed in sequence from early to later phases, and how do these sequential alterations contribute to long-term metabolic health according to recent findings? Select all that apply.
Options:
A: Initial neurobiological changes in appetite-regulating hormones, followed by reshaping of gut microbiota, including increased Akkermansia muciniphila, which influences metabolic pathways.
B: Early reduction in ghrelin levels followed by increased GLP-1 and PYY, leading to enhanced satiety and decreased caloric intake.
C: Immediate structural changes in brain regions involved in reward processing, with no subsequent alterations in gut microbiota composition.
D: Delayed modulation of appetite-regulating hormones occurring only after long-term changes in gut microbiota.

Q685: Considering the temporal sequence of events in the gut-brain axis, which of the following processes occur after the production of short-chain fatty acids (SCFAs) by the gut microbiome but before the modulation of central blood pressure regulation, and which may also precede the development of neuroinflammation in neurodegenerative diseases?
Options:
A: MicroRNAs modulate neuroinflammatory and neurodegenerative pathways in the central nervous system.
B: Amyloid-beta and tau protein aggregation in the brain is promoted by TMAO.
C: Hormones released by enteroendocrine cells bind to receptors on vagus and spinal nerves, relaying information to the brain.
D: SCFAs stimulate enteroendocrine cells to release hormones such as serotonin and peptide YY.

Q686: Considering the temporal progression of neurodegenerative disorders, which of the following events are likely to occur sequentially following gut microbiota dysbiosis, as described in the context? Select all that apply: (1) Altered production of microbial metabolites such as SCFAs, (2) Compromised gut barrier integrity, (3) Increased GFAP expression in astrocytes, and (4) Direct impact on neuroinflammation markers. Indicate all correct options that reflect the order of events supported by the context.
Options:
A: Direct impact on neuroinflammation markers occurs before changes in microbial metabolite production.
B: Compromised gut barrier integrity is followed by increased GFAP expression in astrocytes.
C: Altered production of microbial metabolites such as SCFAs occurs early after gut microbiota dysbiosis.
D: Increased GFAP expression in astrocytes precedes compromised gut barrier integrity.

Q687: Based on the described studies, which of the following events would most likely occur after fecal microbiota transplantation (FMT) from healthy wild-type mice into APP/PS1 transgenic mice, and which events would be expected to precede improvements in cognitive function? Consider the temporal sequence from gut microbiota modulation to behavioral outcomes in Alzheimer's disease models.
Options:
A: Reduction in pro-inflammatory cytokine expression (IL-6, IL-1β, TNF-α) in both gut and brain tissues
B: Immediate restoration of neuronal structure in the hippocampus before any changes in gut microbiota composition
C: Acute increase in pathogenic genera such as Erysipelatoclostridium and Enterobacteriaceae following FMT from healthy donors
D: Enrichment of beneficial microbial taxa such as Bacteroides and Lachnospiraceae in the gut microbiota

Q688: Based on the described mechanisms in APP/PS1 mice, after a decrease in short-chain fatty acids (SCFAs) leads to impaired intestinal barrier integrity and increased NF-κB expression, which of the following events are expected to occur next in the temporal sequence of gut-brain axis dysregulation and neuroinflammation? Select all that apply.
Options:
A: An increase in intestinal inflammatory cytokines such as IL-1β and TNF-α.
B: A restoration of cognitive ability without any intervention.
C: An immediate normalization of FFAR3 expression in the absence of treatment.
D: A further aggravation of neuroinflammation due to the compromised intestinal mucosal barrier.

Q689: Considering the hierarchical and temporal sequence of events described in the context, which of the following processes occur after dietary component interventions modulate gut microbiota composition, and subsequently contribute to improved cancer-depression comorbidity outcomes through multi-step regulatory cascades involving microbial metabolites and host immune responses?
Options:
A: Enhancement of anticancer immune responses and inhibition of abnormal proliferation signals in the tumor microenvironment
B: Immediate restoration of all host metabolic pathways without involvement of microbial metabolites
C: Direct genetic modification of host neurons by dietary components without intermediary steps
D: Modulation of neurotransmitter homeostasis and suppression of neuroinflammation via gut-brain axis interactions

Q690: Considering the temporal progression of events in the gut-brain axis, which of the following sequences accurately reflects the order in which dysbiosis induced by antibiotic use in livestock can lead to neuroinflammation and compromise the gut-microbiota-brain axis integrity? Select all that apply.
Options:
A: Antibiotic use in livestock → neuroinflammation → disruption of gut microbiota → dysbiosis → systemic inflammation
B: Antibiotic use in livestock → disruption of gut microbiota → dysbiosis → systemic inflammation → neuroinflammation
C: Antibiotic use in livestock → disruption of gut microbiota → dysbiosis → compromise of gut-microbiota-brain axis → neuroinflammation
D: Antibiotic use in livestock → compromise of gut-microbiota-brain axis → disruption of gut microbiota → dysbiosis → neuroinflammation

Q691: Considering the temporal sequence of molecular events described in the context, which of the following processes would most likely occur after the modulation of gut microbiota by probiotic Lactobacillus strains in individuals with mild cognitive impairment or Alzheimer's disease, and before the manifestation of improved cognitive outcomes? Select all that apply.
Options:
A: Alteration of gut microbiota composition and production of microbial metabolites
B: Direct accumulation of amyloid-β in the brain without intermediary steps
C: Positive effects on metabolic biomarkers associated with cognitive function
D: Immediate reversal of neurodegeneration without changes in microbiota or metabolites

Q692: Considering the multi-step biological pathways described in the context, which of the following events are likely to occur sequentially after probiotic administration in a rat model of spinal cord injury, according to the gut microbiota-tryptophan metabolites-signaling pathway network? Select all that apply.
Options:
A: Enrichment of Bacillota and Clostridia in the gut microbiota, followed by increased production of tryptophan metabolites.
B: Activation of anti-inflammatory and neuroregenerative gene expression in the spinal cord as a downstream effect of elevated tryptophan metabolites.
C: Direct restoration of spinal cord tissue structure without involvement of microbial metabolites.
D: Immediate upregulation of spinal cord genes without changes in gut microbiota composition.

Q693: Considering the multi-step mechanism by which Buyang Huanwu Decoction (BYHWD) ameliorates cognitive impairment in Alzheimer's disease mice, which of the following events must occur before the suppression of the C/EBPβ/AEP signaling pathway in the hippocampus, and which events are expected to follow the restoration of gut microbiota balance after BYHWD treatment?
Options:
A: Reduction of pathological Aβ plaque deposition and tau hyperphosphorylation follows suppression of the C/EBPβ/AEP pathway.
B: Restoration of gut microbiota balance precedes suppression of the C/EBPβ/AEP pathway in the hippocampus.
C: Release of pro-inflammatory cytokines increases after restoration of gut microbiota balance.
D: Suppression of the C/EBPβ/AEP pathway in the hippocampus precedes restoration of gut microbiota balance.

Q694: Considering the temporal sequence of molecular and cellular events described in the R6/2 mouse model of Huntington's disease after daily propionate supplementation, which of the following changes occur as part of the anti-inflammatory response in the central nervous system before any observable effect on neuronal survival or clinical progression? Select all that apply.
Options:
A: Reduced iNOS positive cells in the motor cortex is detected before any prevention of neuronal loss.
B: Propionate treatment prevents the progression of clinical symptoms before any change in inflammatory markers.
C: Reduction in SPI1-mRNA levels in the CNS occurs prior to any improvement in neuronal survival.
D: Improvement in motor abilities is observed before normalization of TNFα-mRNA in the motor cortex.

Q695: Considering the temporal sequence of events in the lung-brain axis, which of the following processes can occur after the onset of lung injury and contribute to subsequent neurocognitive impairments, according to the described mechanisms involving immune regulation, neural pathways, and hypoxemia?
Options:
A: Neurotransmitter modulation in the gut directly initiates pulmonary inflammation.
B: Hypoxemia resulting from lung injury exacerbates cerebral injury via oxidative stress and impaired perfusion.
C: Lung-derived immune mediators traverse the blood-brain barrier and induce neuroinflammation.
D: Mechanical ventilation prevents all forms of cognitive impairment following lung injury.

Q696: Considering the progression of neurodegenerative diseases as described in the context, which of the following events occur after gut dysbiosis disrupts the intestinal barrier, and are part of the subsequent multi-step pathological cascade leading to neuronal death and neurodegeneration? Select all that apply.
Options:
A: Accumulation of neurotoxic misfolded proteins in and around CNS cells occurs.
B: Protein markers such as TLR4 and ACE2 are immediately upregulated in the gut epithelium.
C: Short-chain fatty acids are rapidly increased in the systemic circulation.
D: Chronic neuroinflammation via dysregulated immune activation is triggered.

Q697: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes are likely to occur after an initial alteration in gut microbiota composition (dysbiosis) but before the manifestation of neurological symptoms in disorders such as Parkinson's disease or schizophrenia? Select all that apply.
Options:
A: Restoration of microbial balance through fecal microbiota transplantation as a first-line event.
B: Modulation of immune responses through altered chemokine and cytokine production.
C: Immediate improvement in cognitive function due to synbiotic supplementation.
D: Activation of neuroinflammatory pathways and microglial activation in the central nervous system.

Q698: Considering the temporal sequence of events in addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage and contribute to subsequent changes in brain function and behavior? Select all that apply.
Options:
A: Systemic inflammatory responses and immune imbalances develop as harmful substances and bacteria cross the compromised intestinal barrier.
B: Gut barrier damage leads to dysbiosis, which then activates immune cells and releases inflammatory factors affecting the brain.
C: Altered mood, cognitive function, and increased substance cravings arise as a result of immune activation and inflammatory signaling following gut dysbiosis.
D: Addictive substance use disorder is alleviated before any changes in the gut microbiota or immune system occur.

Q699: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes occur after the modulation of gut microbiota composition by interventions such as Dendrobium officinale Kimura & Migo flower flavonoids or calorie restriction mimetics, and before the improvement of cognitive function or alleviation of neurodegenerative symptoms in aging or disease models?
Options:
A: Initial alteration in the population size and species of gut microflora due to aging
B: Direct increase in synaptic plasticity and cognitive performance without changes in inflammation or oxidative stress
C: Enhancement of intestinal barrier integrity, such as upregulation of ZO-1 expression and improvement of colonic tissue injury
D: Reduction of pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-1β) and inhibition of microglial activation in the brain

Q700: Considering the temporal progression of biological events in the gut-brain axis and its interaction with the hypothalamus-pituitary-adrenal (HPA) axis, which of the following events would most likely occur after chronic stress leads to HPA axis overactivation and elevated cortisol levels, but before the onset of depressive symptoms? Select all that apply.
Options:
A: Increased gut permeability allowing endotoxins to enter the bloodstream, contributing to neuroinflammation.
B: Restoration of microbial balance through probiotics, leading to improved clinical outcomes.
C: Altered neurotransmitter production, including serotonin, due to gut microbiota imbalance.
D: Resolution of neuroinflammation and normalization of HPA axis activity.

Q701: Considering the temporal sequence of events in the experimental model of Japanese encephalitis, which of the following changes occur after prophylactic administration of short-chain fatty acids (SCFAs) and subsequent JEV infection, and precede the observed increase in survival and delayed symptom onset in mice? Select all that apply.
Options:
A: Upregulation of caspase-3 and increased cellular death in the SCFA + JEV group
B: Downregulation of inflammatory cytokines such as TNF-α, MCP-1, IL-6, and IFN-Υ in brain tissue
C: Immediate restoration of normal neuronal counts prior to infection
D: Reduced glial activation as evidenced by decreased microglia per region of interest

Q702: Considering the multi-step regulatory cascades described in the context, which of the following events would be expected to occur after the oral administration of gold nanospheres (GNS) in the treatment of collagen-induced arthritis (CIA) in mice, and which would occur prior to the suppression of NF-κB activation in synovial tissues? Select all that apply.
Options:
A: Enrichment of the probiotic genus Ligilactobacillus in the gut microbiota.
B: Reduction in disease severity and synovial inflammation.
C: Upregulation of tight junction proteins Claudin-1 and ZO-1, restoring intestinal barrier function.
D: Suppression of synovial hyperplasia and inflammatory infiltration.

Q703: In the context of Alzheimer's disease (AD) pathogenesis, consider the sequence of immune cell involvement and their interactions. Which of the following events occur as part of the temporal progression from early to later stages of AD, specifically involving the transformation of central immune cells and the recruitment of peripheral immune cells to the central nervous system (CNS)? Select all that apply.
Options:
A: Microglia and astrocytes transform into different phenotypes at various stages of AD, exerting differing effects as the disease progresses.
B: Peripheral immune cells such as T cells, B cells, monocytes/macrophages, and neutrophils are recruited to the CNS to mediate the inflammatory response during AD progression.
C: The initial transformation of microglia and astrocytes is followed by interactions between central and peripheral immune cells, contributing to neuroinflammation in AD.
D: Peripheral immune cells remain excluded from the CNS throughout all stages of AD, and only central immune cells participate in neuroinflammation.

Q704: Considering the temporal sequence of events following bacterial stimulation of human peripheral blood immune cells, which of the following steps must occur before a significant increase in BDNF secretion is observed in PBMC cultures, and which events are directly diminished if monocytes are removed prior to stimulation?
Options:
A: Removal of monocytes prior to bacterial stimulation reduces both monocyte-platelet aggregates and stimulant-induced BDNF secretion.
B: Formation of monocyte-platelet aggregates precedes the major increase in BDNF secretion after bacterial antigen exposure.
C: Elevated platelet counts alone, without monocyte interaction, are sufficient to induce maximal BDNF secretion after bacterial stimulation.
D: BDNF secretion from PBMCs after bacterial stimulation occurs independently of any immune-blood cell complex formation.

Q705: Considering the temporal sequence of events in addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage and contribute to subsequent changes in brain function and addictive behaviors? Select all that apply.
Options:
A: Dysbiosis of the gut microbiota leading to activation of immune cells and release of inflammatory factors
B: Systemic inflammatory responses and immune imbalances following translocation of harmful substances and bacteria
C: Immediate improvement of cognitive function due to restoration of gut barrier integrity
D: Direct reversal of addictive substance cravings without intervention

Q706: Considering the temporal progression of gut microbiota dysbiosis and its impact on neurodegenerative disorders, which of the following events are likely to occur sequentially, starting from dysbiosis and leading to neuroinflammation? Select all that apply: First, dysbiosis alters microbial composition, then endotoxin production increases, followed by immune cell activation and enteric neuronal dysfunction, which subsequently disrupts intestinal barrier permeability and impairs blood-brain barrier permeability, ultimately recruiting immune mediators and leading to neuroinflammation.
Options:
A: Altered gut microbial composition due to dysbiosis precedes increased endotoxin production.
B: Recruitment of immune mediators occurs before disruption of intestinal barrier permeability.
C: Immune cell activation and enteric neuronal dysfunction follow increased endotoxin production.
D: Impairment of blood-brain barrier permeability occurs after disruption of intestinal barrier permeability.

Q707: Considering the progression of Alzheimer's disease, which of the following events occur after the initial immune cell-mediated clearance of β-amyloid aggregates, and contribute to the subsequent acceleration of neuronal damage and disease progression? Select all that apply.
Options:
A: Interaction between disrupted lipid metabolism and immune system exacerbating disease progression.
B: Prolonged or excessive activation of immune cells leading to chronic neuroinflammation.
C: Permanent suppression of immune response preventing further neurodegeneration.
D: Immediate restoration of normal lipid metabolism and complete resolution of pathological aggregates.

Q708: Considering the temporal sequence of events in the B. pseudolongum–propionic acid–FFAR3 axis described in the context of time-restricted feeding (TRF) and Alzheimer's disease, which of the following events are expected to occur after the initiation of TRF but before the observed improvement in cognitive function? Select all that apply.
Options:
A: Knockdown of FFAR3 leading to diminished cognitive benefits of TRF before any changes in PA levels.
B: An increase in B. pseudolongum abundance in the gut microbiota.
C: Enhanced production of propionic acid (PA) in the gut following changes in microbiota.
D: A reduction in amyloid-beta deposition in the brain prior to any changes in gut microbiota composition.

Q709: Considering the temporal sequence of molecular events described in the context, which of the following processes would most likely occur after the gut microbiota metabolizes dietary polyphenols, but before the observed protection of microglia against LPS-induced inflammation? Select all that apply.
Options:
A: Generation of polyphenol microbial metabolites (PMMs) with increased gut and blood-brain barrier permeability compared to parent polyphenols.
B: Release of nitric oxide and pro-inflammatory cytokines by microglia as a result of neuroinflammatory stimuli.
C: Translocation of PMMs across the artificial gut and blood-brain barrier models.
D: Up-regulation of pro-inflammatory cytokines (IL-6 and TNF-α) in BV-2 microglia following LPS exposure.

Q710: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of a methionine-restricted (MR) diet or fecal microbiota transplantation (FMT) from MR mice in Alzheimer's disease (AD) mouse models, and contribute to improved learning and memory abilities? Select all that apply.
Options:
A: Activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1, signaling to the brain to mitigate inflammation.
B: Reversal of the reduction in short-chain fatty acids (SCFAs) induced by AD, leading to increased SCFA levels in the gut.
C: Initial onset of cognitive impairment and memory loss in APP/PS1 double transgenic AD mice.
D: Genetic modification of the gut microbiota prior to any dietary intervention.

Q711: Considering the temporal progression of microglial activation following ischemic stroke, which of the following events are likely to occur after the initial pro-inflammatory (M1) response, and are targeted by experimental therapies aiming to promote tissue repair and neurological recovery?
Options:
A: Acute release of pro-inflammatory cytokines by microglia
B: Transition of microglia from M1 to M2 phenotype, promoting anti-inflammatory responses and regeneration
C: Immediate disruption of the blood-brain barrier by activated microglia
D: Activation of key signaling pathways such as PI3K/AKT/mTOR to support M2 polarization

Q712: Considering the progression of Alzheimer's disease in 3 × Tg-AD mouse models, which of the following events occur after the initial detection of memory impairment and altered DKI parameters, and are temporally associated with advancing age (from 6 to 12 months), according to the study's findings on neuroinflammation and gut microbiota dysbiosis?
Options:
A: Diminished Firmicutes/Bacteroidetes ratio and reduction in six kinds of short-chain fatty acids at 12 months.
B: Complete restoration of gut microbial metabolism and systemic inflammation by 12 months.
C: Significant increase in alpha diversity of gut microbiota at 12 months of age.
D: Elevated levels of pro-inflammatory cytokines in serum and increased activity of microglia and astrocytes in memory-related brain regions.

Q713: Following bariatric surgery, a sequence of neurobiological and gut microbiota changes occurs that influences hunger, appetite, and long-term metabolic health. Which of the following events are temporally downstream of the initial reduction in ghrelin and increase in GLP-1 and PYY, and contribute to sustained metabolic improvements over time according to clinical and preclinical studies?
Options:
A: Structural and functional changes in brain regions involved in reward processing and cognitive control, leading to reduced cravings and altered food choices.
B: Increase in beneficial gut species such as Akkermansia muciniphila, influencing metabolic pathways through short-chain fatty acid production and bile acid metabolism.
C: Acute reversal of all neurobiological changes within hours of surgery.
D: Immediate restoration of pre-surgical gut microbiota composition without further metabolic consequences.

Q714: Considering the temporal progression of neurodegenerative diseases, which of the following events occur after persistent bacterial infections compromise the blood-brain barrier, and subsequently perpetuate the cycle of neurodegeneration through molecular interactions described in the context? Select all that apply.
Options:
A: Bacterial amyloids cross-seed human amyloidogenic proteins, worsening neuronal damage and disease progression.
B: Inflammatory molecules and amyloids enter the brain, accelerating misfolding and aggregation of human amyloidogenic proteins.
C: Genetic variations in chaperone genes eliminate the risk of amyloidogenesis and neurodegeneration.
D: Molecular chaperones and heat shock proteins restore protein homeostasis and prevent neuronal damage.

Q715: Considering the temporal progression of heart failure (HF) as influenced by the gut microbiota, which of the following events would most likely occur after the onset of gut dysbiosis but before the implementation of microbiota-modulating therapies such as diet or probiotics? Select all that apply.
Options:
A: Personalized microbiota-based interventions leading to improved heart failure management.
B: Restoration of microbial balance and alleviation of cardiovascular symptoms due to fecal microbiota transplantation.
C: Systemic inflammation and metabolic disturbances resulting from altered microbial composition and function.
D: Impaired cardiovascular homeostasis mediated by microbial metabolite production and inflammatory pathways.

Q716: Considering the temporal sequence of events in the gut-joint axis, which of the following steps must occur before short-chain fatty acids (SCFAs) can exert beneficial effects on osteoarthritis (OA) by preserving cartilage and subchondral bone integrity? Select all that apply. Options may include processes such as microbial fermentation, SCFA production, and their transport via blood circulation, as described in the context.
Options:
A: Transport of SCFAs from the gut to distant tissues and organs via blood circulation
B: Microbial fermentation of dietary fibers in the gut to produce SCFAs
C: Direct application of SCFAs to joint tissue without prior microbial processing
D: SCFA-induced modulation of synbiotic supplementation in neurological disorders

Q717: Considering the temporal sequence of events in Parkinson's disease pathogenesis, which of the following processes are described as occurring after gut microbiota dysbiosis and contribute to disease progression, according to the context? Select all that apply.
Options:
A: Restoration of gut microbiota diversity through fecal microbiota transplantation
B: Initial colonization of the gut by commensal microorganisms
C: Abnormal α-synuclein aggregation and reduced neurotransmitter synthesis
D: Enhanced intestinal permeability and increased intestinal inflammation

Q718: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) in neurodegenerative disorders, which of the following processes are likely to occur after the restoration of microbial diversity in the gut, and before the alleviation of motor and cognitive deficits, according to the described mechanisms in the context?
Options:
A: Immediate improvement in motor and cognitive deficits without intermediary molecular changes
B: Strengthening of gut barrier integrity and regulation of neurotransmitter production
C: Reduction of neuroinflammation through modulation of neuroinflammatory pathways
D: Onset of donor selection complexities prior to any microbial or neurological changes

Q719: Considering the temporal sequence of events in osteoarthritis (OA) progression and therapy, which of the following steps occur after the microbial fermentation of dietary fibers in the gut, ultimately leading to the preservation of joint integrity and potential mitigation of OA symptoms? Select all that apply.
Options:
A: SCFAs preserving intestinal barrier function, which helps maintain the integrity of cartilage and subchondral bone.
B: Initial breakdown of cartilage and subchondral bone due to chronic inflammation in OA.
C: Microbial fermentation of dietary fibers in the gut.
D: Production of short-chain fatty acids (SCFAs) that enter the blood circulation and exert effects on distant tissues.

Q720: Based on the described studies, consider the sequence of events following fecal microbiota transplantation (FMT) from healthy wild-type donors versus DSS-induced colitis donors in APP/PS1 transgenic mice. Which of the following events occur after the initial alteration of gut microbiota composition, and are temporally linked to subsequent changes in Alzheimer's disease pathology and neuroinflammation?
Options:
A: Reduction in amyloid-beta plaque burden and normalization of pro-inflammatory cytokine expression in both gut and brain tissues after FMT from healthy donors.
B: Immediate restoration of cognitive function prior to any detectable changes in gut microbial composition.
C: Direct improvement of blood-brain barrier permeability before any modulation of gut microbiota.
D: Exacerbation of cognitive deficits and increased amyloid-beta deposition following FMT from DSS-induced colitis donors.

Q721: Considering the temporal sequence of events in the development of neurological complications in inflammatory bowel disease (IBD) as described in the context, which of the following processes are likely to occur after the initial induction of IBD in mice, but before the manifestation of depression-like behaviors and cognitive deficits? Select all that apply.
Options:
A: Alterations in the gut microbiome composition, including changes in the abundance of Bacteroides, Turicibacter, Ruminococcus, and Akkermansia.
B: Immediate restoration of normal short-chain fatty acid (SCFA) levels in the colon and hippocampus.
C: Resolution of all neurological symptoms prior to any metabolic changes.
D: Decreased energy metabolism, amino acid levels, and choline metabolism in colonic contents and hippocampal tissue.

Q722: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after gut microbial metabolites interact with their target genes, but before observable changes in neurodegenerative disease symptoms manifest? Select all that apply.
Options:
A: Initial production of neuroactive compounds by gut bacteria within the gut lumen.
B: Clinical observation of improved cognitive function in patients with neurodegenerative diseases.
C: Modulation of inflammatory signaling pathways such as NFKB1, leading to altered neuroinflammation.
D: Regulation of neuronal viability and synaptic plasticity through downstream effects on cellular signaling pathways.

Q723: Considering the temporal sequence of events in the gut-brain axis and its role in neurodegenerative disorders, which of the following processes would most likely occur after an increase in inflammation-associated gut microbiota, and before the manifestation of neurodegenerative disease symptoms? Select all that apply.
Options:
A: Up-regulation of neuroinflammatory responses in the central nervous system due to proinflammatory signals from the gut.
B: Restoration of gut microbiome balance through the introduction of short-chain fatty acid-producing bacteria.
C: Epigenetic modifications of DNA methylome and histone proteins leading to altered neuroinflammatory gene expression.
D: Therapeutic intervention targeting the gut-brain axis to manage neurological movement disorders.

Q724: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after the administration of polyphenols in chronic kidney disease (CKD) patients, but before the potential slowing of CKD progression? Select all that apply.
Options:
A: Long-term stabilization of kidney function without any alteration in gut microbiota or signaling pathways.
B: Immediate reversal of all CKD-related symptoms without any intermediate molecular changes.
C: Modulation of gut microbiota composition and function by polyphenols, leading to changes in microbial metabolites.
D: Regulation of signaling pathways such as NF-κB, MAPK, mTOR, NLRP3, PI3K/Akt, and TLR by polyphenols, impacting inflammation and oxidative stress.

Q725: Considering the temporal sequence of events in the gut-brain axis, which of the following processes are likely to occur after an alteration in gut microbiota composition, ultimately influencing the progression of neurodegenerative diseases through multi-step regulatory cascades involving signaling pathways and metabolite production?
Options:
A: Regulation of amyloid-β protein aggregation, mitochondrial dysfunction, and neurotransmitter release as downstream effects of gut microbiota and cAMP-PKA pathway interaction.
B: Activation of the cAMP-PKA signaling pathway by gut microbiota-derived metabolites, leading to modulation of immune and neuroendocrine systems.
C: Direct genetic modification of neuronal DNA by gut microbiota without intermediary signaling molecules.
D: Immediate restoration of cognitive function without involvement of intermediary molecular pathways.

Q726: Considering the temporal sequence of events in the gut-brain axis and its role in neurodegenerative and neurodevelopmental disorders, which of the following processes would most likely occur after an initial alteration in gut microbiota composition but before the manifestation of behavioral or cognitive symptoms? Select all that apply.
Options:
A: Activation of inflammation-related signaling pathways such as NF-κB, MAPK, or PI3K/AKT/mTOR in response to microbial dysbiosis
B: Changes in microbial metabolite production that influence gut-brain axis signaling
C: Direct modulation of neurotransmitter homeostasis in the central nervous system by dietary phytochemicals without microbial mediation
D: Clinical presentation of cognitive impairments and behavioral abnormalities characteristic of neurodevelopmental disorders

Q727: Considering the temporal sequence of molecular and cellular events described in the context of mild chronic colitis exacerbating intracerebral inflammation in Parkinson's disease (PD) mice, which of the following events are likely to occur after the initial upregulation of LRRK2 expression in both the colon and brain, but before the significant loss of dopaminergic neurons in the substantia nigra? Select all that apply.
Options:
A: Activation of the NF-κB pathway in the brain following increased LRRK2 expression.
B: Recovery of dopaminergic neurons in the substantia nigra and striatum.
C: Elevation of inflammatory cytokines such as IL1-β and TNF-α in the colon and brain.
D: Restoration of intestinal barrier integrity as indicated by increased ZO-1 and Occludin levels.

Q728: Considering the temporal sequence of events in the development of depression and Alzheimer's disease, which of the following processes are described as occurring prior to or during the early stages of disease progression, and are subsequently targeted by interventions such as probiotics, prebiotics, or Semen Cuscutae flavonoids to modulate outcomes? Select all that apply.
Options:
A: Formation of amyloid-β plaques as the initial event before any changes in gut microbiota or neuroinflammation.
B: Direct modulation of hippocampal neurotransmitter systems without involvement of gut microbiota or metabolic changes.
C: Dysregulation of microbial metabolites and metabolic pathways, such as bile acid biosynthesis, occurring before behavioral symptoms in depression models.
D: Alterations in gut microbiota composition that precede or accompany neuroinflammation in Alzheimer's disease and depression.

Q729: Based on the described gut microbiota-tryptophan metabolites-signaling pathway network in spinal cord injury (SCI) models, which of the following events occur after probiotic-induced enrichment of Bacillota and Clostridia, and before the observed neuroprotective and anti-inflammatory outcomes in the spinal cord? Select all that apply.
Options:
A: Immediate restoration of gut microbiota diversity without changes in metabolite profiles.
B: Activation of downstream signaling pathways in the spinal cord involving upregulation of genes related to anti-inflammatory and neuroregenerative processes.
C: Direct modulation of spinal cord gene expression by probiotics without involvement of microbial metabolites.
D: Increased production of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile.

Q730: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after the disruption of gut microbiota by antibiotics introduced through the food chain, and before the potential development of neurodegenerative conditions? Select all that apply.
Options:
A: Immediate restoration of gut-microbiota-brain axis integrity.
B: Dysbiosis-induced systemic inflammation as a result of disrupted microbial balance.
C: Onset of neurodegenerative conditions prior to any changes in gut microbiota.
D: Compromise of the gut-brain barrier following dysbiosis.

Q731: Considering the temporal sequence of events following ischemic stroke (IS) and subsequent intervention with Polygoni Multiflori Radix Praeparata polysaccharides (PMP), which of the following processes are expected to occur after PMP administration and contribute to improved neurological outcomes, according to the described mechanistic pathway from gut microbiota modulation to brain health?
Options:
A: PMP administration leads to improved intestinal barrier integrity by boosting tight junction proteins, which subsequently helps relieve ischemia/reperfusion injury in both brain and intestine.
B: PMP directly increases the levels of pro-inflammatory cytokines TNF-α and IL-1β in the brain, leading to further disruption of the gut barrier.
C: PMP reduces the abundance of Bacteroides, which is immediately followed by a decrease in beneficial amino acid levels in the intestine.
D: PMP increases the abundance of beneficial gut microbiota such as Bifidobacterium and Lactobacillus, which is followed by enhanced production of short-chain fatty acids (SCFAs) in the intestine.

Q732: Considering the temporal sequence of events in the gut-brain axis during neuroinflammatory conditions such as multiple sclerosis and Alzheimer's disease, which of the following processes are likely to occur after the onset of gut dysbiosis but before the manifestation of neuroinflammation, according to the described hierarchical pathways and feedback mechanisms?
Options:
A: Accumulation of amyloid-β and hyperphosphorylation of tau as the initial trigger for gut dysbiosis.
B: Immediate restoration of eubiosis and normalization of the gut microbiota composition.
C: Altered gut barrier integrity leading to increased permeability, facilitating systemic inflammation.
D: Activation of the inflammasome pathway in response to microbial products, resulting in the production of pro-inflammatory cytokines.

Q733: Considering the temporal sequence of events in DSS-induced IBD mice, which of the following changes are observed after the initial induction of colitis and precede the manifestation of depression-like behaviors and cognitive deficits? Select all that apply.
Options:
A: Development of severe paralysis due to demyelination of the myelin sheath.
B: Alterations in gut microbiome composition and metabolome in colonic contents and hippocampal tissue.
C: Decreased energy metabolism, amino acid levels, short-chain fatty acids (SCFAs), and choline metabolism.
D: Restoration of tissue homeostasis through targeted modulation of the microbiota.

Q734: Considering the temporal sequence of molecular and cellular events described in the context of propionate supplementation in the R6/2 mouse model of Huntington's disease, which of the following changes would be expected to occur after the initiation of propionate treatment, and which would be observed at a later stage as a downstream effect of reduced neuroinflammation? Select all that apply.
Options:
A: A decrease in iNOS-positive cells in the motor cortex would occur as a subsequent event following the initial downregulation of inflammatory markers.
B: Prevention of neuronal loss in the striatum and cortex would be a direct and early effect of propionate treatment.
C: A reduction in SPI1-mRNA levels in the brain would be observed soon after propionate treatment, reflecting an early anti-inflammatory effect.
D: Improvement in clasping behavior would be an immediate outcome following propionate supplementation.

Q735: Considering the temporal sequence of events following bariatric surgery (BS), which of the following changes are expected to occur in the early to intermediate phases post-surgery, and which may contribute to long-term metabolic health outcomes through hierarchical gut-brain interactions? Select all that apply.
Options:
A: Reshaping of the gut microbiota, including an increase in beneficial species such as Akkermansia muciniphila, which influences metabolic pathways via short-chain fatty acid production and bile acid metabolism.
B: Immediate restoration of gut microbiome diversity to pre-obesity levels without further metabolic changes.
C: Structural and functional changes in brain regions involved in reward processing and cognitive control, contributing to altered food choices over time.
D: A reduction in ghrelin levels followed by an increase in GLP-1 and PYY, leading to enhanced satiety and decreased caloric intake.

Q736: During the progression of neurodegenerative diseases such as Alzheimer's disease, which of the following sequences or regulatory cascades involving the gut microbiota and its metabolites is supported by the context as contributing to disease modulation or progression over time?
Options:
A: Altered gut microbiota composition leads to changes in microbial metabolite production, which then modulates neuroinflammation and influences neuronal plasticity.
B: Neurodegenerative diseases progress independently of any changes in gut microbiota or microbial metabolite production.
C: Dysregulation of the microbiota-gut-brain axis increases intestinal permeability, which subsequently exacerbates neuroinflammation and contributes to neurodegenerative disease progression.
D: Immediate pharmacological intervention in Alzheimer's disease directly restores synaptic plasticity without involvement of the gut-brain axis or microbial metabolites.

Q737: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after early ethanol exposure during pregnancy, and before the manifestation of cognitive impairment in fetal alcohol spectrum disorder (FASD), according to animal studies and literature reviews?
Options:
A: Resolution of behavioral deficits prior to brain damage
B: Immediate improvement in neurodevelopmental outcomes
C: Alteration of the gut microbiome composition
D: Induction of neuroinflammation

Q738: Considering the temporal sequence of events in the lung-brain axis, which of the following processes are likely to occur after the initial lung injury but before the manifestation of cognitive decline, according to the described mechanisms involving immune regulation and protein markers?
Options:
A: Lung-derived immune mediators traverse the blood-brain barrier and induce neuroinflammation.
B: Microbial translocation from the lung microbiota immediately results in improved neurological function.
C: Prolonged mechanical ventilation directly causes acute respiratory complications in the brain.
D: Protein markers such as TLR4, ACE2, and HMGB1 become elevated and correlate with disease severity.

Q739: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after the restoration of gut microbial balance via fecal microbiota transplantation (FMT) in patients with neurodegenerative disorders, and before the alleviation of neurological symptoms? Select all that apply.
Options:
A: Modulation of gut-brain axis signaling pathways impacting brain health and disease progression.
B: Permanent elimination of the risk for future gut dysbiosis.
C: Increased production of signaling molecules such as short-chain fatty acids and neurotransmitters by the restored microbiota.
D: Immediate reversal of all neurodegenerative pathology in the central nervous system.

Q740: Considering the temporal sequence of events in the pathogenesis of endometriosis (EM), which of the following processes are likely to occur after microbial dysbiosis but before the proliferation of endometriotic lesions, according to the described hierarchical and mechanistic pathways involving the gut microbiota, immune modulation, and estrogen metabolism?
Options:
A: Modulation of estrogen metabolism by the gut microbiota via the estrobolome, resulting in increased systemic estrogen levels.
B: Initial reduction in beneficial gut bacteria such as Lactobacillus and Bifidobacterium.
C: Activation of the TLR4/NF-κB signaling pathway by lipopolysaccharides (LPS) from Gram-negative bacteria, leading to exacerbated inflammation.
D: Onset of chronic pelvic pain and infertility as clinical manifestations of advanced endometriosis.

Q741: Considering the temporal sequence of events described in the context of osteoarthritis (OA) and the gut-joint axis, which of the following processes occur after the microbial fermentation of dietary fibers in the gut, and subsequently contribute to the mitigation of OA progression through multi-step biological pathways?
Options:
A: Initial breakdown of dietary fibers by host digestive enzymes in the stomach prior to microbial fermentation.
B: Production of short-chain fatty acids (SCFAs) that enter blood circulation and exert effects on distant tissues, including joints.
C: Preservation of intestinal barrier function and maintenance of cartilage and subchondral bone integrity mediated by SCFAs.
D: Direct absorption of intact dietary fibers into the bloodstream without microbial processing.

Q742: Considering the temporal sequence of events following cerebral ischemia/reperfusion (I/R) injury in rats, which of the following processes are reported to occur after administration of Polygoni Multiflori Radix Praeparata polysaccharides (PMP), and subsequently contribute to improved neurological outcomes? Select all that apply.
Options:
A: A reversal in the abundance of beneficial gut microbiota (e.g., Bifidobacterium, Muribaculaceae, Lactobacillus) that correlates with improved SCFA and amino acid metabolism.
B: Immediate restoration of neurological function prior to any changes in gut microbiota composition or metabolite levels.
C: An increase in intestinal short-chain fatty acids (SCFAs) such as butyrate and propionate, followed by enhanced gut barrier integrity.
D: A decrease in tight junction protein expression in both brain and intestinal tissues, leading to further barrier disruption.

Q743: Considering the temporal sequence of events following the loss of social dominance in mice, which of the following processes are reported to occur after the initial stress-induced alteration of gut microbiota composition, and are linked to subsequent changes in brain function or behavior according to the context provided?
Options:
A: Altered GABAergic synaptic transmission in prefrontal cortex interneurons
B: Changes in the PI3K-Akt signaling pathway and glutamatergic synapse in the prefrontal cortex
C: Direct increase in neuronal survival in the striatum without involvement of the gut microbiota
D: Immediate restoration of social dominance without behavioral alteration

Q744: Considering the temporal sequence of events within the gut-microbiota-brain axis, which of the following processes would most likely occur after antibiotic-induced disruption of the gut microbiota in livestock, and before the manifestation of neuroinflammation or neurodegenerative symptoms in the host? Select all that apply.
Options:
A: Compromise of the gut-microbiota-brain axis integrity, increasing susceptibility to systemic inflammation.
B: Development of gut microbiota dysbiosis leading to altered microbial metabolite production.
C: Immediate restoration of gut-microbiota-brain axis integrity.
D: Resolution of neurodegenerative symptoms prior to any changes in the gut microbiota.

Q745: Considering the temporal sequence of events in the microbiota-gut-brain axis, which of the following processes are likely to occur after psychological stress initiates alterations in the hypothalamic-pituitary-adrenal (HPA) axis, ultimately exacerbating inflammatory bowel disease (IBD) severity? Select all that apply.
Options:
A: Disruption of the balance between the sympathetic nervous system and vagus nerves, leading to changes in intestinal immunity and permeability.
B: Direct reversal of chronic IBD manifestations without affecting the microbiota-gut-brain axis.
C: Alterations in the homeostasis of intestinal flora and metabolites, contributing to increased disease severity.
D: Immediate improvement in IBD symptoms due to enhanced intestinal flora homeostasis.

Q746: Considering the temporal sequence of events in the pathophysiology of depression, which of the following processes are likely to occur after chronic stress leads to overactivation of the hypothalamus-pituitary-adrenal (HPA) axis, but before the manifestation of depressive symptoms? Select all that apply.
Options:
A: Immediate improvement in mood due to increased serotonin production in the gut.
B: Increased gut permeability allowing endotoxins to enter the bloodstream, contributing to neuroinflammation.
C: Elevated cortisol levels resulting in neuronal damage in the hippocampus and prefrontal cortex.
D: Resolution of neuroinflammation and restoration of immune tolerance by regulatory T cells.

Q747: Considering the temporal sequence of molecular and cellular events described in the context of atorvastatin treatment for ischemic stroke, which of the following processes occur after atorvastatin administration and before the observed improvement in neurobehavioral deficits? Select all that apply.
Options:
A: Inhibition of NF-κB pathway and NLRP3 inflammasome formation
B: Suppression of microglia activation
C: Recruitment of ischemic stroke patients for clinical trials
D: Initial induction of bilateral common carotid artery occlusion (BCCAO)

Q748: Considering the temporal sequence of events in the development and intervention of diabetic retinopathy (DR), which of the following processes occur after acetate supplementation in diabetic mice and are associated with improved retinal outcomes? Select all that apply.
Options:
A: Decrease in the frequency of CD45+ CD11b+ cells and F4/80+ CD206+ CD11c- cells, indicating inhibition of the overactive immune system in the diabetic retina.
B: Improvement of intestinal barrier function, followed by alleviation of retinal thinning and prevention of vessel loss.
C: Immediate increase in circulating SCFA levels, leading directly to changes in retinal DNA methylation without immune modulation.
D: Upregulation of vascular endothelial growth factor and nuclear factor-kappa B pathways in the retina.

Q749: Considering the temporal sequence of events in ischaemic stroke pathophysiology, which of the following processes occur after the initial reduction in cerebral blood flow but before the implementation of therapeutic strategies targeting gut microbial composition, and are directly linked to the progression of neuronal injury according to the context?
Options:
A: Compromise of blood-brain barrier integrity and exacerbation of reperfusion-induced damage
B: Implementation of large-scale, randomised clinical trials for antioxidant supplementation
C: Restoration of microbial diversity through faecal microbiota transplantation
D: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB

Q750: Considering the temporal sequence of events in the pathogenesis of Parkinson's disease (PD) as described in the context, which of the following processes are likely to occur after the onset of gut microbiota dysbiosis but before the manifestation of clinical motor symptoms? Select all that apply.
Options:
A: Abnormal aggregation of α-synuclein and neuroinflammation
B: Enhanced intestinal permeability and increased intestinal inflammation
C: Complete recovery of dopaminergic neurons in the substantia nigra
D: Immediate restoration of gut microbiota diversity through fecal microbiota transplantation (FMT)

Q751: Considering the temporal sequence of events in neurodegenerative disease progression, which of the following steps are supported by the context as occurring after dietary modulation of the gut microbiota but before the manifestation of neuroprotective effects in the central nervous system (CNS)? Select all that apply.
Options:
A: Immediate reduction in neuroinflammation prior to any changes in microbial metabolite levels.
B: Alteration in the production of microbial metabolites such as short-chain fatty acids and amino acid derivatives.
C: Modulation of immune responses and regulation of intestinal permeability by microbial metabolites.
D: Direct improvement in cognitive outcomes without changes in gut microbiota composition.

Q752: Considering the temporal sequence of events following Diquat (DQ) exposure, which of the following processes are described as occurring after the initial induction of oxidative stress in the gastrointestinal tract, and are subsequently linked to potential therapeutic interventions targeting systemic oxidative damage?
Options:
A: Disruption of intestinal barrier integrity and gut dysbiosis, leading to inflammation and mitochondrial dysfunction.
B: Immediate restoration of gut microbiome composition by probiotics before oxidative stress occurs.
C: Alterations in microbial metabolites such as short-chain fatty acids and bile acids, which follow DQ-induced oxidative stress.
D: Direct improvement of systemic health without any impact on the intestinal barrier or microbiome.

Q753: Considering the temporal sequence of events following perinatal chlorpyrifos (CPF) exposure, which of the following processes occur after the initial alteration of gut microbiota composition in offspring, and are subsequently mitigated by inulin supplementation according to the described experimental findings?
Options:
A: Increased expression of tight junction genes in brain microvessels precedes gut microbiota changes.
B: Bacterial translocation to the spleen and liver occurs after gut dysbiosis and is reduced by inulin.
C: CPF exposure directly increases the abundance of Lactobacillus and Bifidobacterium before any other changes.
D: Decreased tight junction gene expression in brain microvessels follows gut dysbiosis and is partially restored by inulin.

Q754: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after short-chain fatty acids (SCFAs) produced by gut microbiota modify the blood-brain barrier (BBB), but before the onset of neurodegenerative disease symptoms such as cognitive deterioration in Alzheimer's disease? Select all that apply.
Options:
A: Alteration of microglia, neuronal, and astrocyte function in the brain due to SCFA influence
B: Changes in synaptic structure and neuroplasticity mediated by MGBA signaling
C: Formation of neuritic plaques and neurofibrillary tangles leading to cognitive deterioration
D: Initial disruption of the intestinal barrier and activation of glial cells in response to alcohol use disorder

Q755: In the context of Alzheimer's disease progression in 3 × Tg-AD mice, which of the following events occur after the initial detection of altered diffusion kurtosis imaging (DKI) parameters indicating neuroinflammation, and are temporally associated with subsequent changes in gut microbiota and systemic inflammation as described in the study?
Options:
A: Elevated levels of pro-inflammatory cytokines in the serum, such as IL-1β, IL-6, TNFα, and IFN-γ, associated with increased microglial and astrocyte activity in memory-related brain regions.
B: An early increase in alpha diversity of gut microbiota prior to any neuroinflammatory changes.
C: Immediate restoration of normal memory function following the onset of neuroinflammation.
D: A reduction in the Firmicutes/Bacteroidetes (F/B) ratio and decreased levels of six short-chain fatty acids (SCFAs) at both 6 and 12 months, indicating disrupted gut microbial metabolism.

Q756: Considering the temporal sequence of events in stress-induced sleep dysregulation, which of the following processes are likely to occur after chronic stress exposure but before the manifestation of neurodegenerative or psychiatric symptoms, according to the described cellular and systemic mechanisms?
Options:
A: Immediate restoration of neurotransmitter balance and synaptic plasticity following acute stress
B: Astrocyte-mediated disruption of adenosine signaling and glymphatic clearance, leading to reduced restorative sleep
C: Resolution of neuroinflammation prior to the onset of sleep disturbances
D: Microglial activation driving neuroinflammatory processes that further impair sleep and exacerbate brain dysfunction

Q757: Considering the temporal sequence of events following ischemic stroke (IS) and subsequent intervention with Polygoni Multiflori Radix Praeparata polysaccharides (PMP), which of the following processes are expected to occur after PMP administration and before the improvement of neurological function, according to the described gut-brain axis mechanisms?
Options:
A: PMP increases the abundance of beneficial gut microbiota such as Bifidobacterium and Lactobacillus, leading to enhanced production of SCFAs and beneficial amino acids.
B: PMP directly restores cognitive function in the brain without affecting gut microbiota or metabolites.
C: PMP boosts tight junction protein expression in both brain and intestinal tissues, thereby improving barrier integrity prior to neurological recovery.
D: PMP causes an immediate reduction in cerebral infarction volume without any intermediate metabolic or microbiota changes.

Q758: Considering the multi-step pathway by which orally administered gold nanospheres (GNS) ameliorate collagen-induced arthritis (CIA) in mice, which of the following events occur after GNS-induced changes in gut microbiota composition but before the suppression of NF-κB activation in synovial tissues? Select all that apply.
Options:
A: Reduction in synovial hyperplasia and inflammatory infiltration
B: Increased production of indole-3-propionic acid (IPA) and indole-3-acetic acid (IAA) in the gut
C: Upregulation of tight junction proteins Claudin-1 and ZO-1, restoring intestinal barrier function
D: Activation of the aryl hydrocarbon receptor (AhR) pathway by IPA/IAA

Q759: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted diet mouse donors to Alzheimer's disease (AD) mice, but before the observed improvement in learning and memory abilities?
Options:
A: A decrease in the diversity of gut microbiota in recipient AD mice
B: An increase in short-chain fatty acids (SCFAs) in the feces of recipient AD mice
C: Activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1 in recipient AD mice
D: Immediate restoration of cognitive function in recipient AD mice

Q760: Based on the described studies, which of the following events occur after modulation of the gut microbiota, and are temporally downstream in the biological hierarchy, specifically in the context of neurodegenerative or neuropsychiatric disorders? Select all that apply.
Options:
A: Altered gut microbiota composition leads to changes in microbial metabolites, which then influence neuroinflammation and neurotransmitter synthesis.
B: Autoantibody formation in bullous skin diseases occurs before any changes in the gut microbiota.
C: Neuroinflammation and protein misfolding in the brain precede any changes in gut microbiota composition.
D: Dietary interventions that modulate gut microbiota can subsequently regulate inflammatory pathways and promote neuroprotection.

Q761: Considering the temporal sequence of events in the microbiota-gut-brain axis, which of the following processes are likely to occur after an initial alteration in gut microbial composition, ultimately influencing neurodegenerative disease progression or mental health outcomes, according to the context provided?
Options:
A: Immediate restoration of cognitive function before any changes in microbial metabolites or immune responses occur.
B: Direct improvement in psychiatric symptoms without any intermediate changes in the gut-brain axis or microbial metabolites.
C: Modulation of immune responses and intestinal permeability, subsequently affecting neuroinflammation and oxidative stress.
D: Changes in microbial metabolite production, such as decreased short-chain fatty acids, leading to increased neuroinflammation.

Q762: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after gut microbiota dysbiosis but before the manifestation of neurodegenerative symptoms, according to the described mechanisms in the context? Select all that apply.
Options:
A: Immediate restoration of gut microbiota composition to a healthy state without intervention.
B: Activation of neuroinflammatory pathways in the central nervous system as a result of changes in gut microbiota.
C: Altered production of microbial metabolites, such as short-chain fatty acids (SCFAs), that can cross the intestinal barrier and influence the brain.
D: Onset of cognitive decline and neuronal loss as the first event following gut microbiota dysbiosis.

Q763: Considering the temporal sequence of events following a high-fibre diet, which of the following steps occur after the production of short-chain fatty acids (SCFAs) by the gut microbiome but before the central nervous system receives information relevant to blood pressure regulation via the gut-brain axis?
Options:
A: The central nervous system directly senses dietary fibre in the gastrointestinal tract.
B: Hormones released by enteroendocrine cells bind to receptors on peripheral nervous system nerves, such as the vagus and spinal nerves.
C: Microbial metabolites are converted into amyloid-β plaques in the brain.
D: SCFAs stimulate enteroendocrine cells to release hormones such as serotonin and peptide YY.

Q764: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after the introduction of fermented dairy products containing live starter cultures, but before observable improvements in metabolic parameters or reductions in systemic inflammation? Select all that apply.
Options:
A: Reductions in blood pressure and systemic inflammation across clinical cohorts
B: Modulation of immune signaling by fermentation-derived metabolites
C: Significant improvements in fasting glucose and lipid profiles in metabolic syndrome patients
D: Enhancement of microbial diversity and upregulation of tight-junction proteins in the gut epithelium

Q765: Considering the temporal sequence of events in neurodegenerative disease progression, which of the following occur after the gut microbiota produces metabolites such as short-chain fatty acids (SCFAs) or trimethylamine N-oxide (TMAO), but before the manifestation of neuronal death or cognitive decline? Select all that apply.
Options:
A: Neuronal death occurs prior to the production of microbial metabolites by the gut microbiota.
B: TMAO crosses the blood-brain barrier and promotes aggregation of amyloid and tau proteins.
C: SCFAs modulate neuroinflammation and preserve blood-brain barrier integrity, influencing neuronal plasticity.
D: Dietary modifications directly cause neuronal death in the central nervous system.

Q766: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after early-life disruption of gut microbiota, and before the manifestation of neurodevelopmental or behavioral deficits in children? Select all that apply.
Options:
A: Induction of neuroinflammation as a result of gut-brain axis signaling.
B: Immediate improvement in cognitive function due to increased microbial diversity.
C: Altered gut microbiota composition leading to changes in neuroactive compound production.
D: Manifestation of physical, neurodevelopmental, and behavioral deficits characteristic of disorders such as FASD.

Q767: Considering the temporal sequence of events in the pathogenesis of cognitive impairment related to gut microbiota, which of the following processes would most likely occur after dysregulated gut microbiota interact with the intestinal epithelium, but before the manifestation of impaired cognitive function? Select all that apply.
Options:
A: Production of microbial toxins and metabolites by dysregulated gut microbiota
B: Impairment of daily activities or social functioning due to cognitive decline
C: Triggering of neuroinflammation and neurodegeneration in the central nervous system
D: Direct improvement of cognitive function by modulation of gut flora

Q768: Based on the described studies, which of the following events occur after perinatal chlorpyrifos (CPF) exposure in a temporal sequence leading to blood-brain barrier (BBB) disruption in offspring, and which interventions can subsequently reverse these effects? Select all that apply.
Options:
A: CPF exposure first induces gut dysbiosis, which is then followed by bacterial translocation to the spleen and liver.
B: Inulin administration prior to and during CPF exposure immediately restores tight junction gene expression before gut microbiota composition is affected.
C: Inulin co-exposure after CPF-induced dysbiosis partially restores gene expression of tight junction markers to control levels.
D: Decreased expression of tight junction genes in brain microvessels occurs after CPF-induced gut dysbiosis and bacterial translocation.

Q769: Considering the temporal sequence of events in OVA-induced food allergy mice, which of the following processes occur after the initial elevation of Th2 signature cytokines and IgE, and are associated with subsequent neurobehavioral changes? Select all that apply.
Options:
A: Disruption of amino acid metabolism correlated with altered gut microbiota abundance
B: Suppression of all neurobehavioral abnormalities before any immune activation
C: Immediate restoration of normal amino acid metabolism in the brain
D: Increased activation of microglia and elevated levels of TNF-α, IL-1β, and IL-6 in the prefrontal cortex

Q770: Considering the temporal sequence of events in obesity-induced cognitive dysfunction, which of the following processes occur after the initial disruption of gut microbiota composition due to a high-fat diet, and contribute to subsequent neurological impairment according to the context provided?
Options:
A: Activation of enterocyte TLR signaling (especially TLR-2 and TLR-4) and downstream MyD88-NF-κB cascade upregulates pro-inflammatory factors, resulting in loss of intestinal mucosal integrity.
B: Increased intestinal permeability allows endotoxins such as lipopolysaccharide (LPS) to enter the bloodstream, leading to neuroinflammation and brain damage.
C: Early lifestyle interventions in childhood directly reverse established neurodegenerative changes in adulthood without affecting gut flora.
D: Obesity-induced changes in the gut flora immediately cause hereditary transmission of cognitive decline without intermediate steps.

Q771: Considering the temporal sequence of events in the gut-brain axis as described in the context, which of the following processes would most likely occur after an increase in Bifidobacterium pseudolongum abundance due to time-restricted feeding, but before the improvement of cognitive function in Alzheimer's disease patients? Select all that apply.
Options:
A: Amyloid-beta deposition increases prior to any gut microbiota changes.
B: Enhanced production of propionic acid (PA) by the gut microbiota.
C: Immediate restoration of cognitive function without intermediary metabolic changes.
D: Activation of the free fatty acid receptor 3 (FFAR3) following increased PA levels.

Q772: Considering the temporal sequence of events in Parkinson's disease (PD) as described in the context, which of the following processes occur after the onset of gut microbiota dysbiosis but before the appearance of clinical motor symptoms, according to the mechanistic pathway involving the gut microbiota-gut-brain axis?
Options:
A: Abnormal α-synuclein aggregation and neuroinflammation
B: Enhanced intestinal permeability and increased intestinal inflammation
C: Complete recovery of dopaminergic neurons in the substantia nigra
D: Immediate restoration of gut microbiota diversity through fecal microbiota transplantation

Q773: Considering the temporal sequence of events in the microbiota-gut-brain axis during psychological stress in inflammatory bowel disease (IBD), which of the following processes are likely to occur before the manifestation of exacerbated IBD symptoms, according to the described mechanisms in the context?
Options:
A: Resolution of chronic intestinal inflammation
B: Long-term improvement in quality of life following psychobiotic supplementation
C: Alterations in the stress response of the hypothalamic-pituitary-adrenal (HPA) axis
D: Disturbance in the homeostasis of the intestinal flora and metabolites

Q774: Following bariatric surgery, a sequence of neurobiological and gut microbiota changes occurs that ultimately influences long-term metabolic health. Which of the following events are described as occurring after the initial modulation of appetite-regulating hormones, and contribute to the progression toward enhanced satiety and altered food choices in the post-surgical timeline?
Options:
A: Immediate restoration of pre-surgical gut microbiota composition without further metabolic effects.
B: Increase in beneficial gut microbiota species such as Akkermansia muciniphila, influencing metabolic pathways through short-chain fatty acid production.
C: Structural and functional changes in brain regions involved in reward processing and cognitive control, leading to reduced cravings.
D: Acute elevation of ghrelin levels, resulting in increased hunger and caloric intake.

Q775: Considering the temporal sequence of events in the pathogenesis of multiple sclerosis (MS), which of the following steps must occur before immune cells can exert their effects on the central nervous system, and which steps are involved in the subsequent progression of MS symptoms according to the described gut-brain axis interactions?
Options:
A: Gut microbiota-derived metabolites influence immune responses locally in the gut or systemically after entering the blood circulation, which can then affect the central nervous system.
B: Activation of innate and adaptive immune cells in the periphery precedes their attraction toward the central nervous system due to blood-brain barrier breakdown.
C: Degeneration and demyelination of the myelin sheath occur before the activation of peripheral immune cells.
D: Paralysis and severe neurological disability symptoms develop prior to the breakdown of the blood-brain barrier.

Q776: Considering the temporal sequence of events described in studies of the microbiota-gut-astrocyte (MGA) axis, which of the following processes are reported to occur after alterations in gut microbiota composition, and are linked to subsequent changes in astrocyte biology or neuroinflammation in neurological disease models? Select all that apply.
Options:
A: Initial changes in rodent behavior prior to any observed alterations in gut microbiota
B: Increased expression of GFAP in astrocytes following compromised gut barrier integrity
C: Direct impact of microbial metabolites on astrocyte biology and neuroinflammatory markers after fecal microbiota transplantation
D: Restoration of gut barrier integrity before any modulation of the gut microbiota

Q777: Considering the temporal sequence of events following atorvastatin administration in ischemic stroke models, which of the following occur after the initial modulation of gut microbiota composition and contribute to improved neurological outcomes through the gut-brain axis? Select all that apply.
Options:
A: Immediate restoration of neurobehavioral function prior to changes in inflammatory cytokine levels
B: Increased abundance of Lachnospiraceae NK4A136 and Ruminococcus torques associated with good outcomes
C: Suppression of microglia activation and inhibition of the NF-κB pathway
D: Reduction in the release of inflammatory cytokines such as IL-1β and IL-18

Q778: Considering the temporal sequence of events described in the context, which of the following processes occur after the modulation of gut microbiota by flavanones or berberine, and before the manifestation of improved cognitive function or neuroprotection in neurodegenerative or seizure models? Select all that apply.
Options:
A: Altered production of short-chain fatty acids (SCFAs) and other gut microbiota-derived metabolites
B: Initial ingestion and metabolic transformation of flavanones or berberine
C: Manifestation of improved cognitive performance or reduced seizure severity
D: Regulation of neuroinflammation via the gut-brain axis

Q779: Considering the temporal sequence of events in obesity-induced neurodegeneration, which of the following processes occur after the initial infiltration of immune cells into adipose tissue but before the manifestation of cognitive decline and motor deficits? Select all that apply.
Options:
A: Manifestation of cognitive decline and motor deficits
B: Circulation of pro-inflammatory cytokines and adipokines leading to propagation of inflammation in the central nervous system
C: Progressive infiltration of immune cells into adipose tissue
D: Development of insulin resistance, mitochondrial dysfunction, and increased oxidative stress in the brain

Q780: Considering the temporal sequence of molecular and cellular events following ischaemic stroke, which of the following processes occur after the initial reduction in cerebral blood flow but before the implementation of therapeutic strategies targeting gut microbial composition? Select all that apply.
Options:
A: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB.
B: Compromise of blood-brain barrier integrity due to a pro-inflammatory milieu.
C: Widespread clinical implementation of antioxidant supplementation and probiotics.
D: Restoration of gut microbial diversity through faecal microbiota transplantation (FMT).

Q781: Considering the temporal sequence of immune cell involvement in Alzheimer's disease (AD) pathogenesis, which of the following events are likely to occur as the disease progresses from early to later stages, based on the interactions between central and peripheral immune cells and their roles in neuroinflammation?
Options:
A: The recruitment of peripheral immune cells to the CNS mediates inflammatory responses that contribute to the progression of AD.
B: Microglia and astrocytes initially detect changes in the brain environment and transform into different phenotypes, exerting stage-specific effects.
C: Peripheral immune cells remain completely excluded from the CNS throughout all stages of AD.
D: Peripheral immune cells such as T cells, B cells, and monocytes/macrophages are recruited to the CNS only after all central immune responses have ceased.

Q782: Considering the temporal sequence of events following probiotic administration in a rat model of spinal cord injury, which of the following processes are supported by the context as occurring after the initial modulation of gut microbiota composition, and contribute to the observed neuroprotective and anti-inflammatory outcomes in spinal cord tissue?
Options:
A: Activation of downstream signaling pathways in the spinal cord involving upregulation of anti-inflammatory and neuroregenerative genes
B: Direct inhibition of spinal cord gene expression before any alteration in microbial metabolites
C: Immediate restoration of spinal cord tissue structure prior to any changes in gut microbiota
D: Enrichment of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile in the gut

Q783: Considering the temporal sequence of molecular and cellular events described in the dual-hit (DSS+MPTP) mouse model of Parkinson's disease with mild chronic colitis, which of the following events are reported to occur after the initial upregulation of LRRK2 expression in the colon and brain, and are part of the downstream inflammatory cascade leading to exacerbated neuropathology?
Options:
A: Primary loss of dopaminergic neurons before any changes in LRRK2 expression
B: Activation of NF-κB signaling pathway in the brain following increased LRRK2 expression
C: Inhibition of Nrf2 pathway in the brain subsequent to LRRK2 upregulation
D: Initial reduction of ZO-1 and Occludin levels prior to LRRK2 upregulation

Q784: Considering the temporal sequence of events in the pathogenesis of autism spectrum disorder (ASD) with metabolic comorbidities, which of the following processes are likely to occur after gut dysbiosis but before the manifestation of altered brain development and behavior, according to the described molecular pathways and feedback mechanisms?
Options:
A: Initial colonization of the gut by butyrate-producing genera leading to enhanced neurodevelopment
B: Resolution of insulin resistance prior to any changes in the gut-brain-metabolic axis
C: Activation of neuroimmune pathways and disruption of PI3K/Akt/mTOR signaling following increased systemic inflammation
D: Increased intestinal permeability and systemic inflammation due to dysbiosis-induced changes in microbial metabolites

Q785: Considering the temporal sequence of events following a dietary intervention aimed at modulating gut microbiota in neurodegenerative diseases, which of the following processes are likely to occur after the initial alteration of gut microbial composition but before observable improvements in cognitive or motor deficits, according to the context provided?
Options:
A: Immediate restoration of cognitive and motor functions in neurodegenerative disease patients
B: Regulation of neurotransmitter production and reduction of neuroinflammatory markers via the gut-brain axis
C: Changes in gut permeability and the synthesis of microbial-derived neurotrophic factors and neurotransmitters
D: Establishment of standardized protocols for fecal microbiota transplantation in clinical practice

Q786: Considering the temporal sequence of events in the pathogenesis and management of Alzheimer's Disease (AD), which of the following processes would most likely occur after gut microbiome perturbations but before the implementation of probiotic-based interventions, according to the described gut-brain axis interactions and therapeutic strategies?
Options:
A: Influence on immune responses and neuroinflammatory responses as a result of gut microbiome alterations
B: Early detection and staging of AD through neuroimaging biomarkers
C: Impairment of intestinal barrier stability and increased blood-brain barrier permeability due to microbial metabolite-mediated pathways
D: Restoration of gut microbiome homeostasis and reinforcement of intestinal barrier integrity by probiotics

Q787: Considering the temporal sequence of events following probiotic treatment in a rat model of spinal cord injury (SCI), which of the following processes are supported by the context as occurring after the modulation of gut microbiota composition, but before the observed improvements in locomotor recovery and structural restoration of spinal cord tissue?
Options:
A: Enrichment of key tryptophan metabolites such as serotonin and 3-Indoleacetonitrile
B: Initial establishment of the rat model of SCI
C: Behavioral evaluation using the Basso Mouse Scale (BMS) and inclined plane tests
D: Activation of anti-inflammatory and neuroregenerative gene expression in spinal cord tissue

Q788: Considering the temporal sequence of events in Alzheimer's Disease (AD) pathogenesis, which of the following processes are likely to occur after gut microbiota dysbiosis but before the manifestation of neurodegenerative changes, according to the described gut-brain axis mechanisms and neuroinflammatory cascades?
Options:
A: Immediate repair of neuronal damage through gene therapy targeting amyloid and tau pathology
B: Early detection and staging of AD using neuroimaging biomarkers prior to any microbiota alterations
C: Increased intestinal permeability leading to translocation of endotoxins like lipopolysaccharides (LPS) into the bloodstream
D: Activation of brain toll-like receptor 4 (TLR4) pathways by circulating endotoxins, resulting in heightened neuroinflammatory responses

Q789: Following spinal cord injury (SCI), a sequence of events involving the gut microbiome and molecular signaling pathways contributes to neuroinflammation and impaired recovery. Based on the described findings, which of the following events occur after administration of Pectin-Zein-IPA nanoparticles, and which are part of the subsequent cascade leading to improved functional outcomes over time?
Options:
A: Accumulation of L-methionine in the intestinal flora increases, leading to heightened neuroinflammation after nanoparticle administration.
B: Improvement of autophagy and inhibition of pyroptosis follow Pectin-Zein-IPA nanoparticle treatment, resulting in reduced neuroinflammation.
C: Inhibition of oxidative stress occurs prior to the administration of Pectin-Zein-IPA nanoparticles and is unrelated to their effects.
D: Activation of the AKT/Nrf-2 signaling pathway occurs after Pectin-Zein-IPA nanoparticle treatment, contributing to enhanced axonal regeneration.

Q790: Considering the temporal sequence of interventions and biological responses, which of the following events are likely to occur after the administration of sodium butyrate supplementation for 12 weeks in patients with active ulcerative colitis, and which are supported by the context as downstream effects in the regulatory cascade involving gut microbiota, inflammation, and psychological factors?
Options:
A: A reduction in hospital anxiety and depression scale (HADS) scores, reflecting improved psychological symptoms.
B: A rapid restoration of gut microbiota diversity within the first hour of supplementation.
C: An immediate increase in proinflammatory markers within the first day of supplementation.
D: A significant decrease in erythrocyte sedimentation rate (ESR) as a marker of reduced inflammation.

Q791: Considering the temporal sequence of events following addictive substance use disorder, which of the following processes are likely to occur after initial intestinal barrier damage but before the manifestation of altered mood and cognitive function? Select all that apply.
Options:
A: Activation of immune cells and release of inflammatory factors as a result of dysbiosis.
B: Direct improvement of addictive substance dependence symptoms without intervention.
C: Immediate restoration of gut barrier integrity and normalization of gut flora composition.
D: Translocation of harmful substances and bacteria into the circulatory system, leading to systemic inflammatory responses.

Q792: Based on the described sequence of events following spinal cord injury (SCI), which of the following processes occur after the administration of Pectin-Zein-IPA nanoparticles, and which are part of the subsequent regulatory cascade leading to reduced neuroinflammation and improved functional recovery? Select all that apply.
Options:
A: Improvement of autophagy and inhibition of pyroptosis follow the reduction of L-methionine accumulation, contributing to alleviated neuroinflammation.
B: Activation of the AKT/Nrf-2 signaling pathway occurs after Pectin-Zein-IPA nanoparticle treatment and precedes enhanced axonal regeneration.
C: Inhibition of oxidative stress is the final event in the cascade, occurring after motor function recovery is fully restored.
D: Reduction in the abundance of Parasutterella occurs before the decrease in L-methionine accumulation in the intestinal flora.

Q793: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after an increase in proinflammatory gut bacterial species in individuals with severe cognitive impairment, and before the manifestation of cognitive decline-related phenotypes?
Options:
A: Direct improvement in cognitive function due to increased proinflammatory species
B: Immediate restoration of beneficial bacterial clades in the gut microbiome
C: Increased microbial capacity for methanogenesis and reduced synthesis of short-chain fatty acids and neurotransmitters
D: Reduced capacity for synthesis of amino acids required for neuroprotective lysosomal activity

Q794: Considering the temporal sequence of events along the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after dietary interventions that increase gut microbial diversity, but before improvements in central nervous system (CNS) disease symptoms are observed? Select all that apply.
Options:
A: Immediate reversal of neurodevelopmental disorders in children without intermediary molecular or cellular changes.
B: Enhanced production of short-chain fatty acids (SCFAs) by gut bacteria, leading to modulation of immune responses.
C: Alteration of gut microbiota composition, resulting in changes to microbial metabolites that influence inflammation and neuroactive compound levels.
D: Direct clinical application of artificial intelligence (AI) for personalized nutrition without prior changes in gut microbiota or metabolite profiles.

Q795: Considering the temporal sequence of events following radiotherapy in abdominal-pelvic cancer patients, which of the following processes are likely to occur early as a direct consequence of radiation exposure, and which may develop subsequently as part of a regulatory cascade involving the gut microbiota and host immune system? Select all that apply.
Options:
A: Activation of inflammatory responses within the intestine follows changes in microbiota-derived metabolites and disruption of the intestinal barrier.
B: Disruption of the intestinal barrier is a late event that only occurs after systemic immune responses have been fully established.
C: Alterations in the diversity and composition of the gut microbiota occur early after radiation exposure, preceding activation of inflammatory responses within the intestine.
D: Influence of the gut microbiota on distant body systems, such as the brain or cardiopulmonary axis, represents an indirect and later phase of the interaction after initial local intestinal changes.

Q796: Considering the sequence of events following neurosurgical procedures, which of the following processes occur after the disruption of the blood-brain barrier (BBB) and contribute to both immediate and long-term cognitive impairments, according to the described temporal and hierarchical mechanisms in the context?
Options:
A: Direct improvement of cognitive function due to increased cerebrospinal fluid exposure to pathogens.
B: Activation of neuroinflammatory responses involving microglia and astrocytes, leading to the release of cytokines such as tumor necrosis factor-alpha and interleukin-1.
C: Impairment of synaptic function and connectivity as a downstream effect of cytokine release and neuroinflammation.
D: Immediate restoration of BBB integrity, preventing further exposure of the brain to pathogens and inflammation.

Q797: Considering the temporal sequence of events in the gut-liver-brain (GLB) axis, which of the following processes would most likely occur after an increase in gut permeability but before the onset of neuroinflammation and cognitive impairments? Select all that apply.
Options:
A: Activation of inflammatory pathways in the liver due to the presence of microbial byproducts.
B: Restoration of gut eubiosis through interventions like probiotics, prebiotics, or fecal microbiota transfer (FMT).
C: Translocation of microbial byproducts such as lipopolysaccharides (LPSs) from the gut into the liver and brain, activating inflammatory pathways.
D: Manifestation of cognitive impairments resulting from hepatic dysfunction.

Q798: Considering the temporal sequence of events in Parkinson's disease (PD) pathogenesis, which of the following processes are likely to occur before the onset of motor symptoms, and which are involved in later neurodegenerative progression? Select all that apply based on the described gut-brain axis and protein aggregation pathways.
Options:
A: Lewy body formation in the substantia nigra pars compacta is a hallmark of later-stage PD and is associated with the development of motor symptoms.
B: Dysregulation of gut neuropeptide signaling is a late event that only occurs after substantial dopaminergic neuron loss in the substantia nigra.
C: Aggregation of alpha-synuclein in the gastrointestinal tract may precede the appearance of motor symptoms by up to 20 years.
D: Microbiome alterations and intestinal inflammation can occur before central nervous system involvement and may contribute to early nonmotor symptoms.

Q799: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after gut microbiota dysbiosis leads to increased intestinal permeability, but before the manifestation of altered mood and cognitive function in addictive substance use disorder? Select all that apply.
Options:
A: Direct improvement of withdrawal symptoms through reshaping the gut-brain axis
B: Systemic inflammatory responses and immune imbalances due to harmful substances and bacteria crossing the intestinal barrier
C: Activation of immune cells and release of inflammatory factors affecting brain function
D: Long-term sustainability of dietary interventions for depression

Q800: Considering the temporal sequence of events described in the context of time-restricted feeding (TRF) and Alzheimer's disease, which of the following steps occur after the initiation of TRF and before the observed improvement in cognitive function? Select all that apply.
Options:
A: Knockdown of FFAR3 leading to enhanced cognitive benefits from TRF.
B: Initial observation of cognitive impairments in Alzheimer's disease patients prior to TRF intervention.
C: Penetration of propionic acid across the blood-brain barrier following its increased production.
D: An increase in Bifidobacterium pseudolongum abundance and propionic acid production in the gut.

Q801: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut dysbiosis initiates increased intestinal permeability, but before the manifestation of altered brain development and behavior in autism spectrum disorder (ASD)? Select all that apply.
Options:
A: Altered brain development and behavioral changes associated with ASD
B: Systemic inflammation resulting from increased intestinal permeability
C: Immediate improvement in cognitive function due to probiotic supplementation
D: Neuroimmune activation as a consequence of systemic inflammation

Q802: Considering the temporal sequence of events in the gut-brain axis, which of the following processes can occur after gut microbiota dysbiosis leads to altered microbial metabolite production, and subsequently influences central nervous system (CNS) physiology or pathology through changes in barrier permeability or immune activation?
Options:
A: Increased permeability of the blood-brain barrier (BBB) leading to neuroinflammation.
B: Immediate restoration of CNS homeostasis without involvement of immune pathways.
C: Direct genetic modification of CNS neurons by gut bacteria without intermediary steps.
D: Activation of the inflammasome pathway resulting in production of pro-inflammatory cytokines such as interleukin-1β and interleukin-18.

Q803: Based on the described temporal sequence of events in Alzheimer's disease (AD) pathogenesis, which of the following processes are reported to occur prior to the accumulation of amyloid-beta (Aβ) in the brain, and which interventions are shown to subsequently reduce Aβ accumulation and improve cognition in preclinical models? Select all that apply.
Options:
A: Fecal microbiota transplantation (FMT) restores gut microbial balance, reduces Aβ accumulation, and improves cognition in preclinical models.
B: Antiviral therapies targeting HSV-1 are administered before gut microbiota dysregulation occurs.
C: Dysregulation of gut microbiota precedes brain Aβ accumulation in transgenic mouse models.
D: Amyloid-beta accumulation in the brain triggers initial gut microbiota dysregulation.

Q804: Considering the temporal sequence of events following addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage and contribute to subsequent changes in brain function and addictive behaviors, according to the described gut-brain axis mechanisms?
Options:
A: Addictive substance cravings decrease due to restoration of gut barrier integrity.
B: Withdrawal symptoms are immediately alleviated without intervention in the gut microbiota.
C: Activation of immune cells and release of inflammatory factors influence brain function.
D: Dysbiosis of the gut microbiota develops, leading to altered microbial composition.

Q805: Considering the temporal sequence of events following traumatic brain injury (TBI) in the mouse model described, which of the following processes are observed as a result of Pan-probiotic (PP) treatment during the acute and chronic phases, and how do these events relate to each other over time?
Options:
A: An increase in SCFA levels at 35 days post-injury occurs before the reduction in lesion volume and cell death at 3 days post-injury.
B: Behavioral improvements in motor recovery and depressive-like behaviors are only observed prior to any changes in microbiome composition induced by PP treatment.
C: PP treatment decreases microglial activation at both 3 and 35 days post-injury, indicating sustained modulation of neuroinflammation across both acute and chronic phases.
D: PP treatment reduces lesion volume and cell death at 3 days post-injury, preceding the elevation of short-chain fatty acid (SCFA) levels observed at 35 days post-injury.

Q806: Considering the temporal sequence of events in the gut-brain axis, which of the following processes are likely to occur after an initial disruption of gut microbiota composition, ultimately contributing to the progression of neurological disorders such as Alzheimer's disease or vascular dementia, according to the context provided?
Options:
A: Direct improvement of cognitive function prior to any changes in gut microbial composition or function.
B: Dysregulation of the kynurenine pathway resulting in the production of neurotoxic metabolites that contribute to neuronal damage.
C: Immediate restoration of cerebral glutamate-GABA balance without modulation of the gut microbiota.
D: Increased gut permeability leading to systemic inflammation and subsequent neuroinflammation via the gut-brain axis.

Q807: Considering the temporal sequence of events in the modulation of gut microbiota and immune responses in inflammatory bowel disease (IBD), which of the following processes are likely to occur after the administration of plant-based dietary compounds, based on their regulatory effects on signaling pathways and metabolite production described in the context?
Options:
A: A decrease in pro-inflammatory cytokines and an increase in anti-inflammatory cytokines following the modulation of pathways such as TGF-β/Smad and NF-κB.
B: An increase in short-chain fatty acid formation, which subsequently helps regulate immune cells to alleviate IBD.
C: Immediate restoration of gut microbiota composition without involvement of signaling pathways or metabolite changes.
D: Direct improvement of psychological symptoms in IBD patients without any changes in inflammation or gut microbiota.

Q808: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after a disruption of gut microbiota due to antibiotic overuse in livestock, but before the onset of neuroinflammation and potential neurodegenerative symptoms in humans? Select all that apply.
Options:
A: Dysbiosis of the gut microbiota leading to compromised gut-microbiota-brain axis integrity
B: Manifestation of cognitive impairment due to chronic neuroinflammation
C: Immediate restoration of microbial balance through dietary modifications
D: Increased intestinal permeability and systemic inflammation as a result of microbial imbalance

Q809: Based on the described sequence of events in neurodegenerative disease pathogenesis, which of the following processes occur after gut dysbiosis disrupts the intestinal barrier but before the accumulation of neurotoxic misfolded proteins in CNS cells? Select all that apply.
Options:
A: Neuronal death in the central nervous system
B: Chronic neuroinflammation via dysregulated immune activation
C: Ingress of pathobionts and toxic metabolites into the systemic circulation causing gut-brain axis dysregulation
D: Therapeutic intervention with prebiotics, probiotics, or fecal microbial transplantation

Q810: Considering the temporal sequence of molecular and cellular events described in the context, which of the following steps occur after an increase in gut-derived propionate but before the reduction of Aβ plaques in the APPPS1-21 Alzheimer's disease mouse model? Select all that apply.
Options:
A: Initial administration of antibiotics leading to increased plasma propionate
B: Reduction in reactive astrocytosis and altered astrocyte gene expression
C: Final observation of reduced Aβ plaque accumulation in the brain
D: Decrease in peripheral Th17 (Rorγt+ CD4+) cells and IL-17 secretion

Q811: Considering the temporal sequence of events following neurosurgical procedures, which of the following processes occur after the disruption of the blood-brain barrier (BBB) and contribute to both immediate and long-term cognitive impairments? Select all that apply.
Options:
A: Initial exposure of cerebrospinal fluid to pathogens prior to BBB disruption
B: Activation of neuroinflammatory responses involving microglia and astrocytes
C: Restoration of neural integrity before the onset of inflammation
D: Release of cytokines such as tumor necrosis factor-alpha and interleukin-1 leading to neuronal damage

Q812: Based on the described studies, consider the sequence of molecular and cellular events following the administration of short-chain fatty acids (SCFAs) such as acetate and propionate in a rat model of delayed encephalopathy after acute carbon monoxide poisoning (DEACMP). Which of the following events are likely to occur in the early to intermediate phases after SCFA treatment, before improvements in cognitive dysfunction and anxiety symptoms are observed?
Options:
A: Increased activation of GPR41 and GPR43 receptors in the hippocampus, leading to downstream modulation of inflammatory cytokines.
B: Immediate restoration of cognitive function and anxiety symptoms without preceding molecular changes.
C: Reduction in hippocampal levels of inflammatory factors such as IL-1β, IL-6, and TNF-α following SCFA-induced receptor activation.
D: Direct increase in dopamine and norepinephrine levels in the hippocampus without changes in inflammation or receptor activity.

Q813: Considering the temporal sequence of events described in the context of neuroinflammaging, which of the following processes occur after environmental exposures induce epigenetic modifications, but before the manifestation of neurodegenerative phenotypes? Select all that apply.
Options:
A: Epigenetic modulation of neuroinflammatory responses in the central nervous system
B: Up-regulation of the inflammatory response at the brain level leading to chronic neuroinflammaging
C: Development of diagnostic biomarkers to increase diagnostic accuracy in neurodegenerative diseases
D: Manifestation of age-related neurodegenerative disorders as a clinical phenotype

Q814: Considering the temporal sequence of events in diabetic retinopathy (DR) pathogenesis as described in the context, which of the following processes occur after a reduction in circulating short-chain fatty acids (SCFAs) and before the manifestation of retinal morphological changes in diabetic mice? Select all that apply.
Options:
A: Immune dysregulation with altered cytokine expression closely correlated with SCFA levels
B: Immediate improvement of intestinal barrier function without prior intervention
C: Significant changes in retinal DNA methylation, including downregulation of key pathways
D: Alleviation of retinal thinning and prevention of vessel loss following acetate supplementation

Q815: Considering the sequence of events described in the context, which of the following processes would most likely occur after the administration of Monascus-fermented ginseng (MFG) and subsequent fecal microbiota transplantation (FMT) in hyperlipidemic mice, but before the improvement in lipid profiles and reduction in hepatic lipid accumulation? Select all that apply.
Options:
A: Initial detection of abnormal serum biochemical parameters associated with hyperlipidemia
B: Normalization of the Firmicutes/Bacteroidetes ratio and enrichment of beneficial microbiota in the gut
C: Manifestation of improved body weight and attenuated hepatic lipid accumulation
D: Promotion of primary-to-secondary bile acid conversion and enhancement of cholesterol excretion

Q816: Considering the temporal sequence of events described in the context of probiotic treatment for spinal cord injury (SCI), which of the following processes are likely to occur after the initial modulation of gut microbiota composition, but before the manifestation of neuroprotective and anti-inflammatory effects in spinal cord tissue?
Options:
A: Immediate restoration of spinal cord structural integrity without changes in gene expression
B: Enrichment of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile in the gut
C: Activation of downstream signaling pathways in the spinal cord by tryptophan metabolites
D: Direct improvement in locomotor recovery prior to any changes in gut microbiota

Q817: Considering the sequential biological events described in the context, which of the following processes would most likely occur after a decrease in SCFA-producing gut bacteria in patients with HIV-associated neurocognitive disorder (HAND), and before the manifestation of cognitive impairment? Select all that apply.
Options:
A: A reduction in plasma short-chain fatty acids (SCFAs)
B: An increase in pro-inflammatory cytokines
C: An increase in anti-inflammatory cytokines
D: A restoration of gut microbiota balance by flavanones

Q818: Considering the temporal sequence of events following bariatric surgery, which of the following changes are expected to occur in the early post-surgical phase and subsequently contribute to long-term metabolic health improvements through hierarchical modulation of gut-brain communication and metabolic pathways?
Options:
A: Reshaping of the gut microbiota with an increase in beneficial species such as Akkermansia muciniphila, which influences metabolic pathways via short-chain fatty acid production and bile acid metabolism.
B: Reduction in ghrelin levels, followed by increased GLP-1 and PYY secretion, leading to enhanced satiety and decreased caloric intake.
C: Acute accumulation of amyloid-β and tau proteins in the central nervous system, triggering neuroinflammation.
D: Immediate restoration of dopaminergic neurons in the brain, directly reversing neurodegeneration.

Q819: Considering the temporal sequence of events along the gut-joint axis in osteoarthritis (OA), which of the following processes must occur before SCFAs can exert their beneficial effects on joint integrity and OA progression, and which processes are likely to follow after SCFA-mediated preservation of the intestinal barrier?
Options:
A: Mitigation of OA progression by SCFAs occurs before their absorption into the bloodstream.
B: Microbial fermentation of dietary fibers in the gut to produce SCFAs precedes SCFA-mediated effects on joint health.
C: SCFA-induced maintenance of cartilage and subchondral bone integrity occurs before the production of SCFAs by gut microbes.
D: Preservation of the intestinal barrier by SCFAs is followed by mitigation of OA progression.

Q820: During the progression of age-related neurodegenerative diseases, which of the following sequential events are supported by the context as occurring after gut microbiota dysbiosis but before the development of neurological dysfunctions, specifically involving changes in barrier permeability and metabolite transit?
Options:
A: Augmented permeability of the gastrointestinal barrier and blood-brain barrier, facilitating the transit of microbial molecules from the gut to the brain
B: Initial alteration in gut microbiota composition and metabolite production
C: Onset of neurological dysfunctions and neurodegenerative disease symptoms
D: Transit of microbial molecules from the gut to the brain via neural, endocrine, and immune pathways

Q821: Considering the temporal sequence of events in the progression of Alzheimer's disease (AD), which of the following processes are likely to occur after the initial establishment of gut dysbiosis but before the development of integrative exosome-based therapies, according to the described context? Select all that apply.
Options:
A: Propagation of pathological proteins via exosomes reflecting the influence of gut microbiota-derived metabolites.
B: Widespread clinical implementation of exosomal engineering for personalized AD treatment.
C: Immediate restoration of immune tolerance through microbiota-based strategies without further research.
D: Modulation of neuroinflammatory responses by exosomes as they mediate gut-brain axis effects.

Q822: Considering the temporal progression of Alzheimer's disease (AD) as described in the context, which of the following events occur as the disease advances from early to later stages, and how do these events relate to the hierarchical cascade from molecular to macroscopic pathology?
Options:
A: Initial disruption in lipid metabolism directly causes macroscopic cortical atrophy before any cellular or molecular changes are observed.
B: Early activation of microglia leads to clearance of β-amyloid aggregates, but prolonged activation results in chronic neuroinflammation and accelerates neuronal damage.
C: Intracellular accumulation of hyperphosphorylated tau proteins forming neurofibrillary tangles precedes the progressive decline of cognitive, behavioral, and social abilities.
D: Widening of the sulci and enlargement of the ventricles are late-stage macroscopic features that follow earlier molecular and cellular pathological changes.

Q823: Considering the temporal sequence of events described in the context of neurodegenerative diseases, which of the following processes would most likely occur after dysbiosis of the gut microbiota but before the onset of clinical neurodegenerative symptoms? Select all that apply.
Options:
A: Progressive degeneration of neurons resulting in clinical manifestations such as cognitive decline or motor symptoms.
B: Structural modifications and increased permeability of the gastrointestinal barrier and blood-brain barrier, facilitating the transit of microbial molecules.
C: Initial dietary changes that modulate the gut microbiota composition.
D: Activation of inflammatory pathways and disruption of cholesterol metabolism by TMAO, contributing to disease progression.

Q824: Considering the temporal sequence of events following gut microbiome dysbiosis, which of the following processes are likely to occur before the onset of neurodegeneration in chronic neurological disorders, according to the described mechanisms linking the gut and brain? Select all that apply.
Options:
A: Neuroinflammation and immune cell activation in the central nervous system are resolved, restoring normal neuronal function.
B: Chronic neurodegeneration is reversed, resulting in restoration of healthy neuronal populations.
C: Disruption of intestinal barrier permeability and subsequent impairment of blood-brain barrier permeability occur.
D: Altered gut microbial composition leads to increased endotoxin production and fewer beneficial metabolites.

Q825: Considering the temporal sequence of immune and cellular events following bacterial stimulation of human peripheral blood immune cells, which of the following steps would most likely occur after the initial exposure to bacterial antigens but before a significant increase in BDNF levels is detected in PBMC cultures? Select all that apply.
Options:
A: Elimination of monocyte-platelet aggregates resulting in reduced BDNF secretion.
B: Formation of monocyte-platelet aggregates in response to bacterial antigens.
C: Direct secretion of BDNF by isolated monocytes without platelet interaction.
D: Interaction between platelets and monocytes leading to increased BDNF production.

Q826: Considering the temporal sequence of events following ischaemic stroke, which of the following processes are likely to occur after the initial reduction in cerebral blood flow, and subsequently contribute to neuronal damage and blood-brain barrier compromise, as described in the context? Select all that apply.
Options:
A: Immediate restoration of blood-brain barrier integrity prior to the onset of oxidative stress.
B: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB.
C: Direct improvement of neuronal survival by gut-derived TMAO without involvement of inflammatory or oxidative pathways.
D: Activation of a pro-inflammatory milieu that intensifies neuronal damage and exacerbates reperfusion-induced injury.

Q827: Considering the temporal sequence of events in the gut-brain axis (GBA) as described in the context, which of the following processes would most likely occur after gut microbiome perturbations but before the manifestation of neuroinflammatory responses in Alzheimer's disease pathophysiology? Select all that apply.
Options:
A: Influence on immune responses and blood-brain barrier permeability through microbial metabolite-mediated pathways
B: Impairment of intestinal barrier stability
C: Restoration of gut microbiome homeostasis by probiotics
D: Manifestation of neuroinflammatory responses

Q828: Considering the temporal sequence of events in Alzheimer's disease progression, which of the following processes are described as occurring after the initial dysregulation of the gut microbiota, ultimately influencing central nervous system pathology through the gut-brain axis and exosome-mediated mechanisms, according to the context provided?
Options:
A: Early coexistence of gut microbiota and host under normal physiological conditions
B: Propagation of pathological proteins in the central nervous system via exosomes
C: Initial maintenance of intestinal barrier integrity by a healthy gut microbiota
D: Modulation of neuroinflammatory responses by exosome-mediated communication

Q829: Considering the temporal sequence of events described in OVA-induced food allergy mice, which of the following processes are observed to occur after the initial elevation of Th2 signature cytokines and allergy-related antibodies, and are associated with subsequent neurobehavioral changes? Select all that apply.
Options:
A: Disruption of amino acid metabolism correlated with altered gut microbiota abundance.
B: Increased levels of TNF-α, IL-1β, and IL-6 and activation of microglia in the prefrontal cortex.
C: Immediate restoration of normal amino acid metabolism in the gut.
D: Suppression of anaphylactic symptoms prior to behavioral testing.

Q830: Considering the temporal sequence of events in the regulation of blood pressure by the gut microbiome, which of the following processes would occur after the production of short-chain fatty acids (SCFAs) by gut microbes but before the central nervous system receives information to modulate blood pressure? Select all that apply.
Options:
A: The central nervous system directly alters blood pressure in response to dietary fiber intake.
B: SCFAs stimulate enteroendocrine cells to release hormones such as serotonin and peptide YY.
C: Hormones released by enteroendocrine cells bind to receptors on peripheral nervous system nerves, such as the vagus nerve.
D: Microbial dysbiosis leads to compromised barrier integrity and pathogen translocation.

Q831: Based on the described studies, which of the following events occur after fecal microbiota transplantation (FMT) from healthy or methionine-restricted donors in Alzheimer's disease mouse models, and are temporally downstream of changes in gut microbiota composition, ultimately leading to improved cognitive function? Select all that apply.
Options:
A: Increased production of short-chain fatty acids (SCFAs) by gut microbiota, followed by activation of free fatty acid receptors (FFAR2, FFAR3) and transport protein MCT1.
B: Normalization of pro-inflammatory cytokine expression in both gut and brain tissues after restoration of beneficial microbial taxa.
C: Direct modulation of central nervous system function by phages without involvement of bacterial metabolites or immune mediators.
D: Immediate reduction in amyloid-beta (Aβ) plaque burden prior to any changes in gut microbial metabolites.

Q832: Considering the temporal sequence of interventions and biological responses described in the context, which of the following events are likely to occur after the administration of probiotics or fermented dairy products, but before the manifestation of improved cognitive or metabolic outcomes in neurodegenerative or metabolic disorders?
Options:
A: Permanent eradication of all pathogenic microorganisms from the gut microbiome.
B: Alteration of gut microbiota composition, including increased microbial diversity and changes in specific bacterial taxa.
C: Immediate reversal of neurodegenerative pathology without any intermediate physiological changes.
D: Upregulation of tight-junction proteins and modulation of immune signaling in the gut epithelium.

Q833: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes are reported to occur after the administration of Pectin-Zein-IPA nanoparticles, and are temporally downstream of changes in gut microbiota composition, ultimately contributing to improved motor function recovery?
Options:
A: Initial disruption of gut microbiome balance and increased neuroinflammation
B: Activation of the AKT/Nrf-2 signaling pathway and enhanced axonal regeneration
C: Onset of SCI-induced oxidative stress and inhibition of axonal regeneration
D: Reduction in L-methionine accumulation and alleviation of neuroinflammation via improved autophagy

Q834: Considering the temporal sequence of events described in the context of gut dysbiosis and its impact on neurodevelopmental and neurodegenerative disorders, which of the following processes are likely to occur after an initial disruption of the gut microbiota but before the manifestation of altered brain function or behavior? Select all that apply.
Options:
A: Translocation of lipopolysaccharide (LPS) into circulation, triggering the release of pro-inflammatory cytokines.
B: Immediate improvement in cognitive function due to increased beneficial bacteria.
C: Direct reversal of neuropathology gene expression in the amygdala without changes in gut metabolites.
D: Increased intestinal permeability leading to systemic inflammation and neuroimmune activation.

Q835: Considering the temporal sequence of events in the pathogenesis of metabolic dysfunction-associated fatty liver disease (MAFLD), which of the following processes are likely to occur after gut microbiota dysbiosis but before the development of chronic liver inflammation, according to the described gut-liver axis mechanisms?
Options:
A: Immediate resolution of hepatic lipid accumulation without immune involvement
B: Enhanced intestinal permeability leading to the translocation of bacterial products like lipopolysaccharide (LPS) to the liver
C: Influence of microbial metabolites such as short-chain fatty acids (SCFAs) and bile acids on hepatic function and immune responses
D: Onset of chronic inflammatory responses in the liver as the initial event

Q836: Considering the temporal sequence of events in Alzheimer's disease (AD) pathogenesis as described in the context, which of the following processes are reported to occur before the accumulation of brain amyloid-beta (Aβ) plaques, and which interventions are shown to subsequently improve cognition by acting earlier in the pathway? Select all that apply.
Options:
A: Standardized methods to identify microbial infections are implemented before any changes in gut microbiota or Aβ accumulation.
B: Gut microbiota dysregulation precedes brain Aβ accumulation in transgenic mouse models.
C: Fecal microbiota transplantation (FMT) restores gut microbial balance, reduces Aβ accumulation, and improves cognition in preclinical models.
D: Antiviral therapies targeting HSV-1 act after Aβ plaque formation to reverse cognitive decline.

Q837: Considering the temporal sequence of events in the gut-brain axis, which of the following processes can occur after gut dysbiosis initiates changes in the intestinal microbiota, and subsequently leads to effects on the central nervous system (CNS) through multi-step pathways involving immune and metabolic signaling?
Options:
A: Altered permeability of the blood-brain barrier (BBB) and neuroinflammation may develop following dysregulation of gut-brain axis signaling.
B: The assembly of the inflammasome complex in CNS cells can precede exposure to microbial metabolites or products.
C: Production of pro-inflammatory cytokines such as interleukin-1β and interleukin-18 can follow inflammasome activation triggered by microbial or danger signals.
D: Progressive degeneration of neurons in neurodegenerative diseases occurs before any influence of gut-derived metabolites on the CNS.

Q838: Considering the temporal sequence of events described in Alzheimer's disease research, which of the following steps must occur before the observed improvement in cognitive function following a 4-month time-restricted feeding (TRF) intervention, according to the B. pseudolongum-propionic acid-FFAR3 axis? Select all that apply.
Options:
A: TRF enhances the production of propionic acid (PA) by modulating gut microbiota composition.
B: Gene therapy is administered to modify AD-related genetic expressions.
C: Propionic acid (PA) crosses the blood-brain barrier and interacts with FFAR3 receptors.
D: Neuroimaging is used to visualize biomarkers for early detection and staging of Alzheimer's disease.

Q839: Considering the temporal sequence of events in the gut-brain axis, which of the following processes are likely to occur after chronic administration of cannabis essential oil (CEO), as opposed to its acute use, and how might these changes subsequently impact cognitive function and gut homeostasis over time?
Options:
A: Progressive disruption of gut-brain axis homeostasis due to long-term microbiota changes
B: Immediate reduction in gut permeability and inflammation
C: Alterations in gut microbiota composition that may impair cognitive function
D: Acute enhancement of neurotransmitter modulation without long-term effects

Q840: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after the ingestion of flavanone-rich citrus fruits but before observable improvements in cognitive function, according to the described mechanisms in the context?
Options:
A: Immediate reduction in oxidative stress within neuronal tissue
B: Manifestation of improved cognitive performance and reduced risk of neurodegenerative disorders
C: Production of short-chain fatty acids and neurotransmitters by the modulated gut microbiota
D: Metabolic transformation of flavanones by gut microbiota, leading to changes in microbial composition

Q841: Considering the temporal sequence of molecular and cellular events described in the dual-hit (DSS+MPTP) mouse model of Parkinson's disease with mild chronic colitis, which of the following events are reported to occur after the initial upregulation of LRRK2 expression in the colon and brain, and contribute to the exacerbation of neuroinflammation and dopaminergic neuron loss?
Options:
A: Initial reduction of ZO-1 and Occludin levels in the colon prior to LRRK2 upregulation
B: Decreased expression of inflammatory cytokines (IL1-β and TNF-α) in the colon after LRRK2 upregulation
C: Inhibition of Nrf2 pathway in the brain subsequent to LRRK2 upregulation
D: Activation of NF-κB signaling pathway in the brain following increased LRRK2 expression

Q842: Considering the temporal sequence of events described in the context of gingerol-enriched ginger (GEG) administration in the spinal nerve ligation (SNL) model of neuropathic pain in female rats, which of the following changes are observed after GEG treatment and are temporally associated with subsequent alterations in amygdala neuropathology gene expression and behavioral outcomes? Select all that apply.
Options:
A: Immediate reversal of anxiety-like behavior prior to any changes in gut microbiota or metabolites.
B: Altered levels of fecal metabolites, including higher levels of val-glu and urocanic acid, after GEG treatment.
C: A decrease in gut microbiome diversity compared to untreated SNL rats, occurring after GEG supplementation.
D: An increase in the abundance of specific gut microbiota phyla, such as Bacteroidota and Firmicutes, following GEG administration.

Q843: Considering the temporal sequence of events described in the context of neurodegenerative diseases, which of the following processes are likely to occur after the onset of gut dysbiosis but before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Neuronal death resulting from proteinopathies
B: Restoration of gut microbiota diversity through dietary interventions
C: Disruption of the intestinal barrier leading to the ingress of pathobionts and toxic metabolites into systemic circulation
D: Chronic neuroinflammation via dysregulated immune activation

Q844: Considering the temporal sequence of events following atorvastatin administration in an ischemic stroke (IS) animal model, which of the following processes are observed after the initial modulation of gut microbiota composition, and are subsequently linked to improved neurological outcomes through a multi-step regulatory cascade involving the gut-brain axis?
Options:
A: Direct increase in blood Proteobacteria abundance as the primary event after atorvastatin treatment.
B: Reduction in the release of inflammatory cytokines such as IL-1β and IL-18, following inhibition of the Akt/NF-κB/NLRP3 pathway.
C: Immediate restoration of myelin sheath integrity in oligodendrocytes prior to any changes in gut microbiota.
D: Suppression of microglia activation and inhibition of the NF-κB pathway, leading to reduced formation of the NLRP3 inflammasome.

Q845: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut microbiota dysbiosis but before the progression of neurodegenerative symptoms such as cognitive decline or motor dysfunction? Select all that apply.
Options:
A: Activation of immune cells and systemic inflammation contributing to neuroinflammation
B: Increased gut permeability leading to translocation of toxins and bacteria into systemic circulation
C: Initial clinical manifestation of cognitive decline and motor dysfunction in neurodegenerative diseases
D: Direct improvement of mood behaviors through neurotransmitter homeostasis without involvement of microbial metabolites

Q846: Considering the temporal sequence of events in the gut-brain axis during dysbiosis, which of the following processes are likely to occur after the initial alteration of gut microbiota but before the manifestation of neuroinflammation and cognitive impairment, according to the described mechanisms in the context?
Options:
A: Immediate restoration of normal blood-brain barrier permeability and complete resolution of neuroinflammation
B: Dysregulation of signaling pathways between the gut and brain, including altered vagus nerve and immune system communication
C: Direct improvement of cognitive function without modulation of gut flora or intervention
D: Increased intestinal permeability and subsequent disruption of the blood-brain barrier

Q847: Considering the temporal sequence of events described in the context of probiotic treatment for spinal cord injury (SCI), which of the following processes are supported as occurring after the administration of probiotics but before the observed neuroprotective and anti-inflammatory outcomes in the spinal cord? Select all that apply.
Options:
A: Enhancement of gut microbiota diversity, particularly with increased abundance of Bacillota and Clostridia.
B: Direct upregulation of spinal cord genes without involvement of microbial metabolites.
C: Enrichment of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile in the gut.
D: Immediate restoration of spinal cord tissue structure without changes in gut microbiota composition.

Q848: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after a pathological shift in gut microbiota composition but before the manifestation of neuropsychological disorders such as major depressive disorder or autism spectrum disorder? Select all that apply.
Options:
A: Immediate improvement in cognitive function due to increased microbial diversity.
B: Direct manifestation of neuropsychological disorders without intermediate molecular or immune changes.
C: Modulation of the immune system and function of tissue barriers such as the blood-brain barrier.
D: Altered production of microbial metabolites such as short-chain fatty acids and signaling molecules.

Q849: Considering the temporal sequence of events in the gut-brain axis, which of the following processes can occur after an initial disruption of gut microbiota homeostasis, and subsequently contribute to the progression of neurodegenerative or neuropsychiatric disorders according to the context provided?
Options:
A: Increased gut permeability leading to systemic inflammation and neuroinflammation via the kynurenine pathway.
B: Direct improvement of synaptic marker expression in the brain before any changes in gut microbiota or metabolite levels.
C: Immediate restoration of cognitive function prior to any modulation of gut microbial composition.
D: Altered production of microbial metabolites such as short-chain fatty acids, which then modulate neuroinflammation and blood-brain barrier integrity.

Q850: Based on the described studies of morphine self-administration in rodents, which of the following events occur in a temporal sequence from early to late phases, and which are observed to persist or emerge during the chronic phase of opioid exposure? Select all that apply.
Options:
A: Gut microbiota changes are observed before the emergence of MRI-detectable alterations in the brain regions such as the striatum and thalamus.
B: Alterations in MRI diffusivity indices in the striatum and thalamus are only observed at baseline, before any morphine exposure.
C: Early changes in gut microbiota diversity and specific abundance are detected during the acute phase and persist into the chronic phase.
D: MRI and gut microbiota analyses show that all changes are restricted to the acute phase and do not persist into the chronic phase.

Q851: Considering the temporal sequence of events in the development of Long COVID, which of the following processes are described as occurring after the initial SARS-CoV-2 infection and contribute to the chronic symptoms observed weeks later? Select all that apply.
Options:
A: Acute upregulation of beneficial short-chain fatty acid-producing bacteria such as Faecalibacterium and Bifidobacterium.
B: Immediate restoration of gut microbiota diversity and function following acute infection.
C: Decreased production of short-chain fatty acids and increased gut leakiness, resulting in translocation of pathogens and release of pro-inflammatory cytokines.
D: Continuous stimulation of the immune response due to persistent viral antigens, leading to multi-organ immune dysregulation.

Q852: Considering the temporal sequence of events following addictive substance use disorder, which of the following processes occur after initial intestinal barrier damage and contribute to subsequent changes in brain function and addictive behaviors? Select all that apply.
Options:
A: Dysbiosis of the gut microbiota develops, leading to activation of immune cells and release of inflammatory factors.
B: Systemic inflammatory responses and immune imbalances arise as harmful substances and bacteria cross the compromised intestinal barrier.
C: Immediate restoration of the gut-brain axis integrity prevents any alteration in mood or cognitive function.
D: Protective short-chain fatty-acid-producing microbes increase, improving cognitive function.

Q853: Considering the temporal sequence of events in DSS-induced IBD mice, which of the following processes are observed to occur after the initial alteration of gut microbiota composition, and are associated with the development of neurological manifestations such as depression-like behaviors and cognitive deficits?
Options:
A: Negative association between certain microbial abundances (e.g., Bacteroides, Turicibacter) and altered metabolite levels in the gut-brain axis.
B: Acute improvement in cognitive function prior to any metabolic or microbial changes.
C: Distinct metabolic changes in colonic contents and hippocampal tissue, including decreased energy metabolism and short-chain fatty acids.
D: Immediate restoration of normal gut-brain metabolite signatures following DSS administration.

Q854: Considering the temporal sequence of events in the pathogenesis of neurodegenerative diseases, which of the following processes are likely to occur after gut dysbiosis disrupts the intestinal barrier but before the accumulation of neurotoxic misfolded proteins in CNS cells? Select all that apply.
Options:
A: Chronic neuroinflammation via dysregulated immune activation
B: Neuronal death resulting from proteinopathies
C: Therapeutic intervention with prebiotics, probiotics, or faecal microbial transplantation
D: Ingress of pathobionts and toxic metabolites into the systemic circulation causing gut-brain axis dysregulation

Q855: Considering the temporal sequence of events in the pathogenesis of cerebral small vessel disease (CSVD) as described in the context, which of the following processes are likely to occur after microbial dysbiosis but before the manifestation of cognitive decline, according to the microbiota-gut-brain axis and glymphatic system interactions?
Options:
A: Impaired waste clearance in the brain develops following microbial dysbiosis and contributes to CSVD progression.
B: Lifestyle factors such as sleep have no impact on the microbiota or CSVD development.
C: Cognitive decline occurs prior to any changes in the gut microbiota composition.
D: Neuroinflammation and vascular dysfunction are promoted by microbial dysbiosis, preceding cognitive decline.

Q856: Considering the temporal sequence of events following probiotic administration in a rat model of spinal cord injury (SCI), which of the following processes are supported by the context as occurring after the initial modulation of gut microbiota composition, but before the observed improvements in locomotor recovery and neuroprotection?
Options:
A: Immediate restoration of spinal cord tissue structure without changes in gene expression
B: Behavioral improvements measured by the Basso Mouse Scale and inclined plane tests
C: Enrichment of tryptophan metabolites such as 3-Indoleacetonitrile and Serotonin in the gut
D: Activation of downstream signaling pathways in the spinal cord involving anti-inflammatory and neuroregenerative genes

Q857: Considering the temporal sequence of events in the gut-brain axis and neurodegeneration, which of the following processes are likely to occur after autophagy-lysosomal pathway (ALP) dysfunction in the gut, but before the acceleration of neurodegeneration, according to the described molecular hierarchy and feedback mechanisms?
Options:
A: Direct reversal of age-associated impairments without involvement of the gut microbiota
B: Triggering of chronic neuroinflammation via gut-brain axis signaling
C: Immediate restoration of cognitive function through synbiotic intervention
D: Disruption of intestinal homeostasis and promotion of gut microbiota dysbiosis

Q858: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut microbial dysbiosis initiates increased endotoxin production, but before the manifestation of neurodegenerative pathology such as amyloid deposition or tauopathy? Select all that apply.
Options:
A: Onset of systemic pro-inflammatory state and neuroinflammation
B: Immediate restoration of microbial balance through dietary intervention
C: Impairment of blood-brain barrier permeability and recruitment of immune mediators
D: Activation of immune cells and disruption of intestinal barrier permeability

Q859: Considering the temporal sequence of events in the gut-lung axis, which of the following processes can occur after an alteration in gut microbiota composition due to clinical intervention, and may subsequently influence the progression or prevention of pulmonary infections according to the context provided?
Options:
A: Changes in gut microbial metabolites that affect immune responses in the lungs.
B: Immediate restoration of lung tissue without involvement of immune modulation.
C: Direct genetic modification of lung cells by gut bacteria without intermediary steps.
D: Modulation of susceptibility to pulmonary infections through altered gut microbiota.

Q860: Considering the temporal sequence of events in the experimental model of Japanese encephalitis described, which of the following changes would be expected to occur after prophylactic administration of short-chain fatty acids (SCFAs) and subsequent JEV infection, but before the onset of terminal illness? Select all that apply.
Options:
A: Reduced glial activation, as evidenced by lower microglia counts in brain tissue sections, compared to JEV-infected animals without SCFA supplementation.
B: Immediate restoration of normal gut microbiota diversity prior to JEV infection.
C: Downregulation of inflammatory cytokines such as TNF-α, MCP-1, IL-6, and IFN-Υ in the brain tissue compared to JEV-infected controls.
D: Significant increase in caspase-3 upregulation in the SCFA-supplemented group compared to the JEV-infected control group.

Q861: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors into Alzheimer's disease (AD) mice, which of the following processes are expected to occur after the initial restoration of short-chain fatty acid (SCFA) levels, but before improvements in learning and memory are observed?
Options:
A: Activation of free fatty acid receptors FFAR2 and FFAR3, as well as the transport protein MCT1, signaling to the brain
B: Immediate reversal of cognitive impairment without intermediary molecular signaling
C: Direct modulation of chromatin structure in neurons prior to any changes in gut metabolite levels
D: Mitigation of neuroinflammation in the brain as a downstream effect of gut-derived signaling

Q862: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after the administration of honokiol-short chain fatty acid (HNK-SCFA) esters to a patient with Parkinson's disease, but before any potential enhancement of levodopa's therapeutic efficacy is observed? Select all that apply.
Options:
A: Inhibition of Enterococcus faecalis growth in a dose-dependent manner by HNK-SCFA esters.
B: Sustained up-regulation of neuroinflammatory responses in the central nervous system due to age-related epigenetic modifications.
C: Hydrolysis of HNK-SCFA esters within bacterial cells, releasing HNK and SCFAs.
D: Long-term restoration of gut microbiota diversity following chronic HNK-SCFA administration.

Q863: Considering the temporal sequence of events in the progression of neurodegenerative diseases, which of the following processes are likely to occur after gut microbiome dysbiosis but before the manifestation of cognitive decline and motor deficits, according to the described hierarchical and mechanistic pathways?
Options:
A: Onset of cognitive decline and motor deficits characteristic of neurodegenerative diseases
B: Impairment of blood-brain barrier permeability and recruitment of immune mediators
C: Restoration of microbial balance through fecal microbiota transplantation
D: Increased intestinal barrier permeability leading to systemic inflammation

Q864: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after a decrease in short-chain fatty acid (SCFA) production due to gut dysbiosis, and before the manifestation of cognitive or behavioral symptoms? Select all that apply.
Options:
A: Immediate improvement in brain blood barrier (BBB) integrity and permeability.
B: Altered microglia and astrocyte function in the central nervous system.
C: Resolution of psychiatric symptoms such as anxiety and depression.
D: Increased neuroinflammation mediated by immune interactions between the gut and brain.

Q865: Considering the temporal sequence of events following antibiotic overuse in livestock, which of the following processes are likely to occur in order, ultimately impacting neurodegenerative disease progression? Select all that apply: (1) Antibiotic-induced gut microbiota dysbiosis, (2) Disruption of the gut-microbiota-brain axis integrity, (3) Systemic inflammation and neuroinflammation, (4) Compromised blood-brain barrier allowing inflammatory molecules and amyloids to enter the brain.
Options:
A: Antibiotic-induced gut microbiota dysbiosis precedes disruption of the gut-microbiota-brain axis integrity.
B: Compromised blood-brain barrier allowing inflammatory molecules and amyloids to enter the brain occurs before gut microbiota dysbiosis.
C: Systemic inflammation and neuroinflammation occur before antibiotic-induced gut microbiota dysbiosis.
D: Disruption of the gut-microbiota-brain axis integrity is followed by systemic inflammation and neuroinflammation.

Q866: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut microbiota dysbiosis initiates chronic inflammation, but before the manifestation of neurodegenerative symptoms such as cognitive impairment or Parkinson’s disease? Select all that apply.
Options:
A: Restoration of normal gut microbial composition through fecal microbiota transplantation.
B: Disruption of intestinal barrier permeability leading to increased systemic pro-inflammatory state.
C: Impairment of blood-brain barrier permeability and recruitment of immune mediators causing neuroinflammation.
D: Bibliometric analysis of global research trends in gut flora and cognitive impairment.

Q867: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbial diversity but before the manifestation of neurodegenerative symptoms, according to the context provided? Select all that apply.
Options:
A: Changes in microbial metabolites that influence neural function and immune responses.
B: Modulation of the native immune system and potential disruption of gut epithelial and blood-brain barrier integrity.
C: Implementation of microbiome-based therapeutics such as probiotics or fecal microbiota transplantation.
D: Direct clinical observation of cognitive decline or motor symptoms in neurodegenerative diseases.

Q868: Considering the temporal sequence of events in the context of intermittent fasting (IF) and its impact on metabolic dysfunction-associated steatotic liver disease (MASLD), which of the following steps are likely to occur before improvements in liver health are observed, according to the described gut-liver axis pathway?
Options:
A: Alterations in gut microbiota composition and diversity following the implementation of intermittent fasting protocols.
B: Changes in the metabolomic profile of the gut microbiota that may mediate beneficial effects on hepatic function.
C: Immediate reversal of MASLD symptoms prior to any changes in gut microbiota or metabolite production.
D: Direct pharmacological intervention targeting hepatic cells without involvement of the gut microbiota.

Q869: Considering the temporal sequence of events following perinatal chlorpyrifos (CPF) exposure in rats, which of the following processes occur after the initial disruption of gut microbiota composition, and are subsequently mitigated by inulin administration, according to the described experimental findings?
Options:
A: Initial CPF exposure directly increases the abundance of Bifidobacterium in the gut before any other changes.
B: Decreased gene expression of tight junction markers in brain microvessels follows CPF-induced gut dysbiosis and is restored by inulin.
C: Translocation of bacteria from the gut to the spleen and liver occurs after gut dysbiosis and is reduced by inulin.
D: Increased expression of tight junction genes in brain microvessels precedes CPF-induced gut dysbiosis.

Q870: Considering the temporal sequence of events in endometriosis pathogenesis, which of the following processes occur after microbial dysbiosis but before the proliferation of endometriotic lesions, according to the described mechanisms involving gut microbiota, immune dysregulation, and estrogen metabolism?
Options:
A: Modulation of estrogen metabolism by the estrobolome, leading to increased systemic estrogen levels
B: Activation of the TLR4/NF-κB signaling pathway by lipopolysaccharides from Gram-negative bacteria
C: Initial reduction in beneficial bacteria such as Lactobacillus and Bifidobacterium
D: Integration of microbiome research with precision medicine to improve treatment efficacy

Q871: Considering the temporal sequence of interventions and their effects on the gut-brain axis, which of the following events are likely to occur after the administration of fecal microbiota transplantation (FMT) in neurodegenerative disorders, according to the described mechanisms and research findings in the context above?
Options:
A: Permanent elimination of the need for donor selection due to universal FMT efficacy.
B: Strengthening of gut barrier integrity, subsequently leading to regulation of neurotransmitter production.
C: Restoration of microbial diversity in the gut, followed by reduction in neuroinflammatory markers.
D: Immediate reversal of all neurodegenerative symptoms prior to any changes in gut barrier integrity.

Q872: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after a disturbance in gut microbiota composition (dysbiosis) but before the manifestation of systemic or localized disease symptoms, such as those seen in retinal or neurological disorders? Select all that apply.
Options:
A: Implementation of precision nutritional interventions targeting the microbiota.
B: Production of metabolic compounds by the disturbed microbiota that enter systemic circulation.
C: Clinical presentation of age-related macular degeneration or cerebral small vessel disease.
D: Alteration of immune signaling and increased intestinal permeability due to dysbiosis.

Q873: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors into Alzheimer's disease (AD) model mice, which of the following processes are expected to occur after the initial restoration of short-chain fatty acid (SCFA) levels, but before the improvement in learning and memory abilities? Select all that apply.
Options:
A: Immediate reversal of neurodegeneration prior to any changes in gut metabolites
B: Activation of free fatty acid receptors FFAR2 and FFAR3 in the gut-brain axis
C: Direct enhancement of cognitive function without involvement of gut-derived metabolites
D: Signaling to the brain to mitigate inflammation via SCFA-mediated pathways

Q874: Considering the temporal sequence of events described in the context of gut dysbiosis and its impact on autism spectrum disorder (ASD), which of the following processes are likely to occur after an initial alteration in gut microbiota composition but before the manifestation of neuroimmune activation and behavioral changes in ASD individuals?
Options:
A: Activation of TLR/NF-κB signaling pathways due to microbial metabolites
B: Increased intestinal permeability leading to systemic inflammation
C: Formation of autoantibodies against basement membrane proteins in the skin
D: Direct modulation of brain development by dietary phytochemicals without involvement of gut microbiota

Q875: Considering the sequence of biological events described in the context, which of the following processes occur after the oral administration of medium-chain triglycerides (MCT) to 5×FAD mice but before the observed improvement in memory deficits? Select all that apply.
Options:
A: The initial onset of memory impairment in 5×FAD mice.
B: An increase in the relative abundance of Akkermansia in the gut microbiota.
C: A reduction in intestinal permeability and elevation of short-chain fatty acids in the brain.
D: The development of neurite atrophy prior to any intervention.

Q876: Considering the temporal sequence of events following fecal microbiota transplantation (FMT) in neurological disorders, which of the following changes are observed as downstream effects after the restoration of gut microbial composition, and how do these changes relate to neuroimmune and cognitive functions over time?
Options:
A: Immediate upregulation of synaptic markers (PSD-95, synapsin-1) prior to any changes in gut microbial composition.
B: A decrease in pro-inflammatory cytokines such as IL-17 and IFN-γ, followed by improved neuroimmune regulation.
C: Reduction in amyloid-β accumulation and subsequent improvement in cognitive function in Alzheimer's disease models.
D: Inhibition of TLR4 and NF-κB expression in Parkinson's disease occurring before any restoration of microbial functionality.

Q877: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after the ingestion of flavanones but before improvements in cognitive performance are observed, according to the described biological hierarchy and regulatory cascades?
Options:
A: Long-term safety profiles of flavanone supplementation are fully established in clinical populations.
B: Neurodegenerative disorders are completely reversed in the host.
C: Gut microbiota produce short-chain fatty acids and neurotransmitters that impact central nervous system function.
D: Flavanones undergo metabolic transformation, leading to modulation of gut microbiota composition.

Q878: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after the restoration of microbial diversity via fecal microbiota transplantation (FMT) in neurodegenerative disease models, but before the alleviation of motor and cognitive deficits? Select all that apply.
Options:
A: Reduction of neuroinflammatory markers in the central nervous system
B: Initial donor selection and preparation for FMT
C: Strengthening of gut barrier integrity and regulation of neurotransmitter production
D: Assessment of long-term safety and clinical outcome consistency

Q879: Considering the temporal sequence of events in the microbiota-gut-brain axis, which of the following processes would most likely occur after an age-associated alteration in gut microbiota composition, but before the manifestation of neurodegenerative disease symptoms, according to the described mechanisms in the context?
Options:
A: Modulation of immune-inflammatory responses and neurodevelopment by the altered gut microbiota.
B: Changes in gut microbial metabolites that influence central nervous system functions via the autonomic nervous system.
C: Immediate restoration of normal brain function solely through dietary intervention, bypassing changes in gut microbiota.
D: Direct clinical presentation of neurodegenerative symptoms without preceding changes in gut microbiota or metabolites.

Q880: Considering the temporal sequence of events in obesity-induced neuroinflammation and neurodegeneration, which of the following processes occur after the initial infiltration of immune cells into adipose tissue but before the manifestation of cognitive decline and motor deficits? Select all that apply.
Options:
A: Progressive impairment of neuronal function leading directly to cognitive decline and motor deficits.
B: Initial excessive fat storage in adipose tissue, promoting immune cell infiltration.
C: Release of pro-inflammatory cytokines and adipokines into the bloodstream, propagating inflammation in the periphery and central nervous system.
D: Development of insulin resistance, mitochondrial dysfunction, autolysosomal dysfunction, and increased oxidative stress within the brain.

Q881: Considering the temporal sequence of events following ischemic stroke, which of the following processes are likely to occur in the progression from initial gut microbiota alterations to the development or exacerbation of post-stroke depression, according to the microbiota-immune-barrier axis model described in the context?
Options:
A: The gut barrier dysfunction occurs independently of gut microbiota changes and does not involve immune regulation in the development of post-stroke depression.
B: After ischemic stroke, inflammatory responses and immunomodulation mediate the effect of gut microbiota on barrier integrity, ultimately influencing the onset and progression of depressive symptoms.
C: Depressive symptoms arise first, which then cause changes in the gut microbiota and later disrupt the gut barrier.
D: Gut microbiota dysbiosis leads to impaired gut barrier function, which subsequently triggers inflammatory and immune responses that contribute to depressive symptoms.

Q882: Considering the temporal sequence of events in neurodegenerative disease progression, which of the following processes are likely to occur after an initial imbalance in gut microbiota, according to the described gut-brain axis mechanisms and their regulatory cascades involving the cAMP-PKA signaling pathway?
Options:
A: Activation of the vagus nerve and modulation of immune and neuroendocrine systems, leading to changes in central nervous system signaling.
B: Altered neurotransmitter release and microglial activation, contributing to the progression of neurological disease symptoms.
C: Immediate restoration of neuronal integrity through stem cell replacement, bypassing molecular signaling pathways.
D: Direct gene-editing of harmful genetic variants in neurons without involvement of gut microbiota or signaling intermediates.

Q883: Considering the temporal sequence of events in Long COVID, which of the following processes occur after the initial SARS-CoV-2 infection and contribute to the progression of gut-brain axis dysregulation, ultimately leading to neuroinflammation and altered serum cortisol levels? Select all that apply.
Options:
A: Decreased stimulation of the vagus nerve, resulting in neuroinflammation and dysregulation of serum cortisol.
B: Immediate restoration of beneficial short-chain fatty acid-producing bacteria in the gut microbiome.
C: Dysbiotic changes in the gut due to impaired mTOR pathway activation and reduced AMP secretion.
D: Increased leakiness of the gut, allowing translocation of pathogens or lipopolysaccharide and release of pro-inflammatory cytokines.

Q884: Considering the temporal sequence of events following cerebral ischemia/reperfusion (I/R) injury in rats, which of the following processes are reported to occur after administration of Polygoni Multiflori Radix Praeparata polysaccharides (PMP), and contribute to the subsequent improvement in both brain and intestinal health? Select all that apply.
Options:
A: A reduction in the abundance of Bifidobacterium, Muribaculaceae, and Lactobacillus in the gut microbiota.
B: An increase in the intestinal levels of short-chain fatty acids (SCFAs) and beneficial amino acids, leading to improved metabolism.
C: Restoration of tight junction protein expression in both brain and intestinal tissues, enhancing barrier integrity.
D: Elevation of inflammatory cytokines such as TNF-α and IL-1β in brain and intestinal tissues.

Q885: Considering the temporal sequence of events in Alzheimer's disease mouse models receiving fecal microbiota transplantation (FMT), which of the following changes are observed after transplantation from healthy donors, and which occur after transplantation from colitis-associated dysbiotic donors, specifically in relation to neuroinflammation and amyloid-beta pathology? Select all that apply.
Options:
A: After FMT from colitis-associated dysbiotic donors, there is a subsequent exacerbation of cognitive deficits, heightened amyloid-beta deposition, and elevated pro-inflammatory cytokine levels.
B: Following FMT from colitis-associated dysbiotic donors, there is an early improvement in spatial memory and exploratory behavior, preceding any changes in amyloid-beta deposition.
C: After FMT from healthy donors, there is a subsequent reduction in amyloid-beta plaque burden and normalization of pro-inflammatory cytokine expression in both gut and brain tissues.
D: FMT from healthy donors leads to an initial increase in neurotoxic metabolites, followed by a later increase in pro-inflammatory pathways in the brain.

Q886: During the progression of herpes simplex encephalitis (HSE) caused by HSV-1 infection, several sequential events occur involving the gut microbiota, microglial activation, and neuroinflammation. Which of the following events are described as occurring after HSV-1 infection but before the administration of exogenous nicotinamide n-oxide (NAMO), according to the described temporal sequence in the context?
Options:
A: HSV-1 infection leads to gut microbiota dysbiosis and microglial antiviral immune response.
B: Mitochondrial dysfunction and impaired mitophagy activate microglia and promote proinflammatory cytokine production.
C: NAMO administration significantly suppresses HSE progression.
D: NAMO restores NAD+-dependent mitophagy to restrain microglial over-activation.

Q887: Considering the temporal sequence of events in the gut-brain axis, which of the following processes can occur after the administration of probiotics and may subsequently influence depressive symptom severity or neurodegenerative disease progression, according to the context provided?
Options:
A: Immediate reversal of chronic, treatment-resistant depression without the need for further mechanistic investigation.
B: Modulation of gut microbiota composition, leading to changes in neurotransmitter production that affect brain function over time.
C: Alteration of inflammatory and immune pathways via the microbiota-gut-brain axis, which can impact the onset and persistence of depression-related symptoms.
D: Permanent elimination of all neuroinflammatory responses in the central nervous system following a single probiotic dose.

Q888: Considering the temporal sequence of events described in the context, which of the following processes occur after gut microbiota dysbiosis initiates changes in metabolite production, and before the manifestation of neurological dysfunctions or neuroinflammation in the central nervous system? Select all that apply.
Options:
A: Clinical symptoms of neurodegenerative diseases, such as Alzheimer's or Parkinson's, are observed before any changes in gut microbiota composition.
B: Microbial shifts directly cause immediate neuronal death in the CNS without intermediary steps.
C: Altered gut microbial metabolites, such as short-chain fatty acids or DHPS, enter the bloodstream and influence systemic physiology.
D: Gut commensal-specific CD4 T cells become dysregulated in the inflamed gut and are licensed to infiltrate the CNS.

Q889: Considering the temporal sequence of events described in the context of post-stroke depression (PSD), which of the following processes occur after cerebral ischemia and contribute to the progression of depressive symptoms through the microbiota-immune-barrier axis? Select all that apply.
Options:
A: Immunomodulation by the gut microbiota affecting the gut-brain axis.
B: Restoration of normal gut microbiota composition prior to stroke.
C: Initial ischemic stroke event causing cerebral injury.
D: Disruption of gut barrier integrity leading to altered inflammatory responses.

Q890: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after a high-fibre diet increases the production of short-chain fatty acids (SCFAs) by the gut microbiome, but before the modulation of blood pressure is observed in hypertensive patients? Select all that apply.
Options:
A: Oligodendrocyte-mediated myelination in the central nervous system is directly enhanced.
B: Hormones released by enteroendocrine cells bind to receptors on peripheral nervous system nerves, such as the vagus nerve.
C: SCFAs stimulate the release of neurotransmitters and hormones such as serotonin and peptide YY by enteroendocrine cells.
D: Clinical improvement in hypertension is documented in multicenter trials.

Q891: Considering the temporal sequence of events in the gut microbiota-brain axis and neurodegenerative disease progression, which of the following processes are likely to occur after an initial alteration in gut microbiota composition, but before the manifestation of neurological symptoms, according to the context provided?
Options:
A: Regulation of intestinal permeability and immune responses by microbial metabolites impacting CNS health
B: Direct application of CRISPR-Cas9-mediated genome editing as the first response to gut microbiota changes
C: Immediate clinical improvement in neurodegenerative disease symptoms following gut microbiota alteration
D: Changes in microbial metabolite production that modulate neuroinflammation and blood-brain barrier integrity

Q892: Considering the temporal sequence of events following bariatric surgery, which of the following changes are expected to occur in the early post-surgical phase and subsequently contribute to long-term improvements in metabolic health through hierarchical modulation of gut-brain communication and metabolic pathways?
Options:
A: Permanent elimination of food cravings without any further neurobiological adaptation.
B: Reduction in ghrelin levels, leading to enhanced satiety and decreased caloric intake.
C: Increase in beneficial gut microbiota species such as Akkermansia muciniphila, influencing metabolic pathways via short-chain fatty acid production.
D: Immediate restoration of all neurobiological structures involved in reward processing.

Q893: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after dietary components alter the gut microbiota composition, but before changes in central nervous system (CNS) functions such as neuroplasticity and neurotransmitter levels are observed in the context of depression?
Options:
A: Modulation of microbial metabolism leading to altered production of microbial metabolites
B: Microbial metabolites influencing gut-brain communication via neural, immune, and endocrine pathways
C: Direct alteration of CNS neuroplasticity by dietary components without involvement of the gut microbiota
D: Immediate improvement in depressive symptoms without intermediary metabolic changes

Q894: Considering the temporal sequence of events in the progression of neurodegenerative diseases, which of the following processes are likely to occur after gut microbial dysbiosis but before the manifestation of neuronal damage, according to the described mechanisms involving biofilm-associated amyloid proteins and inflammatory pathways?
Options:
A: Compromise of the blood-brain barrier by persistent bacterial infections and inflammation, allowing amyloids and inflammatory molecules to enter the brain
B: Restoration of gut microbial balance through probiotic supplementation, leading to reduced CRP and TNF-α levels
C: Production of bacterial amyloids that cross-seed human amyloidogenic proteins, accelerating their misfolding and aggregation
D: Manifestation of clinical symptoms of neurodegeneration such as cognitive decline and motor dysfunction

Q895: Considering the temporal sequence of events in the pathogenesis and treatment of Parkinson's disease (PD), which of the following processes must occur before improvements in clinical symptoms can be observed following fecal microbiota transplantation (FMT), according to the described gut-brain axis mechanisms and regulatory cascades?
Options:
A: Immediate restoration of dopaminergic neurons in the substantia nigra without changes in gut microbiota
B: Modulation of the gut-brain axis by the newly introduced microbiota, influencing neuronal and immune pathways
C: Alteration of gut microbiota composition after FMT, leading to changes in microbial metabolites
D: Direct accumulation of α-synuclein in neurons prior to any gut microbiota changes

Q896: Considering the temporal sequence of events in Parkinson's Disease (PD) as described in the context, which of the following processes occur after the elevation of specific plasma metabolites in PD patients, and are subsequently associated with changes in intestinal barrier function and clinical symptoms? Select all that apply.
Options:
A: ROC curve analysis is performed before the identification of differential plasma metabolites in PD patients.
B: Associations between elevated plasma metabolites and PD clinical symptoms are identified after increased intestinal permeability.
C: Increased intestinal permeability and inflammation are observed following the elevation of plasma metabolites.
D: Alterations in fecal metabolite concentrations precede changes in plasma metabolite levels in PD patients.

Q897: Considering the temporal sequence of events following antibiotic overuse in livestock, which of the following processes are likely to occur in order, ultimately impacting the gut-microbiota-brain axis and potentially leading to neuroinflammation? Select all that apply.
Options:
A: Antibiotic-induced dysbiosis can precede and contribute to neuroinflammation by damaging the gut-brain barrier.
B: Antibiotic overuse in livestock directly causes neurodegenerative conditions in humans without affecting the gut microbiota.
C: Neuroinflammation occurs first, which then leads to antibiotic-induced dysbiosis in the gut microbiota.
D: Antibiotic overuse disrupts gut microbiota balance, leading to dysbiosis, which then induces systemic inflammation and compromises the gut-microbiota-brain axis.

Q898: Considering the temporal sequence of events in the gut-brain axis and neurodegenerative disease progression, which of the following processes are likely to occur after an initial disruption of gut microbiota homeostasis, but before the manifestation of severe cognitive or motor deficits, according to the context provided?
Options:
A: Increased gut permeability leading to endotoxin entry into the bloodstream and subsequent neuroinflammation
B: Immediate restoration of neuronal structure and function in the central nervous system
C: Complete reversal of neurodegenerative pathology through a single dietary intervention
D: Altered neurotransmitter production, including serotonin, due to changes in gut microbiota composition

Q899: Considering the temporal sequence of events following a loss of social status in mice, which of the following processes are likely to occur before observable behavioral alterations, according to the described studies on the microbiota-gut-brain axis? Select all that apply.
Options:
A: Alteration in the composition and function of the gut microbiota, including increased Muribaculaceae abundance and enhanced butanoate metabolism.
B: Changes in GABAergic synaptic transmission in prefrontal cortex interneurons as revealed by transcriptomic analysis.
C: Long-term restoration of social dominance through gut microbial depletion.
D: Behavioral changes associated with hierarchical demotion.

Q900: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after gut microbial dysbiosis disrupts the crosstalk between the microbiota and the immune system, but before the onset of neurodegenerative symptoms? Select all that apply.
Options:
A: Enhanced synaptic function and improved learning and memory due to upregulation of neurotrophins.
B: Compromised immune tolerance due to impaired regulatory T cell (Treg) function in the intestine.
C: Immediate restoration of immune homeostasis through probiotic supplementation.
D: Activation of neuroinflammatory pathways as a result of altered gut-brain interactions.

Q901: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after gut dysbiosis leads to increased gut permeability, but before the progression of neurological disorders such as Alzheimer's or Parkinson's disease? Select all that apply.
Options:
A: Exacerbation of neuroinflammation via the gut-brain axis due to systemic inflammation.
B: Resolution of neuroinflammation and restoration of normal gut microbiota composition.
C: Translocation of toxins and bacteria into systemic circulation, triggering widespread inflammation.
D: Direct neuronal regeneration and synaptogenesis in the brain.

Q902: Considering the temporal sequence of events described in the context, which of the following processes can occur after long-term exposure to extrinsic factors such as diet, air pollution, or stress, and subsequently contribute to the progression of age-related diseases through multi-step biological pathways involving epigenetic regulation and gene expression changes?
Options:
A: Gut microbiome-mediated modifications of host DNA methylation and histone patterns, influencing gene expression and phenotypic plasticity.
B: Immediate reversal of age-related diseases without any changes in gene expression or epigenetic state.
C: Epigenetic changes in the host mediated by endocrine and immune pathways, leading to altered transcriptional profiles.
D: Direct and instantaneous phenotypic changes without involvement of molecular or epigenetic mechanisms.

Q903: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbial diversity but before the manifestation of neurodegenerative pathology, according to the context provided? Select all that apply.
Options:
A: Immediate onset of neurodegenerative symptoms without any intermediate molecular or cellular changes.
B: Modulation of intestinal and blood-brain barrier integrity as a result of altered gut microbiota composition.
C: Direct clinical observation of cognitive decline without preceding changes in gut or immune function.
D: Changes in the production of gut microbial metabolites that can cross the blood-brain barrier and influence central nervous system functions.

Q904: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after the onset of gut microbiota dysbiosis but before the manifestation of chronic neurodegenerative disease symptoms, according to the mechanistic insights provided?
Options:
A: Altered gut microbial composition leads to increased endotoxin production and fewer beneficial metabolites, triggering immune cell activation and enteric neuronal dysfunction.
B: Neurodevelopmental disorders in children are diagnosed prior to any changes in gut microbiota composition.
C: Disruption of intestinal barrier permeability and aggravation of the systemic pro-inflammatory state occur, impairing blood-brain barrier permeability and recruiting immune mediators.
D: The Mediterranean diet is adopted, resulting in immediate improvement of cognitive function and reversal of neurodegeneration.

Q905: Considering the temporal sequence of events in gut microbiota-mediated neurodegeneration, which of the following processes would most likely occur after the initial alteration in gut microbial composition but before the manifestation of neurodegenerative symptoms, according to the context provided? Select all that apply.
Options:
A: Manifestation of clinical symptoms such as cognitive decline or motor dysfunction.
B: Direct replacement of lost neurons by stem cell strategies in the brain.
C: Changes in the levels of gut-derived metabolites such as succinic acid and TMAO detectable in urine.
D: Modulation of intracellular signalling pathways by polyphenol metabolites derived from gut microbiota.

Q906: Considering the temporal sequence of events in Alzheimer's disease (AD) pathogenesis, which of the following processes are likely to occur after alterations in the gut microbiota composition, but before the manifestation of cognitive decline, according to the described gut microbiota-brain axis and neuroinflammation mechanisms?
Options:
A: Activation of microglia and astrocytes leading to neuroinflammation in the central nervous system
B: Immediate restoration of healthy gut microbiota composition following periodontal therapy
C: Bidirectional communication between gut microbiota and the brain via cytokines, neurotransmitters, and hormones
D: Onset of irreversible cognitive decline characteristic of late-stage Alzheimer's disease

Q907: Considering the temporal sequence of events in the gut microbiota–cAMP-PKA signaling pathway interaction, which of the following processes can occur after gut microbiota-derived metabolites modulate the cAMP-PKA pathway, and which can subsequently influence the progression of neurological diseases according to the described feedback mechanisms?
Options:
A: Immediate restoration of gut microbiota composition without involvement of host signaling pathways
B: Regulation of amyloid-β protein aggregation, mitochondrial dysfunction, and neurotransmitter release
C: Permanent inhibition of all gut-brain axis communication
D: Activation of the vagus nerve and modulation of immune and neuroendocrine systems

Q908: Considering the temporal sequence of events following gingerol-enriched ginger (GEG) administration in the spinal nerve ligation (SNL) rat model, which of the following changes are observed after GEG treatment and occur prior to or concurrently with the mitigation of pain-associated behaviors, as supported by the context?
Options:
A: Alterations in gut microbiome composition, including increased abundance of Bacteroidota, Firmicutes, and Verrucomicrobiota phyla.
B: Increased levels of specific hydrophilic fecal metabolites, such as val-glu and L-threonine, following GEG supplementation.
C: Decreased gut microbiome diversity compared to untreated SNL rats prior to GEG administration.
D: Initial upregulation of PLA2G4A gene expression in the amygdala before GEG administration.

Q909: Considering the temporal sequence of events described in the context, which of the following processes occur after the administration of fecal microbiota transplantation (FMT) from methionine-restricted (MR) diet mouse donors to Alzheimer's disease (AD) mice, and before the observed improvement in learning and memory abilities? Select all that apply.
Options:
A: Restoration of short-chain fatty acid (SCFA) levels in the gut of AD mice
B: Onset of cognitive impairment in APP/PS1 double transgenic AD mice
C: Initial reduction of SCFAs induced by AD pathology
D: Activation of free fatty acid receptors (FFAR2 and FFAR3) and the transport protein MCT1 in response to increased SCFAs

Q910: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after the disruption of gut microbiota by antibiotics in livestock, and before the manifestation of neuroinflammation or neurodegenerative symptoms in the host? Select all that apply.
Options:
A: Immediate restoration of gut-microbiota-brain axis integrity without intervention.
B: Dysbiosis leading to systemic inflammation due to disruption of microbial balance.
C: Compromise of the gut-brain barrier as a result of dysbiosis.
D: Direct improvement of neurological symptoms following antibiotic exposure.

Q911: Considering the temporal sequence of molecular and cellular events described in the context of atorvastatin treatment for ischemic stroke, which of the following events are reported to occur after atorvastatin administration and before improved neurobehavioral outcomes, according to the described regulatory cascade involving the gut-brain axis?
Options:
A: Initial induction of bilateral common carotid artery occlusion to establish the ischemic stroke model
B: Reduction in the release of inflammatory cytokines, including IL-1β and IL-18
C: Recruitment of ischemic stroke patients for clinical evaluation
D: Suppression of microglial activation and inhibition of the NF-κB pathway

Q912: Considering the temporal sequence of events following probiotic administration in a rat model of spinal cord injury (SCI), which of the following processes are supported by the context as occurring after the initial modulation of gut microbiota composition, and contribute to the eventual neuroprotective and anti-inflammatory outcomes observed in the spinal cord tissue?
Options:
A: Activation of downstream signaling pathways in the spinal cord involving upregulation of anti-inflammatory and neuroregenerative genes
B: Immediate restoration of spinal cord tissue structure prior to any changes in gut microbiota
C: Enrichment of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile in the gut
D: Reduction of neuroinflammatory markers in multiple sclerosis patients before any modulation of gut microbiota

Q913: Considering the temporal sequence of events in the pathogenesis of HIV-associated neurocognitive disorder (HAND), which of the following steps occur after a reduction in SCFA-producing gut bacteria, and before the manifestation of cognitive impairment, according to the described studies? Select all that apply.
Options:
A: A rise in pro-inflammatory cytokine levels
B: An increase in anti-inflammatory cytokine levels
C: Restoration of gut microbiome homeostasis by probiotics
D: A decrease in plasma short-chain fatty acids (SCFAs)

Q914: Considering the temporal sequence of events in the progression of osteoarthritis (OA) as described in the context, which of the following steps would most likely occur after the microbial fermentation of dietary fibers in the gut but before the mitigation of OA progression? Select all that apply.
Options:
A: Production of short-chain fatty acids (SCFAs) that enter the blood circulation.
B: Diminished physical function and quality of life due to chronic joint inflammation.
C: Preservation of intestinal barrier function and maintenance of cartilage integrity by SCFAs.
D: Microbial fermentation of dietary fibers in the gut.

Q915: Considering the temporal sequence of events following ischaemic stroke, which of the following processes occur after the initial reduction in cerebral blood flow and contribute to the progression of neuronal injury, and which are subsequently modulated by gut microbiota-derived metabolites according to the context provided?
Options:
A: Immediate restoration of blood-brain barrier integrity prior to the onset of oxidative stress
B: Intensification of neuronal damage and inflammation, which may be mitigated or exacerbated by gut-derived short-chain fatty acids (SCFAs) and TMAO
C: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB
D: Initial improvement in cognitive function before the development of neuroinflammatory responses

Q916: Considering the temporal sequence of events following ischaemic stroke, which of the following processes occur after the initial reduction in cerebral blood flow and contribute to subsequent neuronal injury, and which are further modulated by gut microbiota-derived metabolites according to the context provided?
Options:
A: Excessive production of reactive oxygen and nitrogen species (RONS) leading to activation of inflammatory pathways mediated by NF-κB
B: Immediate restoration of blood-brain barrier integrity prior to excitotoxicity
C: Intensification of neuronal damage and blood-brain barrier compromise due to a pro-inflammatory milieu exacerbated by dysbiosis
D: Direct repair of neuronal DNA before mitochondrial dysfunction occurs

Q917: Based on the described experimental phases and molecular findings in the DEACMP rat model, which of the following events occur after the administration of acetate and propionate for two weeks, and are temporally downstream of initial hippocampal inflammation, according to the proposed SCFA treatment pathway?
Options:
A: Restoration of decreased GPR41, GPR43, dopamine, and norepinephrine levels in the hippocampus.
B: Initial increase in hippocampal IL-1β, IL-6, and TNF-α levels prior to intervention.
C: Development of DEACMP rat model and assessment of baseline SCFA serum levels.
D: Improvement in cognitive dysfunction and anxiety symptoms as measured by behavioral tests.

Q918: Considering the temporal sequence of events in the kynurenine pathway and gut-brain axis, which of the following processes are likely to occur after an alteration in gut microbiota composition increases gut permeability, but before the onset of neuropsychiatric symptoms? Select all that apply.
Options:
A: Triggering of systemic inflammation due to increased gut permeability.
B: Immediate restoration of gut barrier function without modulation of the microbiota.
C: Activation of neuroinflammation as a result of systemic inflammation.
D: Direct improvement of cognitive development by probiotics without any intermediary steps.

Q919: Considering the temporal sequence of events following neurosurgical procedures, which of the following processes occur after the disruption of the blood-brain barrier (BBB) and contribute to both immediate and long-term cognitive impairments, according to the described mechanisms in the context?
Options:
A: Release of cytokines such as tumor necrosis factor-alpha and interleukin-1 leading to neuronal damage
B: Initial exposure of cerebrospinal fluid to pathogens prior to BBB disruption
C: Restoration of neural integrity before the onset of inflammation
D: Activation of neuroinflammatory responses involving microglia and astrocytes

Q920: Considering the temporal sequence of events in gut dysbiosis-associated neurodegeneration, which of the following processes are likely to occur after an initial disruption of gut microbiota, but before the manifestation of neurological symptoms, according to the described gut-brain axis mechanisms and regulatory cascades?
Options:
A: Resolution of neuroinflammation prior to any changes in gut microbial composition.
B: Dysregulation of the kynurenine pathway resulting in the production of neurotoxic metabolites such as quinolinic acid.
C: Immediate restoration of neuronal health through direct action of dietary polyphenols on brain tissue.
D: Increased gut permeability leading to systemic inflammation via translocation of toxins and bacteria.

Q921: Considering the temporal sequence of events in Alzheimer's disease as described in the context, which of the following processes occur after gut microbiota dysbiosis and contribute to the progression of neuroinflammation and disease pathology? Select all that apply.
Options:
A: Peripheral and central inflammatory responses cause initial dysbiosis of gut and oral microbiota.
B: Increased intestinal permeability allows endotoxins like LPS to enter the bloodstream, subsequently activating brain TLR4 pathways.
C: Amyloid-beta aggregation in the brain initiates changes in gut microbiota composition.
D: Microbiota-derived metabolites such as SCFAs and amyloid peptides cross the blood-brain barrier and modulate neuroinflammatory responses.

Q922: Considering the temporal sequence of events in Alzheimer's disease (AD) mouse models, which of the following changes are observed prior to or during the progression from 6 to 12 months of age, and are associated with both gut microbiota dysbiosis and neuroinflammation? Select all that apply.
Options:
A: A stable Firmicutes/Bacteroidetes (F/B) ratio in AD mice at 12 months, suggesting no change in microbial composition.
B: An increase in alpha diversity of gut microbiota at 12 months, reflecting enhanced microbial richness.
C: A reduction in short-chain fatty acids (SCFAs) at both 6 and 12 months, indicating disrupted gut microbial metabolism.
D: Elevated levels of pro-inflammatory cytokines in serum, correlating with increased microglial and astrocyte activity in memory-related brain regions.

Q923: In the context of Alzheimer's disease (AD) progression in the APPPS1-21 mouse model, which of the following events occur after the administration of sodium propionate or antibiotics, and are temporally downstream of gut microbiome modulation, ultimately leading to reduced Aβ plaque accumulation? Select all that apply.
Options:
A: An initial increase in proinflammatory gene expression in astrocytes, followed by neurotrophic gene suppression.
B: A direct increase in tau protein accumulation in the brain, independent of gut-derived metabolites.
C: A decrease in peripheral Th17 (Rorγt+ CD4+) cells and IL-17 secretion, which correlates with reduced reactive astrocytosis.
D: Reduced reactive astrocytosis and Aβ plaque accumulation, phenocopying the effects of antibiotic treatment.

Q924: Considering the temporal sequence of events in the gut-brain axis as described in the context, which of the following processes would be expected to occur after the presence of bacterial amyloid in the gut but before the development of endogenous neuronal amyloid within the CNS in Alzheimer's disease? Select all that apply.
Options:
A: Increased immune feedbacks triggered by gut-derived signals
B: Neuroimaging-based visualization of AD biomarkers
C: Early clinical research on probiotics affecting brain function in AD
D: Activation of the immune system in response to bacterial amyloid in the gut

Q925: Following an ischemic stroke, microglia undergo a sequence of activation and polarization events that influence both neuroinflammation and tissue repair. Considering the temporal progression of these processes, which of the following events or interventions are likely to occur after the initial activation of microglia and contribute to the later phases of tissue repair or therapeutic modulation, according to the described regulatory cascades and intervention strategies?
Options:
A: Initial activation of Toll-like receptor 4/nuclear factor kappa B pathway prior to microglial activation.
B: Microglial polarization towards the anti-inflammatory (M2) phenotype, promoting tissue regeneration.
C: Application of small molecule inhibitors or traditional Chinese medicines targeting key signaling pathways to promote M2 polarization.
D: Immediate disruption of the blood-brain barrier by pro-inflammatory microglia before any cytokine release.

Q926: Considering the temporal sequence of events in OVA-induced food allergy mice, which of the following processes are observed to occur after the induction of food allergy and are associated with subsequent neurobehavioral changes, according to the described multi-omics analysis and behavioral assessments?
Options:
A: Direct improvement of social behavior and attention in OVA mice prior to any changes in gut microbiota or metabolite profiles.
B: Significant elevation of serum IgE and Th2 signature cytokine levels, followed by increased TNF-α, IL-1β, and IL-6 in the prefrontal cortex.
C: Disruption of amino acid metabolism correlated with altered gut microbiota abundance, which is associated with impaired neural immune homeostasis and neuronal damage.
D: Immediate restoration of normal amino acid metabolism and gut microbiota composition after OVA sensitization.

Q927: Considering the temporal sequence of events in Alzheimer's disease progression, which of the following processes occur after gut microbiota dysbiosis disrupts gut barrier integrity, but before the implementation of microbiota-targeted therapeutic interventions such as probiotics or fecal microbiota transplantation? Select all that apply.
Options:
A: Promotion of systemic inflammation and exacerbation of neuroinflammatory responses
B: Direct influence of gut microbiota-derived metabolites on microglial activation and amyloid-beta aggregation
C: Restoration of cognitive function through microbiota-targeted therapies
D: Validation of therapeutic findings through randomized controlled trials

Q928: Considering the temporal sequence of events described in the context of autism spectrum disorders (ASDs), which of the following processes are likely to occur after heavy metal exposure disrupts the balance of trace elements in the gut, but before the manifestation of gastrointestinal symptoms? Select all that apply.
Options:
A: Impaired zinc absorption leading to immune dysregulation and oxidative stress in the gut
B: Alterations in gut microbiota composition resulting in changes to the gut-brain axis
C: Development of gastrointestinal symptoms such as inflammation
D: Initial environmental or dietary intake of heavy metals

Q929: Considering the temporal sequence of events following spinal cord injury (SCI), which of the following processes are likely to occur in the progression from acute injury to chronic complications, specifically involving the gut microbiota and neurological recovery? Select all that apply.
Options:
A: Gut microbiota remains unchanged throughout the course of SCI, regardless of nutritional alterations or interventions.
B: Dietary interventions introduced after SCI can modulate gut microbiota interactions, potentially reducing complications and promoting neurological recovery in later phases.
C: Neurological dysfunction after SCI immediately restores gut microbiota balance, leading to improved metabolic status.
D: Gut dysbiosis develops after SCI, which then exacerbates metabolic disturbances and impedes neurological recovery over time.

Q930: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes are likely to occur after the initial dysregulation of gut microbiota in neurodegenerative or neuropsychiatric diseases, and before the manifestation of behavioral or neurological symptoms? Select all that apply.
Options:
A: Direct improvement in quality of life through behavioral therapies without changes in microbiota or metabolites.
B: Altered levels of microbial metabolites such as DHPS, acetate, propionate, and butyrate, leading to metabolic disturbances.
C: Activation of inflammatory pathways and neuroinflammation, including increased proinflammatory cytokines and microglial activation.
D: Immediate restoration of dopaminergic neurons in the substantia nigra without preceding molecular changes.

Q931: Considering the temporal sequence of events in Alzheimer's disease pathogenesis, which of the following processes are likely to occur after gut microbiota dysregulation but before the manifestation of cognitive decline, according to the described hierarchical and time-dependent mechanisms involving the gut-brain axis and CNS immune cells?
Options:
A: Altered gut microbiota composition leads to changes in microbiota-derived metabolites, which then modulate microglial and CNS-associated macrophage activity.
B: Cognitive decline occurs prior to any changes in the gut microbiota or its metabolites.
C: Neuroprotective biomarkers are detected in body fluids before any gut microbiota changes are observed.
D: Microbiota-induced epigenetic alterations contribute to neuroinflammation and protein misfolding before the appearance of clinical symptoms.

Q932: Considering the temporal sequence of events in the progression of autoimmune diseases such as type 1 diabetes (T1D), which of the following processes are described as occurring before the establishment of chronic inflammation and immune dysfunction, according to the Endocannabinoidome-Microbiota (ECBoM) model? Select all that apply.
Options:
A: Implementation of ECS-targeted treatments
B: Development of chronic inflammation and immune dysfunction
C: Depletion of short-chain fatty acids (SCFAs) in the gut
D: Increased intestinal permeability

Q933: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after the production of short-chain fatty acids (SCFAs) by beneficial gut bacteria, but before the manifestation of changes in brain structure or function? Select all that apply.
Options:
A: Initial colonization of the gut by beneficial bacteria such as Akkermansia muciniphila
B: Modification of the blood-brain barrier (BBB) structure and permeability by SCFAs
C: Manifestation of neuroplasticity-related changes in brain structure
D: Influence of SCFAs on microglia, neuronal, and astrocyte function

Q934: Considering the temporal sequence of events following gut microbiota dysbiosis, which of the following processes are likely to occur before the manifestation of cognitive impairment, according to the described gut-brain axis and related molecular cascades? Select all that apply.
Options:
A: Manifestation of cognitive impairment as the initial event in the cascade.
B: Direct improvement of cognitive function through modulation of gut flora without preceding molecular changes.
C: Altered production of microbial metabolites that interact with the intestinal epithelium, triggering neuroinflammation.
D: Activation of neuroinflammatory and neurodegenerative pathways in the central nervous system as a result of microbial toxins and metabolites.

Q935: Based on the described temporal sequence of events in neurodegenerative diseases, which of the following processes are likely to occur after gut dysbiosis disrupts the intestinal barrier but before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Immediate restoration of intestinal barrier function by beneficial gut bacteria.
B: Ingress of pathobionts and toxic metabolites into the systemic circulation, leading to gut-brain axis dysregulation.
C: Chronic neuroinflammation via dysregulated immune activation.
D: Formation of amyloid β plaques and neurofibrillary tangles in the brain.

Q936: Considering the temporal sequence of events in Alzheimer's disease (AD) pathogenesis, which of the following processes occur after age-associated changes in the gut microbiota but before the onset of irreversible neuronal loss and cognitive decline? Select all that apply.
Options:
A: Altered expression of AD risk genes in microglia and CAMs influenced by environmental factors like the host microbiota
B: Progressive and irreversible neuronal loss leading to cognitive decline
C: Restoration of gut health through interventions such as fecal microbiota transplantation (FMT)
D: Activation of microglia and CNS-associated macrophages in response to amyloid-β accumulation

Q937: Based on the described temporal sequence of events in morphine self-administration studies, which of the following statements accurately reflects the order or timing of changes observed in the gut-brain axis, particularly regarding gut microbiota diversity and brain MRI alterations? Select all that apply.
Options:
A: Early changes in gut microbiota diversity are detected during the acute phase, preceding the main MRI-detected alterations in the striatum and thalamus.
B: MRI and gut microbiota changes always occur simultaneously, with no evidence of one preceding the other.
C: Gut microbiota changes observed in the acute phase persist into the chronic phase of morphine self-administration.
D: Alterations in brain MRI diffusivity indices in the striatum and thalamus occur before any detectable changes in gut microbiota diversity.

Q938: Based on the described molecular and cellular events, which of the following processes occur after an increase in gut microbiota-derived trimethylamine N-oxide (TMAO) levels and contribute to the progression of neurodegenerative diseases such as Alzheimer's and Parkinson's? Select all that apply.
Options:
A: Activation of pro-inflammatory pathways such as NF-kB signaling, leading to exacerbated neuroinflammation.
B: Immediate restoration of neuronal integrity through stem cell replacement.
C: Direct correction of harmful genetic variants by CRISPR prior to any protein misfolding.
D: Promotion of amyloid and tau protein aggregation following TMAO crossing the blood-brain barrier.

Q939: Considering the temporal sequence of events in the gut-brain axis, which of the following processes can occur after dietary components alter the gut microbiota, ultimately influencing central nervous system (CNS) functions and depressive outcomes? Select all that apply.
Options:
A: Dietary components directly alter CNS neurotransmitter levels without any involvement of the gut microbiota or its metabolites.
B: Altered gut microbiota composition immediately results in changes to CNS structure without involvement of microbial metabolites.
C: Microbial metabolites produced after dietary changes influence inflammatory responses, which subsequently affect the onset and course of depression.
D: Dietary-induced changes in the gut microbiota modulate the production of microbial metabolites, which then impact neuroplasticity and neurotransmitter levels in the CNS.

Q940: Considering the temporal sequence of events following ischaemic stroke, which of the following processes occur after the initial reduction in cerebral blood flow and contribute to the progression of neuronal injury? Select all that apply.
Options:
A: Excessive production of reactive oxygen and nitrogen species (RONS), leading to activation of inflammatory pathways mediated by NF-κB.
B: Immediate restoration of blood-brain barrier integrity, preventing further neuronal damage.
C: Activation of a pro-inflammatory milieu that intensifies neuronal damage and exacerbates reperfusion-induced injury.
D: Rapid normalization of mitochondrial function, halting excitotoxicity.

Q941: Considering the temporal sequence of events in the gut-brain axis as described in the context, which of the following processes would most likely occur after gut microbiota dysbiosis but before the manifestation of cognitive impairment in neurodegenerative disease models? Select all that apply.
Options:
A: Production of microbial toxins and metabolites that interact with the intestinal epithelium, triggering neuroinflammation.
B: Elevation of pro-inflammatory cytokines (such as IL-6 and TNF-α) in both gut and brain tissues.
C: Restoration of cognitive function through fecal microbiota transplantation from healthy donors.
D: Implementation of dietary and exercise interventions to prevent cognitive dysfunction.

Q942: Considering the temporal sequence of events described in the context, which of the following processes occur after an alteration in gut microbiota composition and subsequently contribute to the progression of obesity or metabolic diseases? Select all that apply.
Options:
A: Immediate improvement in cognitive function prior to any metabolic changes.
B: Development of insulin resistance and adipose tissue accumulation as a result of changes in gut microbiota.
C: Genetic mutations in the host occurring before any changes in gut microbiota.
D: Production of microbial metabolites, such as short-chain fatty acids, that mediate metabolic disorders following gut microbiota alteration.

Q943: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut microbiota dysbiosis but before the onset of overt neurodegeneration in chronic neurodegenerative disorders? Select all that apply.
Options:
A: Disruption of intestinal barrier permeability, aggravation of systemic pro-inflammatory state, and impairment of blood-brain barrier permeability.
B: Increased endotoxin production and reduction of beneficial metabolites, leading to immune cell activation and enteric neuronal dysfunction.
C: Formation of amyloid β (Aβ) plaques and neurofibrillary tangles in the brain.
D: Clinical manifestation of dementia and significant synaptic loss.

Q944: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbiota composition but before the manifestation of neuropsychiatric symptoms such as cognitive impairment or PTSD-like behaviors? Select all that apply.
Options:
A: Onset of neurodegenerative disease symptoms prior to any changes in the gut microbiome or its metabolites.
B: Changes in the production of microbial metabolites, such as short-chain fatty acids, that influence immune cell activity and epigenetic mechanisms.
C: Modulation of inflammatory markers, such as IL-6 and TNF-α, through the action of specific microbial strains like Lactobacillus.
D: Immediate improvement in cognitive function without any intermediate molecular or cellular changes.

Q945: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an alteration in gut microbiota composition but before the manifestation of neurological symptoms such as depression or anxiety? Select all that apply.
Options:
A: Direct improvement of cognitive function through synbiotic supplementation without intermediary steps
B: Modulation of chemokine and cytokine levels by the immune system, impacting neuronal health
C: Manifestation of clinical symptoms such as anxiety or depression prior to any changes in the central nervous system
D: Activation of the hypothalamic-pituitary-adrenal (HPA) axis as part of the bidirectional communication between the gut and brain

Q946: Considering the temporal sequence of events in the pathogenesis of metabolic dysfunction-associated steatotic liver disease (MASLD) and osteoporosis (OP), which of the following processes are likely to occur after dysregulation of gut microbiota but before the acceleration of both diseases’ progression, according to the described mechanisms in the context?
Options:
A: Immediate reversal of hepatic fat accumulation and bone metabolism disorders
B: Altered production of short-chain fatty acids affecting hepatic and bone metabolism
C: Impairment of intestinal barrier function leading to increased systemic chronic inflammation
D: Resolution of estrogen deficiency as a primary event

Q947: Considering the temporal sequence of events described in the context of alcohol use disorder (AUD) therapy, which of the following processes are likely to occur after the enrichment of short-chain fatty acid (SCFA)-producing bacteria in responders, but before the modulation of neuroplasticity-related gene expression? Select all that apply.
Options:
A: Improvement of gut barrier integrity mediated by SCFA-producing bacteria
B: Initial psychotherapeutic intervention and oral diazepam administration
C: Microbiome-mediated modulation of neuroplasticity-related genes such as BDNF and GRIA1
D: Alteration of neurotransmitter synthesis linked to SCFA-producing bacteria

Q948: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after an increase in gut-derived short-chain fatty acids (SCFAs) but before the reduction of neuroinflammation in neurodegenerative diseases? Select all that apply.
Options:
A: Chronic systemic inflammation leads to synaptic dysfunction and cognitive decline.
B: Therapeutic interventions such as prebiotics and probiotics are administered to restore microbial balance.
C: SCFAs decrease the secretion of inflammatory cytokines such as IL-1β and TNF-α by immune-stimulated microglia-like cells.
D: SCFAs cross the blood-brain barrier and interact with microglia, modulating their immune functions.

Q949: Based on the described longitudinal study of morphine self-administration in rodents, which of the following statements accurately reflect the temporal sequence and hierarchical relationship between gut microbiota changes and brain structural alterations? Select all that apply.
Options:
A: Alterations in the striatum and thalamus on MRI occur before any measurable changes in gut microbiota diversity.
B: MRI scanning and faecal matter collection are performed only at the chronic phase, after 14 days of morphine self-administration.
C: Early changes in gut microbiota diversity and abundance are observed during the acute phase, preceding detectable alterations in brain MRI indices.
D: Gut microbiota changes persist from the acute phase into the chronic phase, while brain MRI changes are identified in both within-subject and between-group analyses.

Q950: Considering the temporal sequence of molecular and cellular events described in the context of mild chronic colitis exacerbating Parkinson's disease pathology, which of the following events are likely to occur after the initial upregulation of LRRK2 expression in the colon and brain, but before the significant loss of dopaminergic neurons in the striatum? Select all that apply.
Options:
A: Increase in inflammatory cytokines such as IL1-β and TNF-α in the colon
B: Activation of NF-κB signaling pathway in the brain
C: Restoration of intestinal barrier integrity via increased ZO-1 and Occludin expression
D: Complete recovery of dopaminergic neurons in the substantia nigra

Q951: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after gut microbiota-derived Indoles upregulate aryl hydrocarbon receptor (AhR) production, but before the restoration of synaptic plasticity in APP/PS1 mice? Select all that apply.
Options:
A: Reduction in the release of inflammatory cytokines such as TNF-α, IL-6, IL-1β, and IL-18
B: Promotion of cognitive and behavioral abilities in APP/PS1 mice
C: Inhibition of the NF-κB signaling pathway and suppression of NLRP3 inflammasome formation
D: Accumulation of Aβ and Tau hyperphosphorylation

Q952: Considering the temporal sequence of events in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) as described in the context, which of the following processes are likely to occur before the development of chronic liver injury, and are directly influenced by early gut-brain axis dysregulation?
Options:
A: Alterations in gut microbiota composition leading to increased intestinal permeability
B: Establishment of stable and healthy intestinal microbiota through fecal microbiota transplantation after chronic liver injury
C: Therapeutic intervention with vagus nerve stimulation to mitigate NAFLD progression
D: Neuroinflammation and imbalances in the autonomic nervous system contributing to metabolic dysfunction

Q953: Considering the temporal sequence of events in the development and progression of pulmonary arterial hypertension (PAH), which of the following processes are described as occurring before or during the progression of PAH, and are influenced by the gut microbiome according to the context provided?
Options:
A: Right ventricular failure occurs prior to the onset of vascular and systemic inflammation in PAH.
B: Gut dysbiosis is suggested to occur before or during the progression of PAH, potentially impacting right ventricular function.
C: Alterations in the gut microbiome may initiate or facilitate the progression of PAH by modifying systemic immune responses.
D: Adjunctive therapies are implemented before any evidence of gut microbiome involvement in PAH.

Q954: Considering the temporal sequence of events in gut microbiota-driven neuroinflammation in Alzheimer's disease, which of the following processes are likely to occur after gut dysbiosis disrupts gut barrier integrity but before the acceleration of Alzheimer's disease progression? Select all that apply.
Options:
A: Restoration of cognitive function through microbiota-targeted interventions
B: Exacerbation of neuroinflammatory responses in the brain
C: Promotion of systemic inflammation due to compromised gut barrier
D: Initial formation of amyloid-beta plaques independent of gut microbiota changes

Q955: Considering the temporal sequence of events in neurodegenerative diseases, which of the following processes are described as occurring prior to or during the early phases of disease progression, and are subsequently linked to downstream neuroinflammatory or neurodegenerative outcomes according to the context provided?
Options:
A: Aggregation of disease-specific proteins (such as tau, beta-amyloid, or alpha-synuclein) triggering activation of microglia and astrocytes, resulting in neuroinflammatory responses.
B: Dysbiosis of gut microbiota leading to altered neurotransmitter production and gut barrier integrity, which then influences neuroinflammation and cognitive or motor deficits.
C: The late-stage restoration of microbial diversity through fecal microbiota transplantation after irreversible neuronal loss has already occurred.
D: The exclusive involvement of peripheral immune cells only after all central nervous system damage is complete.

Q956: Considering the temporal sequence of events in the pathogenesis of neurodegenerative diseases as described in the context, which of the following events are likely to occur before the accumulation of neurotoxic misfolded proteins in the central nervous system? Select all that apply.
Options:
A: Therapeutic intervention with prebiotics or probiotics to restore microbial balance and enhance neuroprotective metabolite production.
B: Disruption of the intestinal barrier due to gut dysbiosis, allowing ingress of pathobionts and toxic metabolites into systemic circulation.
C: Chronic neuroinflammation via dysregulated immune activation triggered by gut-brain axis dysregulation.
D: Neuronal death resulting from the accumulation of neurotoxic misfolded proteins.

Q957: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes are likely to occur after the administration of plant-based dietary compounds in the treatment of inflammatory bowel disease (IBD), and before the improvement of barrier function and reduction of oxidative stress?
Options:
A: Increase in anti-inflammatory cytokines and decrease in pro-inflammatory cytokines
B: Regulation of signaling pathways such as TGF-β/Smad and TLR4/NF-κB/MAPK
C: Direct formation of short-chain fatty acids without involvement of gut microbiota
D: Immediate restoration of normal gut microbiota composition without intermediate steps

Q958: Considering the temporal sequence of events in the gut microbiota-brain axis following ischemic stroke, which of the following processes are likely to occur after disturbances in gut microbiota composition, and before the restoration of microbiota-gut-brain axis functions through modulation of tryptophan metabolite levels?
Options:
A: Immediate restoration of normal cerebrovascular function without intervention.
B: Regulation of neuronal excitotoxicity by tryptophan metabolites acting as aryl hydrocarbon receptor agonists.
C: Altered tryptophan metabolism leading to changes in bioactive molecule production that regulate neurological functions.
D: Direct modulation of gene transcription in the brain prior to any changes in gut microbiota or metabolite levels.

Q959: Considering the temporal sequence of events in the progression of neurodegenerative diseases, which of the following processes are likely to occur after an initial dysbiosis of the gut microbiota but before the manifestation of cognitive decline, according to the described gut-brain axis mechanisms and metabolite alterations?
Options:
A: Activation of neuroinflammatory pathways and microglial activation in the central nervous system as a result of dysbiosis.
B: Immediate restoration of cognitive function through synbiotic supplementation without any intermediate molecular changes.
C: Altered production of microbial metabolites such as short-chain fatty acids and amino acids that influence neuroinflammation.
D: Direct onset of motor symptoms in Parkinson’s disease without preceding metabolic or inflammatory changes.

Q960: Considering the temporal sequence of events in the early-life gut microbiome, which of the following statements accurately reflects the progression from birth to later health outcomes, and the hierarchical impact of environmental factors on microbiota composition and subsequent disease risk?
Options:
A: Once the gut microbiome reaches maturity, its composition is fixed and cannot be influenced by environmental factors or interventions.
B: Gut microbiota colonization begins at birth and gradually matures over the first three years, during which environmental factors can transiently reprogram the microbiome, influencing both short- and long-term health outcomes.
C: The mature and stable gut microbiome is established before birth, making early-life environmental factors irrelevant to later disease risk.
D: Manipulation of the early-life intestinal microbiota during its dynamic phase can alter immunological and metabolic responses, thereby affecting health conditions that may extend into adulthood.

Q961: Considering the temporal sequence of events in the gut-brain axis, which of the following processes would most likely occur after dietary intervention alters gut microbiota composition, but before observable changes in cognitive function or neuroinflammation in neurodegenerative diseases? Select all that apply.
Options:
A: Immediate improvement in cognitive function
B: Modulation of gut permeability and production of short-chain fatty acids
C: Long-term reversal of neurodegeneration
D: Changes in the synthesis and secretion of microbial-derived neurotrophic factors and neurotransmitters

Q962: Considering the temporal sequence of events described in the context of Buyang Huanwu Decoction (BYHWD) treatment in Alzheimer's disease mouse models, which of the following processes occur after the restoration of gut microbiota balance and suppression of the C/EBPβ/AEP pathway, and contribute to the subsequent improvement in cognitive function and neuropathology?
Options:
A: Increased release of pro-inflammatory cytokines
B: Reduction of pathological Aβ plaque deposition
C: Diminished tau hyperphosphorylation
D: Initial activation of the C/EBPβ/AEP signaling pathway in the hippocampus

Q963: In the context of mild chronic colitis exacerbating intracerebral inflammation in mice with Parkinson's disease, which of the following events occur sequentially after the induction of colitis and are temporally linked through LRRK2-mediated regulation, ultimately leading to increased brain inflammation? Select all that apply.
Options:
A: Activation of NF-κB and inhibition of Nrf2 in the brain follow the upregulation of LRRK2 expression, contributing to increased neuroinflammation.
B: Reduction in intestinal barrier proteins ZO-1 and Occludin occurs after the increase in inflammatory cytokines in the colon.
C: Upregulation of LRRK2 expression in both the colon and brain precedes the activation of NF-κB and inhibition of Nrf2 in the brain.
D: Dopaminergic neuron loss in the brain occurs before the upregulation of LRRK2 expression in the colon.

Q964: Considering the temporal sequence of events following bariatric surgery, which of the following changes are likely to occur in the early post-surgical phase and subsequently contribute to long-term metabolic health improvements through hierarchical biological pathways involving gut microbiota, hormone regulation, and brain function?
Options:
A: A late-stage reduction in appetite-regulating hormones such as GLP-1 and PYY, leading to increased hunger and caloric intake.
B: Early modulation of appetite-regulating hormones, including reduced ghrelin and increased GLP-1 and PYY, resulting in enhanced satiety and decreased caloric intake.
C: An initial increase in beneficial gut microbiota species such as Akkermansia muciniphila, which influences metabolic pathways via short-chain fatty acid production and bile acid metabolism.
D: Immediate reversal of all neuroimaging-detected structural brain changes prior to any gut microbiota alterations.

Q965: Following an ischemic stroke, microglia undergo a sequence of activation and polarization events that influence both neuroinflammation and tissue repair. Considering the temporal progression of these processes, which of the following events are likely to occur after the initial activation of microglia and before the implementation of experimental therapies targeting regulatory pathways such as Toll-like receptor 4/nuclear factor kappa B or PI3K/AKT/mTOR? Select all that apply.
Options:
A: Traditional Chinese medicines are administered prior to any microglial activation or polarization.
B: Microglia transition between pro-inflammatory (M1) and anti-inflammatory (M2) phenotypes, affecting the balance between neuroinflammation and tissue repair.
C: Activated microglia release cytokines and disrupt the blood-brain barrier, contributing to neuroinflammation.
D: Single-cell RNA sequencing and spatial transcriptomics are immediately applied to modulate microglial function in the acute phase.

Q966: Based on the described experimental model of Japanese encephalitis, which of the following events occur after prophylactic administration of short-chain fatty acids (SCFAs) and subsequent JEV infection, and are temporally downstream of initial SCFA supplementation? Select all that apply.
Options:
A: Increased weight loss and higher hindlimb clasping scores in SCFA-supplemented JEV-infected mice compared to PBS-treated JEV-infected animals.
B: Delayed onset of neurological symptoms and increased survival in SCFA-supplemented JEV-infected mice compared to controls.
C: Immediate upregulation of inflammatory cytokines TNF-α, MCP-1, IL-6, and IFN-Υ following SCFA administration, prior to JEV infection.
D: Reduced glial activation and decreased caspase-3 upregulation in brain tissue collected at terminal illness in SCFA-supplemented JEV-infected mice.

Q967: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after long-term exposure to extrinsic factors such as diet or environmental chemicals, and before the manifestation of age-related diseases like neurodegenerative disorders? Select all that apply.
Options:
A: Transcriptional changes resulting from alterations in the epigenome.
B: Immediate onset of neurodegenerative disease symptoms.
C: Epigenetic changes in the host mediated by endocrine and immune pathways.
D: Restoration of cerebral glutamate-GABA balance via modulation of the glutamine pathway.

Q968: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after the administration of antioxidants or microbiota-targeted interventions in neurodegenerative or neuropsychiatric conditions, but before the manifestation of improved cognitive or behavioral outcomes? Select all that apply.
Options:
A: Reduction in reactive oxygen species (ROS) production and neuroinflammation via modulation of NF-κB, Nrf2, MAPK, and PI3K/AKT pathways.
B: Restoration of microbial homeostasis and increased production of short-chain fatty acids (SCFAs) by beneficial gut bacteria.
C: Bidirectional communication between the gut and brain leading to changes in neurotransmitter levels and immune interactions.
D: Observable improvements in cognitive decline, motor dysfunction, or depression-like behaviors in animal models or patients.

Q969: Considering the temporal sequence of events following chronic unpredictable mild stress (CUMS) in mice, which of the following processes are likely to occur before the restoration of metabolic pathway balance by Semen Cuscutae flavonoids (SCFs) treatment? Select all that apply.
Options:
A: CUMS induces disturbances in gut microbiota composition and diversity.
B: SCFs correct metabolic disturbances in feces by modulating key metabolic pathways.
C: CUMS leads to dysregulation of fecal metabolic pathways, including aldosterone synthesis and secretion.
D: SCFs increase the abundance of Firmicutes and Lactobacillus in the gut microbiota.

Q970: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after dietary modulation alters gut microbiota composition, but before improvements in mood behaviors are observed in cancer-depression comorbidity? Select all that apply.
Options:
A: Modulation of neurotransmitter homeostasis and suppression of neuroinflammation via gut-brain axis interactions
B: Immediate restoration of normal mood behaviors in cancer patients
C: Dietary component intake directly causing improvements in depressive-like behaviors without intermediary steps
D: Changes in gut microbiota-derived metabolites influencing host metabolism and immune function

Q971: Considering the temporal sequence of events in the development and prevention of colorectal cancer (CRC), which of the following steps occur after a decrease in gut microbial short-chain fatty acid (SCFA) production, and before the initiation or progression of CRC, according to the context provided?
Options:
A: Exposure to environmental carcinogens as the initial trigger
B: Modification of epigenetic mechanisms such as DNA methylation and histone modifications
C: Immediate restoration of SCFA levels through microbiota modulation
D: Altered intestinal epithelial barrier function and changes in immunity

Q972: Considering the temporal sequence of events in the gut-brain axis as described in the context, which of the following processes would most likely occur after a dietary intervention that increases beneficial gut microbiota, but before observable improvements in neurodegenerative disease symptoms? Select all that apply.
Options:
A: Enhanced production of neuroprotective microbial metabolites such as short-chain fatty acids and modulation of neuroinflammation.
B: Long-term restoration of microbial balance without any intermediate changes in immune or metabolic pathways.
C: Upregulation of neurotrophic factors and reduction of oxidative stress in the central nervous system following changes in gut microbiota composition.
D: Immediate reversal of cognitive impairment and motor deficits in all patients with neurodegenerative diseases.

Q973: Considering the temporal sequence of molecular and cellular events described in the context of Alzheimer's disease, which of the following processes occur early in the disease before the progression to chronic neuroinflammation and accelerated neuronal damage? Select all that apply.
Options:
A: Microglia identifying and clearing pathological aggregates such as β-amyloid (Aβ)
B: Prolonged or excessive activation of immune cells leading to chronic neuroinflammation
C: Progressive decline of cognitive, behavioral, and social abilities
D: Intracellular accumulation of hyperphosphorylated tau proteins forming neurofibrillary tangles

Q974: Considering the temporal sequence of molecular and cellular events described in the context, which of the following processes would most likely occur after the modulation of gut microbiota but before the manifestation of neuroprotective effects in neurodegenerative diseases? Select all that apply.
Options:
A: Detection of exosomes in peripheral fluids as non-invasive biomarkers before any gut-targeted intervention
B: Enhancement of mitochondrial function and reduction of oxidative stress as a downstream effect of altered gut microbiota
C: Upregulation of neurotrophic factors such as brain-derived neurotrophic factor following probiotic intervention
D: Initial accumulation of amyloid-β in the brain prior to any gut microbiota modulation

Q975: Considering the temporal sequence of events described in the context, which of the following processes occur after social isolation in early-stage Alzheimer's disease mice but before the restoration of gut microbiota homeostasis by oxytocin intervention? Select all that apply.
Options:
A: Restoration of gut microbiota homeostasis
B: Mitigation of behavioral deficits and pathological damage by oxytocin treatment
C: Decreased oxytocin levels and upregulated oxytocin receptor expression in the brain
D: Exacerbation of AD-related pathological features, including increased Aβ plaque deposition and aberrant microglial proliferation

Q976: Considering the temporal sequence of events in neuroinflammation and neurodegeneration, which of the following processes are likely to occur after an initial disruption of gut microbiota composition, but before the manifestation of neurodegenerative symptoms such as cognitive decline or neuronal loss, according to the described gut-brain axis and neuroimmune mechanisms?
Options:
A: Direct accumulation of α-synuclein in neurons without involvement of gut-brain interactions.
B: Modulation of systemic immunity as a result of changes in gut microbiota composition.
C: Immediate restoration of neuronal function and reversal of neurodegenerative pathology.
D: Activation of neuroinflammatory pathways in the central nervous system triggered by altered gut microbiota.

Q977: Considering the temporal sequence of molecular and cellular events described in the context of mild chronic colitis exacerbating intracerebral inflammation in Parkinson's disease (PD) mice, which of the following events are likely to occur after the upregulation of LRRK2 expression in both the colon and brain, but before the significant loss of dopaminergic neurons in the substantia nigra? Select all that apply.
Options:
A: Activation of the NF-κB pathway in the brain
B: Reduction in ZO-1 and Occludin levels in the colon
C: Significant loss of dopaminergic neurons in the substantia nigra
D: Increase in inflammatory cytokines IL1-β and TNF-α in the colon

Q978: Considering the temporal sequence of events described in the context of early social isolation (SI) in APP/PS1 mice, which of the following changes are observed as downstream consequences following a prolonged period of SI, and which may be subsequently mitigated by oxytocin (OXT) intervention? Select all that apply.
Options:
A: Upregulation of OXT receptor expression and decreased OXT levels occurring before SI is initiated.
B: Exacerbation of anxiety-like and depression-like behaviors after SI, which are reduced after OXT intervention.
C: Increased Aβ plaque deposition and aberrant microglial proliferation in the prefrontal cortex after SI, which are alleviated by subsequent OXT treatment.
D: Immediate restoration of gut microbiota homeostasis prior to any behavioral or pathological changes following SI.

Q979: Considering the temporal sequence of events described in the context of obesity, which of the following processes occur after alterations in gut microbiome composition but before the manifestation of inflammatory pathways in the liver? Select all that apply.
Options:
A: Epigenetic modifications in adipocytes leading to cellular 'memory' alterations
B: Development of severe metabolic and inflammatory disorders such as cardiovascular disease
C: Diet-induced modulation of gut microbiome structure
D: Predisposition to weight regain after caloric restriction due to cellular 'memory'

Q980: Considering the temporal sequence of events following probiotic administration in a rat model of spinal cord injury (SCI), which of the following processes are reported to occur after the initial modulation of gut microbiota composition, ultimately leading to neuroprotective and anti-inflammatory outcomes in the spinal cord tissue?
Options:
A: Activation of downstream signaling pathways in the spinal cord by tryptophan metabolites
B: Immediate upregulation of anti-inflammatory genes in the spinal cord prior to any changes in gut microbiota
C: Enrichment of key tryptophan metabolites such as serotonin and 3-Indoleacetonitrile
D: Structural restoration of spinal cord tissue occurring before any changes in gene expression

Q981: Considering the temporal sequence of events following ischemic stroke, which of the following processes occur after the initial activation of microglia, and are involved in the subsequent regulation of neuroinflammation and tissue repair? Select all that apply.
Options:
A: Transition of microglia from a pro-inflammatory (M1) to an anti-inflammatory (M2) phenotype to promote tissue repair.
B: Permanent maintenance of microglia in a single functional state throughout the post-stroke period.
C: Immediate restoration of blood-brain barrier integrity before cytokine release by activated microglia.
D: Activation of signaling pathways such as Toll-like receptor 4/nuclear factor kappa B and Janus kinase/signal transducer and activator of transcription, influencing microglial polarization.

Q982: Considering the temporal sequence of events in the gut-brain axis and neuroimmune regulation, which of the following changes are expected to occur after fecal microbiota transplantation (FMT) is administered to a subject with post-stroke neuroinflammation, and which may occur later as downstream effects on cognitive function or neurodegeneration, according to the context provided?
Options:
A: A decrease in IL-17 and IFN-γ expression as an early effect following FMT administration.
B: Suppression of neuroinflammation in post-stroke conditions occurs only after cognitive improvements are observed.
C: Immediate upregulation of synaptic markers such as PSD-95 and synapsin-1 before any changes in neuroinflammatory cytokines.
D: Lowering of amyloid-β accumulation and upregulation of synaptic markers as later effects following initial restoration of microbial composition.

Q983: Considering the temporal sequence of events described in the context of probiotic treatment for spinal cord injury (SCI), which of the following processes occur after the initial modulation of gut microbiota composition, and are directly linked to subsequent neuroprotective and anti-inflammatory outcomes in the spinal cord? Select all that apply.
Options:
A: Enrichment of tryptophan metabolites such as serotonin and 3-Indoleacetonitrile in the gut following probiotic-induced changes in microbiota.
B: Initial behavioral improvements in locomotor recovery before any modulation of gut microbiota or metabolite profiles.
C: Immediate restoration of spinal cord tissue structure prior to any changes in gut microbiota diversity.
D: Activation of downstream signaling pathways in the spinal cord by tryptophan metabolites, leading to upregulation of genes involved in anti-inflammatory and neuroregenerative processes.

Q984: Considering the temporal sequence of events within the gut-liver-brain axis, which of the following processes would most likely occur after an increase in gut permeability but before the onset of neuroinflammation and cognitive impairment? Select all that apply.
Options:
A: Manifestation of neurodevelopmental disorders such as autism spectrum disorder
B: Restoration of gut eubiosis through synbiotic supplementation
C: Activation of inflammatory pathways in response to microbial byproducts entering systemic circulation
D: Translocation of microbial byproducts such as lipopolysaccharides (LPSs) from the gut into the liver and brain

Q985: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after the initiation of a high-fat diet (HFD) and before the development of cognitive impairment in individuals at risk for Alzheimer's disease, according to the mechanistic pathways involving the gut microbiota and neuroinflammation?
Options:
A: Resolution of neuroinflammation prior to any changes in gut microbiota composition.
B: HFD-induced obesity and type-2 diabetes parallel neuroinflammation and deposition of Amyloid β (Aβ).
C: Immediate improvement in cognitive function due to increased fat intake.
D: HFD induces gut dysbiosis, leading to loss of intestinal barrier integrity and chronic low-grade inflammation.

Q986: Considering the temporal sequence of events in Alzheimer's disease mouse models receiving fecal microbiota transplantation (FMT), which of the following changes are observed after FMT from healthy wild-type donors compared to FMT from colitis-associated dysbiotic donors, and what is the order of these events in relation to neuroinflammation and cognitive function?
Options:
A: FMT from healthy donors first leads to restoration of beneficial gut taxa and anti-inflammatory metabolites, followed by reduced pro-inflammatory cytokine expression and subsequent improvement in cognitive function.
B: FMT from colitis-associated donors initially increases pathogenic gut genera and neurotoxic metabolites, which is then followed by heightened pro-inflammatory cytokine levels and later exacerbation of cognitive deficits.
C: FMT from healthy donors immediately improves cognitive function before any changes in gut microbiota composition or cytokine expression are detected.
D: FMT from colitis-associated donors first reduces Aβ plaque burden, then increases beneficial taxa, and finally normalizes cytokine levels.

Q987: Considering the temporal sequence of molecular and cellular events described in neuroinflammaging and neurodegenerative diseases, which of the following processes would most likely occur after environmental exposure induces epigenetic modifications, but before the appearance of clinical neurodegenerative symptoms? Select all that apply.
Options:
A: Up-regulation of neuroinflammatory responses in the brain due to epigenetic modulation.
B: Manifestation of motor and cognitive decline characteristic of late-stage neurodegenerative disorders.
C: Therapeutic intervention based on established clinical biomarkers for neurodegenerative disease.
D: Altered expression of microRNAs regulating neuroinflammation and neuronal death pathways.

Q988: Considering the temporal sequence of events following early social isolation (SI) in APP/PS1 mice, which of the following changes are observed before the therapeutic intervention with oxytocin (OXT), and which are subsequently mitigated after OXT administration? Select all that apply.
Options:
A: SI leads to decreased OXT levels and upregulated OXT receptor expression prior to OXT intervention.
B: SI-induced changes in gut microbiota composition occur before OXT intervention and are partially restored after OXT treatment.
C: OXT intervention precedes the onset of anxiety-like behaviors and depression-like phenotypes in SI AD mice.
D: OXT administration is followed by mitigation of AD-related pathological features, such as reduced Aβ plaque deposition and restored PSD-95 expression.

Q989: Considering the temporal sequence of events in Alzheimer's disease mouse models treated with Buyang Huanwu Decoction (BYHWD), which of the following processes are observed to occur after the restoration of gut microbiota balance, and are associated with subsequent improvements in cognitive function and neuropathological changes via the gut-brain axis?
Options:
A: Initial deposition of pathological Aβ plaques prior to any intervention
B: Reduction of tau hyperphosphorylation and inhibition of pro-inflammatory cytokine release
C: Suppression of the C/EBPβ/AEP signaling pathway in the hippocampus
D: Onset of cognitive deficits in untreated 3×Tg mice

Q990: Considering the temporal progression of neurodegenerative diseases such as Alzheimer's disease (AD), which of the following events or interventions occur sequentially or influence later stages, according to the described gut microbiota-brain axis and immune cell involvement? Select ALL that apply.
Options:
A: Administration of probiotics may modulate the gut microbiota-brain axis, potentially affecting neurodegenerative processes at later stages.
B: Amyloid-beta plaque formation in the brain is the initial event that triggers changes in the gut microbiota composition.
C: The recruitment of peripheral immune cells to the CNS occurs before any changes in the gut microbiota composition.
D: Early dysbiosis of the gut microbiota can precede and contribute to neuroinflammation in the central nervous system, influencing the onset and progression of AD.

Q991: Considering the temporal sequence of events in the gut-microbiota-brain axis, which of the following processes would most likely occur after a disruption of intestinal barrier integrity by Diquat, but before the onset of systemic chronic inflammation and progression of metabolic dysfunction-associated steatotic liver disease (MASLD) and osteoporosis (OP)? Select all that apply.
Options:
A: Development of chronic systemic inflammation accelerating MASLD and OP progression.
B: Impairment of intestinal barrier function leading to increased gut permeability.
C: Alteration of gut microbiome composition and reduction in short-chain fatty acid production.
D: Immediate restoration of gut homeostasis by short-chain fatty acid-producing bacteria.

Q992: Considering the temporal sequence of events in the pathogenesis of neurodegenerative disorders as described in the context, which of the following processes are likely to occur after gut microbial dysbiosis but before the onset of overt neurodegeneration, and are involved in the regulatory cascade leading to disease progression?
Options:
A: Increased endotoxin production and reduction of beneficial metabolites, triggering immune cell activation and enteric neuronal dysfunction.
B: Immediate restoration of healthy gut microbial composition and normalization of metabolomic profiles.
C: Disruption of intestinal barrier permeability, aggravation of systemic pro-inflammatory state, and impairment of blood-brain barrier permeability.
D: Resolution of neuroinflammation and complete clearance of misfolded proteins from the central nervous system.

Q993: Considering the temporal sequence of events in the microbiota-gut-brain axis (MGBA), which of the following processes would most likely occur after an alteration in gut microbiota composition but before the manifestation of central nervous system (CNS) disease symptoms, according to the context provided? Select all that apply.
Options:
A: Initiation of neuroimmune-mediated disorders via dysregulated MGBA, with pathological processes spreading from the gut to the brain over months or years.
B: Production of hormonal intermediates, metabolites, or toxins by the altered gut microbiota that influence host biochemical pathways.
C: Final clinical diagnosis of neurodegenerative diseases such as Alzheimer's or Parkinson's disease.
D: Immediate improvement of CNS disease symptoms through exercise and microecologics without any intermediary molecular or cellular changes.

Q994: Considering the temporal sequence of events described in the context, which of the following processes occur after the initial disruption of the intestinal barrier in obesity, and contribute to subsequent neuroinflammation and cognitive decline? Select all that apply.
Options:
A: Induction of neuroinflammation and brain damage follows increased intestinal permeability.
B: High-fat and high-sugar diets increase the number of tight junction proteins in the colon.
C: Obesity leads to immediate improvement in cognitive function due to changes in gut flora.
D: Altered composition of intestinal microorganisms allows endotoxins into the blood circulation.

Q995: During the progression of experimental autoimmune encephalomyelitis (EAE) in murine models, which of the following events are likely to occur sequentially as the disease advances, based on the temporal dynamics of the gut microbiome and its metabolic activity? Consider the order of microbiome alteration, predicted gene expression changes, and their impact on host health.
Options:
A: Alterations in gut microbiome composition precede distinct changes in predicted gene expression related to amino acid, carbohydrate, and lipid metabolism.
B: Microbiome homeostasis is established prior to the onset of EAE-induced changes in the gut microbiome.
C: Host health improves before the restoration of microbiome homeostasis during EAE progression.
D: Distinct differences in predicted gene expression of the microbiome occur after the onset of EAE and are related to metabolic pathways.

Q996: Considering the temporal sequence of events described in the context, which of the following processes would most likely occur after gut microbiota dysbiosis is established in Parkinson's disease or Alzheimer's disease, but before the manifestation of clinical neurological symptoms? Select all that apply.
Options:
A: Restoration of gut microbiota diversity and function through fecal microbiota transplantation.
B: Increased intestinal permeability and subsequent neuroinflammation mediated by the gut-brain axis.
C: Enhanced intestinal inflammation leading to abnormal α-synuclein aggregation in the brain.
D: Implementation of personalized therapeutic strategies based on age- and sex-specific gut microbiota biomarkers.

Q997: Considering the temporal sequence of events described in the context, which of the following processes are likely to occur after gut dysbiosis initiates changes in metabolite profiles, but before the development of chronic neurological or oncological symptoms? Select all that apply.
Options:
A: Production of neurotoxic metabolites that may exacerbate neuronal damage, contributing to the progression of neurodegenerative diseases such as Parkinson's disease.
B: Altered intestinal permeability and increased systemic chronic inflammation, which can accelerate the progression of metabolic and bone disorders.
C: Complete resolution of tumor development without further intervention.
D: Immediate restoration of normal neurological function through a single administration of fecal microbiota transplantation.

Q998: Considering the temporal sequence of neuroinflammatory responses in neurological disorders, which of the following events are likely to occur during the transition from the acute to the chronic phase, and how might these changes influence the progression of neurodegenerative diseases according to the context provided?
Options:
A: Neuroinflammation initially promotes neuroprotection in the acute phase, but with chronic activation, it contributes to neuronal injury and degeneration.
B: During chronic neuroinflammation, regulatory balance within neuroinflammatory networks is disrupted, facilitating disease progression.
C: Chronic neuroinflammation directly leads to immediate neuronal regeneration and recovery.
D: Acute neuroinflammation always results in irreversible neuronal loss regardless of subsequent regulatory mechanisms.

Q999: Considering the temporal sequence of events following ischemic stroke, which of the following processes occur after the initial activation of microglia, and are directly influenced by the administration of Chinese herb-derived natural compounds according to the context? Select all that apply.
Options:
A: Direct conversion of M2 microglia to M1 phenotype as the primary neuroprotective mechanism.
B: Suppression of the microglia-mediated detrimental inflammatory response, leading to attenuation of neuroinflammation.
C: Enhancement of microglial anti-inflammatory abilities, thereby accelerating neuronal recovery.
D: Immediate restoration of blood flow to the affected brain region without involvement of immune modulation.

Q1000: Following neurosurgical procedures, a sequence of events can lead to both immediate and long-term cognitive impairments. Based on the described temporal progression, which of the following events are likely to occur after the initial compromise of the blood-brain barrier (BBB) during surgery, but before the manifestation of chronic cognitive dysfunction?
Options:
A: Restoration of full cognitive function without intervention
B: Release of cytokines such as tumor necrosis factor-alpha and interleukin-1 causing neuronal damage
C: Resolution of all neuroinflammation prior to any cognitive symptoms
D: Activation of neuroinflammatory responses involving microglia and astrocytes

